Amedeo Smart

Free Medical Literature Service

 

Amedeo

COVID-19
  Free Subscription

Articles published in
Int J Infect Dis
    April 2024
  1. YU J, Zhang K, Chen T, Lin R, et al
    Temporal patterns of organ dysfunction in COVID-19 patients hospitalized in the intensive care unit: A group-based multitrajectory modelling analysis.
    Int J Infect Dis. 2024 Apr 9:107045. doi: 10.1016/j.ijid.2024.107045.
    >> Share

  2. FAVRESSE J, Gillot C, Cabo J, David C, et al
    Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1 and JN.1 six months after the BNT162b2 bivalent booster.
    Int J Infect Dis. 2024 Apr 5:107028. doi: 10.1016/j.ijid.2024.107028.
    >> Share

  3. TAMURA K, Shimbashi R, Kasamatsu A, Chang B, et al
    Unveiling the role of preceding seasonal influenza in the development of bacteremic pneumococcal pneumonia in older adults before the COVID-19 pandemic in Japan.
    Int J Infect Dis. 2024 Apr 5:107024. doi: 10.1016/j.ijid.2024.107024.
    >> Share

  4. MARKUSSEN DL, Kommedal O, Knoop ST, Ebbesen MH, et al
    Microbial aetiology of community-acquired pneumonia in hospitalized adults: a prospective study utilising comprehensive molecular testing.
    Int J Infect Dis. 2024 Apr 4:107019. doi: 10.1016/j.ijid.2024.107019.
    >> Share

  5. CORRECHER-MARTINEZ E, Lopez-Lacort M, Munoz-Quiles C, Diez-Domingo J, et al
    Risk of herpes zoster in adults with SARS-CoV-2 infection in Spain: a population-based, retrospective cohort study.
    Int J Infect Dis. 2024 Apr 2:107037. doi: 10.1016/j.ijid.2024.107037.
    >> Share

    March 2024
  6. SALVADORI N, Jourdain G, Krittayaphong R, Siripongboonsitti T, et al
    Molnupiravir versus favipiravir in at-risk outpatients with COVID-19: a randomized controlled trial in Thailand.
    Int J Infect Dis. 2024 Mar 30:107021. doi: 10.1016/j.ijid.2024.107021.
    >> Share

  7. WEIRAUCH T, Burger G, Cadar D, Gabriel M, et al
    Vaccine-derived Yellow Fever in an immunocompromised patient on anti-CD20-antibody therapy and its treatment with Sofosbuvir.
    Int J Infect Dis. 2024 Mar 21:107017. doi: 10.1016/j.ijid.2024.107017.
    >> Share

  8. CHEUNG YYH, Lau EHY, Yin G, Lin Y, et al
    Joint analysis of vaccination effectiveness and antiviral drug effectiveness for COVID-19: a causal inference approach.
    Int J Infect Dis. 2024 Mar 21:107012. doi: 10.1016/j.ijid.2024.107012.
    >> Share

  9. MINK S, Drexel H, Leiherer A, Frick M, et al
    Interplay of inflammatory markers and anti-SARS-CoV-2 antibodies in COVID-19 mortality: a prospective cohort study.
    Int J Infect Dis. 2024 Mar 21:107016. doi: 10.1016/j.ijid.2024.107016.
    >> Share

  10. HOSOZAWA M, Hori M, Hayama-Terada M, Arisa I, et al
    Prevalence and risk factors of post-coronavirus disease 2019 condition among children and adolescents in Japan: A matched case-control study in the general population.
    Int J Infect Dis. 2024 Mar 12:107008. doi: 10.1016/j.ijid.2024.107008.
    >> Share

  11. AGUILAR TICONA JP, Xiao M, Li D, Nery JN, et al
    Corrigendum to "Extensive transmission of SARS-CoV-2 BQ.1* variant in a population with high levels of hybrid immunity: A prevalence survey" [International Journal of Infectious Diseases 139 (2024) 159-167].
    Int J Infect Dis. 2024;141:106964.
    >> Share

  12. REES C, Swift B, Haldar P
    State of art of the detection of M. tuberculosis during TB infection by blood tests using the phage technology.
    Int J Infect Dis. 2024 Mar 4:106991. doi: 10.1016/j.ijid.2024.106991.
    >> Share

    February 2024
  13. BOUWMANS P, Malahe SRK, Messchendorp AL, Vart P, et al
    Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: a nested case-control study.
    Int J Infect Dis. 2024 Feb 28:106990. doi: 10.1016/j.ijid.2024.106990.
    >> Share

  14. PETRAS M, Janovska D, Lomozova D, Franklova M, et al
    Understanding the time-driven shifts of vaccine effectiveness against any and severe COVID-19 before and after the surge of Omicron variants within 2.5 years of vaccination: a meta-regression.
    Int J Infect Dis. 2024 Feb 26:106986. doi: 10.1016/j.ijid.2024.106986.
    >> Share

  15. SYLVAIN L, Donatien K, Kadidia K, Viviane C, et al
    SARS-CoV-2 seroprevalence in vaccine-naive participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali.
    Int J Infect Dis. 2024 Feb 26:106985. doi: 10.1016/j.ijid.2024.106985.
    >> Share

  16. DADU A, Yedilbayev A, Migliori GB, Ahmedov S, et al
    PASS to End TB in Europe: Accelerated efforts on Prevention and Systematic Screening to End Tuberculosis in the WHO European Region by 2030.
    Int J Infect Dis. 2024 Feb 23:S1201-9712(24)00051.
    >> Share

  17. FURST T, Bazalova A, Frycak T, Janosek J, et al
    Does the healthy vaccinee bias rule them all? Association of COVID-19 vaccination status and all cause mortality from an analysis of data from 2.2 million individual health records.
    Int J Infect Dis. 2024 Feb 22:S1201-9712(24)00046.
    >> Share

  18. HUANG L, Tong X, Cui J, Du X, et al
    Recurrent and persistent fever after SARS-CoV-2 infection in patients with follicular lymphoma: A case series.
    Int J Infect Dis. 2024;141:106973.
    >> Share

  19. IKEBE T, Okuno R, Uchitani Y, Yamaguchi T, et al
    Epidemiological shifts in and impact of COVID-19 on streptococcal toxic shock syndrome in Japan: A genotypic analysis of Group A Streptococcus isolates.
    Int J Infect Dis. 2024 Feb 19:S1201-9712(24)00022.
    >> Share

  20. BERENTSCHOT JC, Martine Bek L, Heijenbrok-Kal MH, van den Berg-Emons RJG, et al
    Acute COVID-19 treatment is not associated with health problems 2 years after hospitalization.
    Int J Infect Dis. 2024 Feb 15:S1201-9712(24)00036.
    >> Share

  21. BIANCHI FP, Rizzi D, Daleno A, Stefanizzi P, et al
    Assessing the temporal and cause-effect relationship between myocarditis and mRNA COVID-19 vaccines. A retrospective observational study.
    Int J Infect Dis. 2024 Feb 14:S1201-9712(24)00028.
    >> Share

  22. TANG Q, Xie X, Peng L, Yang L, et al
    Pre-existing Renal Graft Dysfunction As A Major Risk Factor for SARS-CoV-2 Omicron Variant Pneumonia: a Post-Infection Cross-Sectional Study of 312 Immunosuppressed Renal Transplant Recipients.
    Int J Infect Dis. 2024 Feb 13:S1201-9712(24)00030.
    >> Share

  23. DOHERTY TM, Pasquale AD, Finnegan G, Lele J, et al
    Sustaining the momentum for adult vaccination post-COVID-19 to leverage the global uptake of life-course immunisation: a scoping review.
    Int J Infect Dis. 2024 Feb 12:S1201-9712(24)00031.
    >> Share

  24. FUENTE A, Postigo T, Ferri FS, Dominguez-Gil M, et al
    Synergistic impact of N-antigenemia profiled by a rapid antigen test and low anti-S1 antibodies on the risk of hospitalization in COVID-19.
    Int J Infect Dis. 2024 Feb 2:S1201-9712(24)00019.
    >> Share

  25. XIA Q, Yang Y, Wang F, Huang Z, et al
    Case fatality rates of COVID-19 during epidemic periods of variants of concern: a meta-analysis by continents.
    Int J Infect Dis. 2024 Feb 1:S1201-9712(24)00018.
    >> Share

    January 2024
  26. VOORDEN AJV, Groot CJM, Ris-Stalpers C, Afink GB, et al
    COVID-19 mRNA vaccination during pregnancy does not harm syncytiotrophoblast development.
    Int J Infect Dis. 2024 Jan 25:S1201-9712(24)00015.
    >> Share

    December 2023
  27. PUGNI L, Crippa BL, Raimondi F, Vento G, et al
    SARS-CoV-2 perinatal transmission and neonatal outcomes across four different waves of COVID-19 pandemic: a nationwide prospective cohort study from the Italian Society of Neonatology.
    Int J Infect Dis. 2023 Dec 27:S1201-9712(23)00814.
    >> Share

  28. BOWN A, Sweed A, Catton M, Cowne JN, et al
    Detection of SARS-CoV-2 BA.2.86 by lateral flow devices.
    Int J Infect Dis. 2023 Dec 25:S1201-9712(23)00813.
    >> Share

  29. SALMON D, Slama D, Linard F, Dumesges N, et al
    Long COVID patients continue to experience significant symptoms at 12 months and factors associated with improvement: a prospective cohort study in France (PERSICOR).
    Int J Infect Dis. 2023 Dec 21:S1201-9712(23)00798.
    >> Share

  30. SILI U MD, PHD, Tekin A MD, Bilgin H MD, MPH, Khan SA MD, et al
    Early empiric antibiotic use in COVID-19 patients: results from the international VIRUS registry.
    Int J Infect Dis. 2023 Dec 19:S1201-9712(23)00810.
    >> Share

  31. MICHAEL F, Mirambo MM, Misinzo G, Minzi O, et al
    Trends of measles in Tanzania: a five-year review of case-based surveillance data, 2018-2022.
    Int J Infect Dis. 2023 Dec 18:S1201-9712(23)00809.
    >> Share

  32. TICONA JPA, Xiao M, Li D, Nery N Jr, et al
    Extensive transmission of SARS-CoV-2 BQ.1* variant in a population with high levels of hybrid immunity: A prevalence survey.
    Int J Infect Dis. 2023 Dec 7:S1201-9712(23)00801.
    >> Share

  33. JUNYONG M, Wang Y, Liu J, Wu Y, et al
    Impact of perioperative SARS-CoV-2 Omicron infection on postoperative complications in liver cancer hepatectomy: A single-center matched study.
    Int J Infect Dis. 2023 Dec 6:S1201-9712(23)00803.
    >> Share

  34. SANTOS CAD, Paula AP, Filho GGF, Alves MM, et al
    Developmental impairment in children exposed during pregnancy to maternal SARS-COV2: A Brazilian cohort study.
    Int J Infect Dis. 2023 Dec 5:S1201-9712(23)00802.
    >> Share

  35. FINSTERER J, Scorza FA
    The frequency of SARS-CoV-2 infection/vaccination-related chorea depends on the inclusion/exclusion criteria.
    Int J Infect Dis. 2023;137:161.
    >> Share

  36. ROSCA EC, Bilavu R, Cornea A, Simu M, et al
    The frequency of SARS-CoV-2 infection/vaccination-related chorea depends on the inclusion/exclusion criteria - author's reply.
    Int J Infect Dis. 2023;137:159-160.
    >> Share

  37. BANDA L, Ho A, Kasenda S, Read JM, et al
    Characterizing the evolving SARS-CoV-2 seroprevalence in urban and rural Malawi between February 2021 and April 2022: A population-based cohort study.
    Int J Infect Dis. 2023;137:118-125.
    >> Share

    November 2023
  38. FLORES-GONZALEZ J, Chavez-Galan L, Falfan-Valencia R, Roldan IB, et al
    Variant rs4986790 of TLR4 affects the signaling and induces cell dysfunction in severe COVID-19 patients.
    Int J Infect Dis. 2023 Nov 27:S1201-9712(23)00793.
    >> Share

  39. YOSHIMURA M, Sakamoto A, Ozuru R, Kurihara Y, et al
    The appearance of anti-spike RBD IgG4 responses after repetitive immunization with mRNA-based COVID-19 vaccines.
    Int J Infect Dis. 2023 Nov 27:S1201-9712(23)00789.
    >> Share

  40. MOSTAGHIM A, Minkove S, Aguilar-Company J, Ruiz-Camps I, et al
    Prior immune checkpoint inhibitor (ICI) therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry.
    Int J Infect Dis. 2023 Nov 27:S1201-9712(23)00782.
    >> Share

  41. TANDLER C, Heitmann JS, Michel TM, Marconato M, et al
    Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults.
    Int J Infect Dis. 2023 Nov 26:S1201-9712(23)00770.
    >> Share

  42. YANG X, Zhang J, Liu Z, Chen S, et al
    COVID-19 breakthrough infections among people with and without HIV: a statewide cohort analysis.
    Int J Infect Dis. 2023 Nov 25:S1201-9712(23)00790.
    >> Share

  43. HARRIES M, Jaeger VK, Rodiah I, Hassenstein MJ, et al
    Bridging the gap - estimation of 2022/2023 SARS-CoV-2 healthcare burden in Germany based on multidimensional data from a rapid epidemic panel.
    Int J Infect Dis. 2023 Nov 24:S1201-9712(23)00776.
    >> Share

  44. NAVARATNAM AM, O'Callaghan C, Beale S, Nguyen V, et al
    Eyeglasses and risk of COVID-19 transmission - analysis of the Virus Watch Community Cohort study.
    Int J Infect Dis. 2023 Nov 24:S1201-9712(23)00759.
    >> Share

  45. NGUYEN TTN, Choo EM, Nakamura Y, Suzuki R, et al
    Pre-existing cross-reactive neutralizing activity against SARS-CoV-2 and seasonal coronaviruses prior to the COVID-19 pandemic (2014-2019) with limited immunity against recent emerging SARS-CoV-2 variants, Vietnam.
    Int J Infect Dis. 2023 Nov 18:S1201-9712(23)00769.
    >> Share

  46. LI Y, Wu Z, Yan Y, Shi Y, et al
    Prevalence of respiratory viruses among hospitalized children with lower respiratory tract infections during the COVID-19 pandemic in Wuhan, China.
    Int J Infect Dis. 2023 Nov 18:S1201-9712(23)00780.
    >> Share

  47. BELLERBA F, Bardeck N, Boehm M, D'Ecclesiis O, et al
    SARS-CoV-2 trends in Italy, Germany and Portugal and school opening during the period of Omicron variant dominance: a quasi-experimental study.
    Int J Infect Dis. 2023 Nov 11:S1201-9712(23)00763.
    >> Share

  48. CHOGA WT, Kurusa Gasenna GK, San JE, Ookame T, et al
    Rapid dynamic changes of FL.2 variant: a case report of COVID-19 breakthrough infection.
    Int J Infect Dis. 2023 Nov 10:S1201-9712(23)00772.
    >> Share

  49. DALLMEYER LK, Schuz ML, Fragkou PC, Omony J, et al
    Epidemiology of respiratory viruses among children during the SARS-CoV-2 pandemic: A systematic review and meta-analysis.
    Int J Infect Dis. 2023 Nov 9:S1201-9712(23)00761.
    >> Share

  50. LOVELL JF, Miura K, Baik YO, Lee C, et al
    One-year Antibody Durability Induced by EuCorVac-19, a Liposome-Displayed COVID-19 RBD Subunit Vaccine, in Healthy Korean Subjects.
    Int J Infect Dis. 2023 Nov 7:S1201-9712(23)00765.
    >> Share

  51. LEE IT, Lin PJ, Yen HH
    Pediatric Neuroimaging Findings and Clinical Presentations of COVID-19: A Systematic Review.
    Int J Infect Dis. 2023 Nov 7:S1201-9712(23)00767.
    >> Share

    October 2023
  52. AGERGAARD J, Gunst JD, Schiottz-Christensen B, Ostergaard L, et al
    Long-term Prognosis at 1.5 years after Infection with Wild-type strain of SARS-CoV-2 and Alpha, Delta, as well as Omicron Variants.
    Int J Infect Dis. 2023 Oct 29:S1201-9712(23)00760.
    >> Share

  53. ROSSI G, Salmanton-Garcia J, Cattaneo C, Marchesi F, et al
    Age, Successive Waves, Immunization, and Mortality in Elderly COVID-19 Haematological Patients: EPICOVIDEHA Findings.
    Int J Infect Dis. 2023 Oct 18:S1201-9712(23)00749.
    >> Share

  54. RAVLO E, Ianevski A, Starheim E, Wang W, et al
    Boosted production of antibodies which neutralized different SARS-CoV-2 variants in a COVID-19 convalescent following mRNA vaccination - a case study.
    Int J Infect Dis. 2023 Oct 16:S1201-9712(23)00748.
    >> Share

  55. SHARMA A, Gupta B, Petersen E, Lee SS, et al
    Enhancing preparedness for reducing transmission and globalisation of Antimicrobial Resistance at the Ardh Kumbh Mela 2025, the world's largest recurring religious mass gathering.
    Int J Infect Dis. 2023 Oct 16:S1201-9712(23)00751.
    >> Share

  56. BERG J, Thies-Lagergren L, Svedenkrans J, Samkutty J, et al
    Umbilical cord clamping in the early phases of the COVID-19 era - A systematic review and meta-analysis of reported practice and recommendations in guidelines.
    Int J Infect Dis. 2023 Oct 13:S1201-9712(23)00747.
    >> Share

  57. XU Y, Chen H, Wang B, Zhu X, et al
    Immunogenicity and safety of concomitant administration of the sabin-strain-based inactivated poliovirus vaccine, the diphtheria-tetanus-acellular pertussis vaccine and measles-mumps-rubella vaccine to healthy infants aged 18 months in China.
    Int J Infect Dis. 2023 Oct 11:S1201-9712(23)00743.
    >> Share

  58. HEJAZI NS, Shen X, Carpp LN, Benkeser D, et al
    Stochastic Interventional Approach to Assessing Immune Correlates of Protection: Application to the COVE mRNA-1273 Vaccine Trial.
    Int J Infect Dis. 2023 Oct 9:S1201-9712(23)00727.
    >> Share

  59. SCHUZ ML, Dallmeyer L, Fragkou PC, Omony J, et al
    Global prevalence of respiratory virus infections in adults and adolescents during the COVID-19 pandemic: A systematic review and meta-analysis.
    Int J Infect Dis. 2023 Oct 6:S1201-9712(23)00738.
    >> Share

  60. INABA M, Miyake Y, Yasuda K
    Secondary household transmission of SARS-CoV-2: A case-control study on factors associated with reduced transmission risk.
    Int J Infect Dis. 2023 Oct 1:S1201-9712(23)00733.
    >> Share

  61. GONCALVES YMP, de Assuncao TSF, de Sousa MAD, Ferreira LM Junior, et al
    Progressive multifocal leukoencephalopathy triggered by COVID-19 in a previously asymptomatic person living with undiagnosed HIV infection.
    Int J Infect Dis. 2023 Oct 1:S1201-9712(23)00730.
    >> Share

    September 2023
  62. FOCOSI D, Maggi F, D'Abramo A, Nicastri E, et al
    Antiviral combination therapies for persistent COVID-19 in immunocompromised patients.
    Int J Infect Dis. 2023 Sep 29:S1201-9712(23)00734.
    >> Share

  63. LAI MY, Bukhari FDM, Zulkefli NZ, Ismail I, et al
    Corrigendum to "Colorimetric detection of SARS-CoV-2 by uracil-DNA glycosylase (UDG) reverse transcription loop-mediated isothermal amplification (RT-LAMP)" [International Journal of Infectious Diseases 120 (2023) Pages 132-134].
    Int J Infect Dis. 2023;136:91.
    >> Share

  64. WONG HM, Mun CH, Loke WK, Lim WQ, et al
    Moist heat as a promising method to decontaminate N95 masks - a large scale clinical study comparing four decontamination modalities: moist heat, steam, ultraviolet-C irradiation and hydrogen peroxide plasma.
    Int J Infect Dis. 2023 Sep 25:S1201-9712(23)00729.
    >> Share

  65. CASTRO-RODRIGUEZ B, Morales-Jadan D, Viteri-Davila C, Rodriguez AS, et al
    "The fake positive results of COVID-19 rapid antigen tests with the use of beverages vary between brands of test kits".
    Int J Infect Dis. 2023 Sep 22:S1201-9712(23)00718.
    >> Share

  66. GIACOMELLI A, Gagliardini R, Tavelli A, De Benedittis S, et al
    Risk of COVID-19 in-hospital mortality in people living with HIV compared to general population according to age and CD4 strata: data from the Icona network.
    Int J Infect Dis. 2023 Sep 21:S1201-9712(23)00728.
    >> Share

  67. PREGER A, Wei R, Berg B, Golomb BA, et al
    Covid-19-Associated Rhabdomyolysis: A Scoping Review.
    Int J Infect Dis. 2023 Sep 18:S1201-9712(23)00713.
    >> Share

  68. KAYA H, Tani H, Inasaki N, Yazawa S, et al
    Virus evolution and reduced viral viability during treatment of persistent COVID-19 Omicron BA.5 infection in an immunocompromised host.
    Int J Infect Dis. 2023 Sep 16:S1201-9712(23)00721.
    >> Share

  69. HUJAMBERDIEVA LM, Chimed-Ochir O, Yumiya Y, Tanaka J, et al
    Relationship between clinical symptom profiles and COVID-19 infection status during delta-dominant period versus omicron-dominant period - analysis of real-world data collected in Hiroshima Prefecture, Japan.
    Int J Infect Dis. 2023 Sep 15:S1201-9712(23)00717.
    >> Share

  70. NAYYERABADI M, Fourcade L, Joshi SA, Chandrasekaran P, et al
    Vaccination after developing long COVID: impact on clinical presentation, viral persistence and immune responses.
    Int J Infect Dis. 2023 Sep 15:S1201-9712(23)00720.
    >> Share

  71. CHEMAITELLY H, Faust JS, Krumholz HM, Ayoub HH, et al
    Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: A national cohort study.
    Int J Infect Dis. 2023 Sep 15:S1201-9712(23)00719.
    >> Share

  72. SSALI I, Mugaba S, Watelo AK, Bemanzi J, et al
    Spike Protein is a key target for stronger and more persistent T-Cell Responses - A study of mild and asymptomatic SARS-CoV-2 Infection.
    Int J Infect Dis. 2023 Sep 6:S1201-9712(23)00714.
    >> Share

  73. MIDDELKOOP K, Stewart J, Walker N, Delport C, et al
    Vitamin D supplementation to prevent tuberculosis infection in South African schoolchildren: multicenter phase 3 double-blind randomized placebo-controlled trial (ViDiKids).
    Int J Infect Dis. 2023;134:63-70.
    >> Share

  74. FAN Y, Gao R, Shang Y, Tian X, et al
    Presence of SARS-CoV-2 in middle ear fluid and characterization of otitis media with effusion in COVID-19 patients.
    Int J Infect Dis. 2023 Sep 1:S1201-9712(23)00709.
    >> Share

    August 2023
  75. HAUTEFORT C, Corre A, Poillon G, Jourdaine C, et al
    Local budesonide therapy in the management of persistent hyposmia in suspected non-severe COVID-19 patients: Results of a randomized controlled trial.
    Int J Infect Dis. 2023 Aug 29:S1201-9712(23)00707.
    >> Share

  76. YAN X, Li K, Lei Z, Luo J, et al
    Prevalence and associated outcomes of co-infection between SARS-CoV-2 and influenza: a systematic review and meta-analysis.
    Int J Infect Dis. 2023 Aug 28:S1201-9712(23)00705.
    >> Share

  77. DIEXER S, Klee B, Gottschick C, Xu C, et al
    Association between Virus Variants, Vaccination, Previous Infections, and Post COVID-19 Risk.
    Int J Infect Dis. 2023 Aug 25:S1201-9712(23)00702.
    >> Share

  78. MI Y, Huang L, Liu J, Chao H, et al
    High-altitude Resident Pulmonary Edema Induced by SARS-CoV-2 Infection in Children - A Case Series.
    Int J Infect Dis. 2023 Aug 21:S1201-9712(23)00700.
    >> Share

  79. JANHA RE, Bah A, Jah H, Touray F, et al
    SARS-CoV-2 seroprevalence in pregnant women during the first three COVID-19 waves in The Gambia.
    Int J Infect Dis. 2023 Aug 14:S1201-9712(23)00697.
    >> Share

  80. EDELSTEIN M, Beiruti KW, Ben-Amram H, Beer N, et al
    Vaccine-induced and hybrid immunity to SARS-CoV-2 after three or four doses of BNT162b2 - results from 22 months follow-up of a healthcare workers cohort, Israel, 2020-2022.
    Int J Infect Dis. 2023 Aug 10:S1201-9712(23)00694.
    >> Share

  81. CHAE C, Kim RK, Jang EJ, Shim JA, et al
    Comparing the Effectiveness of Bivalent and Monovalent COVID-19 Vaccines against COVID-19 Infection during the Winter Season of 2022-2023: A Real-World Retrospective Observational Matched Cohort Study in the Republic of Korea.
    Int J Infect Dis. 2023 Aug 10:S1201-9712(23)00695.
    >> Share

  82. LOW EV, Pathmanathan MD, Chidambaram SK, Kim WR, et al
    Real world nirmatrelvir-ritonavir outpatient treatment in reducing hospitalization for high-risk COVID-19 patients during Omicron BA.4, BA.5 and XBB subvariants dominance in Malaysia: A retrospective cohort study.
    Int J Infect Dis. 2023 Aug 9:S1201-9712(23)00688.
    >> Share

  83. WAILI BA, Yazidi LA, Hashami HA, Gheilani MA, et al
    A comparative study of SARS-CoV-2 and common human coronavirus infections among children presenting to tertiary care in Oman.
    Int J Infect Dis. 2023 Aug 9:S1201-9712(23)00690.
    >> Share

  84. DOMNICH A, Orsi A, Ricucci V, De Pace V, et al
    Real-world performance of SARS-CoV-2 rapid antigen testing through the Alpha-, Delta- and Omicron-dominant waves of the COVID-19 pandemic.
    Int J Infect Dis. 2023 Aug 2:S1201-9712(23)00679.
    >> Share

  85. TANAKA H, Namkoong H, Chubachi S, Irie S, et al
    Clinical characteristics of patients with COVID-19 harboring detectable intracellular SARS-CoV-2 RNA in peripheral blood cells.
    Int J Infect Dis. 2023 Aug 2:S1201-9712(23)00680.
    >> Share

    July 2023
  86. AGUARELES J, Villares-Fernandez P, Carralon-Gonzalez MM, Forne C, et al
    Outcomes and clinical characteristics of the compassionate use of plitidepsin for immunocompromised adult patients with COVID-19.
    Int J Infect Dis. 2023 Jul 21:S1201-9712(23)00661.
    >> Share

  87. FANG X, Lu K, Sun S, Zhang H, et al
    Infection caused by Cupriavidus gilardii in a convalescent COVID-19 patient.
    Int J Infect Dis. 2023 Jul 20:S1201-9712(23)00663.
    >> Share

  88. LIANG W, Lv H, Chen C, Sun Y, et al
    Lack of neutralizing antibodies against influenza A viruses in adults during the 2022/2023 winter season - a serological study using retrospective samples collected in Hong Kong.
    Int J Infect Dis. 2023 Jul 20:S1201-9712(23)00659.
    >> Share

  89. TIAN T, Fu L, Lu Z, Wu X, et al
    Changes in HPV prevalence, incidence, and clearance among MSM in Xinjiang, China after implementation of nonpharmaceutical interventions to control COVID-19: An interrupted time series analysis.
    Int J Infect Dis. 2023 Jul 13:S1201-9712(23)00654.
    >> Share

  90. HOWARD LM, Huang X, Chen W, Liu Y, et al
    Association between nasopharyngeal colonization with multiple pneumococcal serotypes and total pneumococcal colonization density in young Peruvian children.
    Int J Infect Dis. 2023 Jul 12:S1201-9712(23)00653.
    >> Share

  91. ROSCA EC, Bilavu R, Cornea A, Simu M, et al
    Chorea following SARS-CoV-2 infection and vaccination: a systematic review of reported cases.
    Int J Infect Dis. 2023 Jul 7:S1201-9712(23)00652.
    >> Share

  92. PUYAT JH, Fowokan A, Wilton J, Janjua NZ, et al
    Risk of COVID-19 Hospitalization in People Living with HIV and HIV-Negative Individuals and the Role of COVID-19 Vaccination: A Retrospective Cohort Study.
    Int J Infect Dis. 2023 Jul 5:S1201-9712(23)00650.
    >> Share

  93. COWAN J, Amson A, Christofides A, Chagla Z, et al
    Monoclonal antibodies as COVID-19 prophylaxis therapy in immunocompromised patient populations.
    Int J Infect Dis. 2023 Jul 1:S1201-9712(23)00645.
    >> Share

    June 2023
  94. SIRIPONGBOONSITTI T, Ungtrakul T, Tawinprai K, Nimmol T, et al
    Efficacy of Combination Therapy of Fluvoxamine and Favipiravir versus Favipiravir Monotherapy to Prevent Severe COVID-19 among Mild to Moderate COVID-19 Patients: Open-label Randomized Controlled Trial (EFFaCo Study).
    Int J Infect Dis. 2023 Jun 29:S1201-9712(23)00641.
    >> Share

  95. BONNA AS, Pavel SR, Mehjabin T, Ali M, et al
    Dengue in Bangladesh.
    Int J Infect Dis. 2023 Jun 29:S1201-9712(23)00644.
    >> Share

  96. MAEDA M, Murata F, Fukuda H
    Effect of COVID-19 Vaccination on Household Transmission of SARS-CoV-2 in the Omicron Era: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.
    Int J Infect Dis. 2023 Jun 23:S1201-9712(23)00642.
    >> Share

  97. KANG JM, Kang M, Kim YE, Choi Y, et al
    Severe coronavirus disease 2019 in pediatric solid organ transplant recipients: Big data convergence study in Korea (K-COV-N cohort).
    Int J Infect Dis. 2023 Jun 21:S1201-9712(23)00640.
    >> Share

  98. JIAO Y, Zhao J, Wang Z, Chen X, et al
    How do Orphan Disease Patients Live Under the Pandemic of Omicron Variant? - A Nationwide Survey of Spinal Muscular Atrophy Patients in China.
    Int J Infect Dis. 2023 Jun 21:S1201-9712(23)00639.
    >> Share

  99. VERGORI A, Matusali G, Lepri AC, Cimini E, et al
    Neutralizing activity and T Cell response after bivalent fifth dose of mRNA vaccine in person living with HIV.
    Int J Infect Dis. 2023 Jun 19:S1201-9712(23)00632.
    >> Share

  100. IOANNIDIS JPA, Contopoulos-Ioannidis DG
    Pre-pandemic cross-reactive humoral immunity to SARS-CoV-2 in Africa: systematic review and meta-analysis.
    Int J Infect Dis. 2023 Jun 14:S1201-9712(23)00631.
    >> Share

  101. MORENO-TORRES V, Martinez-Urbistondo M, Calderon-Parra J, Patricia Mills, et al
    COVID-19 in hospitalized solid organ transplant recipients in a nationwide registry study.
    Int J Infect Dis. 2023 Jun 13:S1201-9712(23)00629.
    >> Share

  102. COHEN PJF, Rybak DA, Werner DA, Kochert DF, et al
    Surveillance of non-invasive group A Streptococcus infections in French ambulatory pediatrics before and during the COVID-19 pandemic: a prospective multicenter study from 2018 to 2022.
    Int J Infect Dis. 2023 Jun 6:S1201-9712(23)00622.
    >> Share

  103. PITA-MARTINEZ C, Perez-Garcia F, Berdices AV, Martin-Vicente M, et al
    A deficient immune response to SARS-CoV-2 in the nasopharynx is associated with severe COVID-19 pneumonia.
    Int J Infect Dis. 2023 Jun 6:S1201-9712(23)00623.
    >> Share

    May 2023
  104. ZHANG R, Wen J, Wu K, Lin S, et al
    Influenza-associated neurologic complications in children from an H3N2 outbreak in Shenzhen, China during COVID-19 lockdown.
    Int J Infect Dis. 2023 May 30:S1201-9712(23)00616.
    >> Share

  105. BLANQUART F, Abad C, Ambroise J, Bernard M, et al
    Temporal, age and geographical variation in vaccine efficacy against infection by the Delta and Omicron variants in the community in France, December 2021 to March 2022.
    Int J Infect Dis. 2023 May 12:S1201-9712(23)00539.
    >> Share

  106. SERVIER C, Porcher R, Pane I, Ravaud P, et al
    Trajectories of the evolution of post COVID-19 condition, up to two years after symptoms onset.
    Int J Infect Dis. 2023 May 12:S1201-9712(23)00558.
    >> Share

  107. HUI DS, Yung L, Chan KK, Ng SS, et al
    Risk of air and surface contamination during application of different non-invasive respiratory support for patients with COVID-19.
    Int J Infect Dis. 2023 May 12:S1201-9712(23)00560.
    >> Share

  108. MARANGONI D, Antonello RM, Coppi M, Palazzo M, et al
    Combination regimen of nirmatrelvir/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: a case report and a scoping review of the literature.
    Int J Infect Dis. 2023 May 5:S1201-9712(23)00546.
    >> Share

  109. KUODI P, Gorelik Y, Gausi B, Bernstine T, et al
    Characterisation of post-COVID syndromes by symptom cluster and time period up to 12 months post-infection: A systematic review and meta-analysis.
    Int J Infect Dis. 2023 May 5:S1201-9712(23)00549.
    >> Share

  110. ZENS KD, Llanas-Cornejo D, Menges D, Fehr JS, et al
    Longitudinal Humoral and Cell-Mediated Immune Responses in a Population-Based Cohort in Zurich, Switzerland from March to June 2022 - Evidence for Protection against Omicron SARS-CoV-2 Infection by Neutralizing Antibodies and Spike-specific T cells.
    Int J Infect Dis. 2023 May 4:S1201-9712(23)00538.
    >> Share

  111. ORLANDO SA, Calderon JL, Leon-Sosa A, Patino L, et al
    Corrigendum to ";SARS-CoV-2 transmission from infected owner to household dogs and cats is associated with food sharing" [International Journal of Infectious Diseases, 122 (2022) Pages 295-299].
    Int J Infect Dis. 2023;130:214-215.
    >> Share

  112. ALBERTO-ORLANDO S, Garcia-Bereguiain MA
    Concerns regarding risk factors for SARS-CoV-2 transmission to pets: author's reply.
    Int J Infect Dis. 2023;130:212-213.
    >> Share

  113. WEESE S
    Concerns regarding risk factors for SARS-CoV-2 transmission to pets.
    Int J Infect Dis. 2023;130:211.
    >> Share

  114. GOLETTI D, Al-Abri S, Migliori GB, Coler R, et al
    World Tuberculosis Day 2023 theme "Yes! We Can End TB!".
    Int J Infect Dis. 2023;130 Suppl 1:S1-S3.
    >> Share

  115. GOLETTI D, Al-Abri S, Migliori GB, Coler R, et al
    World Tuberculosis Day 2023 theme "Yes! We Can End TB!".
    Int J Infect Dis. 2023;130 Suppl 1:S1-S3.
    >> Share

  116. GOLETTI D, Al-Abri S, Migliori GB, Coler R, et al
    World Tuberculosis Day 2023 theme "Yes! We Can End TB!".
    Int J Infect Dis. 2023;130 Suppl 1:S1-S3.
    >> Share

  117. GOLETTI D, Al-Abri S, Migliori GB, Coler R, et al
    World Tuberculosis Day 2023 theme "Yes! We Can End TB!".
    Int J Infect Dis. 2023;130 Suppl 1:S1-S3.
    >> Share

    April 2023
  118. TANAKA H, Chubachi S, Asakura T, Namkoong H, et al
    Characteristics and Clinical Effectiveness of COVID-19 Vaccination in Hospitalized Patients in Omicron-dominated Epidemic Wave - A Nationwide Study in Japan.
    Int J Infect Dis. 2023 Apr 20:S1201-9712(23)00529.
    >> Share

  119. HUIBERTS AJ, de Gier B, Hoeve CE, de Melker HE, et al
    Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from 12 July 2021 to 6 June 2022: a prospective cohort study.
    Int J Infect Dis. 2023 Apr 20:S1201-9712(23)00534.
    >> Share

  120. MOLINA KC, Kennerley V, Beaty LE, Bennett TD, et al
    Real-World Evaluation of Bebtelovimab Effectiveness During the Period of COVID-19 Omicron Variants including BA.4/BA.5.
    Int J Infect Dis. 2023 Apr 16:S1201-9712(23)00525.
    >> Share

  121. COHEN D, Izak M, Stoyanov E, Mandelboim M, et al
    Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic.
    Int J Infect Dis. 2023 Apr 16:S1201-9712(23)00526.
    >> Share

  122. LEE VH, Chan SK, Tam YH, Chau TC, et al
    Predictive factors of delayed viral clearance of asymptomatic omicron-related COVID-19 screened positive in cancer patients receiving active anti-cancer treatment.
    Int J Infect Dis. 2023 Apr 16:S1201-9712(23)00527.
    >> Share

  123. YIN S, Ren J, Xue J, Li P, et al
    Disparities in COVID-19 clinical studies from high-income and low-and middle-income countries.
    Int J Infect Dis. 2023 Apr 15:S1201-9712(23)00522.
    >> Share

  124. BUTT AA, Guerrero MD, Canlas EB, Al-Dwairi H, et al
    Immediate and Contributory Causes of Death in Patients Hospitalized with COVID-19.
    Int J Infect Dis. 2023 Apr 13:S1201-9712(23)00514.
    >> Share

  125. BRYNILDSRUD OB, Watle SV, Alfsnes K, Caugant DA, et al
    Invasive meningococcal disease in Norway in the two decades prior to the COVID-19 pandemic.
    Int J Infect Dis. 2023 Apr 6:S1201-9712(23)00136.
    >> Share

    March 2023
  126. VON BARTHELD CS, Wang L
    The prevalence of olfactory dysfunction with Omicron has decreased in Asia, similar to Western countries.
    Int J Infect Dis. 2023 Mar 30:S1201-9712(23)00121.
    >> Share

  127. LAWAL BJ, Gallagher KE, Kitonsa J, Tindanbil D, et al
    Prevalence of IgG and IgM to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone and Uganda: A Longitudinal Study.
    Int J Infect Dis. 2023 Mar 29:S1201-9712(23)00128.
    >> Share

  128. AZHAR EI, Velavan TP, Rungsung I, Traore T, et al
    Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - a ten-year (2012-2022) global analysis of human and camel infections, genomic sequences, lineages, and geographical origins.
    Int J Infect Dis. 2023 Mar 28:S1201-9712(23)00125.
    >> Share

  129. BODNER K, Irvine MA, Kwong JC, Mishra S, et al
    Observed negative vaccine effectiveness could be the canary in the coal mine for biases in observational Covid-19 studies.
    Int J Infect Dis. 2023 Mar 27:S1201-9712(23)00102.
    >> Share

  130. GUO Y, Wu S, Ye W, Zhao Z, et al
    Impact of public health and social measures on contact dynamics during a SARS-CoV-2 Omicron variant outbreak in Quanzhou, China, March to April 2022.
    Int J Infect Dis. 2023 Mar 24:S1201-9712(23)00104.
    >> Share

  131. NAVEED Z, Li J, Naus M, Garcia HAV, et al
    A Population-Based Assessment of Myocarditis Following mRNA COVID-19 booster Vaccination Among Adult Recipients.
    Int J Infect Dis. 2023 Mar 24:S1201-9712(23)00106.
    >> Share

  132. LARSEN SE, Baldwin SL, Coler RN
    TB Vaccines Update: is an RNA-based vaccine feasible for TB?
    Int J Infect Dis. 2023 Mar 22:S1201-9712(23)00114.
    >> Share

  133. ZINSZER K, Charland K, Pierce L, Saucier A, et al
    Pre-Omicron seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and teenagers in Montreal, Canada.
    Int J Infect Dis. 2023 Mar 22:S1201-9712(23)00115.
    >> Share

  134. TAN KS, Ong SWX, Koh MH, Tay DJW, et al
    SARS-CoV-2 Omicron variant shedding during respiratory activities.
    Int J Infect Dis. 2023 Mar 20:S1201-9712(23)00109.
    >> Share

  135. WU J, Shi X, Tao B, Zhan Y, et al
    Inactivated COVID-19 vaccines booster dose shortened the viral shedding time of patients infected with the Omicron variant BA.2.
    Int J Infect Dis. 2023 Mar 20:S1201-9712(23)00107.
    >> Share

  136. DAVIDO B, Jaffal K, Gault E, Bourlet S, et al
    Back to the Future of Viruses: A Case of Triple Coinfection caused by RSV, HCov-OC43 and Rhinovirus.
    Int J Infect Dis. 2023 Mar 20:S1201-9712(23)00101.
    >> Share

  137. NAJAFI-FARD S, Aiello A, Navarra A, Cuzzi G, et al
    Characterization of the immune impairment of tuberculosis and COVID-19 coinfected patients.
    Int J Infect Dis. 2023 Mar 19:S1201-9712(23)00099.
    >> Share

  138. NEVOLA R, Feola G, Ruocco R, Russo A, et al
    Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study.
    Int J Infect Dis. 2023 Mar 19:S1201-9712(23)00110.
    >> Share

  139. CHILLON TS, Demircan K, Weiss G, Minich WB, et al
    Detection of antibodies to SARS-CoV-2 after vaccination in seminal plasma and their association to sperm parameters.
    Int J Infect Dis. 2023 Mar 16:S1201-9712(23)00095.
    >> Share

  140. HAMA HO, Chenal T, Pible O, Miotello G, et al
    An ancient coronavirus from individuals in France, circa 16(th) century.
    Int J Infect Dis. 2023 Mar 14:S1201-9712(23)00093.
    >> Share

  141. ZANNOLI S, Brandolini M, Marino MM, Denicolo A, et al
    SARS-CoV-2 Co-Infection in Immunocompromised Host Leads to Generation of Recombinant Strain.
    Int J Infect Dis. 2023 Mar 14:S1201-9712(23)00088.
    >> Share

  142. MA Y, Gu Y, Shan Z, Huang Y, et al
    Safety and efficacy of inactivated COVID-19 vaccines in women vaccinated during the first trimester of pregnancy.
    Int J Infect Dis. 2023 Mar 14:S1201-9712(23)00094.
    >> Share

  143. WANG X, Tang Q, Li H, Jiang H, et al
    Autoantibodies against type I interferons in COVID-19 infection: a systematic review and meta-analysis.
    Int J Infect Dis. 2023 Mar 10:S1201-9712(23)00087.
    >> Share

  144. HOUBEN F, den Heijer CD, Dukers-Muijrers NH, Daamen AM, et al
    Facility- and ward-level factors associated with SARS-CoV-2 outbreaks among residents in long-term care facilities: a retrospective cohort study.
    Int J Infect Dis. 2023 Mar 9:S1201-9712(23)00082.
    >> Share

  145. THONG PM, Chong HT, Chang AJW, Ong CWM, et al
    COVID-19, the escalation of diabetes and the repercussions on Tuberculosis.
    Int J Infect Dis. 2023 Mar 8:S1201-9712(23)00055.
    >> Share

  146. NALUNJOGI J, Mucching-Toscano S, Sibomana JP, Centis R, et al
    Impact of COVID-19 on diagnosis of TB, MDR-TB and on mortality in 11 countries in Europe, Northern America and Australia. A Global Tuberculosis Network study.
    Int J Infect Dis. 2023 Mar 7:S1201-9712(23)00076.
    >> Share

  147. VENETI L, Berild JD, Watle SV, Starrfelt J, et al
    Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022.
    Int J Infect Dis. 2023 Mar 7:S1201-9712(23)00080.
    >> Share

  148. EVANS TS, Tan CW, Aung O, Phyu S, et al
    Exposure to diverse sarbecoviruses indicates frequent zoonotic spillover in human communities interacting with wildlife.
    Int J Infect Dis. 2023 Mar 2:S1201-9712(23)00064.
    >> Share

  149. VELAVAN TP, Ntoumi F, Kremsner PG, Lee SS, et al
    Emergence and geographic dominance of Omicron subvariants XBB/XBB.1.5 and BF.7 - the public health challenges.
    Int J Infect Dis. 2023;128:307-309.
    >> Share

  150. ZILVER SJM, de Groot CJM, Grobben M, Remmelzwaal S, et al
    Vaccination from the early second trimester onwards gives a robust SARS-CoV-2 antibody response throughout pregnancy and provides antibodies for the neonate.
    Int J Infect Dis. 2023 Mar 1:S1201-9712(23)00071.
    >> Share

    February 2023
  151. KANG W, Yang P, Dang B, Zhang W, et al
    Dynamics of disease characteristics and viral RNA decay in patients with asymptomatic and mild infections during the Omicron wave in Shanghai, China: A retrospective cohort study.
    Int J Infect Dis. 2023 Feb 25:S1201-9712(23)00067.
    >> Share

  152. HOWARD-JONES AR, Arnott A, Draper J, Gall M, et al
    Emergent Omicron BR.2.1 Sublineage of SARS-CoV-2 in New South Wales, Australia: A Subvariant with High Fitness but Without Increased Disease Severity.
    Int J Infect Dis. 2023 Feb 24:S1201-9712(23)00068.
    >> Share

  153. SANTOS AP, Werneck GL, Dalvi APR, Dos Santos CC, et al
    The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2 - The results of ProBCG: A Multicenter Randomized Clinical Trial in Brazil.
    Int J Infect Dis. 2023 Feb 23:S1201-9712(23)00065.
    >> Share

  154. CHANTASRISAWAD N, Techasaensiri C, Kosalaraksa P, Phongsamart W, et al
    The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial.
    Int J Infect Dis. 2023 Feb 23:S1201-9712(23)00066.
    >> Share

  155. PEREIRA PD, Pires MC, Gomes VMR, Nogueira MCA, et al
    Clinical characteristics and outcomes of hospital-manifested COVID-19 among Brazilians.
    Int J Infect Dis. 2023 Feb 20:S1201-9712(23)00059.
    >> Share

  156. WU Y, Guo Z, Yuan J, Cao G, et al
    Duration of viable virus shedding and PCR positivity of the SARS-CoV-2 Omicron variant in upper respiratory tract: a systematic review and meta-analysis.
    Int J Infect Dis. 2023 Feb 17:S1201-9712(23)00057.
    >> Share

  157. VAIRA LA, De Riu G, Mayo-Yanez M, Gengler IM, et al
    Prevalence of chemosensitive disorders with Omicron infections and the possible impacts of vaccination.
    Int J Infect Dis. 2023 Feb 15:S1201-9712(23)00054.
    >> Share

  158. BELLO-CHAVOLLA OY, Antonio-Villa NE, Valdes-Ferrer SI, Fermin-Martinez CA, et al
    Effectiveness of a nation-wide COVID-19 vaccination program in Mexico against symptomatic COVID-19, hospitalizations, and death: a retrospective analysis of national surveillance data.
    Int J Infect Dis. 2023 Feb 10:S1201-9712(23)00042.
    >> Share

  159. BANGAR S, Sonar P, Mane A, Sane S, et al
    Prevention of recurrence of bacterial vaginosis using lactobacilli-containing vaginal tablets among women with HIV: a randomized, placebo-controlled, double-blinded phase IV trial.
    Int J Infect Dis. 2023;129:197-204.
    >> Share

  160. DE CASTRO MV, Silva MVR, Oliveira LM, Gozzi-Silva SC, et al
    "Immunological evaluation of unvaccinated young patients with Turner Syndrome after COVID-19".
    Int J Infect Dis. 2023 Feb 7:S1201-9712(23)00044.
    >> Share

  161. SAITOH H, Sakai-Tagawa Y, Nagasawa S, Torimitsu S, et al
    High titers of infectious SARS-CoV-2 in COVID-19 corpses.
    Int J Infect Dis. 2023 Feb 6:S1201-9712(23)00047.
    >> Share

  162. SWETS MC, Moss RJ, Kor F, Hilarius D, et al
    A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19: a natural experiment due to drug shortages.
    Int J Infect Dis. 2023 Feb 2:S1201-9712(23)00041.
    >> Share

  163. LIU C, Lu J, Li P, Feng S, et al
    A Comparative study on epidemiological characteristics, transmissibility, and pathogenicity of three COVID-19 outbreaks caused by different variants.
    Int J Infect Dis. 2023 Feb 1:S1201-9712(23)00039.
    >> Share

  164. PATEL S, Truong GT, Rajan A, Creech Z, et al
    Discharge Disposition and Clinical Outcomes of Patients Hospitalized with COVID-19.
    Int J Infect Dis. 2023 Feb 1:S1201-9712(23)00040.
    >> Share

    January 2023
  165. BANKO A, Miljanovic D, Cirkovic A
    Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old players on the new field.
    Int J Infect Dis. 2023 Jan 31:S1201-9712(23)00037.
    >> Share

  166. SEERY V, Raiden S, Penedo JMG, Borda M, et al
    Persistent symptoms after COVID-19 in children and adolescents from Argentina.
    Int J Infect Dis. 2023 Jan 31:S1201-9712(23)00033.
    >> Share

  167. LIU Y, Xu L, Piao X, Li H, et al
    Epidemiological, Clinical and Household Transmission Characteristics of Children and Adolescents Infected with SARS-CoV-2 Omicron Variant in Shanghai, China: a Retrospective Multicenter Observational Study.
    Int J Infect Dis. 2023 Jan 29:S1201-9712(23)00031.
    >> Share

  168. PETRONE D, Mateo-Urdiales A, Sacco C, Riccardo F, et al
    Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 - February 2022).
    Int J Infect Dis. 2023 Jan 25:S1201-9712(23)00027.
    >> Share

  169. WU S, Wang L, Dong J, Bao Y, et al
    The Dose- and Time-Dependent Effectiveness and Safety Associated with COVID-19 Vaccination During Pregnancy: A Systematic Review and Meta-analysis.
    Int J Infect Dis. 2023;128:335-46.
    >> Share

  170. ATEF S, Hosani FA, AbdelWareth L, Al-Rifai RH, et al
    Susceptibility to Reinfection with SARS-CoV-2 Virus Relative to Existing Antibody Concentrations and T cell Response.
    Int J Infect Dis. 2023 Jan 23:S1201-9712(23)00005.
    >> Share

  171. YAMAMOTO S, Matsuda K, Maeda K, Horii K, et al
    Neutralizing antibodies following three doses of BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron predominant wave.
    Int J Infect Dis. 2023 Jan 21:S1201-9712(23)00023.
    >> Share

  172. METCHURTCHLISHVILI R, Chkhartishvili N, Abutidze A, Endeladze M, et al
    Effect of remdesivir on mortality and the need for mechanical ventilation among hospitalized COVID-19 patients: real-world data from resource-limited country.
    Int J Infect Dis. 2023 Jan 20:S1201-9712(23)00022.
    >> Share

  173. HELLER M, Henrici C, Buttner J, Leube S, et al
    SARS-CoV-2 Neutralizing Antibody Therapies: Early retrospective cohort study of 26 hospitalized patients treated with Bamlanivimab or Casirivimab/Imdevimab.
    Int J Infect Dis. 2023 Jan 20:S1201-9712(23)00012.
    >> Share

  174. NAGGIE S, Milstone A, Castro M, Collins SP, et al
    Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: A randomized, multicenter, placebo-controlled trial (HERO-HCQ).
    Int J Infect Dis. 2023 Jan 19:S1201-9712(23)00019.
    >> Share

  175. NIYOMNAITHAM S, Jongkaewwattana A, Meesing A, Pinpathomrat N, et al
    Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 mRNA vaccine after two doses of CoronaVac vaccines against Delta and Omicron variants.
    Int J Infect Dis. 2023 Jan 19:S1201-9712(23)00021.
    >> Share

  176. SONG J, Jing Q, Zhu E, Liu Q, et al
    Alterations in smell or taste in individuals infected with SARS-CoV-2 during periods of Omicron variant dominance.
    Int J Infect Dis. 2023 Jan 16:S1201-9712(23)00017.
    >> Share

  177. HIRAE K, Hoshina T, Koga H
    Impact of COVID-19 pandemic on the epidemiology of other communicable diseases in Japan.
    Int J Infect Dis. 2023 Jan 12:S1201-9712(23)00013.
    >> Share

  178. CHEN SH, Wu JL, Liu YC, Yen TY, et al
    Differential clinical characteristics and performance of home antigen tests between parents and children following household transmission of SARS-CoV-2 during the Omicron variant pandemic.
    Int J Infect Dis. 2023 Jan 12:S1201-9712(23)00014.
    >> Share

  179. SANTOS VS, Allgayer MF, Kontogianni K, Rocha JE, et al
    Pooling of sputum samples to increase tuberculosis diagnostic capacity in Brazil during the COVID-19 pandemic.
    Int J Infect Dis. 2023 Jan 12:S1201-9712(23)00011.
    >> Share

  180. LIN SM, Lee CS, Huang AC, Chiu TH, et al
    Effects of Dexamethasone Use on Viral Clearance Among Patients with COVID-19: A Multicenter Cohort Study.
    Int J Infect Dis. 2023 Jan 12:S1201-9712(23)00010.
    >> Share

  181. NUCHNOI P, Piromtong P, Siribal S, Anansilp K, et al
    Applicability of a Colorimetric RT-LAMP Assay for SARS-CoV-2 Detection in High Exposure Risk Setting.
    Int J Infect Dis. 2023 Jan 12:S1201-9712(23)00009.
    >> Share

  182. AHSBERG J, Bjerrum S, Ganu VJ, Kwashie A, et al
    The in-hospital tuberculosis diagnostic cascade and early clinical outcomes among people living with HIV before and during the COVID-19 pandemic - a prospective multisite cohort study from Ghana.
    Int J Infect Dis. 2023 Jan 9:S1201-9712(22)00683.
    >> Share

  183. JANG YR, Oh YJ, Kim JY
    Regdanvimab for patients with mild-to-moderate COVID-19: a retrospective cohort study and subgroup analysis of patients with the Delta variant.
    Int J Infect Dis. 2023 Jan 6:S1201-9712(22)00674.
    >> Share

  184. NGUIPDOP-DJOMO P, Oswald WE, Halliday KE, Cook S, et al
    Risk factors for SARS-CoV-2 infection in primary and secondary school students and staff in England in the 2020/2021 school year: a longitudinal study.
    Int J Infect Dis. 2023 Jan 5:S1201-9712(22)00673.
    >> Share

  185. IKEDA M, Okugawa S, Kashiwabara K, Moritoyo T, et al
    Multicenter, Single-Blind, Randomized Controlled Study of the Efficacy and Safety of Favipiravir and Nafamostat Mesilate in Patients with COVID-19 Pneumonia.
    Int J Infect Dis. 2023 Jan 3:S1201-9712(22)00684.
    >> Share

  186. BONACINA F, Boelle PY, Colizza V, Lopez O, et al
    Global patterns and drivers of influenza decline during the COVID-19 pandemic.
    Int J Infect Dis. 2023 Jan 3:S1201-9712(22)00682.
    >> Share

  187. WEE LE, Tan JY, Oon LLE, Pena AMT, et al
    Relapsing COVID-19 infection as a manifestation of Good's syndrome: a case report and literature review.
    Int J Infect Dis. 2023 Jan 3:S1201-9712(22)00681.
    >> Share

    December 2022
  188. JOO KIM W, Roberts CC, Young Song J, Yoon JG, et al
    Safety and immunogenicity of the bi-cistronic GLS-5310 COVID-19 DNA vaccine delivered with the GeneDerm suction device.
    Int J Infect Dis. 2022 Dec 30:S1201-9712(22)00678.
    >> Share

  189. JASSAT W, Mudara C, Vika C, Welch R, et al
    A cohort study of Post COVID-19 Condition across the Beta, Delta and Omicron waves in South Africa: 6-month follow up of hospitalised and non-hospitalised participants.
    Int J Infect Dis. 2022 Dec 29:S1201-9712(22)00676.
    >> Share

  190. KOHMER N, Stein S, Schenk B, Grikscheit K, et al
    Heterologous prime-boost immunisation with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study.
    Int J Infect Dis. 2022 Dec 29:S1201-9712(22)00672.
    >> Share

  191. MARKL B, Dintner S, Schaller T, Sipos E, et al
    Fatal cases after Omicron BA.1 and BA.2 infection: results of an autopsy study.
    Int J Infect Dis. 2022 Dec 27:S1201-9712(22)00669.
    >> Share

  192. YANG SL, Ripen AM, Ven Lee J, Koh K, et al
    Time from last immunity event against infection during Omicron dominant period in Malaysia.
    Int J Infect Dis. 2022 Dec 26:S1201-9712(22)00667.
    >> Share

  193. KAIZER AM, Shapiro NI, Wild J, Brown SM, et al
    Lopinavir/ritonavir for Treatment of Non-Hospitalized Patients with COVID-19: A Randomized Clinical Trial.
    Int J Infect Dis. 2022 Dec 26:S1201-9712(22)00665.
    >> Share

  194. HEIDARZADEH A, Moridani MA, Khoshmanesh S, Kazemi S, et al
    Effectiveness of COVID-19 vaccines on hospitalization and death in Guilan, Iran: a test negative case-control study.
    Int J Infect Dis. 2022 Dec 23:S1201-9712(22)00664.
    >> Share

  195. MOHAMMED NI, Mackenzie G, Ezeani E, Sidibeh M, et al
    Quantifying Excess Mortality during the Covid-19 pandemic in 2020 in The Gambia: A time-series analysis of three Health and Demographic Surveillance Systems.
    Int J Infect Dis. 2022 Dec 22:S1201-9712(22)00654.
    >> Share

  196. WESTERHOF I, de Hoog M, Ieven M, Lammens C, et al
    The impact of variant and vaccination on SARS-CoV-2 symptomatology; three prospective household cohorts.
    Int J Infect Dis. 2022 Dec 22:S1201-9712(22)00656.
    >> Share

  197. WATASE M, Masaki K, Chubachi S, Namkoong H, et al
    Impact of accumulative smoking exposure and chronic obstructive pulmonary disease on COVID-19 outcomes: Report based on findings from the Japan COVID-19 Task Force.
    Int J Infect Dis. 2022 Dec 20:S1201-9712(22)00655.
    >> Share

  198. FANO-SIZGORICH D, Vasquez-Velasquez C, Orellana LR, Ponce-Torres C, et al
    RISK OF DEATH, HOSPITALIZATION AND ICU ADMISSION BY SARS-CoV-2 VARIANTS IN PERU, A RETROSPECTIVE STUDY.
    Int J Infect Dis. 2022 Dec 20:S1201-9712(22)00657.
    >> Share

  199. PLASSE TF, Delgado B, Potts J, Abramson D, et al
    Randomized, placebo-controlled pilot study of upamostat, a host-directed serine protease inhibitor, for outpatient treatment of COVID-19.
    Int J Infect Dis. 2022 Dec 19:S1201-9712(22)00638.
    >> Share

  200. TENE L, Bergroth T, Eisenberg A, Ben David SS, et al
    Risk factors, health outcomes, healthcare services utilization, and direct medical costs of long COVID patient.
    Int J Infect Dis. 2022 Dec 15:S1201-9712(22)00640.
    >> Share

  201. PERETA I, Moracho A, Lopez N, Ibanez B, et al
    Hospital at Home treatment with Remdesivir for patients with COVID-19: Real life experience.
    Int J Infect Dis. 2022 Dec 12:S1201-9712(22)00648.
    >> Share

  202. NGALAMIKA O, Lidenge SJ, Mukasine MC, Kawimbe M, et al
    SARS-CoV-2 Specific T-cell and Humoral Immunity in HIV-infected and -uninfected Individuals in an African Population: A Prospective Cohort Study.
    Int J Infect Dis. 2022 Dec 11:S1201-9712(22)00646.
    >> Share

  203. TORRES C, Garcia J, Mesle F, Barbieri M, et al
    Identifying age- and sex-specific COVID-19 mortality trends over time in six countries.
    Int J Infect Dis. 2022 Dec 9:S1201-9712(22)00641.
    >> Share

  204. NGIAM JN, Chhabra S, Goh W, Sim MY, et al
    Continued demographic shifts in hospitalised COVID-19 patients from migrant workers to a vulnerable and more elderly local population at risk of severe disease.
    Int J Infect Dis. 2022 Dec 9:S1201-9712(22)00643.
    >> Share

  205. GUO Y, Wang H, Xiao M, Guan X, et al
    Long-term outcomes of COVID-19 convalescents: An 18.5-month longitudinal study in Wuhan.
    Int J Infect Dis. 2022 Dec 9:S1201-9712(22)00642.
    >> Share

  206. GARCIA HAV, Adu PA, Harrigan S, Wilton J, et al
    Risk factors for COVID-19 hospitalization following COVID-19 Vaccination: a population-based cohort study in Canada.
    Int J Infect Dis. 2022 Dec 8:S1201-9712(22)00639.
    >> Share

  207. LUO Y, Lv H, Zhao S, Sun Y, et al
    Age-related seroprevalence trajectories of seasonal coronaviruses in children including neonates in Guangzhou, China.
    Int J Infect Dis. 2022 Dec 5:S1201-9712(22)00636.
    >> Share

  208. NYAGWANGE J, Kutima B, Mwai K, Karanja HK, et al
    Serum IgG and mucosal IgA antibodies from pre-pandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro.
    Int J Infect Dis. 2022 Dec 4:S1201-9712(22)00633.
    >> Share

  209. VUORIO A, Raal F, Kovanen PT
    Drug-drug interaction with oral antivirals for early treatment of COVID-19.
    Int J Infect Dis. 2022 Dec 2:S1201-9712(22)00632.
    >> Share

  210. LARSEN CS
    Drug-drug interaction with oral antivirals for early treatment of COVID-19 - Authors' reply.
    Int J Infect Dis. 2022 Dec 2:S1201-9712(22)00631.
    >> Share

    November 2022
  211. FRIMPONG SO, Paintsil E
    Community engagement in Ebola outbreaks in sub-Saharan Africa and implications for COVID-19 control: A scoping review.
    Int J Infect Dis. 2022 Nov 30:S1201-9712(22)00625.
    >> Share

  212. FOWOKAN A, Samji H, Puyat J, Janjua N, et al
    Effectiveness of COVID-19 Vaccines in People Living with HIV in British Columbia and comparisons with a matched HIV-Negative Cohort: A Test Negative Design.
    Int J Infect Dis. 2022 Nov 30:S1201-9712(22)00624.
    >> Share

  213. WU S, Li Y, Mishra S, Bodner K, et al
    Effect of the incremental protection of previous infection against Omicron infection among individuals with a hybrid of infection- and vaccine-induced immunity: a population-based cohort study in Canada.
    Int J Infect Dis. 2022 Nov 28:S1201-9712(22)00620.
    >> Share

  214. CHUNG HY, Jian MJ, Chang CK, Chen CS, et al
    The application of a novel 5-in-1 multiplex RT-PCR assay for rapid detection of SARS-CoV-2 and differentiation between variants of concern.
    Int J Infect Dis. 2022 Nov 28:S1201-9712(22)00619.
    >> Share

  215. DAVIES MA, Morden E, Rosseau P, Arendse J, et al
    Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa.
    Int J Infect Dis. 2022 Nov 24:S1201-9712(22)00615.
    >> Share

  216. MIOCH D, Vanbrabant L, Reimerink J, Kuiper S, et al
    SARS-CoV-2 antibodies persist up to 12 months after natural infection in healthy employees working in non-medical contact-intensive professions.
    Int J Infect Dis. 2022 Nov 24:S1201-9712(22)00616.
    >> Share

  217. KANOKUDOM S, Chansaenroj J, Suntronwong N, Assawakosri S, et al
    Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (Covovax(TM)) after homologous and heterologous two-dose regimens.
    Int J Infect Dis. 2022 Nov 22:S1201-9712(22)00614.
    >> Share

  218. BYGDELL M, Leach S, Lundberg L, Gyll D, et al
    A comprehensive characterisation of patients diagnosed with post-COVID-19 condition in Sweden 16 months after the introduction of the ICD-10 diagnosis code (U09.9): a population-based cohort study.
    Int J Infect Dis. 2022 Nov 18:S1201-9712(22)00612.
    >> Share

  219. PUGA-GOMEZ R, Ricardo-Delgado Y, Rojas-Iriarte C, Cespedes-Henriquez L, et al
    Open-label phase I/II clinical trial of SARS-CoV-2 RBD-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with RBD-protein vaccine (FINLAY-FR-1A) in children.
    Int J Infect Dis. 2022 Nov 17:S1201-9712(22)00601.
    >> Share

  220. LANGER-GOULD A, Xu S, Myers LC, Chen A, et al
    Anakinra or high-dose corticosteroids in COVID-19 pneumonia patients who deteriorate on low-dose dexamethasone: An observational study of comparative effectiveness.
    Int J Infect Dis. 2022 Nov 17:S1201-9712(22)00603.
    >> Share

  221. JUTHI RT, Sazed SA, Sarmin M, Haque R, et al
    COVID-19 and Diarrhea: Putative Mechanisms and Management.
    Int J Infect Dis. 2022 Nov 17:S1201-9712(22)00602.
    >> Share

  222. BRUNVOLL SH, Nygaard AB, Fagerland MW, Holland P, et al
    Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection.
    Int J Infect Dis. 2022 Nov 11. pii: S1201-9712(22)00596.
    >> Share

  223. INTAWONG K, Chariyalertsak S, Chalom K, Wonghirundecha T, et al
    Heterologous third and fourth dose vaccines reduce severity and mortality in COVID-19 patients during the periods of delta and omicron predominance in Thailand.
    Int J Infect Dis. 2022 Nov 10. pii: S1201-9712(22)00593.
    >> Share

  224. LV Y, Yu G, Zhang X, Gu J, et al
    Comparative analysis of elderly hospitalized patients with coronavirus disease 2019 or influenza A H1N1 virus infections.
    Int J Infect Dis. 2022 Nov 9. pii: S1201-9712(22)00590.
    >> Share

  225. DECENTI EC, Salvatore MA, Mancon A, Portella G, et al
    A large series of molecular and serological specimens to evaluate mother-to-child SARS-CoV-2 transmission: a prospective study from the Italian Obstetric Surveillance System.
    Int J Infect Dis. 2022 Nov 8. pii: S1201-9712(22)00584.
    >> Share

  226. KITAGAWA H, Nomura T, Kaiki Y, Kakimoto M, et al
    Viable SARS-CoV-2 detected in the air of hospital rooms of COVID-19 patients with early infection.
    Int J Infect Dis. 2022 Nov 7. pii: S1201-9712(22)00589.
    >> Share

  227. SALDIVAR-ESPINOZA B, Macip G, Pujadas G, Garcia-Vallve S, et al
    Could nucleocapsid be a next-generation COVID-19 vaccine candidate?
    Int J Infect Dis. 2022 Nov 5. pii: S1201-9712(22)00586.
    >> Share

  228. S S, J LR, N W, P M, et al
    High prevalence of SARS-CoV-2 antibodies in pregnant women, after the second wave of infections in the inner city of Johannesburg, Gauteng Province, South Africa.
    Int J Infect Dis. 2022 Nov 5. pii: S1201-9712(22)00575.
    >> Share

  229. ORONS B, Larson C, Caroen S, Reid TR, et al
    Could nucleocapsid be a next-generation COVID-19 vaccine candidate - author's reply.
    Int J Infect Dis. 2022 Nov 5. pii: S1201-9712(22)00587.
    >> Share

  230. MUHAMMAD AZAMI NA, Perera D, Thayan R, Bakar SA, et al
    SARS-CoV-2 genomic surveillance in Malaysia: Displacement of B.1.617.2 with AY lineages as dominant Delta variants and the introduction of Omicron during the fourth epidemic wave.
    Int J Infect Dis. 2022 Nov 3. pii: S1201-9712(22)00582.
    >> Share

  231. ALVAREZ-DIAZ DA, Ruiz-Moreno HA, Zapata-Bedoya S, Franco-Munoz C, et al
    Clinical outcomes associated with Mu variant infection during the third epidemic peak of COVID-19 in Colombia.
    Int J Infect Dis. 2022 Nov 1. pii: S1201-9712(22)00566.
    >> Share

    October 2022
  232. LAKATOS B, Szabo BG, Bobek I, Kiss-Dala N, et al
    Baricitinib versus tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: A prospective, investigational, real-world study.
    Int J Infect Dis. 2022 Oct 31. pii: S1201-9712(22)00577.
    >> Share

  233. FARRONI C, Aiello A, Picchianti-Diamanti A, Lagana B, et al
    Booster dose of SARS-CoV-2 mRNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study.
    Int J Infect Dis. 2022 Oct 31. pii: S1201-9712(22)00576.
    >> Share

  234. MATONO T, Izumiya H, Koga H, Kaku M, et al
    Epidemiologic and genomic investigations of an unusual increase in Salmonella enterica serovar Paratyphi A infection among travelers returning from Myanmar in 2015.
    Int J Infect Dis. 2022;125:170-176.
    >> Share

  235. LANGER-GOULD A, Xu S, Myers LC, Chen A, et al
    High-dose corticosteroids in patients hospitalized for COVID-19 pneumonia: an observational study of comparative effectiveness.
    Int J Infect Dis. 2022;125:184-191.
    >> Share

  236. XIN H, Wang Z, Feng S, Sun Z, et al
    Transmission dynamics of SARS-CoV-2 Omicron variant infections in Hangzhou, Zhejiang, China, January-February 2022.
    Int J Infect Dis. 2022;126:132-135.
    >> Share

  237. VISSER MPJ, Walk J, Vermeer C, Bilkova S, et al
    Enhanced vitamin K expenditure as a major contributor to vitamin K deficiency in COVID-19.
    Int J Infect Dis. 2022;125:275-277.
    >> Share

  238. CHEN CS, Chang CN, Chen SJ, Hu CF, et al
    Workup of cerebral involvement in patients with COVID-19 - authors' reply.
    Int J Infect Dis. 2022 Oct 26. pii: S1201-9712(22)00563.
    >> Share

  239. SCORZA CA, Finsterer J, Scorza FA, Almeida AG, et al
    Workup of cerebral involvement in COVID-19 requires at least cerebral imaging, EEG, and cerebrospinal fluid studies.
    Int J Infect Dis. 2022 Oct 20. pii: S1201-9712(22)00564.
    >> Share

  240. WANG X, Wen D, He Q, Yang J, et al
    Effect of Corticosteroids in Patients with COVID-19: A Bayesian Network Meta-analysis: Corticosteroids in COVID-19.
    Int J Infect Dis. 2022 Oct 19. pii: S1201-9712(22)00557.
    >> Share

  241. SESSA R, Masciullo L, Filardo S, Pietro MD, et al
    SARS-CoV-2 vertical transmission in a twin-pregnant woman: a case report.
    Int J Infect Dis. 2022 Oct 19. pii: S1201-9712(22)00558.
    >> Share

  242. BLACKMORE C, Czachorowski M, Farrington E, O'Moore E, et al
    Testing for COVID-19 during an outbreak within a large UK prison: an evaluation of mass testing to inform outbreak control.
    Int J Infect Dis. 2022 Oct 17. pii: S1201-9712(22)00556.
    >> Share

  243. DAHL VN, Molhave M, Floe A, van Ingen PJ, et al
    Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review.
    Int J Infect Dis. 2022 Oct 13. pii: S1201-9712(22)00551.
    >> Share

  244. YIN J, Chen Y, Li Y, Wang C, et al
    Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis.
    Int J Infect Dis. 2022 Oct 11. pii: S1201-9712(22)00542.
    >> Share

  245. WANG X, Xu H, Chu P, Zeng Y, et al
    Effects of COVID-19-targeted NPIs on children's respiratory admissions in China: a national multicenter time series study.
    Int J Infect Dis. 2022 Oct 11. pii: S1201-9712(22)00546.
    >> Share

  246. AGGARWAL NR, Beaty LE, Bennett TD, Carlson NE, et al
    Change in Effectiveness of Sotrovimab for Preventing Hospitalization and Mortality for At-risk COVID-19 Outpatients During an Omicron BA.1 and BA.1.1-Predominant Phase.
    Int J Infect Dis. 2022 Oct 10. pii: S1201-9712(22)00540.
    >> Share

  247. MIMURA W, Ishiguro C, Maeda M, Murata F, et al
    Effectiveness of mRNA vaccines against SARS-CoV-2 infections during the periods of Delta and Omicron variant predominance in Japan: The VENUS Study.
    Int J Infect Dis. 2022 Oct 8. pii: S1201-9712(22)00539.
    >> Share

  248. DE FREITAS AVC, Magalhaes AM, Carricondo PC, Avakian Shinzato A, et al
    Face masks can reduce the frequency of face touching: an observational crossover study.
    Int J Infect Dis. 2022;123:54-57.
    >> Share

    September 2022
  249. DAITCH V, Yelin D, Awwad M, Guaraldi G, et al
    Characteristics of long COVID among older adults: a cross-sectional study.
    Int J Infect Dis. 2022 Sep 30. pii: S1201-9712(22)00535.
    >> Share

  250. MUADCHIMKAEW M, Siripongboonsitti T, Wongpatcharawarakul S, Boonsankaew C, et al
    Effect of Inactivated SARS-CoV-2 Vaccines and ChAdOx1 nCoV-19 Vaccination to Prevent COVID-19 in Thai Households (VacPrevent trial).
    Int J Infect Dis. 2022 Sep 27. pii: S1201-9712(22)00531.
    >> Share

  251. ALHINAI Z, Park S, Choe YJ, Michelow IC, et al
    A global epidemiological analysis of COVID-19 vaccine types and clinical outcomes.
    Int J Infect Dis. 2022 Sep 22. pii: S1201-9712(22)00514.
    >> Share

  252. CHOBER D, Czajkowski Z, Aksak-Was B, Dalewska-Kucharczyk K, et al
    Improved survival in ICU in severe COVID-19 associated with amantadine use - retrospective study.
    Int J Infect Dis. 2022 Sep 21. pii: S1201-9712(22)00525.
    >> Share

  253. ZAQOUT A, Almaslamani MA, Chemaitelly H, Hashim SA, et al
    Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild-to-moderate SARS-CoV-2 in Qatar.
    Int J Infect Dis. 2022;124:96-103.
    >> Share

  254. TAMURA D, Yamagishi H, Morisawa Y, Mato T, et al
    Diagnostic accuracy of a novel severe acute respiratory syndrome coronavirus 2 rapid antigen test and usefulness of specimens collected from the anterior nasal cavity.
    Int J Infect Dis. 2022 Sep 16. pii: S1201-9712(22)00517.
    >> Share

  255. FENIZIA C, Vanetti C, Rana F, Cappelletti G, et al
    SARS-CoV-2 vertical transmission during the first trimester of pregnancy in asymptomatic women.
    Int J Infect Dis. 2022 Sep 16. pii: S1201-9712(22)00520.
    >> Share

  256. KUBO M, Kubo K, Kobayashi KI, Komiya N, et al
    Non-severe COVID-19 complicated by cytotoxic lesions of the corpus callosum (mild encephalitis/encephalopathy with a reversible splenial lesion): a case report and literature review.
    Int J Infect Dis. 2022 Sep 16. pii: S1201-9712(22)00508.
    >> Share

  257. ANDO M, Satonaga Y, Takaki R, Yabe M, et al
    Acute asthma exacerbation due to SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine [Comirnaty(R)]).
    Int J Infect Dis. 2022 Sep 16. pii: S1201-9712(22)00518.
    >> Share

  258. VICENTINI C, Bordino V, Cornio AR, Meddis D, et al
    Seroprevalence of infection-induced SARS-CoV-2 antibodies among healthcare users of Northern Italy - results from two serosurveys (October-November 2019 - September-October 2021).
    Int J Infect Dis. 2022 Sep 15. pii: S1201-9712(22)00513.
    >> Share

  259. ROTUNDO S, Vecchio E, Abatino A, Giordano C, et al
    Spike-specific T-cell responses in COVID-19 patients successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2.
    Int J Infect Dis. 2022 Sep 15. pii: S1201-9712(22)00515.
    >> Share

  260. KIM AY, Woo W, Yon DK, Lee SW, et al
    Corrigendum to 'Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis' International Journal of Infectious Diseases, Volume 119, June 2022, Page 130-139.
    Int J Infect Dis. 2022;123:166.
    >> Share

  261. D'ABRAMO A, Vita S, Colavita F, Cimini E, et al
    The first case of meningitis associated to SARS-Coronavirus-2 BA.2 variant infection with persistent viremia.
    Int J Infect Dis. 2022 Sep 12. pii: S1201-9712(22)00510.
    >> Share

  262. ANTONAZZO IC, Fornari C, Rozza D, Conti S, et al
    Azithromycin use and outcomes in COVID-19 patients: an observational real-world study.
    Int J Infect Dis. 2022 Sep 8. pii: S1201-9712(22)00504.
    >> Share

  263. GIUSEPPE S, Guarini R, Vaia F, Maggi F, et al
    Monitoring of SARS-CoV-2 circulation using saliva testing in school children, Rome, Italy.
    Int J Infect Dis. 2022 Sep 8. pii: S1201-9712(22)00502.
    >> Share

  264. ZAYET S, Vuillemenot JB, Josset L, Gendrin V, et al
    Simultaneous co-infection with Omicron (B.1.1.529) and Delta (21A/478K.V1) SARS-CoV-2 variants confirmed by whole genome sequencing.
    Int J Infect Dis. 2022 Sep 7. pii: S1201-9712(22)00501.
    >> Share

  265. CHEN CS, Chang CN, Hu CF, Jian MJ, et al
    Critical pediatric neurological illness associated with COVID-19 (Omicron BA.2.3.7 variant) infection in Taiwan: Immunological assessment and viral genome analysis in tertiary medical center.
    Int J Infect Dis. 2022 Sep 7. pii: S1201-9712(22)00500.
    >> Share

  266. ABROI A, Talas UG, Pauskar M, Shablinskaja A, et al
    SARS-CoV-2 dual infection of Delta and Omicron variants in an immunocompetent host - a case report.
    Int J Infect Dis. 2022 Sep 5. pii: S1201-9712(22)00497.
    >> Share

  267. LI YE, Wang S, Reiter RJ, Ren J, et al
    Clinical Cardiovascular Emergencies and the Cellular Basis of COVID-19 Vaccination: from a Dream to Reality?
    Int J Infect Dis. 2022 Sep 5. pii: S1201-9712(22)00498.
    >> Share

  268. LEE SS, Viboud C, Petersen E
    Understanding the rebound of influenza in the post COVID-19 pandemic period holds important clues for epidemiology and control.
    Int J Infect Dis. 2022;122:1002-1004.
    >> Share

    August 2022
  269. WAITS A, Chen JY, Cheng WH, Yeh JI, et al
    Safety and Immunogenicity of MVC-COV1901 Vaccine in Older Adults: Phase 2 Randomized Dose-Comparison Trial.
    Int J Infect Dis. 2022 Aug 29. pii: S1201-9712(22)00491.
    >> Share

  270. BRUNNER WM, Freilich D, Victory J, Krupa N, et al
    Comparison of Antibody Response Durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 Vaccines in Healthcare Workers.
    Int J Infect Dis. 2022 Aug 28. pii: S1201-9712(22)00492.
    >> Share

  271. ASSERI AA, Assiri M, Alshehri MA, Asseri M, et al
    Acute Encephalopathy in a 6-Year-Old Child with Concurrent Coronavirus Disease-2019 Infection: A Case Report from Saudi Arabia.
    Int J Infect Dis. 2022 Aug 20. pii: S1201-9712(22)00483.
    >> Share

  272. SAINZ-GARCIA A, Toledano P, Muro-Fraguas I, Alvarez-Erviti L, et al
    Mask Disinfection using Atmospheric Pressure Cold Plasma.
    Int J Infect Dis. 2022 Aug 19. pii: S1201-9712(22)00482.
    >> Share

  273. OEHLER RL, Vega VR
    Global Vaccine Inequality Threatens to Unleash the Next COVID-19 Variant.
    Int J Infect Dis. 2022 Aug 18. pii: S1201-9712(22)00480.
    >> Share

  274. GHAFFARZADEGAN N
    Effect of mandating vaccination on COVID-19 cases in colleges and universities.
    Int J Infect Dis. 2022 Aug 17. pii: S1201-9712(22)00477.
    >> Share

  275. VIEL S, Markowicz S, Ait-Medjber L, Ouissa R, et al
    Dedicated team to ambulatory care for patients with COVID-19 requiring oxygen: low rate of hospital readmission.
    Int J Infect Dis. 2022 Aug 17. pii: S1201-9712(22)00452.
    >> Share

  276. YU T, Liu F, Yin H, Yi N, et al
    Comment to the article by Pedro Brotons: Validation and implementation of a direct RT-qPCR method for rapid screening of SARS-CoV-2 infection by using non-invasive saliva samples, IJID 110 (2021) 363-370.
    Int J Infect Dis. 2022 Aug 17. pii: S1201-9712(22)00478.
    >> Share

  277. SANCHEZ-CONDE M, Vizcarra P, Perez-Garcia JM, Gion M, et al
    Pembrolizumab in combination with tocilizumab in high-risk hospitalized COVID-19 patients (COPERNICO): A randomized proof-of-concept phase II study.
    Int J Infect Dis. 2022 Aug 17. pii: S1201-9712(22)00475.
    >> Share

  278. NAVARATNAM AMD, Shrotri M, Nguyen V, Braithwaite I, et al
    Nucleocapsid and spike antibody responses post virologically confirmed SARS-CoV-2 infection: An observational analysis in the Virus Watch community cohort.
    Int J Infect Dis. 2022 Aug 17. pii: S1201-9712(22)00449.
    >> Share

  279. RAYMENANTS J, Duthoo W, Stakenborg T, Verbruggen B, et al
    Exhaled breath SARS-CoV-2 shedding patterns across variants of concern.
    Int J Infect Dis. 2022 Aug 3. pii: S1201-9712(22)00466.
    >> Share

  280. LIANG Y, Mao X, Kuang M, Zhi J, et al
    IL-6 affects the severity of olfactory disorder: A cross-sectional survey of 148 patients who recovered from Omicron infection using the Sniffin' Sticks test in Tianjin, China.
    Int J Infect Dis. 2022 Aug 2. pii: S1201-9712(22)00468.
    >> Share

  281. ALMADHI M, Alsayyad AS, Conroy R, Atkin S, et al
    EPIDEMIOLOGICAL ASSESSMENT OF SARS-COV-2 REINFECTION.
    Int J Infect Dis. 2022 Aug 2. pii: S1201-9712(22)00470.
    >> Share

    July 2022
  282. DE OLIVEIRA JF, de Avila RE, de Oliveira NR, da Cunha Severino Sampaio N, et al
    Persistent symptoms, quality of life and risk factors in long COVID: a cross-sectional study of hospitalized patients in Brazil.
    Int J Infect Dis. 2022 Jul 28. pii: S1201-9712(22)00458.
    >> Share

  283. SRECKOVIC M, Marjanovic RR, Jovicic BP, Jankovic S, et al
    MULTISYSTEM INFLAMMATORY SYNDROME IN YOUNG ADULT SUCCESSFULLY TREATED WITH PLASMAPHERESIS, IMMUNOGLOBULINS AND CORTICOSTEROIDS: A CASE REPORT.
    Int J Infect Dis. 2022 Jul 28. pii: S1201-9712(22)00454.
    >> Share

  284. LI T, Song R, Wang J, Zhang J, et al
    Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer.
    Int J Infect Dis. 2022 Jul 26. pii: S1201-9712(22)00446.
    >> Share

  285. DAHAL S, Mamelund SE, Luo R, Sattenspiel L, et al
    Investigating COVID-19 transmission and mortality differences among Indigenous and non-Indigenous populations in Mexico.
    Int J Infect Dis. 2022 Jul 26. pii: S1201-9712(22)00447.
    >> Share

  286. AIELLO A, Coppola A, Vanini V, Petrone L, et al
    Accuracy of QuantiFERON SARS-CoV-2 RUO assay and characterization of the CD4(+) and CD8(+) T-cell-SARS-CoV-2 response: comparison with a homemade IFN-gamma release assay.
    Int J Infect Dis. 2022 Jul 22. pii: S1201-9712(22)00444.
    >> Share

  287. DORIA G, Clemente C, Coelho E, Colaco J, et al
    An isothermal lab-on-phone test for easy molecular diagnostic of SARS-CoV-2 near patient and in less than 1 hour.
    Int J Infect Dis. 2022 Jul 22. pii: S1201-9712(22)00436.
    >> Share

  288. VALLADARES-GARRIDO MJ, Failoc-Rojas VE, Soto-Becerra P, Zena-Nanez S, et al
    Clinical-epidemiological variation in patients treated in the first and second wave of COVID-19 in Lambayeque, Peru: A cluster analysis.
    Int J Infect Dis. 2022 Jul 21. pii: S1201-9712(22)00442.
    >> Share

  289. VILLAFUERTE DB, Lavrynenko O, Qazi R, Passeri MF, et al
    Chronic Active Epstein-Barr Exacerbated by COVID-19 Co-Infection.
    Int J Infect Dis. 2022 Jul 21. pii: S1201-9712(22)00439.
    >> Share

  290. AKHMETZHANOV AR, Ponce L, Thompson RN
    Emergence potential of Monkeypox in the Western Pacific Region, July 2022.
    Int J Infect Dis. 2022 Jul 21. pii: S1201-9712(22)00441.
    >> Share

  291. LU J, Zhu J, Zhu J, Duong TQ, et al
    LSTM machine learning of longitudinal clinical data accurately predicts acute kidney injury onset in COVID-19: a two-center study.
    Int J Infect Dis. 2022 Jul 21. pii: S1201-9712(22)00429.
    >> Share

  292. ASSAWAKOSRI S, Kanokudom S, Chansaenroj J, Suntronwong N, et al
    Persistence of immunity against Omicron BA.1 and BA.2 following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-doses AZD1222 vaccination.
    Int J Infect Dis. 2022 Jul 18. pii: S1201-9712(22)00433.
    >> Share

  293. BAIRD D, Muir A, Logan L, MacLennan M, et al
    Validation of the NeuMoDx SARS-CoV-2 Assay with COPAN eNAT(R) and E&O Viral PCR Sample Solution (VPSS) collection media types in comparison with other validated SARS-CoV-2 RNA assays.
    Int J Infect Dis. 2022 Jul 15. pii: S1201-9712(22)00418.
    >> Share

  294. BHATNAGAR T, Chaudhuri S, Ponnaiah M, Yadav PD, et al
    Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: A multi-centric hospital-based case-control study.
    Int J Infect Dis. 2022 Jul 14. pii: S1201-9712(22)00427.
    >> Share

  295. YIN Q, Li Y, Pan H, Hui T, et al
    Atypical pneumonia caused by Chlamydia Psittaci during the COVID-19 pandemic.
    Int J Infect Dis. 2022 Jul 13. pii: S1201-9712(22)00422.
    >> Share

  296. VOOR IN 'T HOLT AF, Haanappel CP, Rahamat-Langendoen J, Molenkamp R, et al
    Admissions to a large tertiary care hospital and Omicron BA.1 and BA.2 SARS-CoV-2 PCR positivity: primary, contributing, or incidental COVID-19.
    Int J Infect Dis. 2022 Jul 13. pii: S1201-9712(22)00424.
    >> Share

  297. MAAMARI KA, Busaidi IA, Kindi MA, Zadjali F, et al
    Short and long-term immune changes in different severity groups of COVID-19 disease.
    Int J Infect Dis. 2022 Jul 12. pii: S1201-9712(22)00421.
    >> Share

  298. ALOTAIBY M, Krissaane I, Seraihi AA, Alshenaifi J, et al
    SARS-CoV-2 Reinfection Rate and Outcomes in Saudi Arabia: A National Retrospective Study.
    Int J Infect Dis. 2022 Jul 12. pii: S1201-9712(22)00420.
    >> Share

  299. JUANOLA-FALGARONA M, Penarrubia L, Jimenez-Guzman S, Porco R, et al
    Ct values as a diagnostic tool for monitoring SARS-CoV-2 viral load using the QIAstat-Dx(R) Respiratory SARS-CoV-2 Panel.
    Int J Infect Dis. 2022 Jul 12. pii: S1201-9712(22)00419.
    >> Share

  300. TOCZYLOWSKI K, Lasecka-Zadrozna J, Palyga-Bysiecka I, Ludwikowska KM, et al
    Use of broad-spectrum antibiotics in children diagnosed with multisystem inflammatory syndrome temporarily associated with SARS-CoV-2 infection in Poland: the MOIS-CoR study.
    Int J Infect Dis. 2022 Jul 10. pii: S1201-9712(22)00416.
    >> Share

  301. DASTENAE ZH, Bahadori A, Dehghani M, Asadi-Samani M, et al
    Comparison of the effect of intravenous dexamethasone and methylprednisolone on the treatment of hospitalized patients with COVID-19: A randomized clinical trial.
    Int J Infect Dis. 2022 Jul 8. pii: S1201-9712(22)00413.
    >> Share

  302. PETERSEN MS, Kongsstovu SI, Eliasen EH, Larsen S, et al
    Clinical characteristics of the Omicron variant - results from a Nationwide Symptoms Survey in the Faroe Islands.
    Int J Infect Dis. 2022 Jul 7. pii: S1201-9712(22)00405.
    >> Share

  303. NATH H, Mallick A, Roy S, Kayal T, et al
    COVID-19 serum can be cross-reactive and neutralizing against Dengue virus (DV) as observed by DV neutralization test.
    Int J Infect Dis. 2022 Jul 7. pii: S1201-9712(22)00408.
    >> Share

  304. BIBER A, Harmelin G, Lev D, Ram L, et al
    The effect of ivermectin on the viral load and culture viability in early treatment of non-hospitalized patients with mild COVID-19 - A double-blind, randomized placebo-controlled trial.
    Int J Infect Dis. 2022 Jul 7. pii: S1201-9712(22)00399.
    >> Share

  305. FUKUSHIMA T, Chubachi S, Namkoong H, Otake S, et al
    U-shaped association between abnormal serum uric acid levels and COVID-19 severity: Reports from the Japan COVID-19 Task Force.
    Int J Infect Dis. 2022 Jul 7. pii: S1201-9712(22)00409.
    >> Share

  306. MURUGESAN M, Venkatesan P, Kumar S, Thangavelu P, et al
    Epidemiological investigation of the COVID-19 outbreak in Vellore district in South India using Geographic Information Surveillance (GIS).
    Int J Infect Dis. 2022 Jul 7. pii: S1201-9712(22)00402.
    >> Share

  307. RICCIARDI A, Zelini P, Cassaniti I, Avanzini MA, et al
    Serum and breastmilk SARS-CoV-2 specific antibodies following BNT162b2 vaccine: Prolonged protection from SARS-CoV-2 in newborns and older children.
    Int J Infect Dis. 2022 Jul 5. pii: S1201-9712(22)00392.
    >> Share

  308. TOBBACK E, Degroote S, Buysse S, Delesie L, et al
    Efficacy and safety of camostat mesylate in early Covid-19 disease in an ambulatory setting: A randomized placebo-controlled phase II trial.
    Int J Infect Dis. 2022 Jul 5. pii: S1201-9712(22)00388.
    >> Share

  309. MALINOWSKA J, Malecka-Gieldowska M, Bankowska D, Borecka K, et al
    Hypermagnesemia and hyperphosphatemia are highly prevalent in COVID-19 patients and increase the risk of death.
    Int J Infect Dis. 2022 Jul 5. pii: S1201-9712(22)00394.
    >> Share

  310. SALEH T, Kerin T, Fuller T, Paiola S, et al
    Clinical and epidemiological characteristics of SARS-CoV-2 Infection in Los Angeles County youth during the first year of the pandemic.
    Int J Infect Dis. 2022 Jul 5. pii: S1201-9712(22)00374.
    >> Share

  311. LARSEN CS
    Assessing the proportion of the Danish population at risk of clinically significant drug-drug interactions with new oral antivirals for early treatment of COVID-19.
    Int J Infect Dis. 2022 Jul 5. pii: S1201-9712(22)00391.
    >> Share

  312. DESWAL V, Phogat R, Sharma P, Kataria S, et al
    Is single dose of ChAdOx1 nCoV-19 vaccine (AZD1222) enough for persons with prior SARS-CoV-2 infection or baseline seropositive status?
    Int J Infect Dis. 2022 Jul 3. pii: S1201-9712(22)00384.
    >> Share

  313. DING L, Chen Y, Su N, Xu X, et al
    Comparison of acute respiratory distress syndrome in patients with COVID-19 and influenza A (H7N9) virus infection.
    Int J Infect Dis. 2022 Jul 3. pii: S1201-9712(22)00387.
    >> Share

  314. KOH K, Tang KC, Axhausen K, Loo BP, et al
    A metropolitan-scale, three-dimensional agent-based model to assess the effectiveness of the COVID-19 Omicron wave interventions in a hyperdense city: a case study of Hong Kong.
    Int J Infect Dis. 2022 Jul 3. pii: S1201-9712(22)00376.
    >> Share

  315. XIONG L, Li Q, Cao X, Xiong H, et al
    Recovery of functional fitness, lung function and immune function in health care workers with non-severe and severe COVID-19 at 13 months after discharge from the hospital: a prospective cohort study.
    Int J Infect Dis. 2022 Jul 3. pii: S1201-9712(22)00386.
    >> Share

  316. CHEN NY, Liu ZH, Kao SW, Lin HS, et al
    Changes in Interferon-Gamma Release Assay Readout after COVID-19 Vaccination: A Prospective Cohort Study.
    Int J Infect Dis. 2022 Jul 1. pii: S1201-9712(22)00382.
    >> Share

  317. ORONSKY B, Larson C, Caroen S, Hedjran F, et al
    Nucleocapsid as a Next Generation COVID-19 Vaccine Candidate.
    Int J Infect Dis. 2022 Jul 1. pii: S1201-9712(22)00379.
    >> Share

  318. ISA F, Forleo-Neto E, Meyer J, Zheng W, et al
    Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19.
    Int J Infect Dis. 2022 Jul 1. pii: S1201-9712(22)00380.
    >> Share

    June 2022
  319. FARIDL M, Mellyani K, Khoirunnisa K, Septiani P, et al
    RNA-seq analysis of nasopharyngeal swabs from asymptomatic and mildly symptomatic COVID-19 patients.
    Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00368.
    >> Share

  320. DOS SANTOS PG, Vieira HCVS, Wietholter V, Gallina JP, et al
    When to test for COVID-19 using RT-PCR: a systematic review.
    Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00370.
    >> Share

  321. SBERNA G, Fabeni L, Berno G, Carletti F, et al
    Rapid and qualitative identification of SARS-CoV-2 mutations associated with Variants Of Concern (VOC) using a multiplex RT-PCR assay coupled with melting analysis.
    Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00367.
    >> Share

  322. HIROTSU Y, Maejima M, Shibusawa M, Natori Y, et al
    Classification of Omicron BA.1, BA.1.1 and BA.2 sublineages by TaqMan assay consistent with whole genome analysis data.
    Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00373.
    >> Share

  323. FINSTERER J, Scorza FA
    Rule out appropriately all differentials before attributing severe rhabdomyolysis to SARS-CoV-2 vaccination: COVID-19 associated abdominal epilepsy.
    Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00372.
    >> Share

  324. KAMURA Y, Matsue K
    Severe rhabdomyolysis and SARS-CoV-2 vaccination: A reply to the letter by Dr Josef Finsterer.
    Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00366.
    >> Share

  325. PETERSEN MS, Kristiansen MF, Hanusson KD, Foldbo BM, et al
    Prevalence of long COVID in a national cohort: longitudinal measures from disease onset until 8 months follow up.
    Int J Infect Dis. 2022 Jun 23. pii: S1201-9712(22)00364.
    >> Share

  326. RUTER J, Pallerla SR, Meyer CG, Casadei N, et al
    Host genetic loci LZTFL1 and CCL2 associated with SARS-CoV-2 infection and severity of COVID-19.
    Int J Infect Dis. 2022 Jun 23. pii: S1201-9712(22)00365.
    >> Share

  327. KSHATRI JS, Giri S, Bhattacharya D, Palo SK, et al
    Analysis of the COVID-19 testing parameters and progression of the pandemic at the district level- findings from the ICMR- Hundred Million Test (HMT) database during the first wave in India.
    Int J Infect Dis. 2022 Jun 22. pii: S1201-9712(22)00361.
    >> Share

  328. ROVIDA F, Esposito GL, Rissone M, Novelli V, et al
    Characteristics and outcome of vaccinated and non-vaccinated patients hospitalized in a single Italian HUB for COVID-19 during the Delta and Omicron waves in Northern Italy.
    Int J Infect Dis. 2022 Jun 21. pii: S1201-9712(22)00362.
    >> Share

  329. RIZZO R, Bortolotti D, Morandi L, Rizzo S, et al
    Humoral and adaptive immune responses to SARS-CoV-2 vaccine.
    Int J Infect Dis. 2022 Jun 21. pii: S1201-9712(22)00355.
    >> Share

  330. QUARANTA EG, Fusaro A, Giussani E, D'Amico V, et al
    SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient.
    Int J Infect Dis. 2022 Jun 17. pii: S1201-9712(22)00359.
    >> Share

  331. STAMBOULI N, Driss A, Gargouri F, Bahrini K, et al
    COVID-19 prophylaxis with Doxycycline and Zinc in Health Care Workers: A prospective randomized double-blind clinical trial.
    Int J Infect Dis. 2022 Jun 17. pii: S1201-9712(22)00349.
    >> Share

  332. QIN J, Wang G, Han D
    Benefits of plasma exchange on mortality in patients with COVID-19: a systematic review and meta-analysis.
    Int J Infect Dis. 2022 Jun 13. pii: S1201-9712(22)00348.
    >> Share

  333. KOLLER JE, Villinger K, Lages NC, Absetz P, et al
    Individual and collective protective responses during the early phase of the COVID-19 pandemic in 10 different countries: Results from the EUCLID online-survey.
    Int J Infect Dis. 2022 Jun 13. pii: S1201-9712(22)00347.
    >> Share

  334. CLARO F, Silva D, Bogado JAP, Rangel HR, et al
    Lasting SARS-CoV-2 specific IgG Antibody response in health care workers from Venezuela, 6 months after vaccination with Sputnik V.
    Int J Infect Dis. 2022 Jun 8. pii: S1201-9712(22)00341.
    >> Share

  335. TARNAS MC, Desai AN, Parker DM, Almhawish N, et al
    Syndromic surveillance of respiratory infections during protracted conflict: experiences from northern Syria 2016-2021.
    Int J Infect Dis. 2022 Jun 7. pii: S1201-9712(22)00336.
    >> Share

  336. SASANAMI M, Kayano T, Nishiura H
    Monitoring the COVID-19 immune landscape in Japan.
    Int J Infect Dis. 2022 Jun 7. pii: S1201-9712(22)00338.
    >> Share

  337. MANNATHOKO N, Mospele M, Gross R, Smith RM, et al
    Colonization with Extended-Spectrum Cephalosporin-Resistant Enterobacterales (ESCrE) and Carbapenem-Resistant Enterobacterales (CRE) in Healthcare and Community Settings in Botswana: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
    Int J Infect Dis. 2022 Jun 7. pii: S1201-9712(22)00337.
    >> Share

  338. KHONGYOT T, Moriyasu T
    Invasive Pneumococcal Disease diminish during the coronavirus disease 2019 in Japan between 2019 and 2022.
    Int J Infect Dis. 2022 Jun 4. pii: S1201-9712(22)00333.
    >> Share

  339. HERNANDEZ PORTO M, Garcia S, Delgado T, Rodriguez Y, et al
    Humoral response to SARS-COV-2 after vaccination and C in dialyzed patients.
    Int J Infect Dis. 2022 Jun 4. pii: S1201-9712(22)00335.
    >> Share

  340. DIVINO F, Alaimo Di Loro P, Farcomeni A, Jona-Lasinio G, et al
    Decreased severity of the Omicron variant of concern: further evidence from Italy.
    Int J Infect Dis. 2022;119:21-23.
    >> Share

    May 2022
  341. LAI X, Deng S, Hu L, Chen R, et al
    J-shaped associations and joint effects of fasting glucose with inflammation and cytokines on COVID-19 mortality.
    Int J Infect Dis. 2022 May 31. pii: S1201-9712(22)00324.
    >> Share

  342. BORDI L, Sberna G, Piscioneri CN, Cocchiara RA, et al
    Longitudinal dynamics of SARS-CoV2 anti-Receptor Binding Domain IgG antibodies in a wide population of health care workers after BNT162b2 vaccination.
    Int J Infect Dis. 2022 May 31. pii: S1201-9712(22)00325.
    >> Share

  343. BACHELARD A, Sautereau A, Digumber M, Isernia V, et al
    Risk Factors Associated with Severe/Critical COVID-19 in People Living with HIV-1.
    Int J Infect Dis. 2022 May 29. pii: S1201-9712(22)00320.
    >> Share

  344. JIN T, Chen X, Nishio M, Zhuang L, et al
    Interventions to prevent surface transmission of an infectious virus based on real human touch behavior: A case study of the norovirus.
    Int J Infect Dis. 2022 May 29. pii: S1201-9712(22)00311.
    >> Share

  345. ALBERTO-ORLANDO S, Calderon JL, Leon-Sosa A, Patino L, et al
    SARS-CoV-2 transmission from infected owner to household dogs and cats is associated to food sharing.
    Int J Infect Dis. 2022 May 25. pii: S1201-9712(22)00313.
    >> Share

  346. TEGETHOFF SA, Danziger G, Kuhn D, Kimmer C, et al
    TRAIL, IP-10, and CRP in predicting the progression of SARS-CoV-2 infection: A prospective, cohort study.
    Int J Infect Dis. 2022 May 25. pii: S1201-9712(22)00315.
    >> Share

  347. ALI M, Bonna AS, Sarkar AS, Islam MA, et al
    SARS-CoV-2 infection is associated with low back pain: Findings from a community based case-control study.
    Int J Infect Dis. 2022 May 25. pii: S1201-9712(22)00312.
    >> Share

  348. WAWINA-BOKALANGA T, Logist AS, Sinnesael R, Van Holm B, et al
    Genomic evidence of co-identification with Omicron and Delta SARS-CoV-2 variants: A report of two cases.
    Int J Infect Dis. 2022 May 20. pii: S1201-9712(22)00304.
    >> Share

  349. KORAYEM GB, Aljuhani O, Altebainawi AF, Shaya AIA, et al
    The Safety and Efficacy of Tocilizumab in Older Adult Critically Ill Patients with Coronavirus Disease 2019 (COVID-19): A Multi-center, Cohort Study.
    Int J Infect Dis. 2022 May 20. pii: S1201-9712(22)00302.
    >> Share

  350. MATTIUZZI C, Lippi G
    Real-world effectiveness of COVID-19 vaccination among children in Italy.
    Int J Infect Dis. 2022 May 19. pii: S1201-9712(22)00309.
    >> Share

  351. NTAGEREKA PB, Oyola SO, Baenyi SP, Rono GK, et al
    Whole-Genome Sequencing of SARS-CoV-2 Reveals Diverse Mutations in Circulating Alpha and Delta Variants during the First, Second and Third Waves of Covid-19 in South Kivu, East of the Democratic Republic of Congo.
    Int J Infect Dis. 2022 May 19. pii: S1201-9712(22)00307.
    >> Share

  352. KUDHAIL K, Thompson J, Mathews V, Morrison B, et al
    Randomised controlled trials in COVID-19 patients: a systematic review and critical appraisal.
    Int J Infect Dis. 2022 May 18. pii: S1201-9712(22)00299.
    >> Share

  353. KIRSCH F, Lindemann AK, Geppert J, Borzekowski D, et al
    Personal Protective Measures During the Coronavirus Pandemic in Germany.
    Int J Infect Dis. 2022 May 18. pii: S1201-9712(22)00297.
    >> Share

  354. EYU P, Elyanu P, Ario AR, Ntono V, et al
    Investigation of Possible Preventable Causes of COVID-19 Deaths in the Kampala Metropolitan Area, Uganda, 2020-2021.
    Int J Infect Dis. 2022 May 17. pii: S1201-9712(22)00296.
    >> Share

  355. GUPTA S, Gupta T, Gupt N
    Global Respiratory Virus Surveillance: Strengths, Gaps and Way Forward.
    Int J Infect Dis. 2022 May 15. pii: S1201-9712(22)00294.
    >> Share

  356. XUE L, Jing S, Zhang K, Milne R, et al
    Infectivity versus fatality of SARS-CoV-2 mutations and influenza.
    Int J Infect Dis. 2022 May 15. pii: S1201-9712(22)00295.
    >> Share

  357. OKOTURO E, Amure M
    SARS-CoV-2 saliva testing using reverse transcriptase - polymerase chain reaction (RT-PCR): A Systematic Review.
    Int J Infect Dis. 2022 May 13. pii: S1201-9712(22)00272.
    >> Share

  358. NISHIURA H, Jung SM, Hayashi K
    High population burden of Omicron variant (B.1.1.529) is associated with the emergence of severe hepatitis of unknown etiology in children.
    Int J Infect Dis. 2022 May 13. pii: S1201-9712(22)00290.
    >> Share

  359. MARCO R, Angelo DV
    Commentary to the paper: Association of smoking and severity of covid-19 infection among 5889 patients in malaysia: a multi-centre observational study, by Ismail N, Hassan N, Hamid MHNA, Yusoff UN, Khamal NR, Omar MA, et al. published in Int J Infect
    Int J Infect Dis. 2022 May 12. pii: S1201-9712(22)00284.
    >> Share

  360. INGHELS M, Kane R, Lall P, Nelson D, et al
    Ethnicity and risk of SARS-CoV-2 infection among the healthcare workforce: Results of a retrospective cohort study in rural United Kingdom.
    Int J Infect Dis. 2022 May 12. pii: S1201-9712(22)00281.
    >> Share

  361. YILDIZ Y, Ozger HS, Senol E, Karakus R, et al
    Evaluation of long term antibody kinetics in healthcare workers (HCWs) vaccinated with inactivated COVID-19 vero cell vaccine (CoronaVac), a propensity score matched observational study: Antibody kinetics in HCWs after CoronaVac vaccination.
    Int J Infect Dis. 2022 May 11. pii: S1201-9712(22)00271.
    >> Share

  362. OLIVEIRA-SILVA J, Reis T, Lopes C, Batista-Silva R, et al
    Long term serological SARS-CoV-2 IgG kinetics following mRNA COVID-19 vaccine: real-world data from a large cohort of healthcare workers.
    Int J Infect Dis. 2022 May 11. pii: S1201-9712(22)00289.
    >> Share

  363. CHEN F, Tian Y, Zhang L, Shi Y, et al
    The Role of Children in Household Transmission of COVID-19: A Systematic Review and Meta-Analysis.
    Int J Infect Dis. 2022 May 10. pii: S1201-9712(22)00283.
    >> Share

  364. ICHIKAWA T, Torii S, Suzuki H, Takada A, et al
    Mutations in the non-structural proteins of SARS-CoV-2 may contribute to adverse clinical outcome in COVID-19 patients.
    Int J Infect Dis. 2022 May 10. pii: S1201-9712(22)00275.
    >> Share

  365. BALUSHI AA, Ajmi AA, Sinani QA, Menon V, et al
    COVID-19 Associated Mucormycosis: Opportunistic Fugal Infection. A case series and review.
    Int J Infect Dis. 2022 May 6. pii: S1201-9712(22)00267.
    >> Share

  366. COLANERI M, Amarasinghe N, Rezzonico L, Pieri TC, et al
    Early Remdesivir to prevent severe COVID-19 in solid organ transplant recipients: a real-life study from Northern Italy.
    Int J Infect Dis. 2022 May 6. pii: S1201-9712(22)00263.
    >> Share

    April 2022
  367. KAMEGAI K, Iwamoto N, Togano T, Maeda K, et al
    A Fatal Breakthrough Coronavirus Disease 2019 Case Following Bendamustine-Rituximab Therapy.
    Int J Infect Dis. 2022 Apr 29. pii: S1201-9712(22)00258.
    >> Share

  368. YOSHIMURA Y, Sasaki H, Miyata N, Miyazaki K, et al
    An autopsy case of COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination.
    Int J Infect Dis. 2022 Apr 29. pii: S1201-9712(22)00257.
    >> Share

  369. HUSIN M, Tok PSK, Suah JL, Thevananthan T, et al
    Real-world effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection among adolescents (12 to 17-year-olds) in Malaysia.
    Int J Infect Dis. 2022 Apr 29. pii: S1201-9712(22)00251.
    >> Share

  370. BHAKTA S, Sanghavi DK, Johnson PW, Kunze KL, et al
    Clinical and Laboratory Profiles of SARS-CoV-2 Delta Variant Compared to Pre-Delta Variants.
    Int J Infect Dis. 2022 Apr 26. pii: S1201-9712(22)00252.
    >> Share

  371. PAROLINA L, Pshenichnaya N, Vasilyeva I, Lizinfed I, et al
    Clinical characteristics of COVID-19 in TB patients and factors associated with the disease severity.
    Int J Infect Dis. 2022 Apr 25. pii: S1201-9712(22)00232.
    >> Share

  372. LI J, Liu B, Tang X, Wu Z, et al
    Development of a smartphone based quantum-dot lateral flow immunoassay strip for ultrasensitive detection of anti-SARS-CoV-2 IgG and neutralizing antibodies.
    Int J Infect Dis. 2022 Apr 25. pii: S1201-9712(22)00235.
    >> Share

  373. MURILLO-ZAMORA E, Trujillo X, Huerta M, Rios-Silva M, et al
    COVID-19 vaccines provide better protection against related pneumonia than previous symptomatic infection.
    Int J Infect Dis. 2022 Apr 24. pii: S1201-9712(22)00245.
    >> Share

  374. XIA Y, Ma H, Buckeridge DL, Brisson M, et al
    Mortality trends and lengths of stay among hospitalized COVID-19 patients in Ontario and Quebec (Canada): a population-based cohort study of the first three epidemic waves.
    Int J Infect Dis. 2022 Apr 24. pii: S1201-9712(22)00246.
    >> Share

  375. STEIN M, Cohen H, Nemet I, Atari N, et al
    Human Metapneumovirus prevalence during 2019-2021 in Israel is influence by the COVID-19 pandemic.
    Int J Infect Dis. 2022 Apr 23. pii: S1201-9712(22)00241.
    >> Share

  376. TORRES JP, Saure D, Basso LJ, Zuniga M, et al
    SARS-COV-2 IgG positivity in vaccinated and non-vaccinated Chilean children: a national cross-sectional study in Schools.
    Int J Infect Dis. 2022 Apr 23. pii: S1201-9712(22)00238.
    >> Share

  377. LAI MY, Bukhari FDM, Zulkefli NZ, Ismail I, et al
    Colorimetric detection of SARS-CoV-2 by uracil-DNA glycosylase (UDG) reverse transcription loop-mediated isothermal amplification (RT-LAMP).
    Int J Infect Dis. 2022 Apr 23. pii: S1201-9712(22)00239.
    >> Share

  378. MAMETJA S, Dessie ZG, Matoti L, Semenya M, et al
    Clinical Management of COVID-19 in Hospitals and the Community: A Snapshot from a Medical Insurance Database in South Africa.
    Int J Infect Dis. 2022 Apr 22. pii: S1201-9712(22)00231.
    >> Share

  379. HUNG DT, Ghula S, Aziz JMA, Makram AM, et al
    The efficacy and adverse effects of favipiravir on COVID-19 patients: a systematic review and meta-analysis of published clinical trials and observational studies.
    Int J Infect Dis. 2022 Apr 22. pii: S1201-9712(22)00237.
    >> Share

  380. PETRONE L, Picchianti-Diamanti A, Sebastiani GD, Aiello A, et al
    Humoral and cellular responses to spike of delta SARS-CoV-2 variant in vaccinated patients with Immune Mediated Inflammatory Diseases.
    Int J Infect Dis. 2022 Apr 21. pii: S1201-9712(22)00229.
    >> Share

  381. LIU Y, Yu Y, Zhao Y, He D, et al
    Reduction in the infection fatality rate of Omicron variant compared to previous variants in South Africa.
    Int J Infect Dis. 2022 Apr 21. pii: S1201-9712(22)00228.
    >> Share

  382. KOUTALOS AA, Stefanou N, Malizos KN
    Post-acute sequelae of SARS-CoV-2 infection. Osteonecrosis must not be overlooked.
    Int J Infect Dis. 2022 Apr 21. pii: S1201-9712(22)00226.
    >> Share

  383. JAHAN N, Brahma A, Kumar MS, Bagepally BS, et al
    Corrigendum to 'Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020-August 2021: a systematic review and meta-analysis' [International Journal of Infectious Diseases, Volume 116 (2022) P59-67].
    Int J Infect Dis. 2022;119:119.
    >> Share

  384. VOO TC, Ballantyne A, Jenn NC, Cowling BJ, et al
    Public acceptability of COVID-19 control measures in Singapore, Hong Kong, and Malaysia: A cross-sectional survey.
    Int J Infect Dis. 2022 Apr 14. pii: S1201-9712(22)00222.
    >> Share

  385. TEGELER CM, Bilich T, Maringer Y, Salih HR, et al
    Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort.
    Int J Infect Dis. 2022 Apr 14. pii: S1201-9712(22)00219.
    >> Share

  386. RAMIREZ C, Duron RM
    The Russia-Ukraine war could bring catastrophic public-health challenges beyond COVID-19.
    Int J Infect Dis. 2022 Apr 12. pii: S1201-9712(22)00215.
    >> Share

  387. TEMBO J, Egbe NF, Maluzi K, Mulonga K, et al
    Evaluation of SARS-CoV-2 diagnostics and risk factors associated with SARS-CoV-2 infection in Zambia.
    Int J Infect Dis. 2022 Apr 12. pii: S1201-9712(22)00216.
    >> Share

  388. LIU K, Wang X, Song G
    Association of epicardial adipose tissue with the severity and adverse clinical outcomes of COVID-19: A meta-analysis.
    Int J Infect Dis. 2022 Apr 11. pii: S1201-9712(22)00212.
    >> Share

  389. JABAL KA, Edelstein M
    Using SARS-CoV-2 anti-S IgG levels as a marker of previous infection: Example from an Israeli Healthcare worker cohort.
    Int J Infect Dis. 2022 Apr 9. pii: S1201-9712(22)00209.
    >> Share

  390. WOLDAY D, de Wit TFR
    Response to Abdelrahman M et al commentary on "Parasites Protect from Severe COVID-19. Myth or Reality?"
    Int J Infect Dis. 2022 Apr 9. pii: S1201-9712(22)00211.
    >> Share

  391. SOMAN R, Chakraborty S, Joe G
    Posaconazole or Isavuconazole as sole or predominant anti-fungal therapy for COVID-19 associated Mucormycosis. A retrospective observational case series.
    Int J Infect Dis. 2022 Apr 8. pii: S1201-9712(22)00208.
    >> Share

  392. HAMBRIDGE HL, Kahn R, Onnela JP
    Effect of a Two-Dose vs Three-Dose Vaccine Strategy in Residential Colleges Using an Empirical Proximity Network.
    Int J Infect Dis. 2022 Apr 8. pii: S1201-9712(22)00206.
    >> Share

  393. DI LEGO V, Sanchez-Romero M, Prskawetz A
    The impact of COVID-19 vaccines on the Case Fatality Rate: The importance of monitoring breakthrough infections.
    Int J Infect Dis. 2022 Apr 6. pii: S1201-9712(22)00197.
    >> Share

  394. HO LL, Gurung S, Mirza I, Nicolas HD, et al
    Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns.
    Int J Infect Dis. 2022 Apr 6. pii: S1201-9712(22)00204.
    >> Share

  395. WANG X, Wei J, Zhu R, Chen L, et al
    Contribution of CD4+ T cell mediated inflammation to diarrhoea in patients with COVID-19.
    Int J Infect Dis. 2022 Apr 6. pii: S1201-9712(22)00201.
    >> Share

  396. MEDHAT R, El Lababidi R, Abdelsalam M, Nusair A, et al
    Varicella Zoster Virus (VZV) Meningitis in an Immunocompetent Adult following BNT162b2 mRNA COVID-19 Vaccination: A Case Report.
    Int J Infect Dis. 2022 Apr 6. pii: S1201-9712(22)00200.
    >> Share

    March 2022
  397. BURANASAKDA M, Kotruchin P, Phanthachai K, Mootsikapun P, et al
    Varicella zoster meningitis following COVID-19 vaccination: a report of two cases.
    Int J Infect Dis. 2022 Mar 30. pii: S1201-9712(22)00192.
    >> Share

  398. KLOPFENSTEIN T, Tipirdamaz C, Gendrin V, Osman M, et al
    Third of patients have gustatory dysfunction 9 months after SARS-CoV-2 infection: the ANOSVID study.
    Int J Infect Dis. 2022 Mar 29. pii: S1201-9712(22)00193.
    >> Share

  399. JEGERLEHNER S, Suter-Riniker F, Jent P, Bittel P, et al
    Diagnostic accuracy of SARS-CoV-2 saliva antigen testing in a real-life clinical setting.
    Int J Infect Dis. 2022 Mar 29. pii: S1201-9712(22)00176.
    >> Share

  400. GHOSH A, Walia S, Rattan R, Kanampalliwar A, et al
    Genomic profiles of vaccine breakthrough SARS-CoV-2 strains from Odisha, India.
    Int J Infect Dis. 2022 Mar 28. pii: S1201-9712(22)00181.
    >> Share

  401. ARKELL P, Gusmao C, Sheridan SL, Tanesi MY, et al
    Serological surveillance of healthcare workers to evaluate natural infection- and vaccine-derived immunity to SARS-CoV-2 during an outbreak in Dili, Timor-Leste.
    Int J Infect Dis. 2022 Mar 28. pii: S1201-9712(22)00183.
    >> Share

  402. JACKSON I, Jaradeh H, Aurit S, Aldamen A, et al
    Role of procalcitonin as a predictor of clinical outcomes in hospitalized patients with COVID-19.
    Int J Infect Dis. 2022 Mar 28. pii: S1201-9712(22)00179.
    >> Share

  403. ABU-ODAH H, Su JJ, Musa SS
    Unwillingness or reluctance of Palestinians to get COVID-19 vaccine: the reasons behind it and how to persuade them.
    Int J Infect Dis. 2022 Mar 25. pii: S1201-9712(22)00178.
    >> Share

  404. CHANDA-KAPATA P, Ntoumi F, Kapata N, Lungu P, et al
    Tuberculosis, HIV/AIDS and Malaria Health Services in sub-Saharan Africa - A Situation Analysis of the Disruptions and Impact of the COVID-19 Pandemic.
    Int J Infect Dis. 2022 Mar 24. pii: S1201-9712(22)00173.
    >> Share

  405. KIM AY, Woo W, Yon DK, Lee SW, et al
    Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis.
    Int J Infect Dis. 2022 Mar 23. pii: S1201-9712(22)00171.
    >> Share

  406. LI R, Liu H, Fairley CK, Zou Z, et al
    Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States.
    Int J Infect Dis. 2022 Mar 22. pii: S1201-9712(22)00168.
    >> Share

  407. SUAH JL, Husin M, Keng PS, Hwa B, et al
    Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study.
    Int J Infect Dis. 2022 Mar 21. pii: S1201-9712(22)00167.
    >> Share

  408. GUO Q, Wang J, Estill J, Lan H, et al
    Risk of COVID-19 Transmission Aboard Aircraft: An Epidemiological Analysis Based on the National Health Information Platform.
    Int J Infect Dis. 2022 Mar 21. pii: S1201-9712(22)00163.
    >> Share

  409. MAKRAM AM, Alied M, Khan ZA, Huy NT, et al
    Parasites Protect from Severe COVID-19. Myth or Reality?
    Int J Infect Dis. 2022 Mar 21. pii: S1201-9712(22)00164.
    >> Share

  410. JEREMIAH C, Petersen E, Nantanda R, Mungai BN, et al
    The WHO Global Tuberculosis 2021 Report - not so good news and turning the tide back to End TB.
    Int J Infect Dis. 2022 Mar 20. pii: S1201-9712(22)00149.
    >> Share

  411. SHANAUBE K, Schaap A, Klinkenberg E, Floyd S, et al
    SARS-CoV-2 seroprevalence and associated risk factors in peri-urban Zambia: a population-based study.
    Int J Infect Dis. 2022 Mar 16. pii: S1201-9712(22)00158.
    >> Share

  412. INADA M, Ishikane M, Terada M, Matsunaga A, et al
    Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection.
    Int J Infect Dis. 2022 Mar 16. pii: S1201-9712(22)00155.
    >> Share

  413. ONO A, Koizumi R, Tsuzuki S, Asai Y, et al
    Antimicrobial Use Fell Substantially in Japan in 2020-The COVID-19 Pandemic May Have Played a Role.
    Int J Infect Dis. 2022 Mar 16. pii: S1201-9712(22)00157.
    >> Share

  414. ELEC F, Magnusson J, Elec A, Muntean A, et al
    COVID-19 AND KIDNEY TRANSPLANTATION: THE IMPACT OF REMDESIVIR ON RENAL FUNCTION AND OUTCOME- A RETROSPECTIVE COHORT STUDY.
    Int J Infect Dis. 2022 Mar 14. pii: S1201-9712(22)00151.
    >> Share

  415. NTOUMI F, Petersen E, Mwaba P, Aklillu E, et al
    Blue Skies research is essential for ending the Tuberculosis pandemic and advancing a personalized medicine approach for holistic management of Respiratory Tract infections.: Invited viewpoint: IJID World TB Day series 2022.
    Int J Infect Dis. 2022 Mar 14. pii: S1201-9712(22)00150.
    >> Share

  416. O'KELLY B, Vidal L, Avramovic G, Broughan J, et al
    Assessing the impact of COVID-19 at 1 year using the SF-12 questionnaire: Data from the Anticipate longitudinal cohort study.
    Int J Infect Dis. 2022 Mar 14. pii: S1201-9712(22)00152.
    >> Share

  417. MATTIUZZI C, Henry BM, Lippi G
    COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a light at the end of the tunnel?
    Int J Infect Dis. 2022 Mar 9. pii: S1201-9712(22)00146.
    >> Share

  418. LEE DS, Kim JW, Lee KL, Jung YJ, et al
    Adverse events following coronavirus disease 2019 vaccination in South Korea between February 28 and August 21, 2021: A nationwide observational study.
    Int J Infect Dis. 2022 Mar 8. pii: S1201-9712(22)00145.
    >> Share

  419. GLINERT I, Ben-Shmuel A, Szwartcwort-Cohen M, Beth-Din A, et al
    Revisiting SARS-CoV-2 environmental contamination by COVID-19 patients: The Omicron variant does not differ from previous strains.
    Int J Infect Dis. 2022 Mar 4. pii: S1201-9712(22)00139.
    >> Share

  420. LIU ZG, Li XY
    Interpretation of Discrepancies between Cities in the Transmission of COVID-19: Evidence from China in the First Weeks of the Pandemic: Interpreting the Discrepancies of COVID-19 Transmission.
    Int J Infect Dis. 2022 Mar 4. pii: S1201-9712(22)00142.
    >> Share

  421. MORENO-GARCIA E, Puerta-Alcalde P, Letona L, Meira F, et al
    Bacterial co-infection at hospital admission in patients with COVID-19.
    Int J Infect Dis. 2022 Mar 4. pii: S1201-9712(22)00143.
    >> Share

  422. ADRIEN CSK, Alexandre C, Marie M, Cedric J, et al
    Number of initial symptoms is more related to long COVID-19 than acute severity of infection: a prospective cohort of hospitalized patients.
    Int J Infect Dis. 2022 Mar 4. pii: S1201-9712(22)00141.
    >> Share

  423. RODRIGUEZ GD, Wu Y, Karnik K, Ruddy S, et al
    Implementation of a Collaborated Antimicrobial Stewardship Program and Outpatient Parenteral Antimicrobial Therapy (OPAT) Unit-driven Monoclonal Antibody Therapy Program for COVID-19 at a NYC Hospital.
    Int J Infect Dis. 2022 Mar 3. pii: S1201-9712(22)00137.
    >> Share

  424. ASSAL HH, Abdelrahman S, Abdelbasset MA, Abdelaziz M, et al
    Presepsin as a Novel Biomarker in predicting Inhospital Mortality in COVID-19 Pneumonia Patients.
    Int J Infect Dis. 2022 Mar 3. pii: S1201-9712(22)00136.
    >> Share

  425. PETERSEN E, Al-Abri S, Chakaya J, Goletti D, et al
    World TB Day 2022: Revamping and Reshaping Global TB Control Programs by Advancing Lessons learnt from the COVID-19 pandemic.
    Int J Infect Dis. 2022 Mar 3. pii: S1201-9712(22)00138.
    >> Share

  426. MUSSO N, Maugeri JG, Bongiorno D, Stracquadanio S, et al
    SARS-CoV-2's high rate of genetic mutation under immune selective pressure: from oropharyngeal B.1.1.7 to intrapulmonary B.1.533 in a post-vaccine patient.
    Int J Infect Dis. 2022 Mar 2. pii: S1201-9712(22)00123.
    >> Share

  427. LAYER E, Hoehl S, Ciesek S, Widera M, et al
    SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach.
    Int J Infect Dis. 2022 Mar 2. pii: S1201-9712(22)00121.
    >> Share

  428. EFIMENKO I, Nackeeran S, Jabori S, Zamora JAG, et al
    REMOVED: Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients: Analysis of a National Federated Database.
    Int J Infect Dis. 2022;116S:S40.
    >> Share

    February 2022
  429. HUSSEY H, Davies MA, Heekes A, Williamson C, et al
    Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections - a survival analysis.
    Int J Infect Dis. 2022 Feb 27. pii: S1201-9712(22)00129.
    >> Share

  430. SHURRAB FM, Younes N, Al-Sadeq DW, Liu N, et al
    Performance evaluation of novel fluorescent-based lateral immune flow assay (LIFA) for rapid detection and quantification of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals.
    Int J Infect Dis. 2022 Feb 26. pii: S1201-9712(22)00130.
    >> Share

  431. ROUAMBA T, Ouedraogo E, Barry H, Yameogo NV, et al
    Assessment of Recovery Time, Worsening and Death, among COVID-19 inpatients and outpatients, under treatment with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso.
    Int J Infect Dis. 2022 Feb 25. pii: S1201-9712(22)00111.
    >> Share

  432. ALBAHRANI S, Ahmadi NA, Hamdan S, Elsheikh N, et al
    Clinical Presentation and Outcome of hospitalized patients with COVID-19 in the first and second wave in Saudi Arabia.
    Int J Infect Dis. 2022 Feb 25. pii: S1201-9712(22)00127.
    >> Share

  433. THEOHARIDES TC, Guerra L, Patel K
    Successful Treatment of a Severe COVID-19 Patient Using an Integrated Approach Addressing Mast Cells and Their Mediators.
    Int J Infect Dis. 2022 Feb 25. pii: S1201-9712(22)00128.
    >> Share

  434. HIRATA M, Fukuchi T, Sugawara H
    Trajectory of SARS-CoV-2 anti-S IgG levels following transfusion and a third dose of BNT162b2 vaccine in a patient with massive postoperative bleeding: A case report.
    Int J Infect Dis. 2022 Feb 24. pii: S1201-9712(22)00122.
    >> Share

  435. XIE M, Dong N, Zhang X, He D, et al
    Exported Cases were Infected on the Way: A Conjecture Derived from Analysis on Hong Kong Monthly Exported Covid-19 Cases.
    Int J Infect Dis. 2022 Feb 23. pii: S1201-9712(22)00102.
    >> Share

  436. ROSENTHAL VD, Myatra SN, Divatia JV, Biswas S, et al
    The impact of COVID-19 on healthcare-associated infections in intensive care units in low and middle income countries: International Nosocomial Infection Control Consortium (INICC) findings.
    Int J Infect Dis. 2022 Feb 23. pii: S1201-9712(22)00120.
    >> Share

  437. LITCHFIELD M, Brookes P, Ojrzynska A, Kavi J, et al
    Comparison of the clinical sensitivity and specificity of two commercial RNA SARS-CoV-2 assays.
    Int J Infect Dis. 2022 Feb 22. pii: S1201-9712(22)00109.
    >> Share

  438. VICKERS DM, Baral S, Mishra S, Kwong JC, et al
    Stringency of Containment and Closures on the Growth of SARS-CoV-2 in Canada prior to Accelerated Vaccine Roll-Out.
    Int J Infect Dis. 2022 Feb 21. pii: S1201-9712(22)00108.
    >> Share

  439. CUCUNAWANGSIH C, Wijaya RS, Lugito NPH, Suriapranata I, et al
    Antibody response after a third dose mRNA-1273 vaccine among vaccinated healthcare workers with two doses of inactivated SARS-CoV-2 vaccine.
    Int J Infect Dis. 2022 Feb 19. pii: S1201-9712(22)00114.
    >> Share

  440. TSUZUKI S, Hayakawa K, Uemura Y, Shinozaki T, et al
    Efficacy of remdesivir in hospitalized nonsevere COVID-19 patients in Japan: A large observational study using the COVID-19 Registry Japan.
    Int J Infect Dis. 2022 Feb 19. pii: S1201-9712(22)00118.
    >> Share

  441. DIAS R, Caldas JP, Silva-Pinto A, Costa A, et al
    Delirium severity in critical COVID-19 patients from an Infectious Disease Intensive Care Unit.
    Int J Infect Dis. 2022 Feb 19. pii: S1201-9712(22)00112.
    >> Share

  442. DHUMAL S, Patil A, More A, Kamtalwar S, et al
    SARS-COV-2 reinfection after previous infection and vaccine breakthrough infection through the second wave of pandemic in India: An observational study.
    Int J Infect Dis. 2022 Feb 19. pii: S1201-9712(22)00115.
    >> Share

  443. GRAVNINGEN K, Henriksen S, Hungnes O, Svendsen K, et al
    Risk factors, immune response and whole-genome sequencing of SARS-CoV-2 in a cruise ship outbreak in Norway.
    Int J Infect Dis. 2022 Feb 18. pii: S1201-9712(22)00104.
    >> Share

  444. KAMURA Y, Terao T, Akao S, Kono Y, et al
    Fatal thrombotic microangiopathy with rhabdomyolysis as an initial symptom after the first dose of mRNA-1273 vaccine: A case report.
    Int J Infect Dis. 2022 Feb 18. pii: S1201-9712(22)00107.
    >> Share

  445. MORITA Y, Kurano M, Jubishi D, Ikeda M, et al
    Urine sediment findings were milder in patients with COVID-19-associated renal injuries than in those with non-COVID-19-associated renal injuries.
    Int J Infect Dis. 2022 Feb 16. pii: S1201-9712(22)00101.
    >> Share

  446. KAKINOKI Y, Yamada K, Tanino Y, Suzuki K, et al
    Impact of Antibody Cocktail Therapy Combined with Casirivimab and Imdevimab on Clinical Outcome for Covid-19 patients in A Real-Life Setting: A Single Institute Analysis.
    Int J Infect Dis. 2022 Feb 14. pii: S1201-9712(22)00076.
    >> Share

  447. FALTIN K, Lewandowska Z, Malecki P, Czyz K, et al
    SARS-CoV-2 attacks the weakest point - COVID-19 course in a pediatric patient with Friedreich's ataxia.
    Int J Infect Dis. 2022 Feb 13. pii: S1201-9712(22)00098.
    >> Share

  448. MORENO-PEREZ O, Ribes I, Boix V, Martinez-Garcia MA, et al
    Hospitalized patients with breakthrough COVID-19: Clinical features and poor outcome predictors.
    Int J Infect Dis. 2022 Feb 13. pii: S1201-9712(22)00084.
    >> Share

  449. HAFEZ W, Ziade MA, Arya A, Saleh H, et al
    Reduced ADAMTS13 Activity in Correlation with Pathophysiology, Severity, and Outcome of COVID-19; A Retrospective Observational Study.
    Int J Infect Dis. 2022 Feb 12. pii: S1201-9712(22)00097.
    >> Share

  450. MURILLO-ZAMORA E, Sanchez-Pina RA, Trujillo X, Huerta M, et al
    Independent risk factors of COVID-19 pneumonia in vaccinated Mexican adults.
    Int J Infect Dis. 2022 Feb 12. pii: S1201-9712(22)00078.
    >> Share

  451. FINSTERER J, Matovu D
    Exclude differentials before diagnosing SARS-CoV-2 assocaited acute, hemorrhaghic, necrotising encephalitis.
    Int J Infect Dis. 2022 Feb 10. pii: S1201-9712(22)00094.
    >> Share

  452. MIERZEWSKA-SCHMIDT M, Baranowski A, Szymanska K, Ciaston M, et al
    Authors' response to Dr Finsterer's comment "Exclude differentials before diagnosing SARS-CoV-2 associated acute, hemorrhaghic, necrotising encephalitis".
    Int J Infect Dis. 2022 Feb 10. pii: S1201-9712(22)00092.
    >> Share

  453. KOJIMA N, Roshani A, Brobeck M, Baca A, et al
    Incidence of Severe Acute Respiratory Syndrome Coronavirus-2 infection among previously infected or vaccinated employees.
    Int J Infect Dis. 2022 Feb 10. pii: S1201-9712(22)00091.
    >> Share

  454. BIRGAND G, Charani E, Ahmad R, Bonaconsa C, et al
    Interventional research to tackle antimicrobial resistance in Low Middle Income Countries in the era of the COVID-19 pandemic: lessons in resilience from an international consortium.
    Int J Infect Dis. 2022 Feb 9. pii: S1201-9712(22)00090.
    >> Share

  455. FERNANDEZ-DE-LAS-PENAS C, Martin-Guerrero JD, Cancela-Cilleruelo I, Moro-Lopez-Menchero P, et al
    Exploring the Trajectory Recovery Curve of the number of Post-COVID Symptoms: The LONG-COVID-EXP-CM Multicenter Study.
    Int J Infect Dis. 2022 Feb 9. pii: S1201-9712(22)00083.
    >> Share

  456. VICIANI E, Gaibani P, Castagnetti A, Liberatore A, et al
    Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in Candida spp colonized patients.
    Int J Infect Dis. 2022 Feb 9. pii: S1201-9712(22)00088.
    >> Share

  457. MONTANO MA, Bemer MJ, Heller KB, Meisner A, et al
    Performance of anterior nares and tongue swabs for nucleic acid, Nucleocapsid and Spike antigen testing for detecting SARS-CoV-2 against nasopharyngeal PCR and viral culture.
    Int J Infect Dis. 2022 Feb 8. pii: S1201-9712(22)00086.
    >> Share

  458. GARGOURI S, Abid N, Karray-Hakim H, Rebai A, et al
    Reply to letter to the editor by Lippi and Plebani: << The presence of anti-SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization >> (THEIJID-D-22-00085).
    Int J Infect Dis. 2022 Feb 6. pii: S1201-9712(22)00067.
    >> Share

  459. LIU N, Yang D, Zhang T, Sun J, et al
    Systematic review and meta-analysis of olfactory and gustatory dysfunction in coronavirus disease 2019.
    Int J Infect Dis. 2022 Feb 5. pii: S1201-9712(22)00079.
    >> Share

  460. AVERHOFF F, Berg M, Rodgers M, Osmanov S, et al
    The Abbott Pandemic Defense Coalition: a unique multi-sector approach adds to global pandemic preparedness efforts.
    Int J Infect Dis. 2022 Feb 5. pii: S1201-9712(22)00080.
    >> Share

  461. LIM RHF, Htun HL, Li AL, Guo H, et al
    Fending off Delta - Hospital measures to reduce nosocomial transmission of COVID-19.
    Int J Infect Dis. 2022 Feb 3. pii: S1201-9712(22)00077.
    >> Share

  462. XIE H, Wen X, Li J, Chen W, et al
    Evaluation of Immunogenicity by Pseudovirus Neutralization Assays for Coronavirus Disease 2019 (COVID-19) Variants after Primary and Booster Immunization.
    Int J Infect Dis. 2022 Feb 2. pii: S1201-9712(22)00075.
    >> Share

  463. MARZOUK M, Alhiraki OA, Aguas R, Gao B, et al
    SARS-CoV-2 transmission in opposition-controlled Northwest Syria: modelling pandemic responses during political conflict.
    Int J Infect Dis. 2022 Feb 2. pii: S1201-9712(22)00071.
    >> Share

  464. ZHANG H, Liu X, Liu Q, Mei H, et al
    Serological reactivity of inactivated SARS-CoV-2 vaccine based on an S-RBD neutralizing antibody assay.
    Int J Infect Dis. 2022 Feb 1. pii: S1201-9712(22)00069.
    >> Share

  465. JONES T, Marimuthu K, Bearman G
    Virtual Infection Prevention and Control in Low- and Middle-Income Countries.
    Int J Infect Dis. 2022 Feb 1. pii: S1201-9712(22)00074.
    >> Share

    January 2022
  466. LIU B, Su X, Yu G, Yang S, et al
    Corrigendum to 'An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 neutralizing antibody levels in COVID-19 patients and vaccines ' [International Journal of Infectious Diseases, Volume 115, 2022, Pages 116-125, ISSN 1201-9712].
    Int J Infect Dis. 2022 Jan 31. pii: S1201-9712(22)00045.
    >> Share

  467. LIPPI G, Plebani M
    The presence of anti-SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization.
    Int J Infect Dis. 2022 Jan 31. pii: S1201-9712(22)00066.
    >> Share

  468. MUSA SS, Zhao S, Abdullahi ZU, Habib AG, et al
    COVID-19 and Lassa fever in Nigeria: A deadly alliance?
    Int J Infect Dis. 2022 Jan 30. pii: S1201-9712(22)00065.
    >> Share

  469. ZHA L, Sobue T, Hirayama A, Takeuchi T, et al
    Characteristics and Outcomes of COVID-19 in Reproductive-Aged Pregnant and Non-Pregnant Women in Osaka, Japan.
    Int J Infect Dis. 2022 Jan 29. pii: S1201-9712(22)00063.
    >> Share

  470. MA X, Wu K, Li Y, Li S, et al
    Contact tracing period and epidemiological characteristics of an outbreak by SARS-CoV-2 Delta variant in Guangzhou.
    Int J Infect Dis. 2022 Jan 28. pii: S1201-9712(22)00036.
    >> Share

  471. WEE LE, Conceicao EP, Sim JX, Venkatachalam I, et al
    Correspondence on "The Low Yield of SARS-CoV-2 Rapid Antigen Testing in Screening Asymptomatic Hospital Visitors in Low-incidence Settings".
    Int J Infect Dis. 2022 Jan 27. pii: S1201-9712(22)00057.
    >> Share

  472. RADULESCU A, Istrate A, Muntean M
    Treatment with Tocilizumab in Adult Patients with Moderate to Critical COVID-19 Pneumonia: A Single-Center Retrospective Study.
    Int J Infect Dis. 2022 Jan 27. pii: S1201-9712(22)00056.
    >> Share

  473. BODDETI NL, Berezowski I, Taylor D, Prajapati D, et al
    The Low Yield of SARS-CoV-2 Rapid Antigen Testing in Screening Asymptomatic Hospital Visitors in Low-incidence Settings.
    Int J Infect Dis. 2022 Jan 27. pii: S1201-9712(22)00054.
    >> Share

  474. SAN-JUAN R, Fernandez-Ruiz M, Lopez-Medrano F, Carretero O, et al
    Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19.
    Int J Infect Dis. 2022 Jan 23. pii: S1201-9712(22)00050.
    >> Share

  475. HONGE BL, Hindhede L, Kaspersen KA, Harritshoj LH, et al
    Long-term detection of SARS-CoV-2 antibodies after infection and risk of re-infection.
    Int J Infect Dis. 2022 Jan 22. pii: S1201-9712(22)00046.
    >> Share

  476. JURAJ S, Martin K, Kristina B, Samuel N, et al
    COVID-19 pneumonia patients with 25(OH)D levels lower than 12 ng/ml are at increased risk of death.
    Int J Infect Dis. 2022 Jan 22. pii: S1201-9712(22)00052.
    >> Share

  477. KOYAMA AK, Koumans EH, Sircar K, Lavery A, et al
    Severe Outcomes, Readmission, and Length of Stay Among COVID-19 Patients with Intellectual and Developmental Disabilities.
    Int J Infect Dis. 2022 Jan 22. pii: S1201-9712(22)00048.
    >> Share

  478. LUO T, Wang J, Wang Q, Wang X, et al
    Reconstruction of the Transmission Chain of COVID-19 Outbreak in Beijing's Xinfadi Market, China.
    Int J Infect Dis. 2022 Jan 21. pii: S1201-9712(22)00037.
    >> Share

  479. MORENO-TORRES V, Munoz A, Calderon-Parra J, Mills-Sanchez P, et al
    Mortality by Covid-19 Prior to Vaccination - One Year Experience of Hospitalized Patients in Madrid.
    Int J Infect Dis. 2022 Jan 21. pii: S1201-9712(22)00049.
    >> Share

  480. KO YK, Furuse Y, Ninomiya K, Otani K, et al
    Secondary transmission of SARS-CoV-2 during the first two waves in Japan: Demographic characteristics and overdispersion.
    Int J Infect Dis. 2022 Jan 20. pii: S1201-9712(22)00034.
    >> Share

  481. PEREIRA DN, Silveira LFG, Guimaraes MMM, Polanczyk CA, et al
    Hypothyroidism does not lead to worse prognosis in COVID-19: findings from the Brazilian COVID-19 registry.
    Int J Infect Dis. 2022 Jan 19. pii: S1201-9712(22)00016.
    >> Share

  482. AMIYA S, Fujimoto J, Matsumoto K, Yamamoto M, et al
    Case report: Acute exacerbation of interstitial pneumonia related to mRNA COVID-19 vaccination.
    Int J Infect Dis. 2022 Jan 19. pii: S1201-9712(22)00032.
    >> Share

  483. HU Z, Tao B, Li Z, Song Y, et al
    Effectiveness of inactivated COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant-infected patients in Jiangsu, China.
    Int J Infect Dis. 2022 Jan 19. pii: S1201-9712(22)00033.
    >> Share

  484. NAKANISHI Y, Honda S, Yamano M, Kawasaki T, et al
    Constrictive pericarditis after SARS-CoV-2 vaccination: A case report.
    Int J Infect Dis. 2022 Jan 18. pii: S1201-9712(22)00027.
    >> Share

  485. LUCIENA CMO, Lenzoni F, Suarez MV, Duarte AA, et al
    Hypersensitivity reaction to hyaluronic acid dermal filler after vaccination against COVID-19: A series of cases in Sao Paulo, Brazil.
    Int J Infect Dis. 2022 Jan 18. pii: S1201-9712(22)00029.
    >> Share

  486. TARDIF JC, Cossette M, Guertin MC, Bouabdallaoui N, et al
    Predictive risk factors for hospitalization and response to colchicine in patients with COVID-19.
    Int J Infect Dis. 2022 Jan 14. pii: S1201-9712(22)00021.
    >> Share

  487. MOLLER IJB, Utke AR, Rysgaard UK, Ostergaard LJ, et al
    Diagnostic performance, user acceptability, and safety of unsupervised SARS-CoV-2 rapid antigen detecting tests performed at home.
    Int J Infect Dis. 2022 Jan 14. pii: S1201-9712(22)00020.
    >> Share

  488. KRIGER O, Gefen-Halevi S, Leshem E, Smollan G, et al
    Viral co-pathogens in COVID-19 acute respiratory syndrome - what did we learn from the first year of pandemic?
    Int J Infect Dis. 2022 Jan 13. pii: S1201-9712(22)00018.
    >> Share

  489. ISMAIL N, Hassan N, Hamid MHNA, Yusoff UN, et al
    ASSOCIATION OF SMOKING AND SEVERITY OF COVID-19 INFECTION AMONG 5889 PATIENTS IN MALAYSIA: A MULTI-CENTRE OBSERVATIONAL STUDY.
    Int J Infect Dis. 2022 Jan 9. pii: S1201-9712(22)00012.
    >> Share

  490. ZHANG Z, Lin F, Liu F, Li Q, et al
    Proteomic profiling reveals a distinctive molecular signature for critically ill COVID-19 patients compared with asthma and COPD: A distinctive molecular signature for critically ill COVID-19 patients.
    Int J Infect Dis. 2022 Jan 8. pii: S1201-9712(22)00001.
    >> Share

  491. GARGOURI S, Souissi A, Abid N, Chtourou A, et al
    Evidence of SARS-CoV-2 Symptomatic Reinfection in Four Health Care Professionals from the Same Hospital Despite the Presence of Antibodies.
    Int J Infect Dis. 2022 Jan 8. pii: S1201-9712(22)00005.
    >> Share

  492. WU H, Dai R, He P, Liang J, et al
    Characteristics analysis for clinical study design relating to COVID-19 based on the database of ClinicalTrials.gov.
    Int J Infect Dis. 2022 Jan 8. pii: S1201-9712(22)00015.
    >> Share

  493. FERNANDEZ-DE-LAS-PENAS C, Pellicer-Valero OJ, Navarro-Pardo E, Palacios-Cena D, et al
    Symptoms Experienced at the Acute Phase of SARS-CoV-2 Infection as Risk Factor of Long-term Post-COVID Symptoms: The LONG-COVID-EXP-CM Multicenter Study.
    Int J Infect Dis. 2022 Jan 8. pii: S1201-9712(22)00007.
    >> Share

  494. YIN Y, Gao J, Zhang Y, Zhang X, et al
    Evaluation of reporting quality of abstracts of randomized controlled trials regarding patients with COVID-19 using the CONSORT statement for abstracts.
    Int J Infect Dis. 2022 Jan 6. pii: S1201-9712(22)00003.
    >> Share

  495. NOVAZZI F, Baj A, Pasciuta R, Genoni A, et al
    A CLUSTER OF SARS-COV-2 DELTA VARIANT OF CONCERN ADDITIONALLY HARBORING F490S, NORTHERN LOMBARDY, ITALY.
    Int J Infect Dis. 2022 Jan 4. pii: S1201-9712(21)01258.
    >> Share

  496. DRAGO F, Broccolo F, Ciccarese G
    Comment on a case of pityriasis rosea shortly after Moderna COVID-19 vaccination.
    Int J Infect Dis. 2022 Jan 3. pii: S1201-9712(21)01260.
    >> Share

  497. YAKOVLEV AS, Belyaletdinova IK, Mazankova LN, Samitova ER, et al
    SARS-CoV-2 infection in children in Moscow in 2020: clinical features and impact on circulation of other respiratory viruses.
    Int J Infect Dis. 2022 Jan 2. pii: S1201-9712(21)01216.
    >> Share

  498. KOHANOVSKI I, Obolski U, Ram Y
    Inferring the effective start dates of non-pharmaceutical interventions during COVID-19 outbreaks.
    Int J Infect Dis. 2022 Jan 2. pii: S1201-9712(21)01262.
    >> Share

  499. MARTINOT M
    Should remdesivir be recommended in France in the early stage of COVID-19.
    Int J Infect Dis. 2022 Jan 2. pii: S1201-9712(21)01259.
    >> Share

  500. CURCIO R, Gandolfo V, Alcidi R, Giacomino L, et al
    VACCINE-INDUCED MASSIVE PULMONARY EMBOLISM AND THROMBOCYTOPENIA FOLLOWING A SINGLE DOSE OF JANSSEN AD26.COV2.S VACCINATION.
    Int J Infect Dis. 2022 Jan 2. pii: S1201-9712(21)01244.
    >> Share

  501. BAOS E, Delgado-Iribarren A, O Connor S, Bardon I, et al
    Negative effect of the second dose of the BNT162b2 vaccine in a significant percentage of individuals with previous COVID infection.
    Int J Infect Dis. 2022;114:85-87.
    >> Share

    December 2021
  502. GROBUSCH LC, Grobusch MP
    A hot topic at the environment-health nexus: Investigating the impact of climate change on infectious diseases.
    Int J Infect Dis. 2021 Dec 29. pii: S1201-9712(21)01250.
    >> Share

  503. CALDERON-PARRA J, Cuervas-Mons V, Moreno-Torres V, Rubio-Rivas M, et al
    Influence of chronic corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: Analysis of a nationwide registry.
    Int J Infect Dis. 2021 Dec 28. pii: S1201-9712(21)01222.
    >> Share

  504. ABDULLAH F, Myers J, Basu D, Tintinger G, et al
    Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa.
    Int J Infect Dis. 2021 Dec 28. pii: S1201-9712(21)01256.
    >> Share

  505. DAYANAND D, Irudhayanathan I, Kundu D, Manesh A, et al
    Community seroprevalence and risk factors for SARS CoV-2 infection in different subpopulations in Vellore, India and its implications for future prevention.
    Int J Infect Dis. 2021 Dec 28. pii: S1201-9712(21)01255.
    >> Share

  506. JAHAN N, Brahma A, Kumar MS, Bagepally BS, et al
    Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020-August 2021: a systematic review and meta-analysis.
    Int J Infect Dis. 2021 Dec 27. pii: S1201-9712(21)01251.
    >> Share

  507. CHAN EWW, Leung MTY, Lau LKW, Leung J, et al
    Comparing self-reported reactogenicity between adolescents and adults following the use of BNT162b2 (Pfizer-BioNTech) messenger RNA Covid-19 vaccine: a prospective cohort study.
    Int J Infect Dis. 2021 Dec 26. pii: S1201-9712(21)01253.
    >> Share

  508. HWANG J, Han YJ, Yon DK, Lee SW, et al
    Clinical significance of hepatosplenic thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination.
    Int J Infect Dis. 2021 Dec 24. pii: S1201-9712(21)01248.
    >> Share

  509. AFZAL A, Gutierrez VP, Gomez E, Mon AM, et al
    Bloodstream infections in hospitalized patients before and during the COVID-19 surge in a community hospital in the South Bronx.
    Int J Infect Dis. 2021 Dec 24. pii: S1201-9712(21)01249.
    >> Share

  510. PROMLEK T, Thanunchai M, Phumisantiphong U, Hansirisathit T, et al
    Performance of colorimetric RT-LAMP as a diagnostic tool for SARS-CoV-2 infection during the fourth wave of COVID-19 in Thailand.
    Int J Infect Dis. 2021 Dec 24. pii: S1201-9712(21)01252.
    >> Share

  511. CAKMAKLI C, Demiralp S, Ergonul O, Yesiltas S, et al
    The Role of Institutional, Cultural, and Economic Factors on the Effectiveness of the Lockdown Measures.
    Int J Infect Dis. 2021 Dec 23. pii: S1201-9712(21)01233.
    >> Share

  512. LIEU A, Mah J, Church D
    A Case of Multisystem Inflammatory Syndrome in Adults Following Natural Infection and Subsequent Immunization.
    Int J Infect Dis. 2021 Dec 23. pii: S1201-9712(21)01239.
    >> Share

  513. O'FEE JR, Li J, Chang JR
    Bell's Phenomenon is a normal finding, distinct from Bell's Palsy; Response to "Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database" by Sato et al.
    Int J Infect Dis. 2021 Dec 23. pii: S1201-9712(21)01246.
    >> Share

  514. MCKINNON JE, Wang DD, Zervos M, Saval M, et al
    Safety and Tolerability of Hydroxychloroquine in healthcare workers and first responders for the prevention of COVID-19: WHIP COVID-19 Study.
    Int J Infect Dis. 2021 Dec 22. pii: S1201-9712(21)01243.
    >> Share

  515. HOEFER A, Pampaka D, Castrillejo D, Luenga-Cabrera J, et al
    Considerations for COVID-19 management in reception centers for refugees, asylum seekers and migrants, Spain 2020.
    Int J Infect Dis. 2021 Dec 21. pii: S1201-9712(21)01240.
    >> Share

  516. CLAISE C, Saleh J, Rezek M, Vaulont S, et al
    Low Transferrin Levels Predict Heightened Inflammation in COVID-19 Patients: New Insights.
    Int J Infect Dis. 2021 Dec 21. pii: S1201-9712(21)01237.
    >> Share

  517. DIEZ JM, Romero C, Gajardo R
    Effective presence of antibodies against common human coronavirus in IgG immunoglobulin medicinal products.: Antibodies to common coronaviruses in IgG medicinal products.
    Int J Infect Dis. 2021 Dec 17. pii: S1201-9712(21)01228.
    >> Share

  518. MIERZEWSKA-SCHMIDT M, Baranowski A, Szymanska K, Ciaston M, et al
    The case of fatal acute hemorrhagic necrotizing encephalitis in a two-month-old boy with Covid-19.
    Int J Infect Dis. 2021 Dec 17. pii: S1201-9712(21)01232.
    >> Share

  519. BIN-GOUTH AS, Al-Shoteri S, Mahmoud N, Musani A, et al
    SARS-CoV-2 Seroprevalence in Aden, Yemen: A population-based study.
    Int J Infect Dis. 2021 Dec 17. pii: S1201-9712(21)01229.
    >> Share

  520. MEINUS C, Singer R, Nandi B, Jagot O, et al
    SARS-CoV-2 prevalence and immunity: a hospital-based study from Malawi.
    Int J Infect Dis. 2021 Dec 17. pii: S1201-9712(21)01234.
    >> Share

  521. AYAZ A, Demir AGO, Ozturk G, Kocak M, et al
    A Pooled RT-PCR Testing Strategy for More Efficient Covid-19 Pandemic Management.
    Int J Infect Dis. 2021 Dec 15. pii: S1201-9712(21)01225.
    >> Share

  522. RUIZ-STERNBERG AM, Chaparro-Solano HM, Albornoz LLA, Pinzon-Rondon AM, et al
    GENOMIC CHARACTERIZATION OF SARS-CoV-2 AND ITS ASSOCIATION WITH CLINICAL OUTCOMES: A ONE-YEAR LONGITUDINAL STUDY OF THE PANDEMIC IN COLOMBIA.
    Int J Infect Dis. 2021 Dec 14. pii: S1201-9712(21)01220.
    >> Share

  523. KOSEKI T, Nakajima K, Iwasaki H, Yamada S, et al
    Baseline uric acid levels and steady-state favipiravir concentrations are associated with occurrence of hyperuricemia among COVID-19 patients.
    Int J Infect Dis. 2021 Dec 12. pii: S1201-9712(21)01219.
    >> Share

  524. KOBAYASHI T, Yoshii K, Linton NM, Suzuki M, et al
    Age dependence of the natural history of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): An analysis of Diamond Princess data.
    Int J Infect Dis. 2021 Dec 10. pii: S1201-9712(21)01213.
    >> Share

  525. VENETI L, Salamanca BV, Seppala E, Starrfelt J, et al
    No difference in risk of hospitalisation between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway.
    Int J Infect Dis. 2021 Dec 10. pii: S1201-9712(21)01218.
    >> Share

  526. TRAN LK, Huang DW, Li NK, Li LM, et al
    The impact of the COVID-19 preventive measures on influenza transmission: molecular and epidemiological evidence.
    Int J Infect Dis. 2021 Dec 10. pii: S1201-9712(21)01215.
    >> Share

  527. FINSTERER J, Scorza FA, Fiorini AC
    Impaired hearing following SARS-CoV-2 vaccinations.
    Int J Infect Dis. 2021 Dec 9. pii: S1201-9712(21)01209.
    >> Share

  528. LIU B, Su X, Yu G, Yang S, et al
    An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 Neutralizing antibody levels in COVID-19 patients and vaccinees.
    Int J Infect Dis. 2021 Dec 9. pii: S1201-9712(21)01207.
    >> Share

  529. GUREVICH M, Zilkha-Falb R, Sonis P, Magalashvili D, et al
    SARS-COV-2 Memory B and T Cells Profile in Mild COVID-19 Convalescents subjects.
    Int J Infect Dis. 2021 Dec 8. pii: S1201-9712(21)01203.
    >> Share

  530. DAVIES M, Bramwell LR, Jeffery N, Bunce B, et al
    Persistence of clinically-relevant levels of SARS-CoV2 envelope gene subgenomic RNAs in non-immunocompromised individuals.
    Int J Infect Dis. 2021 Dec 7. pii: S1201-9712(21)01206.
    >> Share

  531. YADAV SK, Zhao S, Akhter Y
    Response to Comments on "Preliminary estimation of the basic reproduction number of novel Coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven Analysis in the early phase of the outbreak".
    Int J Infect Dis. 2021 Dec 5. pii: S1201-9712(21)01204.
    >> Share

  532. CLAPHAM HE, Chia WN, Tan LWL, Kumar V, et al
    Contrasting SARS-CoV-2 epidemics in Singapore: Cohort studies in migrant workers and the general population.
    Int J Infect Dis. 2021 Dec 2. pii: S1201-9712(21)00891.
    >> Share

  533. PETERSEN E, Ntoumi F, Hui DS, Abubakar A, et al
    Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts.
    Int J Infect Dis. 2021 Dec 1. pii: S1201-9712(21)00888.
    >> Share

    November 2021
  534. RINDI LV, Moghazi SA, Donno DR, Cataldo MA, et al
    Predictive scores for the diagnosis of Pulmonary Embolism in COVID-19: A systematic review.
    Int J Infect Dis. 2021 Nov 27. pii: S1201-9712(21)00885.
    >> Share

  535. NGUYEN NN, Hoang VT, Dao TL, Meddeb L, et al
    Long-term persistence of symptoms of dyspnoea in COVID-19 patients.
    Int J Infect Dis. 2021 Nov 27. pii: S1201-9712(21)00882.
    >> Share

  536. JIAN MJ, Perng CL, Chung HY, Chang CK, et al
    Clinical assessment of SARS-CoV-2 antigen rapid detection compared with RT-PCR assay for emerging variants at a high-throughput community testing site in Taiwan.
    Int J Infect Dis. 2021 Nov 26. pii: S1201-9712(21)00883.
    >> Share

  537. LI H, Wu Q, Qin Z, Hou X, et al
    Serum levels of laminin and von Willebrand factor in COVID-19 survivors 6 months after discharge.
    Int J Infect Dis. 2021 Nov 26. pii: S1201-9712(21)00879.
    >> Share

  538. FAGYAS M, Fejes Z, Suto R, Nagy Z, et al
    Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients.
    Int J Infect Dis. 2021 Nov 25. pii: S1201-9712(21)00876.
    >> Share

  539. RAMACHANDRAN R, Bhosale V, Reddy H, Atam V, et al
    Phase III, Randomized, Double-blind, Placebo controlled trial of Efficacy, Safety and Tolerability of Antiviral drug Umifenovir vs Standard care of therapy in non-severe COVID-19 patients.
    Int J Infect Dis. 2021 Nov 18. pii: S1201-9712(21)00872.
    >> Share

  540. ASAI S, Seki A, Akai Y, Tazawa H, et al
    Nationwide external quality assessment of SARS-CoV-2 nucleic acid amplification tests in Japan.
    Int J Infect Dis. 2021 Nov 17. pii: S1201-9712(21)00869.
    >> Share

  541. FERNANDEZ LS, Iturriaga LAR, Yandiola PPE, Ocana RM, et al
    BACTERAEMIC PNEUMOCOCCAL PNEUMONIA AND SARS-CoV-2 PNEUMONIA: DIFFERENCES AND SIMILARITIES.
    Int J Infect Dis. 2021 Nov 17. pii: S1201-9712(21)00871.
    >> Share

  542. ZOU Z, Fairley CK, Shen M, Scott N, et al
    Critical timing and extent of public health interventions to control outbreaks dominated by SARS-CoV-2 variants in Australia: a mathematical modelling study.
    Int J Infect Dis. 2021 Nov 17. pii: S1201-9712(21)00870.
    >> Share

  543. ZHENG C, Shao W, Chen X, Zhang B, et al
    Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis.
    Int J Infect Dis. 2021 Nov 17. pii: S1201-9712(21)00857.
    >> Share

  544. DOTAN A, Shoenfeld Y
    Post-COVID syndrome: the aftershock of SARS-CoV-2.
    Int J Infect Dis. 2021 Nov 13. pii: S1201-9712(21)00867.
    >> Share

  545. ALI MM, Malik SMMR, Ahmed AY, Bashir AM, et al
    Survival analysis of all critically ill patients with COVID-19 admitted to the main hospital in Mogadishu, Somalia, 30 March-12 June 2020: what interventions are proving effective in fragile states?
    Int J Infect Dis. 2021 Nov 12. pii: S1201-9712(21)00865.
    >> Share

  546. WEE LE, Conceicao EP, Sim JX, Venkatachalam I, et al
    Utilisation of SARS-CoV-2 rapid antigen assays in screening asymptomatic hospital visitors: mitigating the risk in low-incidence settings.
    Int J Infect Dis. 2021 Nov 9. pii: S1201-9712(21)00859.
    >> Share

  547. GHOSH P, Chowdhury R, Hossain ME, Hossain F, et al
    Evaluation of recombinase-based isothermal amplification assays for point-of-need detection of SARS-CoV-2 in resource-limited settings.
    Int J Infect Dis. 2021 Nov 7. pii: S1201-9712(21)00854.
    >> Share

  548. JIAN MJ, Chung HY, Chang CK, Lin JC, et al
    SARS-CoV-2 Variants with T135I Nucleocapsid Mutations may Affect Antigen Test Performance.
    Int J Infect Dis. 2021 Nov 7. pii: S1201-9712(21)00853.
    >> Share

  549. FAVAS C, Jarrett P, Ratnayake R, Watson OJ, et al
    Country differences in transmissibility, age distribution and case-fatality of SARS-CoV-2: a global ecological analysis.
    Int J Infect Dis. 2021 Nov 5. pii: S1201-9712(21)00850.
    >> Share

  550. ABOBAKER A, Idris MA, Ogunjimi O
    A localised vasculitic-like skin rash following the second dose of COVID-19 vaccine.
    Int J Infect Dis. 2021 Nov 3. pii: S1201-9712(21)00848.
    >> Share

  551. MANOUANA GP, Maloum MN, Bikangui R, Oye Bingono SO, et al
    Emergence of B.1.1.318 SARS-CoV-2 viral lineage and high incidence of alpha B.1.1.7 variant of concern in Republic of Gabon.
    Int J Infect Dis. 2021 Nov 3. pii: S1201-9712(21)00846.
    >> Share

  552. SHIN SH, Hong JK, Hong SA, Li K, et al
    Pityriasis rosea shortly after mRNA-1273 COVID-19 vaccination.
    Int J Infect Dis. 2021 Nov 2. pii: S1201-9712(21)00844.
    >> Share

  553. VAN GORDON MM
    Regional differences in NPI efficacy and recommendations for Africa.
    Int J Infect Dis. 2021;112:235-236.
    >> Share

    October 2021
  554. HOEBEL J, Michalski N, Diercke M, Hamouda O, et al
    Emerging socioeconomic disparities in COVID-19-related deaths during the second pandemic wave in Germany.
    Int J Infect Dis. 2021 Oct 29. pii: S1201-9712(21)00832.
    >> Share

  555. KUCHINSKI KS, Nguyen J, Lee TD, Hickman R, et al
    Mutations in emerging variant of concern lineages disrupt genomic sequencing of SARS-CoV-2 clinical specimens.
    Int J Infect Dis. 2021 Oct 29. pii: S1201-9712(21)00838.
    >> Share

  556. LANDSBERG HE, Turcinovic J, Sullivan M, Connor JH, et al
    Efficacy of Pfizer-BioNTech in SARS-CoV-2 Delta cluster.
    Int J Infect Dis. 2021 Oct 29. pii: S1201-9712(21)00840.
    >> Share

  557. LEUNG WF, Chorlton S, Tyson J, Al-Rawahi GN, et al
    COVID-19 in an Immunocompromised Host: Persistent Shedding of Viable SARS-CoV-2 and Emergence of Multiple Mutations, a Case Report.
    Int J Infect Dis. 2021 Oct 28. pii: S1201-9712(21)00829.
    >> Share

  558. BOGERE N, Bongomin F, Katende A, Ssebambulidde K, et al
    Performance and Cost-Effectiveness of a Pooled-Testing Strategy for SARS-CoV-2 Using Real-Time Polymerase Chain Reaction in Uganda.
    Int J Infect Dis. 2021 Oct 28. pii: S1201-9712(21)00834.
    >> Share

  559. PENETRA SLS, da Silva MFB, Resende P, Pina-Costa A, et al
    Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil.
    Int J Infect Dis. 2021 Oct 28. pii: S1201-9712(21)00836.
    >> Share

  560. DESAI A, Desai P, Mehta J, Sachora W, et al
    "Measuring the Impact of single dose of ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant) on hospital stay, ICU requirement, and mortality outcome in a tertiary care centre".
    Int J Infect Dis. 2021 Oct 21. pii: S1201-9712(21)00819.
    >> Share

  561. HOU X, Fan W, Wang G, Chen X, et al
    T cell receptor repertoires as potential diagnostic markers for patients with COVID-19.
    Int J Infect Dis. 2021 Oct 21. pii: S1201-9712(21)00820.
    >> Share

  562. RIEDEL PG, Sakai VF, Castro Cardoso Toniasso S, Brum MCB, et al
    Heart failure secondary to myocarditis after SARS-CoV-2 reinfection: a case report.
    Int J Infect Dis. 2021 Oct 21. pii: S1201-9712(21)00822.
    >> Share

  563. FEKADU G, Jiang X, Yao J, You JHS, et al
    Cost-effectiveness of video-observed therapy for ambulatory management of active tuberculosis during COVID-19 pandemic in a high-income country.
    Int J Infect Dis. 2021 Oct 21. pii: S1201-9712(21)00817.
    >> Share

  564. AMARSY R, Trystram D, Cambau E, Monteil C, et al
    Surging bloodstream infections and antimicrobial resistance during the first wave of COVID-19: a study in a large multihospital institution in the Paris region.
    Int J Infect Dis. 2021 Oct 21. pii: S1201-9712(21)00821.
    >> Share

  565. ASANO M, Okada H, Itoh Y, Hirata H, et al
    Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: A double-blind, randomized controlled phase 1/2 trial.
    Int J Infect Dis. 2021 Oct 21. pii: S1201-9712(21)00818.
    >> Share

  566. DAHAL S, Luo R, Swahn MH, Chowell G, et al
    Geospatial Variability in Excess Death Rates during the COVID-19 Pandemic in Mexico: Examining Socio Demographic, Climate and Population Health Characteristics.
    Int J Infect Dis. 2021 Oct 19. pii: S1201-9712(21)00814.
    >> Share

  567. THIRION-ROMERO DI, Guerrero-Zuniga DS, Arias-Mendoza DA, Cornejo-Juarez DDP, et al
    EVALUATION OF PANBIO RAPID ANTIGEN TEST FOR SARS-CoV-2 IN SYMPTOMATIC PATIENTS AND THEIR CONTACTS: A MULTICENTER STUDY.
    Int J Infect Dis. 2021 Oct 19. pii: S1201-9712(21)00811.
    >> Share

  568. JEONG J, Choi HS
    Sudden sensorineural hearing loss after COVID-19 vaccination.
    Int J Infect Dis. 2021 Oct 17. pii: S1201-9712(21)00815.
    >> Share

  569. BRANDAO AAGS, de Oliveira CZ, Rojas SO, Ordinola AAM, et al
    Thromboembolic and bleeding events in ICU patients with COVID-19: results from a Brazilian tertiary hospital.
    Int J Infect Dis. 2021 Oct 17. pii: S1201-9712(21)00812.
    >> Share

  570. BOZZI G, Lombardi A, Ludovisi S, Muscatello A, et al
    TRANSIENT INCREASE OF PLASMA HIV RNA AFTER COVID-19 VACCINATION WITH mRNA-1272.
    Int J Infect Dis. 2021 Oct 16. pii: S1201-9712(21)00806.
    >> Share

  571. HASAN ZT, Atrakji DMQYMAA, Mehuaiden DAK
    The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients.
    Int J Infect Dis. 2021 Oct 12. pii: S1201-9712(21)00798.
    >> Share

  572. HERIYANTO RS, Kurniawan A, Wijovi F, Halim DA, et al
    The role of COVID-19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after sinovac vaccine administration on clinical year medical student in Indonesia.
    Int J Infect Dis. 2021 Oct 12. pii: S1201-9712(21)00797.
    >> Share

  573. MASAI AN, Akin PL
    Practice of COVID-19 preventive measures and risk of acute respiratory infections: a longitudinal study in students from 95 countries.
    Int J Infect Dis. 2021 Oct 12. pii: S1201-9712(21)00803.
    >> Share

  574. SPICER KB, Glick C, Cavanaugh AM, Thoroughman D, et al
    Protective Immunity after Natural Infection with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) - Kentucky, USA, 2020.
    Int J Infect Dis. 2021 Oct 11. pii: S1201-9712(21)00800.
    >> Share

  575. LUO G, Zhang X, Zheng H, He D, et al
    Infection fatality ratio and case fatality ratio of COVID-19.
    Int J Infect Dis. 2021 Oct 7. pii: S1201-9712(21)00793.
    >> Share

  576. GIOVACCHINI N, Coppi M, Aiezza N, Baccani I, et al
    Rapid screening for SARS-CoV-2 VOC Alpha (202012/01, B.1.1.7) using the Allplex SARS-CoV-2 / FluA / FluB / RSV Assay.
    Int J Infect Dis. 2021 Oct 7. pii: S1201-9712(21)00792.
    >> Share

  577. ANDRADE MC, Bonan PRF, Hilan E, Marques NP, et al
    COVID-19 Pandemic Causes Increased Clinic Visits with Diagnosis of Tegumentary Leishmaniasis in Brazil in 2020.
    Int J Infect Dis. 2021 Oct 7. pii: S1201-9712(21)00795.
    >> Share

  578. RAMIREZ-ROSAS A, Benitez-Guerrero T, Corona-Cervantes K, Velez-Ixta JM, et al
    Study of perinatal transmission of SARS-CoV-2 in a Mexican public hospital.
    Int J Infect Dis. 2021 Oct 7. pii: S1201-9712(21)00790.
    >> Share

  579. JUNG SM, Endo A, Akhmetzhanov AR, Nishiura H, et al
    Predicting the effective reproduction number of COVID-19: Inference using human mobility, temperature, and risk awareness.
    Int J Infect Dis. 2021 Oct 7. pii: S1201-9712(21)00794.
    >> Share

  580. PIERCE J, Stevens MP
    COVID-19 and Antimicrobial Stewardship: Lessons Learned, Best Practices and Future Implications.
    Int J Infect Dis. 2021 Oct 5. pii: S1201-9712(21)00789.
    >> Share

  581. HAMBRIDGE HL, Kahn R, Onnela JP
    Examining SARS-CoV-2 Interventions in Residential Colleges Using an Empirical Network.
    Int J Infect Dis. 2021 Oct 5. pii: S1201-9712(21)00796.
    >> Share

  582. CUCUNAWANGSIH C, Wijaya RS, Lugito NPH, Suriapranata I, et al
    Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia.
    Int J Infect Dis. 2021 Oct 3. pii: S1201-9712(21)00787.
    >> Share

  583. BERTIN D, Kaphan E, Weber S, Babacci B, et al
    Persistent IgG anti-cardiolipin autoantibodies are associated with post-covid syndrome.
    Int J Infect Dis. 2021 Oct 3. pii: S1201-9712(21)00788.
    >> Share

  584. ZIMMERMANN IR, Sanchez MN, Alves LC, Frio GS, et al
    COVID-19 as a leading cause of hospitalizations with death in the Brazilian Public Health System in 2020.
    Int J Infect Dis. 2021 Oct 1. pii: S1201-9712(21)00785.
    >> Share

    September 2021
  585. PAN L, Zhang Y, Cui Y, Wu X, et al
    Bilateral uveitis after inoculation with COVID-19 vaccine: A case report.
    Int J Infect Dis. 2021 Sep 30. pii: S1201-9712(21)00779.
    >> Share

  586. AL-ABRI SS, Al-Wahaibi A, Al-Kindi H, Kurup PJ, et al
    SARS-COV-2 antibody seroprevalence in the general population of Oman: results from four successive nationwide seroepidemiological surveys.
    Int J Infect Dis. 2021 Sep 30. pii: S1201-9712(21)00770.
    >> Share

  587. ROQUEBERT B, Haim-Boukobza S, Trombert-Paolantoni S, Lecorche E, et al
    SARS-CoV-2 variants of concern are associated with lower RT-PCR amplification cycles between January and March 2021 in France.
    Int J Infect Dis. 2021 Sep 30. pii: S1201-9712(21)00784.
    >> Share

  588. KRUSE M, Dark C, Aspden M, Cochrane D, et al
    Performance of the T-SPOT(R).COVID test for detecting SARS-CoV-2-responsive T cells.
    Int J Infect Dis. 2021 Sep 30. pii: S1201-9712(21)00778.
    >> Share

  589. HEYMING TW, Nugent D, Tongol A, Knudsen-Robbins C, et al
    Rapid antibody testing for SARS-CoV-2 vaccine response in pediatric healthcare workers.
    Int J Infect Dis. 2021 Sep 30. pii: S1201-9712(21)00772.
    >> Share

  590. TANAKA H, Lee H, Morita A, Namkoong H, et al
    Clinical Characteristics of Patients with Coronavirus Disease (COVID-19): Preliminary Baseline Report of Japan COVID-19 Task Force, a Nation-wide Consortium to Investigate Host Genetics of COVID-19.
    Int J Infect Dis. 2021 Sep 30. pii: S1201-9712(21)00775.
    >> Share

  591. MUSA S, Kissling E, Valenciano M, Dizdar F, et al
    Household transmission of SARS-CoV-2: a prospective observational study in Bosnia and Herzegovina, August - December 2020.
    Int J Infect Dis. 2021 Sep 29. pii: S1201-9712(21)00771.
    >> Share

  592. SHINOZUKA J, Hata M, Eguchi H, Mori M, et al
    COVID-19 vaccination: effective utilization of low dead space (LDS) syringes.
    Int J Infect Dis. 2021 Sep 29. pii: S1201-9712(21)00776.
    >> Share

  593. SBERNA G, Basile F, Guarino ML, Capobianchi MR, et al
    Comparison of Allplex SARS-CoV-2 Assay, Easy SARS-CoV-2 WE and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19.
    Int J Infect Dis. 2021 Sep 28. pii: S1201-9712(21)00781.
    >> Share

  594. NIGO M, Rasmy L, May SB, Rao A, et al
    Real World Long-term Assessment of The Efficacy of Tocilizumab in Patients with COVID19: Results From A Large De-identified Multicenter Electronic Health Record Dataset in the United States.
    Int J Infect Dis. 2021 Sep 28. pii: S1201-9712(21)00774.
    >> Share

  595. HAWLADER MDH, Rahman ML, Nazir A, Ara T, et al
    Belief, Attitude, and Intention to take COVID-19 Vaccine among South Asian Population: A Multi-country Study.
    Int J Infect Dis. 2021 Sep 28. pii: S1201-9712(21)00759.
    >> Share

  596. KARALI EA, Karadenizli A, Uzuner H, Karakaya N, et al
    Comparison of an inactivated Covid19 vaccine-induced antibody response with concurrent natural Covid19 infection.
    Int J Infect Dis. 2021 Sep 28. pii: S1201-9712(21)00768.
    >> Share

  597. SAIA RS, Giusti H, Silva FL, Pedroso KJB, et al
    Clinical investigation of intestinal fatty acid-binding protein (I-FABP) as a biomarker of SARS-CoV-2 infection.
    Int J Infect Dis. 2021 Sep 28. pii: S1201-9712(21)00761.
    >> Share

  598. SAVVA D, Battineni G, Amenta F, Nittari G, et al
    Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2 virus.
    Int J Infect Dis. 2021 Sep 28. pii: S1201-9712(21)00773.
    >> Share

  599. FREMONT-SMITH M, Gherlone N, Smith N, Tisdall P, et al
    Models for COVID-19 Early Cardiac Pathology Following SARS-CoV-2 Infection.
    Int J Infect Dis. 2021 Sep 27. pii: S1201-9712(21)00763.
    >> Share

  600. OYGAR PD, Buyukcam A, Bal ZS, Dalgic N, et al
    SARS-CoV-2 seropositivity among pediatric health care personnel just after the first peak of pandemic: A nationwide surveillance.
    Int J Infect Dis. 2021 Sep 27. pii: S1201-9712(21)00762.
    >> Share

  601. RAVINDRA K, Ahlawat A
    Five probable factors responsible for COVID-associated mucormycosis outbreak in India.
    Int J Infect Dis. 2021 Sep 27. pii: S1201-9712(21)00765.
    >> Share

  602. MARUKI T, Ishikane M, Suzuki T, Ujiie M, et al
    A case of varicella zoster virus meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient.
    Int J Infect Dis. 2021 Sep 26. pii: S1201-9712(21)00767.
    >> Share

  603. BAMOROVAT M, Sharifi I, Aflatoonian MR, Karamoozian A, et al
    Prophylactic effect of cutaneous leishmaniasis against COVID-19: A case-control field assessment.
    Int J Infect Dis. 2021 Sep 24. pii: S1201-9712(21)00757.
    >> Share

  604. WARSAME A, Bashiir F, Freemantle T, Williams C, et al
    Excess mortality during the COVID-19 pandemic: a geospatial and statistical analysis in Mogadishu, Somalia.
    Int J Infect Dis. 2021 Sep 24. pii: S1201-9712(21)00758.
    >> Share

  605. MORECCHIATO F, Coppi M, Baccani I, Maggini N, et al
    Evaluation of extraction-free RT-PCR methods for faster and cheaper detection of SARS-CoV-2 using two commercial systems.
    Int J Infect Dis. 2021 Sep 23. pii: S1201-9712(21)00754.
    >> Share

  606. BUCHY P, Buisson Y, Cintra O, Dwyer DE, et al
    COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control.
    Int J Infect Dis. 2021 Sep 23. pii: S1201-9712(21)00752.
    >> Share

  607. WEINSTOCK LB, Brook JB, Walters AS, Goris A, et al
    Mast cell activation symptoms are prevalent in Long-COVID.
    Int J Infect Dis. 2021 Sep 23. pii: S1201-9712(21)00751.
    >> Share

  608. BRUNETTI ND, Poliseno M, Bottalico IF, Centola A, et al
    Safety and heart rate changes in Covid-19 patients treated with Remdesivir.
    Int J Infect Dis. 2021 Sep 19. pii: S1201-9712(21)00741.
    >> Share

  609. FINSTERER J
    SARS-CoV-2 in cardiomyocytes.
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00737.
    >> Share

  610. EGWANG TG, Owalla TJ, Okurut E, Apungia G, et al
    Differential pre-pandemic breast milk IgA reactivity against SARS-CoV-2 and circulating human coronaviruses in Ugandan and American mothers.
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00747.
    >> Share

  611. KHALIFA BA, Abbey EJ, Ayeh SK, Yusuf HE, et al
    The Global Health Security Index is not predictive of vaccine rollout responses among OECD countries.
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00744.
    >> Share

  612. BONACCORSI G, Paoli S, Biamonte MA, Moscadelli A, et al
    COVID-19 and schools: what is the risk of contagion? The results of an antigen rapid test-based screening campaign in Florence (Italy).
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00734.
    >> Share

  613. CORREIA AM, Borges V, Isidro J, Lima AR, et al
    Potential recurrence of COVID-19 in a healthcare professional: SARS-CoV-2 genome sequencing confirms contagiousness after re-positivity.
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00739.
    >> Share

  614. MORENO A, Vargas C, Azocar F, Villarroel F, et al
    STEROIDS AND MORTALITY IN NON-CRITICALLY ILL COVID-19 PATIENTS: A PROPENSITY SCORE WEIGHTED STUDY IN A CHILEAN COHORT.
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00745.
    >> Share

  615. COLANERI M, De Filippo M, Licari A, Marseglia A, et al
    COVID vaccination and asthma exacerbation: might there be a link?
    Int J Infect Dis. 2021 Sep 18. pii: S1201-9712(21)00733.
    >> Share

  616. DESPHANDE GR, Kaduskar O, Deshpande K, Bhatt V, et al
    Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2.
    Int J Infect Dis. 2021 Sep 17. pii: S1201-9712(21)00732.
    >> Share

  617. LUTALO T, Nalumansi A, Olara D, Kayiwa J, et al
    Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute.
    Int J Infect Dis. 2021 Sep 15. pii: S1201-9712(21)00728.
    >> Share

  618. VACHARATHIT V, Srichatrapimuk S, Manopwisedjaroen S, Kirdlarp S, et al
    SARS-CoV-2 neutralizing antibodies decline after one year and patients with severe COVID-19 pneumonia display a unique cytokine profile.
    Int J Infect Dis. 2021 Sep 15. pii: S1201-9712(21)00729.
    >> Share

  619. BARANDALLA I, Alvarez C, Barreiro P, de Mendoza C, et al
    Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in Spain.
    Int J Infect Dis. 2021 Sep 15. pii: S1201-9712(21)00730.
    >> Share

  620. VON HUTH S, Lillevang ST, Roge BT, Madsen JS, et al
    SARS-CoV-2 seroprevalence among 7,950 health-care workers in the Region of Southern Denmark. (THEIJID-D-21-01420R1).
    Int J Infect Dis. 2021 Sep 14. pii: S1201-9712(21)00731.
    >> Share

  621. HASAN MR, Kalikiri MKR, Mirza F, Sundararaju S, et al
    Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar.
    Int J Infect Dis. 2021 Sep 12. pii: S1201-9712(21)00709.
    >> Share

  622. ZHAO Y, Yang C, An X, Xiong Y, et al
    Follow-up study on the COVID-19 survivors after one year discharged from hospital.
    Int J Infect Dis. 2021 Sep 11. pii: S1201-9712(21)00726.
    >> Share

  623. ELOY P, Tardivon C, Martin-Blondel G, Isnard M, et al
    Severity of self-reported symptoms and psychological burden 6-months after hospital admission for COVID-19: a prospective cohort study.
    Int J Infect Dis. 2021 Sep 10. pii: S1201-9712(21)00724.
    >> Share

  624. ZHOU D, Wang Q, Liu H
    Coronavirus disease-19 and the gut-lung axis.
    Int J Infect Dis. 2021 Sep 10. pii: S1201-9712(21)00722.
    >> Share

  625. LEINER J, Pellissier V, Nitsche A, Konig S, et al
    SARS-CoV-2 rapid antigen testing in the healthcare sector: A clinical prediction model for identifying false negative results.
    Int J Infect Dis. 2021 Sep 10. pii: S1201-9712(21)00717.
    >> Share

  626. HARA H, Uemura Y, Hayakawa K, Togano T, et al
    Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan.
    Int J Infect Dis. 2021 Sep 10. pii: S1201-9712(21)00725.
    >> Share

  627. LOBIE TA, Roba AA, Booth JA, Kristiansen KI, et al
    Antimicrobial resistance: A challenge awaiting the post COVID-19 era.
    Int J Infect Dis. 2021 Sep 8. pii: S1201-9712(21)00708.
    >> Share

  628. GOLDIN L, Elders T, Werhane L, Korwek K, et al
    Reactions and COVID-19 disease progression following SARS-CoV-2 monoclonal antibody infusion.
    Int J Infect Dis. 2021 Sep 8. pii: S1201-9712(21)00713.
    >> Share

  629. BYLICKI O, Delarbre D, Mayet A, Ferrier A, et al
    Neutralizing antibodies response to SARS-CoV-2 are persistent 9 months post symptom onset in mild or asymptomatic patients.
    Int J Infect Dis. 2021 Sep 8. pii: S1201-9712(21)00707.
    >> Share

  630. SATO K, Mano T, Niimi Y, Toda T, et al
    Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of self-reporting database.
    Int J Infect Dis. 2021 Sep 4. pii: S1201-9712(21)00704.
    >> Share

  631. LOUCA S
    SARS-CoV-2 infections in 165 countries over time.
    Int J Infect Dis. 2021 Sep 3. pii: S1201-9712(21)00701.
    >> Share

  632. VICENTI I, Basso M, Gatti F, Scaggiante R, et al
    Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose.
    Int J Infect Dis. 2021 Sep 2. pii: S1201-9712(21)00683.
    >> Share

  633. NGERE I, Dawa J, Hunsperger E, Otieno N, et al
    sssHigh seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya.
    Int J Infect Dis. 2021 Sep 2. pii: S1201-9712(21)00696.
    >> Share

    August 2021
  634. DE GUADIANA-ROMUALDO LG, Martinez MM, Mulero MDR, Torrella PE, et al
    Circulating MR-proADM levels, as indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients.
    Int J Infect Dis. 2021 Aug 27. pii: S1201-9712(21)00692.
    >> Share

  635. SALVAGNO GL, Henry BM, Lippi G
    The strength of association between pre- and post-booster BNT162b2 anti-SARS-CoV-2 antibodies levels depends on the immunoassay.
    Int J Infect Dis. 2021 Aug 26. pii: S1201-9712(21)00693.
    >> Share

  636. DIRKX KKT, Mulder B, Post AS, Rutten MH, et al
    The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained.
    Int J Infect Dis. 2021 Aug 26. pii: S1201-9712(21)00691.
    >> Share

  637. CHEN Y, Yao H, Fu J, Shu Q, et al
    The low contagiousness and new A958D mutation of SARS-CoV-2 in children: An observational cohort study.
    Int J Infect Dis. 2021 Aug 25. pii: S1201-9712(21)00672.
    >> Share

  638. POUR OB, Yahyavi Y, Karimi A, Khamaneh AM, et al
    Serum trace elements levels and clinical outcomes among Iranian COVID-19 patients.
    Int J Infect Dis. 2021 Aug 25. pii: S1201-9712(21)00686.
    >> Share

  639. BHANUPRASAD K, Manesh A, Devasagayam E, Varghese L, et al
    Risk Factors Associated with the Mucormycosis Epidemic During the COVID-19 Pandemic.
    Int J Infect Dis. 2021 Aug 24. pii: S1201-9712(21)00670.
    >> Share

  640. VAN DAM CS, Lede I, Schaar J, Al-Dulaimy M, et al
    Herpes Zoster after COVID-vaccination.
    Int J Infect Dis. 2021 Aug 21. pii: S1201-9712(21)00681.
    >> Share

  641. VAN HEERDEN J, Nel J, Moodley P, Govender P, et al
    Multisystem Inflammatory Syndrome (MIS): a multicentre retrospective review of adults and adolescents in South Africa.
    Int J Infect Dis. 2021 Aug 21. pii: S1201-9712(21)00673.
    >> Share

  642. YANG J, Han Y, Zhang R, Zhang R, et al
    Comparison of analytical sensitivity of SARS-CoV-2 molecular detection kits.
    Int J Infect Dis. 2021 Aug 21. pii: S1201-9712(21)00676.
    >> Share

  643. L SBB, Wanve S, Koradia P, Bhomia V, et al
    Efficacy and Safety of Pegylated Interferon-alpha2b in Moderate COVID-19: A phase 3, randomized, comparator-controlled, open-label study.
    Int J Infect Dis. 2021 Aug 21. pii: S1201-9712(21)00677.
    >> Share

  644. MOUALLEM RE, Moussally K, Williams A, Repetto E, et al
    How COVID-19 highlighted the need for infection prevention and control measures to become central to the global conversation: experience from the conflict settings of the Middle-East.
    Int J Infect Dis. 2021 Aug 19. pii: S1201-9712(21)00668.
    >> Share

  645. TIMELLI L, Liuzzi G, Cannavacciuolo A, Petrosillo N, et al
    Association of COVID-19 case-fatality rate with disease burden: an ecological analysis in Italy during the first wave.
    Int J Infect Dis. 2021 Aug 19. pii: S1201-9712(21)00665.
    >> Share

  646. GONG C, Song X, Li X, Lu L, et al
    Immunological Changes after COVID-19 Vaccination in an HIV-Positive Patient.
    Int J Infect Dis. 2021 Aug 19. pii: S1201-9712(21)00667.
    >> Share

  647. VELAVAN T, Pallerla S, Kremsner P
    How to ab(use) a COVID-19 antigen rapid test with soft drinks?
    Int J Infect Dis. 2021 Aug 18. pii: S1201-9712(21)00654.
    >> Share

  648. CUI LY, Cheng WW, Mou ZW, Xiao D, et al
    Risk factors for pulmonary embolism in patients with COVID-19: a systemic review and meta-analysis.
    Int J Infect Dis. 2021 Aug 18. pii: S1201-9712(21)00649.
    >> Share

  649. ELMOHEEN A, Abdelhafez I, Awad W, Bahgat M, et al
    External Validation and Recalibration of the CURB-65 and PSI for Predicting 30-Day Mortality and Critical Care Intervention in Multiethnic Patients with COVID-19.
    Int J Infect Dis. 2021 Aug 17. pii: S1201-9712(21)00660.
    >> Share

  650. PASQUINI Z, Barocci I, Brescini L, Candelaresi B, et al
    Bloodstream infections in the COVID-19 era: results from an Italian multicenter study.
    Int J Infect Dis. 2021 Aug 17. pii: S1201-9712(21)00623.
    >> Share

  651. DARBANDI A, Asadi A, Ghanavati R, Afifirad R, et al
    Corrigendum to 'The effect of probiotics on respiratory tract infection with special emphasis on COVID-19: Systemic review 2010-20' [International Journal of Infectious Diseases 105 (April 2021) 91-104].
    Int J Infect Dis. 2021;110:337.
    >> Share

  652. TADESSE EB, Endris AA, Solomon H, Alayu M, et al
    Seroprevalence and risk factors for SARS-CoV-2 Infection in selected urban areas in Ethiopia: a cross-sectional evaluation during July 2020.
    Int J Infect Dis. 2021 Aug 16. pii: S1201-9712(21)00661.
    >> Share

  653. IMAI K, Matsuoka M, Tabata S, Kitagawa Y, et al
    Cross-reactive humoral immune responses against seasonal human coronaviruses in COVID-19 patients with different disease severity.
    Int J Infect Dis. 2021 Aug 15. pii: S1201-9712(21)00659.
    >> Share

  654. WRIGHT J, Achana F, Diwakar L, Semple MG, et al
    Cycle threshold values are inversely associated with poorer outcomes in hospitalised patients with Covid-19: a prospective, observational cohort study conducted at a UK tertiary hospital.
    Int J Infect Dis. 2021 Aug 14. pii: S1201-9712(21)00657.
    >> Share

  655. SELINGER C, Choisy M, Alizon S
    Predicting COVID-19 incidence in French hospitals using human contact network analytics.
    Int J Infect Dis. 2021 Aug 14. pii: S1201-9712(21)00662.
    >> Share

  656. BIRKHEAD M, Glass AJ, Allan-Gould H, Goossens C, et al
    Ultrastructural evidence for vertical transmission of SARS-CoV2.
    Int J Infect Dis. 2021 Aug 14. pii: S1201-9712(21)00653.
    >> Share

  657. LIANG L, Guo Q, Zhang H, Lin S, et al
    Low infectious risk of re-positive COVID-19 patients: a single-center study.
    Int J Infect Dis. 2021 Aug 12. pii: S1201-9712(21)00652.
    >> Share

  658. KEITOKU K, Nishimura Y, Hagiya H, Koyama T, et al
    Impact of the World Antimicrobial Awareness Week on public interest between 2015 and 2020: A Google Trends analysis.
    Int J Infect Dis. 2021 Aug 12. pii: S1201-9712(21)00651.
    >> Share

  659. MARRA V, Quartin M
    A Bayesian estimate of the early COVID-19 infection fatality ratio in Brazil based on a random seroprevalence survey.
    Int J Infect Dis. 2021 Aug 11. pii: S1201-9712(21)00648.
    >> Share

  660. NONAKA CKV, Graf T, Barcia CAL, Costa VF, et al
    SARS-CoV-2 variant of concern P.1 (Gamma) infection in young and middle-aged patients admitted to the intensive care units of a single hospital in Salvador, northeast Brazil, February 2021.
    Int J Infect Dis. 2021 Aug 11. pii: S1201-9712(21)00635.
    >> Share

  661. SAEED BQ, Al-Shahrabi R, Alhaj SS, Alkokhardi ZM, et al
    Side Effects and Perceptions Following Sinopharm COVID-19 Vaccination.
    Int J Infect Dis. 2021 Aug 9. pii: S1201-9712(21)00646.
    >> Share

  662. NAKAMURA Y, Katano H, Nakajima N, Sato Y, et al
    SARS-CoV-2 is localized in cardiomyocytes: a post-mortem biopsy case.
    Int J Infect Dis. 2021 Aug 9. pii: S1201-9712(21)00647.
    >> Share

  663. JACOB L, Koyanagi A, Smith L, Haro JM, et al
    Prevalence of and factors associated with COVID-19 diagnosis in symptomatic patients followed in general practices in Germany between March 2020 and March 2021.
    Int J Infect Dis. 2021 Aug 8. pii: S1201-9712(21)00642.
    >> Share

  664. BUTT AA, Nafady-Hego H, Chemaitelly H, Abou-Samra AB, et al
    Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination: Breakthrough SARS-CoV-2 infection.
    Int J Infect Dis. 2021 Aug 7. pii: S1201-9712(21)00639.
    >> Share

  665. PIMENOFF VN, Bjornstedt M, Dillner J
    Severe features during outbreak but low mortality observed immediately before and after a March-May Covid-19 outbreak in Stockholm, Sweden.: Mortality before, during and after a COVID-19 outbreak.
    Int J Infect Dis. 2021 Aug 7. pii: S1201-9712(21)00637.
    >> Share

  666. DIAZ-AROCUTIPA C, Melgar-Talavera B, Alvarado-Yarasca A, Saravia-Bartra MM, et al
    Statins reduce mortality in patients with COVID-19: an updated meta-analysis of 147,824 patients.
    Int J Infect Dis. 2021 Aug 7. pii: S1201-9712(21)00636.
    >> Share

  667. THANGARAJU P, B AK, Venkatesan S
    Vigilance in selection of low-dose versus high-dose steroids in COVID-19.
    Int J Infect Dis. 2021;109:54-55.
    >> Share

    July 2021
  668. CLARO F, Silva D, Rodriguez M, Rangel R, et al
    IgG Antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals might need just one vaccine dose.
    Int J Infect Dis. 2021 Jul 31. pii: S1201-9712(21)00626.
    >> Share

  669. CHAU NVV, Nhan LNT, Nguyet LA, Tu NTK, et al
    Absence of SARS-CoV-2 antibodies in pre-pandemic plasma from children and adults in Vietnam.
    Int J Infect Dis. 2021 Jul 30. pii: S1201-9712(21)00629.
    >> Share

  670. PATINO LH, Ballesteros N, Munoz M, Castaneda S, et al
    SARS-CoV-2 in transit: characterization of SARS-CoV-2 genomes from Venezuelan migrants in Colombia.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00624.
    >> Share

  671. YARANAGULA SD, Koduri VKC
    DimachkieSpectrum of Acute Neuropathy Associated with Covid-19: Clinical and electrophysiological study of 13 patients from a single center.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00621.
    >> Share

  672. AMIR M, Yoseph H, Farisi ATA, Phie JKP, et al
    Symptomatic Bradycardia in Covid-19 Hospitalized Patients: a Case Series.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00625.
    >> Share

  673. CHEN YH, Fang CT, Huang YL
    Effect of Non-lockdown Social Distancing and Testing-Contact Tracing During a COVID-19 Outbreak in Daegu, South Korea, February to April 2020: A Modeling Study.
    Int J Infect Dis. 2021 Jul 29. pii: S1201-9712(21)00614.
    >> Share

  674. VELASQUEZ SR, Jacques L, Dalal J, Sestito P, et al
    The toll of COVID-19 on African children: A descriptive analysis on the COVID-19-related morbidity and mortality among the pediatric population in Sub-Saharan Africa.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00616.
    >> Share

  675. PALOMBA E, Carrabba M, Zuglian G, Alagna L, et al
    Treatment of SARS-CoV-2 Relapse with Remdesivir and Neutralizing Antibodies Cocktail in a Patient with X-Linked Agammaglobulinemia.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00619.
    >> Share

  676. PERKMANN T, Perkmann-Nagele N, Mucher P, Radakovics A, et al
    Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00620.
    >> Share

  677. QUACH HL, Nguyen KC, Hoang NA, Pham TQ, et al
    Association of public health interventions and COVID-19 incidence in Vietnam, January to December 2020.
    Int J Infect Dis. 2021 Jul 28. pii: S1201-9712(21)00600.
    >> Share

  678. ZANDI M, Behboudi E, Soltani S
    Can seasonal influenza vaccine for 2019/2020 has cross reactivity with some of SARS-CoV-2 proteins?
    Int J Infect Dis. 2021 Jul 26. pii: S1201-9712(21)00611.
    >> Share

  679. PAUL E, Brown GW, Dechamps M, Kalk A, et al
    Covid-19: An extra-terrestrial disease?
    Int J Infect Dis. 2021 Jul 26. pii: S1201-9712(21)00609.
    >> Share

  680. ILIC I, Stojanovic DU, Loncar G
    Influenza immunization and COVID-19 - can viral structure be responsible for the effect?
    Int J Infect Dis. 2021 Jul 26. pii: S1201-9712(21)00610.
    >> Share

  681. AHMED S, Khan WA
    A Five-day Course of Ivermectin may Reduce the Duration of COVID-19 Illness.
    Int J Infect Dis. 2021 Jul 26. pii: S1201-9712(21)00606.
    >> Share

  682. ALBAHRANI S, AlBarraK A, Alghamdi OA, Abdullah Alghamdi M, et al
    Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 vaccine in Vaccinee in Saudi Arabia.
    Int J Infect Dis. 2021 Jul 25. pii: S1201-9712(21)00608.
    >> Share

  683. BROTONS P, Perez-Arguello A, Launes C, Torrents F, et al
    Validation and implementation of a direct RT-qPCR method for rapid screening of SARS-CoV-2 infection by using non-invasive saliva samples.
    Int J Infect Dis. 2021 Jul 25. pii: S1201-9712(21)00607.
    >> Share

  684. MARCOLINO MS, Pires MC, Ramos LEF, Silva RT, et al
    ABC2-SPH risk score for in-hospital mortality in COVID-19 patients: development, external validation and comparison with other available scores.
    Int J Infect Dis. 2021 Jul 23. pii: S1201-9712(21)00605.
    >> Share

  685. GORDON PDMMV, McCarthy PDKA, Proctor PDJL, Hagedorn MBL, et al
    Evaluating COVID-19 reporting data in the context of testing strategies across 31 LMICs.
    Int J Infect Dis. 2021 Jul 22. pii: S1201-9712(21)00599.
    >> Share

  686. KUMAR NP, Padmapriyadarsini C, Rajamanickam A, Bhavani PK, et al
    BCG vaccination induces enhanced frequencies of dendritic cells and altered plasma levels of type I and type III interferons in elderly individuals.
    Int J Infect Dis. 2021 Jul 21. pii: S1201-9712(21)00598.
    >> Share

  687. SIRIPURAPU G, Samad SA, Fatima S, Wig N, et al
    SUCCESSFUL MANAGEMENT OF POST-COVID-19 ACANTHAMOEBIC ENCEPHALITIS.
    Int J Infect Dis. 2021 Jul 21. pii: S1201-9712(21)00602.
    >> Share

  688. GERTLER M, Krause E, van Loon W, Krug N, et al
    Self-collected oral, nasal and saliva samples yield sensitivity comparable to professional-collected oro-nasopharyngeal swabs in SARS-CoV-2 diagnosis among symptomatic outpatients.
    Int J Infect Dis. 2021 Jul 21. pii: S1201-9712(21)00601.
    >> Share

  689. LELI C, Matteo LD, Gotta F, Cornaglia E, et al
    Performance of a SARS CoV-2 antigen rapid immunoassay in patients admitted to the Emergency Department.
    Int J Infect Dis. 2021 Jul 21. pii: S1201-9712(21)00597.
    >> Share

  690. OKPALA OV, Dim CC, Ugwu CI, Onyemaechi S, et al
    Population seroprevalence of SARS-CoV-2 antibodies in Anambra state, South-East, Nigeria.
    Int J Infect Dis. 2021 Jul 19. pii: S1201-9712(21)00596.
    >> Share

  691. ALSHUKAIRI AN, El-Kafrawy SA, Dada A, Yasir M, et al
    Re-infection with different SARS-CoV-2 clade and prolonged viral shedding in a patient with hematopoietic stem cell transplantation: SARS-CoV-2 Re-infection with different clade.
    Int J Infect Dis. 2021 Jul 18. pii: S1201-9712(21)00592.
    >> Share

  692. RENISI G, Lombardi A, Massimo S, Alessandro I, et al
    ANTERIOR UVEITIS ONSET AFTER BNT162b2 VACCINATION: IS THIS JUST A COINCIDENCE?
    Int J Infect Dis. 2021 Jul 18. pii: S1201-9712(21)00591.
    >> Share

  693. LALWANI P, Salgado BB, Filho IVP, da Silva DSS, et al
    SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00576.
    >> Share

  694. ALKOFIDE H, Almohaizeie A, Almuhaini S, Alotaibi B, et al
    Tocilizumab and Systemic Corticosteroids in the Management of COVID-19 Patients:A Systematic Review and Meta-Analysis.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00578.
    >> Share

  695. HUSNAYAIN A, Chuang TW, Fuad A, Su EC, et al
    High variability in model performance of Google relative search volume in spatially clustered COVID-19 areas of the United States.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00587.
    >> Share

  696. YAMAGUCHI T, Shinagawa T, Kobata H, Nakagawa H, et al
    Immunity against seasonal human coronavirus OC43 mitigates fatal deterioration of COVID-19.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00571.
    >> Share

  697. MARKEWITZ R, Torge A, Wandinger KP, Pauli D, et al
    Analysis of SARS-CoV-2 RT-qPCR Ct values vis-a-vis anti-SARS-CoV-2 antibodies from a high incidence region.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00570.
    >> Share

  698. DARCIS G, Bouquegneau A, Maes N, Thys M, et al
    Long-term clinical follow up of patients suffering from moderate to severe COVID-19 infection: A monocentric prospective observational cohort study.
    Int J Infect Dis. 2021 Jul 14. pii: S1201-9712(21)00572.
    >> Share

  699. TONIASSOA SCC, Fernandesa FS, Jovelevithsb D, Filhoc FFD, et al
    Reduction in COVID-19 prevalence in health care workers in a university hospital in southern Brazil after the start of vaccination.
    Int J Infect Dis. 2021 Jul 13. pii: S1201-9712(21)00582.
    >> Share

  700. CONNOR BA, Couto-Rodriguez M, Barrows JE, Gardner M, et al
    Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case.
    Int J Infect Dis. 2021 Jul 13. pii: S1201-9712(21)00586.
    >> Share

  701. IRWIN N, Murray L, Ozynski B, Richards GA, et al
    nnAge significantly influences the sensitivity of SARS-CoV-2 rapid antibody assays.
    Int J Infect Dis. 2021 Jul 13. pii: S1201-9712(21)00585.
    >> Share

  702. NUNEZ-ZAPATA SF, Benites-Peralta B, Mayta-Tristan P, Rodriguez-Morales AJ, et al
    High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for heard immunity!
    Int J Infect Dis. 2021 Jul 11. pii: S1201-9712(21)00579.
    >> Share

  703. KIM JH, Roh YH, Ahn JG, Kim MY, et al
    Respiratory syncytial virus and influenza epidemics disappearance in Korea during the 2020-2021 season of COVID-19.
    Int J Infect Dis. 2021 Jul 7. pii: S1201-9712(21)00560.
    >> Share

  704. MALIK M, Kunze AC, Bahmer T, Herget-Rosenthal S, et al
    SARS-CoV-2: Viral Loads of Exhaled Breath and Oronasopharyngeal Specimens in Hospitalized Patients with COVID-19.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00567.
    >> Share

  705. SOLDEVILA L, Valerio-Sallent L, Roure S, Perez-Quilez O, et al
    Drug exposure may have a substantial influence on COVID-19 prognosis among residents of long-term care facilities: an exploratory analysis.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00562.
    >> Share

  706. ALSHAMRANI MM, El-Saed A, Zunitan MA, Almulhem R, et al
    Risk of COVID-19 morbidity and mortality among healthcare workers working in a Large Tertiary Care Hospital.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00564.
    >> Share

  707. ELHARAKE JA, Galal B, Alqahtani SA, Kattan RF, et al
    COVID-19 Vaccine Acceptance among Health Care Workers in the Kingdom of Saudi Arabia.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00559.
    >> Share

  708. JEGERLEHNER S, Suter-Riniker F, Jent P, Bittel P, et al
    Diagnostic accuracy of a SARS-CoV-2 rapid antigen test in real-life clinical settings.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00565.
    >> Share

  709. ROVIDA F, Cassaniti I, Percivalle E, Sarasini A, et al
    Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-control study.
    Int J Infect Dis. 2021 Jul 6. pii: S1201-9712(21)00558.
    >> Share

  710. MUCHELENG'ANGA LA, Telendiy V, Hamukale A, Shibemba AL, et al
    COVID-19 and Sudden Unexpected Community Deaths in Lusaka, Zambia, Africa - A Medico-Legal Whole-Body Autopsy Case Series.
    Int J Infect Dis. 2021;109:160-167.
    >> Share

  711. JACOB L, Koyanagi A, Smith L, Tanislav C, et al
    Prevalence of and factors associated with long-term COVID-19 sick leave in working-age patients followed in general practices in Germany.
    Int J Infect Dis. 2021 Jul 2. pii: S1201-9712(21)00552.
    >> Share

    June 2021
  712. FERGUSON J, Murugesan K, Banaei N, Liu A, et al
    Interferon-gamma release assay testing to assess COVID-19 vaccination response in a SARS-CoV-2 seronegative patient on rituximab: a case report.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00542.
    >> Share

  713. W T, A A, A T, V V, et al
    Evaluation of potassium peroxymonosulfate (MPS) efficacy against SARS-CoV-2 virus using RT-qPCR-based method.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00545.
    >> Share

  714. BALUSHI AA, AlShekaili J, Kindi MA, Ansari Z, et al
    Immunological predictors of disease severity in patients with COVID-19.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00546.
    >> Share

  715. HSU SH, Chang SH, Gross C, Wang SY, et al
    Relative risks of Covid-19 fatality between the first and second waves of the pandemic in Ontario, Canada.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00548.
    >> Share

  716. BUNDGAARD JS, Raaschou-Pedersen DT, Todsen T, Ringgaard A, et al
    Danish Citizen s Preferences for at-home Oropharyngeal/nasal SARS-CoV-2 Specimen Collection.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00550.
    >> Share

  717. LASTRUCCI V, Bonaccorsi G, Forni S, D'Arienzo S, et al
    The indirect impact of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia in the elderly: a region-wide population-based study in Tuscany, Italy.
    Int J Infect Dis. 2021 Jun 30. pii: S1201-9712(21)00547.
    >> Share

  718. PANDIT A, Bhalani N, Bhushan BLS, Koradia P, et al
    Corrigendum to "Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study" [International Journal of Infectious Diseases, Volume 105, April 2021, Pages 516-521].
    Int J Infect Dis. 2021 Jun 27. pii: S1201-9712(21)00519.
    >> Share

  719. WIBOWO A, Pranata R, Lim MA, Akbar MR, et al
    Endotheliopathy Marked by High von Willebrand Factor (vWF) Antigen in COVID-19 is Associated with Poor Outcome: A Systematic Review and Meta-analysis.
    Int J Infect Dis. 2021 Jun 27. pii: S1201-9712(21)00540.
    >> Share

  720. KUMAR SHUKLA DA, Misra DS
    Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible.
    Int J Infect Dis. 2021 Jun 24. pii: S1201-9712(21)00535.
    >> Share

  721. SPEECKAERT MM, Delanghe JR
    The potential significance of vitamin D binding protein polymorphism in COVID-19.
    Int J Infect Dis. 2021 Jun 23. pii: S1201-9712(21)00532.
    >> Share

  722. YAMAMOTO K, Suzuki M, Yamada G, Sudo T, et al
    Corrigendum to "Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission" [Int J Infect Dis 104 (2021) 65-72].
    Int J Infect Dis. 2021 Jun 22. pii: S1201-9712(21)00498.
    >> Share

  723. BRUNO A, de Mora D, Freire-Paspuel B, Rodriguez AS, et al
    Analytical and clinical evaluation of a heat shock SARS-CoV-2 diagnosis method without RNA extraction for N and E genes RT-qPCR.
    Int J Infect Dis. 2021 Jun 21. pii: S1201-9712(21)00526.
    >> Share

  724. KAMALADASA A, Gunasekara B, Jeewandara C, Jayathilaka D, et al
    Comparison of two assays to detect IgG antibodies to the receptor binding domain of the SARSCoV2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients.
    Int J Infect Dis. 2021 Jun 20. pii: S1201-9712(21)00520.
    >> Share

  725. ALHINAI ZA, Elsidig N
    Countries with similar Covid-19 vaccination rates yet divergent outcomes: are all vaccines created equal?
    Int J Infect Dis. 2021 Jun 19. pii: S1201-9712(21)00527.
    >> Share

  726. FW H, Tc L, Dt A, R L, et al
    Is convalescent plasma futile in COVID-19? A Bayesian re-analysis of the RECOVERY randomised controlled trial.
    Int J Infect Dis. 2021 Jun 19. pii: S1201-9712(21)00523.
    >> Share

  727. TANISALI G, Sozak A, Bulut AS, Sander TZ, et al
    Effectiveness of different types of Masks in Aerosol Dispersion in SARS-CoV-2 Infection.
    Int J Infect Dis. 2021 Jun 17. pii: S1201-9712(21)00518.
    >> Share

  728. DUARTE CM, Jamil T, Gojobori T, Alam I, et al
    Detection of SARS-CoV-2 variants requires urgent global coordination.
    Int J Infect Dis. 2021 Jun 17. pii: S1201-9712(21)00516.
    >> Share

  729. HIMWAZE CM, Telendiy V, Maate F, Mupeta S, et al
    Post-mortem examination of Hospital Inpatient COVID-19 Deaths in Lusaka, Zambia - A Descriptive Whole-body Autopsy Series.
    Int J Infect Dis. 2021;108:363-369.
    >> Share

  730. SONG G, Qiao W, Wang X, Yu X, et al
    Association of lung ultrasound score with mortality and severity of COVID-19: A Meta-analysis and Trial Sequential Analysis.
    Int J Infect Dis. 2021 Jun 16. pii: S1201-9712(21)00513.
    >> Share

  731. AKHMETZHANOV AR, Jung SM, Cheng HY, Thompson RN, et al
    A hospital-related outbreak of SARS-CoV-2 associated with a novel variant Cal.20C (B.1.429) in Taiwan: transmission potential and outbreak containment under intensified contact tracing, January-February 2021.
    Int J Infect Dis. 2021 Jun 16. pii: S1201-9712(21)00517.
    >> Share

  732. HANS L, Steegen K, Ketseoglou I, Mahlumba Z, et al
    Preparing for the next pandemic: Lessons from rapid scale-up of SARS-CoV-2 testing in a South African high-throughput automated HIV molecular laboratory.
    Int J Infect Dis. 2021 Jun 14. pii: S1201-9712(21)00508.
    >> Share

  733. MONEDERO-RECUERO I, Gegia M, Wares DF, S Chadha S, et al
    Situational analysis of the 10 high drug resistant tuberculosis burden countries two years post-UNHLM declaration: progress and setbacks in a changing landscape.
    Int J Infect Dis. 2021 Jun 14. pii: S1201-9712(21)00511.
    >> Share

  734. BOOGAARD LH, Sikkema RS, van Beek J, Brockhoff HJ, et al
    A mixed methods approach to elucidate SARS-CoV-2 transmission routes and clustering in outbreaks in native workers and labour migrants in the fruit and vegetable packaging industry in South Holland, the Netherlands, May to July 2020.
    Int J Infect Dis. 2021 Jun 14. pii: S1201-9712(21)00510.
    >> Share

  735. KASPERSEN KA, Greve T, Nielsen KJ, Jespersen S, et al
    Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020.
    Int J Infect Dis. 2021 Jun 11. pii: S1201-9712(21)00506.
    >> Share

  736. GUZMAN NA, De la Hoz Restrepo F, Serrano-Coll H, Gastelbondo B, et al
    Using serological studies to assess COVID-19 infection fatality rate in developing countries. A case study from one Colombian department.
    Int J Infect Dis. 2021 Jun 11. pii: S1201-9712(21)00507.
    >> Share

  737. VALLEJO-JANETA AP, Morales-Jadan D, Freire-Paspuel B, Lozada T, et al
    COVID-19 outbreaks at shelters for women victims of gender-based violence from Ecuador.
    Int J Infect Dis. 2021 Jun 10. pii: S1201-9712(21)00501.
    >> Share

  738. MEDINA N, Alastruey-Izquierdo A, Bonilla O, Ortiz B, et al
    Impact of the COVID-19 pandemic on HIV care in Guatemala.
    Int J Infect Dis. 2021 Jun 10. pii: S1201-9712(21)00500.
    >> Share

  739. PORTO MH, Castro B, Diaz Z, Pedroso Y, et al
    SARS-CoV-2 infection in properly vaccinated healthcare workers.
    Int J Infect Dis. 2021 Jun 9. pii: S1201-9712(21)00499.
    >> Share

  740. DIAZ Y, Ortiz A, Weeden A, Castillo D, et al
    SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama.
    Int J Infect Dis. 2021 Jun 6. pii: S1201-9712(21)00493.
    >> Share

  741. CHEN S, Zheng T, Wang S, Yu Y, et al
    Association between risk of VTE and mortality in patients with COVID-19.
    Int J Infect Dis. 2021 Jun 6. pii: S1201-9712(21)00494.
    >> Share

  742. YEN MY, Yen YF, Chen SY, Lee TI, et al
    Learning from the past: Taiwan's responses to COVID-19 versus SARS.
    Int J Infect Dis. 2021 Jun 4. pii: S1201-9712(21)00490.
    >> Share

  743. LI X, Yin Y, Pang L, Xu S, et al
    Colloidal gold immunochromatographic assay (GICA) is an effective screening method for identifying detectable anti-SARS-CoV-2 neutralizing antibodies.
    Int J Infect Dis. 2021 Jun 3. pii: S1201-9712(21)00484.
    >> Share

  744. MAYANSKIY N, Brzhozovskaya E, Fedorova N, Lebedin Y, et al
    Parallel detection of SARS-CoV-2 RNA and nucleocapsid antigen in nasopharyngeal specimens from a COVID-19 patient screening cohort.
    Int J Infect Dis. 2021 Jun 3. pii: S1201-9712(21)00486.
    >> Share

  745. KINOSHITA M, Sato K, Vellingiri B, Green SJ, et al
    Inverse association between hypertension treatment and COVID-19 prevalence in Japan.
    Int J Infect Dis. 2021 Jun 2. pii: S1201-9712(21)00474.
    >> Share

  746. TOCZYLOWSKI K, Jackowska K, Lewandowski D, Kurylonek S, et al
    Rotavirus gastroenteritis in children hospitalized in northeastern Poland in 2006-2020: severity, seasonal trends, and impact of immunization.
    Int J Infect Dis. 2021 Jun 2. pii: S1201-9712(21)00473.
    >> Share

  747. MOLINA GA, Ayala AV, Endara SA, Aguayo WG, et al
    Ecuador and Covid-19, A Pandemic we won't be able to run away from.
    Int J Infect Dis. 2021 Jun 2. pii: S1201-9712(21)00480.
    >> Share

  748. GREUEL S, Ihlow J, Dragomir MP, Streit S, et al
    COVID-19: Autopsy findings in six patients between 26 and 46 years of age.
    Int J Infect Dis. 2021 Jun 2. pii: S1201-9712(21)00472.
    >> Share

  749. PETERSEN E, Schlagenhauf P, Lee SS, Blumberg L, et al
    Mandatory immunization against SARS-CoV-2 of athletes, companions and supporters for the Tokyo Olympics.
    Int J Infect Dis. 2021;108:156-158.
    >> Share

  750. RAGHAV K, Anand S, Gothwal A, Singh P, et al
    Underreporting of race/ethnicity in COVID-19 research.
    Int J Infect Dis. 2021 Jun 1. pii: S1201-9712(21)00479.
    >> Share

  751. CAMELENA F, Poncin T, Dudoignon E, Salmona M, et al
    rcent agreement; NPA: negative percent agreeRapid identification of bacteria from respiratory samples of patients hospitalized in intensive care units, with FilmArray Pneumonia Panel Plus.
    Int J Infect Dis. 2021 Jun 1. pii: S1201-9712(21)00477.
    >> Share

  752. LEIXNER G, Voill-Glaninger A, Bonner E, Kreil A, et al
    Evaluation of the AMP SARS-CoV-2 Rapid Antigen Test in a Hospital Setting.
    Int J Infect Dis. 2021 Jun 1. pii: S1201-9712(21)00466.
    >> Share

  753. NG DC, Tan KK, Ling C, Ali MM, et al
    Clinical and epidemiological characteristics of children with COVID-19 in Negeri Sembilan, Malaysia.
    Int J Infect Dis. 2021 Jun 1. pii: S1201-9712(21)00476.
    >> Share

  754. KAMSTRUP P, Sivapalan P, Eklof J, Hoyer N, et al
    Hydroxychloroquine as a primary prophylactic agent against sars-cov-2 infection: a cohort study.
    Int J Infect Dis. 2021 Jun 1. pii: S1201-9712(21)00478.
    >> Share

    May 2021
  755. HIROTSU Y, Sugiura H, Maejima M, Hayakawa M, et al
    Comparison of Roche and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19.
    Int J Infect Dis. 2021 May 31. pii: S1201-9712(21)00470.
    >> Share

  756. LIM AY, Cheong HK, Oh YJ, Lee JK, et al
    Modeling the early temporal dynamics of viral load in respiratory tract specimens of COVID-19 patients in Incheon, the Republic of Korea.
    Int J Infect Dis. 2021 May 28. pii: S1201-9712(21)00465.
    >> Share

  757. YOUSEFINAGHANI S, Dara R, Mubareka S, Papadopoulos A, et al
    An Analysis of COVID-19 Vaccine Sentiments and Opinions on Twitter.
    Int J Infect Dis. 2021 May 27. pii: S1201-9712(21)00462.
    >> Share

  758. PAGNESI M, Inciardi RM, Lombardi CM, Agostoni P, et al
    Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study.
    Int J Infect Dis. 2021 May 27. pii: S1201-9712(21)00458.
    >> Share

  759. UMEMURA Y, Mitsuyama Y, Minami K, Nishida T, et al
    Efficacy and safety of nintedanib for pulmonary fibrosis in severe pneumonia induced by Coronavirus disease 2019: An interventional study.
    Int J Infect Dis. 2021 May 25. pii: S1201-9712(21)00456.
    >> Share

  760. ARMINANZAS C, Arnaiz de Las Revillas F, Gutierrez Cuadra M, Arnaiz A, et al
    USEFULNESS OF THE COVID-GRAM AND CURB-65 SCORES FOR PREDICTING SEVERITY IN PATIENTS WITH COVID-19.
    Int J Infect Dis. 2021 May 24. pii: S1201-9712(21)00450.
    >> Share

  761. RUBIO CP, Franco-Martinez L, Resalt CS, Torres-Cantero A, et al
    Evaluation of different sample treatments options in a simple and safe procedure for the detection of SARS-COV-2 in saliva.
    Int J Infect Dis. 2021 May 24. pii: S1201-9712(21)00455.
    >> Share

  762. LEE H, Noh E, Jeon H, Nam EW, et al
    Association between the traffic level from other areas and the COVID-19 prevalence at the provincial levels in South Korea.
    Int J Infect Dis. 2021 May 24. pii: S1201-9712(21)00457.
    >> Share

  763. AHMAD F, Ahmed A, Rajendraprasad SS, Loranger A, et al
    Multisystem Inflammatory Syndrome in Adults: A Rare Sequela of SARS-CoV-2 Infection.
    Int J Infect Dis. 2021 May 24. pii: S1201-9712(21)00452.
    >> Share

  764. LUKITO AA, Widysanto A, Lemuel TAY, Prasetya IB, et al
    Candesartan as a tentative treatment for COVID-19: a prospective non-randomized open-label study.
    Int J Infect Dis. 2021 May 23. pii: S1201-9712(21)00420.
    >> Share

  765. NAGANO H, Takada D, Shin JH, Morishita T, et al
    Corrigendum to 'Hospitalization of mild cases of community-acquired pneumonia decreased more than severe cases during the COVID-19 pandemic.' [Int J Infect Dise. Vol 106 (2021) P323-328].
    Int J Infect Dis. 2021;107:254.
    >> Share

  766. BABU GR, Sundaresan R, Athreya S, Akhtar J, et al
    The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide sentinel-based population survey in Karnataka, India.
    Int J Infect Dis. 2021 May 21. pii: S1201-9712(21)00445.
    >> Share

  767. CAMICI M, Zuppi P, Lorenzini P, Scarnecchia L, et al
    The role of testosterone in SARS-CoV-2 infection: a key pathogenic factor and a biomarker for severe pneumonia.
    Int J Infect Dis. 2021 May 20. pii: S1201-9712(21)00444.
    >> Share

  768. MURHEKAR MV, Bhatnagar T, Thangaraj JWV, Saravanakumar V, et al
    SARS-CoV-2 sero-prevalence among general population and healthcare workers in India, December 2020 - January 2021.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00442.
    >> Share

  769. NIELSEN KJ, Vestergaard JM, Schlunssen V, Bonde JP, et al
    Day by day symptoms following positive and negative PCR tests for SARS-CoV-2 in non-hospitalised health-care workers: a 90-day follow-up study.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00434.
    >> Share

  770. KIM J, Gomez REG, Hong K, Yum S, et al
    The changing influenza activity in the Southern hemisphere countries during the COVID-19 pandemic.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00441.
    >> Share

  771. RAY JG, Colacci M, Schull MJ, Vermeulen MJ, et al
    Non-ABO red cell antibodies and risk of COVID-19.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00440.
    >> Share

  772. FAY FF, Alvarez-Moreno CA, Bonvehi PE, Espinoza CC, et al
    A simplified alternative diagnostic algorithm for SARS-CoV-2 suspected symptomatic patients and confirmed close contacts (asymptomatic): A consensus of Latin American experts.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00412.
    >> Share

  773. HAMMER CC, Boender TS, Thomas DR
    Social media for field epidemiologists (#SoMe4epis): How to use Twitter during the #COVID19 pandemic.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00437.
    >> Share

  774. SASIKALA M, Shashidhar J, Deepika G, Ravikanth V, et al
    Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00436.
    >> Share

  775. VICENTI I, Gatti F, Scaggiante R, Boccuto A, et al
    Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection.
    Int J Infect Dis. 2021 May 19. pii: S1201-9712(21)00435.
    >> Share

  776. HAYER J, Kasapic D, Zemmrich C
    Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: A systematic meta-analysis of available data as per November 20, 2020.
    Int J Infect Dis. 2021 May 17. pii: S1201-9712(21)00431.
    >> Share

  777. ALSHUKAIRI AN, Tolah AM, Dada A, Al-Tawfiq JA, et al
    Test-based De-isolation in COVID-19 Immunocompromised patients: Ct value versus SARS-CoV-2 viral cultures.
    Int J Infect Dis. 2021 May 15. pii: S1201-9712(21)00429.
    >> Share

  778. FATTEH N, Sutherland GE, Santos RG, Zeidan R, et al
    Association of Hypothermia with Increased Mortality Rate in SARS-CoV-2 Infection.
    Int J Infect Dis. 2021 May 15. pii: S1201-9712(21)00433.
    >> Share

  779. MUMOLI N, Evangelista I, Colombo A, Conte G, et al
    Transient perivascular inflammation of the carotid artery (TIPIC) syndrome in a patient with COVID-19.
    Int J Infect Dis. 2021 May 14. pii: S1201-9712(21)00418.
    >> Share

  780. JASPARD M, Sow MS, Juchet S, Diendere E, et al
    Clinical presentation, outcomes and factors associated with mortality: a prospective study from three COVID-19 referral care centers in West Africa.
    Int J Infect Dis. 2021 May 14. pii: S1201-9712(21)00425.
    >> Share

  781. MARTHA JW, Pranata R, Lim MA, Wibowo A, et al
    Active Prescription of Low-dose Aspirin During or Prior to Hospitalization and Mortality in COVID-19 - A Systematic Review and Meta-analysis of Adjusted Effect Estimates.
    Int J Infect Dis. 2021 May 14. pii: S1201-9712(21)00417.
    >> Share

  782. ZAQOUT A, Daghfal J, Alaqad I, Hussein SAN, et al
    The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout.
    Int J Infect Dis. 2021 May 13. pii: S1201-9712(21)00422.
    >> Share

  783. CUCUNAWANGSIH C, Wijaya RS, Lugito NPH, Suriapranata I, et al
    Post-vaccination COVID-19 cases among healthcare workers at Siloam Teaching Hospital, Indonesia.
    Int J Infect Dis. 2021 May 13. pii: S1201-9712(21)00421.
    >> Share

  784. SMAGHI BS, Collins J, Dagina R, Hiawalyer G, et al
    Barriers and enablers experienced by health care workers in swabbing for COVID-19 in Papua New Guinea: a multi-methods cross-sectional study, November - December 2020.
    Int J Infect Dis. 2021 May 12. pii: S1201-9712(21)00390.
    >> Share

  785. DE SIQUEIRA IC, Camelier AA, Maciel EAP, Nonaka CKV, et al
    Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil.
    Int J Infect Dis. 2021 May 11. pii: S1201-9712(21)00411.
    >> Share

  786. WANNIGAMA DL, Amarasiri M, Hurst C, Phattharapornjaroen P, et al
    Tracking COVID-19 with wastewater to understand asymptomatic transmission.
    Int J Infect Dis. 2021 May 11. pii: S1201-9712(21)00406.
    >> Share

  787. WU J, Chen X, Gong L, Huo S, et al
    Epidemiological and clinical features of SARS-CoV-2 cluster infection in Anhui Province, Eastern China.
    Int J Infect Dis. 2021 May 10. pii: S1201-9712(21)00376.
    >> Share

  788. ZHANG X, Jiang M, Yang J
    Potential value of circulating endothelial cells for the diagnosis and treatment of COVID-19.
    Int J Infect Dis. 2021 May 6. pii: S1201-9712(21)00402.
    >> Share

  789. SUZUKI T, Kutsuna S, Saito S, Kawashima A, et al
    Clinical course of alopecia after severe acute respiratory syndrome coronavirus 2 infection.
    Int J Infect Dis. 2021 May 4. pii: S1201-9712(21)00400.
    >> Share

  790. BEZERRA ALVES JG, Natal Figueiroa J, Urquia ML
    Impact of COVID-19 on immunization of Brazilian infants.
    Int J Infect Dis. 2021 May 4. pii: S1201-9712(21)00401.
    >> Share

  791. PENA M, Ampuero M, Garces C, Gaggero A, et al
    Performance of SARS-CoV-2 rapid antigen test compared with real-time RT-PCR in asymptomatic individuals.
    Int J Infect Dis. 2021 May 1. pii: S1201-9712(21)00399.
    >> Share

  792. CAVALCANTE PINTO V JUNIOR, Moura LFWG, Cavalcante RC, Rubens Costa Lima J, et al
    Prevalence of COVID-19 in children, adolescents, and adults in remote education situation in the city of Fortaleza - Brazil.
    Int J Infect Dis. 2021 May 1. pii: S1201-9712(21)00398.
    >> Share

  793. HAUSDORFF WP, Flores J
    Hausdorff and Flores Author Reply to Letter to the Editor by Prof G. Bauer (THEIJID-D-21-00652).
    Int J Infect Dis. 2021;106:78.
    >> Share

  794. BONILLA-ALDANA DK, Jimenez-Diaz SD, Arango-Duque JS, Aguirre-Florez M, et al
    Reply to "Misconceptions and misinformation about bats and viruses".
    Int J Infect Dis. 2021;106:197-198.
    >> Share

    April 2021
  795. NASIRI M, Khodadadi J, Molaei S
    Does vitamin D serum level affect prognosis of COVID-19 patients?
    Int J Infect Dis. 2021 Apr 30. pii: S1201-9712(21)00395.
    >> Share

  796. PETERSEN E, Buchy P
    Vaccination against SARS-CoV-2 should be included in childhood vaccination programs.
    Int J Infect Dis. 2021 Apr 29. pii: S1201-9712(21)00394.
    >> Share

  797. CASTRO ABREU PINTO T, Silva Costa N, Andrade Oliveira LM
    The World Meningitis Day and the WHO roadmap to defeat bacterial meningitis in the COVID-19 pandemic era.
    Int J Infect Dis. 2021 Apr 28. pii: S1201-9712(21)00382.
    >> Share

  798. GERHARDS C, Thiaucourt M, Kittel M, Becker C, et al
    Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescent from COVID-19 infection.
    Int J Infect Dis. 2021 Apr 28. pii: S1201-9712(21)00392.
    >> Share

  799. LUO C, Liu M, Li Q, Zheng X, et al
    Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: multiple factors-based analysis.
    Int J Infect Dis. 2021 Apr 28. pii: S1201-9712(21)00389.
    >> Share

  800. SONG Y, Chen C, Wang Y, Zhang J, et al
    Early and consecutive RT-PCR tests with both oropharyngeal swabs and sputum could improve testing yield for patients with COVID-19: An Observation Cohort Study in China.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00388.
    >> Share

  801. SORIANO V, de Mendoza C, Gomez-Gallego F, Corral O, et al
    Third wave of COVID-19 in Madrid, Spain.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00386.
    >> Share

  802. AZNAR ML, Espinosa-Pereiro J, Saborit N, Jove N, et al
    Impact of the COVID-19 pandemic on tuberculosis management in Spain.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00387.
    >> Share

  803. SEVILLANO G, Ortega-Paredes D, Loaiza K, Zurita-Salinas C, et al
    Evidence of SARS-CoV-2 reinfection within the same clade in Ecuador: A case study.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00385.
    >> Share

  804. AL-MAANI A, Al Wahaibi A, Al-Sooti J, Al Abri B, et al
    The role of supporting services in driving SARS-CoV-2 transmission within healthcare settings: a multicenter seroprevalence study.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00383.
    >> Share

  805. BRUZZONE B, De Pace V, Caligiuri P, Ricucci V, et al
    Comparative diagnostic performance of different rapid antigen detection tests for COVID-19 in the real-world hospital setting.
    Int J Infect Dis. 2021 Apr 27. pii: S1201-9712(21)00384.
    >> Share

  806. LAGI F, Trevisan S, Piccica M, Graziani L, et al
    Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00377.
    >> Share

  807. LACAP EM JR, Varghese A, Khamis F, Bahrani MA, et al
    Development and Validation of CoV19-OM Intensive Care Unit Score: An Early ICU Identification for Laboratory-Confirmed SARS-CoV-2 Patients from a Retrospective Cohort Study in Oman.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00381.
    >> Share

  808. D'ABRAMO A, Vita S, Maffongelli G, Mariano A, et al
    Prolonged and severe SARS-CoV-2 infection in patients under B-cell-depleting drug successfully treated: a tailored approach.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00380.
    >> Share

  809. RADULESCU A, Istrate A, Flonta M, Lupse M, et al
    Antibody and viral RNA kinetics in SARS-CoV2 infected patients admitted in a Romanian University Hospital of Infectious Diseases.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00379.
    >> Share

  810. CRUZ C, White NJ
    COVID-19 chemoprevention.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00356.
    >> Share

  811. LEBOURGEOIS S, Storto A, Gout B, Le Hingrat Q, et al
    Performance Evaluation of the QIAstat-Dx(R) Respiratory SARS-CoV-2 Panel.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00378.
    >> Share

  812. LEDNICKY JA, Lauzardo M, Alam MM, Elbadry MA, et al
    Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness.
    Int J Infect Dis. 2021 Apr 23. pii: S1201-9712(21)00375.
    >> Share

  813. NEKLUDOVA GV, Avdeev SN, Tsareva NA, Trushenko NV, et al
    Using TAPSE as a predictor of poor prognosis of COVID-19: is it enough?
    Int J Infect Dis. 2021 Apr 22. pii: S1201-9712(21)00368.
    >> Share

  814. AL-SAKKAF E, Ghaleb Y, Al-Dabis E, Qairan M, et al
    First COVID-19 Cases with High Secondary Infection among Health Workers, Sana'a Capital, April 2020: Lessons Learned and Future Opportunities.
    Int J Infect Dis. 2021 Apr 22. pii: S1201-9712(21)00333.
    >> Share

  815. ARNAUD DE, Apoline SK, Risgou OA, Lucien DD, et al
    Predictors of severe hypoxemia among COVID-19 patients in Burkina Faso (West Africa): findings from hospital based cross-sectional study.
    Int J Infect Dis. 2021 Apr 21. pii: S1201-9712(21)00318.
    >> Share

  816. OSMAN W, Al Fahdi F, Khamis F, Salmi IA, et al
    Serum Calcium and Vitamin D levels correlation with severity of COVID-19 in hospitalized patients in Royal Hospital, Oman.
    Int J Infect Dis. 2021 Apr 20. pii: S1201-9712(21)00361.
    >> Share

  817. SUGHAYER MA, Mansour A, Al Nuirat A, Souan L, et al
    Dramatic Rise of Seroprevalence Rates of SARS-CoV-2 Antibodies among Healthy Blood Donors: The evolution of a Pandemic.
    Int J Infect Dis. 2021 Apr 20. pii: S1201-9712(21)00371.
    >> Share

  818. BIRLUTIU V, Feiereisz AI, Oprinca G, Dobritoiu S, et al
    Cutaneous manifestations associated with anosmia, ageusia and enteritis in SARS-CoV-2 infection - a possible pattern? Observational study and review of the literature.
    Int J Infect Dis. 2021 Apr 19. pii: S1201-9712(21)00370.
    >> Share

  819. SIAMI Z, Aghajanian S, Mansouri S, Mokhames Z, et al
    Effect of Ammonium Chloride in addition to standard of care in outpatients and hospitalized COVID-19 patients: a randomized clinical trial.
    Int J Infect Dis. 2021 Apr 17. pii: S1201-9712(21)00354.
    >> Share

  820. CAPUTO V, Bax C, Colantoni L, Peconi C, et al
    Comparative analysis of antigen and molecular tests for the detection of Sars-CoV-2 and related variants: a study on 4266 samples.
    Int J Infect Dis. 2021 Apr 17. pii: S1201-9712(21)00359.
    >> Share

  821. HANSEN T, Titze U, Kulamadayil-Heidenreich NSA, Glombitza S, et al
    First case of postmortem study in a patient vaccinated against SARS CoV2.
    Int J Infect Dis. 2021 Apr 16. pii: S1201-9712(21)00364.
    >> Share

  822. KADALI RAK, Janagama R, Peruru S, Malayala SV, et al
    Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers.
    Int J Infect Dis. 2021 Apr 15. pii: S1201-9712(21)00358.
    >> Share

  823. AIELLO A, Fard SN, Petruccioli E, Petrone L, et al
    Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients.
    Int J Infect Dis. 2021 Apr 14. pii: S1201-9712(21)00344.
    >> Share

  824. SEET RCS, Quek AML, Ooi DSQ, Sengupta S, et al
    Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: an open-label randomized trial.
    Int J Infect Dis. 2021 Apr 14. pii: S1201-9712(21)00345.
    >> Share

  825. MEHLER K, Jung N, Oberthuer A
    Is it all MIS-C? - Unusual findings in a series of nine German patients with multi-system inflammatory syndrome in children (MIS-C) after SARS-CoV2 infection.
    Int J Infect Dis. 2021 Apr 14. pii: S1201-9712(21)00355.
    >> Share

  826. ROEST S, Brugts JJ, van Kampen JJA, von der Thusen JH, et al
    COVID-19-related myocarditis post-heart transplantation.
    Int J Infect Dis. 2021 Apr 13. pii: S1201-9712(21)00324.
    >> Share

  827. GHAFARI M, Kadivar A, Katzourakis A
    Excess deaths associated with the Iranian COVID-19 epidemic: A province-level analysis.
    Int J Infect Dis. 2021 Apr 13. pii: S1201-9712(21)00326.
    >> Share

  828. INABA M, Higashimoto Y, Toyama Y, Horiguchi T, et al
    Diagnostic accuracy of LAMP versus PCR over the course of SARS-CoV-2 infection.
    Int J Infect Dis. 2021 Apr 13. pii: S1201-9712(21)00329.
    >> Share

  829. HU B, Ning P, Qiu J, Tao V, et al
    Modeling the complete spatiotemporal spread of the COVID-19 epidemic in mainland China.
    Int J Infect Dis. 2021 Apr 13. pii: S1201-9712(21)00332.
    >> Share

  830. METTLER SK, Park J, Ozbek O, Mettler LK, et al
    Diagnostic Serial Interval as an Indicator for Effectiveness of Contact Tracing in the COVID-19 Pandemic - A Simulation Study.
    Int J Infect Dis. 2021 Apr 13. pii: S1201-9712(21)00340.
    >> Share

  831. OULHAJ A, Alsuwaidi AR, Suliman A, Gasmelseed H, et al
    Admission levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) Associate with Development of Severe Complications in Hospitalised COVID-19 Patients: A Prospective Cohort Study.
    Int J Infect Dis. 2021 Apr 13. pii: S1201-9712(21)00337.
    >> Share

  832. MAKHOUL K, Shukha Y, Abu Hanna L, Nitecki S, et al
    A Case of Rapidly Progressive Upper Limb Ischemic Necrosis in a Patient with COVID-19.
    Int J Infect Dis. 2021 Apr 13. pii: S1201-9712(21)00334.
    >> Share

  833. MORRIS CR, Iyer S
    Reply to Letter to the Editor regarding hospital-based triage travel screens during the COVID-19 pandemic.
    Int J Infect Dis. 2021 Apr 12. pii: S1201-9712(21)00327.
    >> Share

  834. DEWI R, Kaswandani N, Karyanti MR, Setyant DB, et al
    Mortality in children with COVID-19: Lessons learned from a tertiary referral hospital in Indonesia.
    Int J Infect Dis. 2021 Apr 12. pii: S1201-9712(21)00330.
    >> Share

  835. SCHADE W, Reimer V, Seipenbusch M, Willer U, et al
    Viral aerosol transmission of COVID-19 from simulated human emission in a concert hall.
    Int J Infect Dis. 2021 Apr 12. pii: S1201-9712(21)00339.
    >> Share

  836. WU Q, Hou X, Li H, Guo J, et al
    A Follow-Up Study of Respiratory and Physical Functions After Discharge in re-detectable positive SARS-CoV-2 nucleic acid results in Recovered COVID-19 Patients.
    Int J Infect Dis. 2021 Apr 12. pii: S1201-9712(21)00331.
    >> Share

  837. JAWADE K, Sinha AY, Bhagat S, Bhowmick S, et al
    A novel ORF-1a based SARS-CoV-2 RT-PCR assay to resolve inconclusive samples.
    Int J Infect Dis. 2021 Apr 11. pii: S1201-9712(21)00317.
    >> Share

  838. GABOR JJ, Kreidenweiss A, Weber S, Salama M, et al
    A call to caution when hydroxychloroquine is given to elderly COVID-19 patients.
    Int J Infect Dis. 2021 Apr 10. pii: S1201-9712(21)00320.
    >> Share

  839. SUEN YT, Chan RCH, Wong EMY
    An Exploratory Study of Factors Associated with Difficulties in Accessing HIV Services During COVID-19 among Chinese Gay and Bisexual Men in Hong Kong.
    Int J Infect Dis. 2021 Apr 9. pii: S1201-9712(21)00316.
    >> Share

  840. GOUVEA-REIS FA, Borja LS, Dias PO, Silva DCS, et al
    SARS-CoV-2 among inmates over 60 years of age during a COVID-19 outbreak in a penitentiary complex in Brazil: positive health outcomes despite high prevalence.
    Int J Infect Dis. 2021 Apr 9. pii: S1201-9712(21)00298.
    >> Share

  841. OLLIARO P, Torreele E
    Managing the risks of making the wrong diagnosis: First, do no harm.
    Int J Infect Dis. 2021 Apr 9. pii: S1201-9712(21)00315.
    >> Share

  842. XUE L, Jing S, Sun W, Liu M, et al
    Evaluating the impact of the travel ban within mainland China on the epidemic of the COVID-19.
    Int J Infect Dis. 2021 Apr 7. pii: S1201-9712(21)00306.
    >> Share

  843. FENG YF, Wang KP, Mo JG, Xu YH, et al
    The spatiotemporal trend of renal involvement in COVID-19: a pooled analysis of 17,134 patients.
    Int J Infect Dis. 2021 Apr 3. pii: S1201-9712(21)00300.
    >> Share

  844. JI Y, Shao J, Tao B, Song H, et al
    Are we ready to deal with a global COVID-19 pandemic? Rethinking countries' capacity based on the Global Health Security Index.
    Int J Infect Dis. 2021 Apr 3. pii: S1201-9712(21)00307.
    >> Share

  845. LAGIER JC, Amrane S, Mailhe M, Gainnier M, et al
    High-flow oxygen therapy in elderly patients infected with SARS-CoV2 with a contraindication for transfer to an intensive care unit: a preliminary report.
    Int J Infect Dis. 2021 Apr 3. pii: S1201-9712(21)00305.
    >> Share

  846. GREENKY D, Linam M, Yaffee A, Costello B, et al
    Response to "Prevalence of SARS-CoV-2 Antibodies in Pediatric Healthcare Workers (pHCWs)".
    Int J Infect Dis. 2021 Apr 3. pii: S1201-9712(21)00310.
    >> Share

  847. TRACHOOTHAM D, Thongyen S, Lam-Ubol A, Chotechuang N, et al
    Simultaneously Complete but Not Partial Taste and Smell Losses were Associated with SAR-CoV-2 Infection.
    Int J Infect Dis. 2021 Apr 2. pii: S1201-9712(21)00301.
    >> Share

  848. BAUER G
    Comment to the manuscript by William P. Hausdorff and Jorge Flores: Low-dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19, IJID 103 (2021) 37-41.
    Int J Infect Dis. 2021 Apr 2. pii: S1201-9712(21)00302.
    >> Share

  849. MICHOTTE N, Allard S, Payen MC, Dauby N, et al
    Aortic thrombosis in a patient with COVID-19-associated hyperinflammatory syndrome.
    Int J Infect Dis. 2021 Apr 1. pii: S1201-9712(21)00299.
    >> Share

  850. UDWADIA ZF, Barkate H, Patil S, Rangwala S, et al
    Response to the comments received on article "Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial" by Udwadia et a
    Int J Infect Dis. 2021;105:686-687.
    >> Share

  851. AL MOHAJER M, Panthagani KM, Lasco T, Lembcke B, et al
    Association between universal face shield in a quaternary care center and reduction of SARS-COV2 infections among healthcare personnel and hospitalized patients.
    Int J Infect Dis. 2021;105:252-255.
    >> Share

  852. PUECHMAILLE SJ, Ar Gouilh M, Dechmann D, Fenton B, et al
    Misconceptions and misinformation about bats and viruses.
    Int J Infect Dis. 2021;105:606-607.
    >> Share

  853. ZHOU F, Zhou XH
    Confusion about the definition of imported cases in the early stage of the epidemic.
    Int J Infect Dis. 2021;105:413.
    >> Share

    March 2021
  854. WANG Z, Wang Y, Yang Z, Wu H, et al
    The use of non-invasive ventilation in COVID-19: a systematic review.
    Int J Infect Dis. 2021 Mar 30. pii: S1201-9712(21)00296.
    >> Share

  855. NAGANO H, Takada D, Shin JH, Morishita T, et al
    Hospitalization of mild cases of community-acquired pneumonia decreased more than severe ones during the COVID-19 epidemic.
    Int J Infect Dis. 2021 Mar 29. pii: S1201-9712(21)00292.
    >> Share

  856. NACHEGA JB, Maeurer M, Sam-Agudu NA, Chakaya J, et al
    Bacille Calmette-Guerin (BCG) Vaccine and Potential Cross-Protection against SARS-CoV-2 Infection - Assumptions, Knowns, Unknowns and Need for Developing an Accurate Scientific Evidence Base.
    Int J Infect Dis. 2021 Mar 29. pii: S1201-9712(21)00279.
    >> Share

  857. FOURNIER PE, Colson P, Levasseur A, Devaux CA, et al
    Emergence and outcome of the SARS-CoV-2 "Marseille-4" variant.
    Int J Infect Dis. 2021 Mar 27. pii: S1201-9712(21)00286.
    >> Share

  858. DENNISON D, Khabori MA, Mamari SA, Aurelio A, et al
    Circulating activated neutrophils in COVID-19: an independent predictor for mechanical ventilation and death.
    Int J Infect Dis. 2021 Mar 26. pii: S1201-9712(21)00284.
    >> Share

  859. VELAVAN TP, Meyer CG, Esen M, Kremsner PG, et al
    COVID-19 and Syndemic challenges in 'Battling the Big Three': HIV, TB and malaria.
    Int J Infect Dis. 2021 Mar 26. pii: S1201-9712(21)00289.
    >> Share

  860. CHEW NWS, Cheong C, Kong G, Phua K, et al
    An Asia-Pacific study on healthcare worker's perception and willingness to receive COVID-19 vaccination.
    Int J Infect Dis. 2021 Mar 26. pii: S1201-9712(21)00287.
    >> Share

  861. KNIPPER M, Sedas AC, Keshavjee S, Abbara A, et al
    The need for protecting and enhancing TB health policies and services for forcibly displaced and migrant populations during the ongoing COVID-19 pandemic.
    Int J Infect Dis. 2021 Mar 25. pii: S1201-9712(21)00265.
    >> Share

  862. NYASULU JCY, Munthali RJ, Nyondo-Mipando AL, Pandya H, et al
    COVID-19 pandemic in Malawi: Did public social-political events gatherings contribute to its first wave local transmission?
    Int J Infect Dis. 2021 Mar 23. pii: S1201-9712(21)00273.
    >> Share

  863. BARRY M, Althabit N, Akkielah L, AlMohaya A, et al
    Clinical Characteristics and Outcomes of Hospitalized COVID-19 Patients in a MERS-CoV Referral Hospital during the Peak of the Pandemic.
    Int J Infect Dis. 2021 Mar 23. pii: S1201-9712(21)00276.
    >> Share

  864. MACINTYRE CR, Nguyen PY, Chughtai AA, Trent M, et al
    Mask use, risk mitigation behaviours and pandemic fatigue during the COVID-19 pandemic in five cities in Australia, the UK and USA: a cross-sectional survey.
    Int J Infect Dis. 2021 Mar 23. pii: S1201-9712(21)00274.
    >> Share

  865. NACHEGA JB, Kapata N, Sam-Agudu NA, Decloedt EH, et al
    Minimizing the Impact of the Triple Burden of COVID-19, Tuberculosis and HIV on Health Services in sub-Saharan Africa.
    Int J Infect Dis. 2021 Mar 20. pii: S1201-9712(21)00256.
    >> Share

  866. LISEWSKI AM
    Interim estimates in null models of COVID-19 vaccine effectiveness.
    Int J Infect Dis. 2021 Mar 18. pii: S1201-9712(21)00268.
    >> Share

  867. ZUMLA A, Chakaya J, Khan M, Fatima R, et al
    World Tuberculosis Day 2021 Theme - 'THE CLOCK IS TICKING' - and the world is running out of time to deliver the United Nations General Assembly commitments to End TB due to the COVID-19 pandemic.
    Int J Infect Dis. 2021 Mar 18. pii: S1201-9712(21)00264.
    >> Share

  868. MBOUMBA BOUASSA RS, Veyer D, Pere H, Belec L, et al
    Analytical performances of the point-of-care SIENNA COVID-19 Antigen Rapid Test for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: A prospective evaluation during the COVID-19 second wave in France.
    Int J Infect Dis. 2021 Mar 18. pii: S1201-9712(21)00269.
    >> Share

  869. MURAI Y, Kawasuji H, Takegoshi Y, Kaneda M, et al
    A case of COVID-19 diagnosed with favipiravir induced drug fever based on positive drug-induced lymphocyte stimulation test.
    Int J Infect Dis. 2021 Mar 18. pii: S1201-9712(21)00266.
    >> Share

  870. GABBRIELLI M, Gandolfo C, Anichini G, Candelori T, et al
    How long can SARS-CoV-2 persist in human corpses?
    Int J Infect Dis. 2021 Mar 18. pii: S1201-9712(21)00270.
    >> Share

  871. EL-SAED A, Alshamrani MM
    RE: COVID-19 and healthcare workers: A systematic review and meta-analysis.
    Int J Infect Dis. 2021 Mar 17. pii: S1201-9712(21)00247.
    >> Share

  872. ECOCHARD R, Wimba P, Bengehya J, Bianga PK, et al
    The COVID-19 pandemic is deepening the health crisis in South Kivu.
    Int J Infect Dis. 2021 Mar 17. pii: S1201-9712(21)00261.
    >> Share

  873. FATIMA R, Akhtar N, Yaqoob A, D Harries A, et al
    Building better tuberculosis control systems in a post-COVID world: learning from Pakistan during the COVID-19 pandemic.
    Int J Infect Dis. 2021 Mar 17. pii: S1201-9712(21)00244.
    >> Share

  874. ABRAHA HE, Gessesse Z, Gebrecherkos T, Kebede Y, et al
    Clinical Features and Risk Factors Associated with Morbidity and Mortality Among COVID-19 Patients in Northern Ethiopia.
    Int J Infect Dis. 2021 Mar 16. pii: S1201-9712(21)00255.
    >> Share

  875. ALKINDI S, Elsadek RA, Al-Madhani A, Al-Musalhi M, et al
    Impact of the coronavirus 2019 (COVID-19) on vasooclusive crisis in patients with sickle cell anaemia.
    Int J Infect Dis. 2021 Mar 16. pii: S1201-9712(21)00262.
    >> Share

  876. GHOLAMI M, Khamis AH, Ho SB
    Response to "RE: COVID-19 and healthcare workers: A systematic review and meta-analysis."
    Int J Infect Dis. 2021 Mar 16. pii: S1201-9712(21)00252.
    >> Share

  877. NISAR MI, Ansari N, Khalid F, Amin M, et al
    Serial population-based sero-surveys for COVID-19 in two neighborhoods of Karachi, Pakistan.
    Int J Infect Dis. 2021 Mar 15. pii: S1201-9712(21)00258.
    >> Share

  878. NOUSHAD M, Al-Saqqaf ISA
    COVID-19: Is herd immunity, the only option for fragile Yemen?
    Int J Infect Dis. 2021 Mar 15. pii: S1201-9712(21)00248.
    >> Share

  879. ZINELLU A, Paliogiannis P, Carru C, Mangoni AA, et al
    Serum amyloid A concentrations, COVID-19 severity and mortality: an updated systematic review and meta-analysis.
    Int J Infect Dis. 2021 Mar 15. pii: S1201-9712(21)00243.
    >> Share

  880. NTOUMI F, Mapanguy CCM, Tomazatos A, Pallerla SR, et al
    Genomic surveillance of SARS-CoV-2 in the Republic of Congo.
    Int J Infect Dis. 2021 Mar 15. pii: S1201-9712(21)00254.
    >> Share

  881. BASARAN S, Simsek-Yavuz S, Mese S, Cagatay A, et al
    The effect of tocilizumab, anakinra, and prednisolone on antibody response to SARS-CoV-2 in patients with COVID-19: A prospective cohort study with multivariate analysis of factors affecting the antibody response.
    Int J Infect Dis. 2021 Mar 15. pii: S1201-9712(21)00249.
    >> Share

  882. TANG M, Zhang H, Cai J
    Coronavirus disease 2019 in pregnancy - letter to the editor.
    Int J Infect Dis. 2021 Mar 15. pii: S1201-9712(21)00245.
    >> Share

  883. MORRIS CR, Sullivan P, Mantus G, Sanchez T, et al
    Prevalence of SARS-CoV-2 Antibodies in Pediatric Healthcare Workers.
    Int J Infect Dis. 2021 Mar 12. pii: S1201-9712(21)00234.
    >> Share

  884. BAVARO DF, Diella L, Fabrizio C, Sulpasso R, et al
    Peculiar clinical presentation of COVID- 19 and predictors of mortality in the elderly: a Multicentre Retrospective Cohort Study.
    Int J Infect Dis. 2021 Mar 12. pii: S1201-9712(21)00239.
    >> Share

  885. SAHU S, Ditiu L, Singh Sachdeva K, Zumla A, et al
    Recovering from the Impact of the Covid-19 Pandemic and Accelerating to Achieving the United Nations General Assembly Tuberculosis Targets.
    Int J Infect Dis. 2021 Mar 11. pii: S1201-9712(21)00164.
    >> Share

  886. CHAKAYA J, Khan M, Ntoumi F, Aklillu E, et al
    Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts.
    Int J Infect Dis. 2021 Mar 11. pii: S1201-9712(21)00193.
    >> Share

  887. MATHEVET I, Ost K, Traverson L, Zinszer K, et al
    Accounting for health inequities in the design of contact tracing interventions: a rapid review.
    Int J Infect Dis. 2021 Mar 11. pii: S1201-9712(21)00227.
    >> Share

  888. KIZNY GORDON A, Marais B, Walker TM, Sintchenko V, et al
    Clinical and public health utility of Mycobacterium tuberculosis whole genome sequencing.
    Int J Infect Dis. 2021 Mar 11. pii: S1201-9712(21)00200.
    >> Share

  889. BAUER G
    The potential significance of high avidity IgG for protective immunity towards SARS-CoV-2.
    Int J Infect Dis. 2021 Mar 10. pii: S1201-9712(21)00072.
    >> Share

  890. PANDIT A, Bhalani N, Bhushan BLS, Koradia P, et al
    Efficacy and Safety of Pegylated Interferon alfa-2b in Moderate COVID-19: A phase II, randomized, controlled, open-label study.
    Int J Infect Dis. 2021 Mar 10. pii: S1201-9712(21)00232.
    >> Share

  891. PETRONE L, Petruccioli E, Vanini V, Cuzzi G, et al
    Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2.
    Int J Infect Dis. 2021 Mar 10. pii: S1201-9712(21)00176.
    >> Share

  892. TIBERI S, Vjecha MJ, Zumla A, Galvin J, et al
    Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic.
    Int J Infect Dis. 2021 Mar 10. pii: S1201-9712(21)00153.
    >> Share

  893. TEN-CATEN F, Gonzalez-Dias P, Castro I, Ogava RLT, et al
    In-depth Analysis of Laboratory Parameters Reveals the Interplay Between Sex, Age and Systemic Inflammation in Individuals with COVID-19.
    Int J Infect Dis. 2021 Mar 10. pii: S1201-9712(21)00233.
    >> Share

  894. KOCK R, Michel AL, Yeboah-Manu D, Azhar EI, et al
    Zoonotic tuberculosis - The changing landscape.
    Int J Infect Dis. 2021 Mar 10. pii: S1201-9712(21)00177.
    >> Share

  895. NETO FL, Salzstein GA, Cortez AL, Bastos TL, et al
    Comparative Assessment of Mortality Risk Factors Between Admission and Follow-up Models Among Patients Hospitalized with COVID-19.
    Int J Infect Dis. 2021 Mar 9. pii: S1201-9712(21)00230.
    >> Share

  896. ALISHAQ M, Jeremijenko A, Nafady-Hego H, Al Ajmi JA, et al
    SARS-CoV-2 Infection in Mortuary and Cemetery Workers.
    Int J Infect Dis. 2021 Mar 9. pii: S1201-9712(21)00229.
    >> Share

  897. WANG Q, Dong W, Yang K, Ren Z, et al
    Temporal and spatial analysis of COVID-19 transmission in China and its influencing factors.
    Int J Infect Dis. 2021 Mar 9. pii: S1201-9712(21)00231.
    >> Share

  898. KAYA H, Kaji M, Usuda D
    Soluble interleukin-2 receptor levels on admission associated with mortality in coronavirus disease 2019.
    Int J Infect Dis. 2021 Mar 9. pii: S1201-9712(21)00228.
    >> Share

  899. WUNGU CDK, Khaerunnisa S, Putri EAC, Hidayati HB, et al
    Meta-analysis of cardiac markers for predictive factors on severity and mortality of COVID-19.
    Int J Infect Dis. 2021 Mar 9. pii: S1201-9712(21)00225.
    >> Share

  900. SORIANO V, Ganado-Pinilla P, Sanchez-Santos M, Gomez-Gallego F, et al
    Main Differences Between the First and Second Waves of COVID-19 in Madrid, Spain.
    Int J Infect Dis. 2021 Mar 5. pii: S1201-9712(21)00201.
    >> Share

  901. CALISTRI P, Amato L, Puglia I, Cito F, et al
    Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads in nasopharyngeal swabs.
    Int J Infect Dis. 2021 Mar 5. pii: S1201-9712(21)00210.
    >> Share

  902. CHAN AX, Ritter M, Bakhoum MF
    Bilateral cotton wool spots after ambulatory COVID-19.
    Int J Infect Dis. 2021 Mar 5. pii: S1201-9712(21)00205.
    >> Share

  903. MONDI A, Lorenzini P, Castilletti C, Gagliardini R, et al
    Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted in an Italian Reference Hospital.
    Int J Infect Dis. 2021 Mar 3. pii: S1201-9712(21)00203.
    >> Share

  904. BERNAS SN, Baldauf H, Wendler S, Heidenreich F, et al
    CCR5Delta32 mutations do not determine COVID-19 disease course.
    Int J Infect Dis. 2021 Mar 2. pii: S1201-9712(21)00195.
    >> Share

  905. WIBOWO A, Pranata R, Akbar MR, Purnomowati A, et al
    The Prognostic Performance of Troponin in COVID-19: A Diagnostic Meta-analysis and Meta-regression.
    Int J Infect Dis. 2021 Mar 2. pii: S1201-9712(21)00199.
    >> Share

  906. LINTON NM, Akhmetzhanov AR, Nishiura H
    Localized end-of-outbreak determination for coronavirus disease 2019 (COVID-19): examples from clusters in Japan.
    Int J Infect Dis. 2021 Mar 1. pii: S1201-9712(21)00192.
    >> Share

    February 2021
  907. BOUDJELAL M, Almajed F, Salman AM, Alharbi NK, et al
    COVID-19 Vaccines: Global Challenges and Prospects Forum Recommendations.
    Int J Infect Dis. 2021 Feb 27. pii: S1201-9712(21)00179.
    >> Share

  908. MEHTA RM, Bansal S, Bysani S, Kalpakam H, et al
    A shorter symptom-onset to remdesivir treatment (SORT) interval is associated with a lower mortality in moderate-to-severe COVID-19: a real-world analysis.
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00178.
    >> Share

  909. ALMADHI MA, Abdulrahman A, Sharaf SA, AlSaad D, et al
    The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19.
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00186.
    >> Share

  910. LOPEZ-MEDRANO F, Perez-Jacoiste Asin MA, Fernandez-Ruiz M, Carretero O, et al
    Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: a single-center retrospective study.
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00185.
    >> Share

  911. BYEON KH, Kim DW, Kim J, Choi BY, et al
    Factors Affecting the Survival of Early COVID-19 Patients in South Korea: An Observational Study based on the Korean National Health Insurance Big Data.
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00187.
    >> Share

  912. GILI A, Paggi R, Russo C, Cenci E, et al
    Evaluation of automated test Lumipulse(R) G SARS-CoV-2 antigen assay for detection of SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening.
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00184.
    >> Share

  913. LU G, Muller O, Li Y
    Imported covid-19 cases: a hot topic with a lack of a clear definition.
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00167.
    >> Share

  914. BENNASRALLAH C, Zemni I, Dhouib W, Sriha H, et al
    Factors Associated with a prolonged negative conversion of viral RNA in patients with Coronavirus Disease 2019 (COVID-19).
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00175.
    >> Share

  915. RODRIGUEZ A, Arrizabalaga M, Fernandez-Baca V, Lainez MP, et al
    Seroprevalence of SARS-CoV-2 antibody among healthcare workers in a university hospital in Mallorca, Spain, during the first wave of COVID-19 pandemic.
    Int J Infect Dis. 2021 Feb 26. pii: S1201-9712(21)00190.
    >> Share

  916. SINGH V, Upadhyay P, Reddy J, Granger J, et al
    SARS-CoV-2 Respiratory Co-Infections: Incidence of Viral and Bacterial Co-Pathogens.
    Int J Infect Dis. 2021 Feb 25. pii: S1201-9712(21)00173.
    >> Share

  917. FRANCO-PAREDES C, Suarez JA, Henao-Martinez AF
    Correspondence Global COVID-19 Vaccine Equity Should Precede Requiring Travelers Proof of Vaccination.
    Int J Infect Dis. 2021 Feb 25. pii: S1201-9712(21)00147.
    >> Share

  918. PETERSEN E, Lucey D, Blumberg L, Kramer LD, et al
    Answer to Paredes et al. commenting on "COVID-19 vaccines under the International Health Regulations - We must use the WHO International Certificate of Vaccination or Prophylaxis".
    Int J Infect Dis. 2021 Feb 24. pii: S1201-9712(21)00162.
    >> Share

  919. HOANG VT
    Comment to Sands et al: No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19.
    Int J Infect Dis. 2021 Feb 24. pii: S1201-9712(21)00165.
    >> Share

  920. DUGAS M, Grote-Westrick T, Vollenberg R, Lorentzen E, et al
    Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1).
    Int J Infect Dis. 2021 Feb 23. pii: S1201-9712(21)00171.
    >> Share

  921. VETTER M, Kaufmann MD, Neurath MF, Kremer AE, et al
    Purple Urine in a Patient after Recovery from a SARS-CoV-2 Infection.
    Int J Infect Dis. 2021 Feb 23. pii: S1201-9712(21)00169.
    >> Share

  922. MUNOZ M, Patino LH, Ballesteros N, Paniz-Mondolfi A, et al
    Characterizing SARS-CoV-2 genome diversity circulating in South American countries: signatures of potentially emergent lineages?
    Int J Infect Dis. 2021 Feb 19. pii: S1201-9712(21)00159.
    >> Share

  923. NAKAJO K, Nishiura H
    Transmissibility of asymptomatic COVID-19: Data from Japanese clusters.
    Int J Infect Dis. 2021 Feb 19. pii: S1201-9712(21)00151.
    >> Share

  924. NG JKC, Ngai JCL, Ng SSS, Hui DSC, et al
    Collection of Lower Respiratory Specimen by Bronchoscopy for Diagnosis of COVID-19.
    Int J Infect Dis. 2021 Feb 18. pii: S1201-9712(21)00152.
    >> Share

  925. CYPRIAN F, Sohail MU, Abdelhafez I, Salman S, et al
    SARS-CoV-2-Immune-Microbiome Interaction: Lessons from Respiratory Viral Infections.
    Int J Infect Dis. 2021 Feb 18. pii: S1201-9712(21)00156.
    >> Share

  926. SHANKAR H, Champati Ray PK
    GIS-Based Analysis of COVID-19 Cases in India during Pre-lockdown, Lockdown and Unlock Phases.
    Int J Infect Dis. 2021 Feb 18. pii: S1201-9712(21)00157.
    >> Share

  927. BUTTERFIELD TR, Bruce-Mowatt A, Phillips YZR, Brown N, et al
    Assessment of Commercial SARS-CoV-2 Antibody Assays, Jamaica.
    Int J Infect Dis. 2021 Feb 18. pii: S1201-9712(21)00145.
    >> Share

  928. THOMMES L, Burkert FR, Ottl KW, Goldin D, et al
    Comparative evaluation of four SARS-CoV-2 antigen tests in hospitalized patients.
    Int J Infect Dis. 2021 Feb 17. pii: S1201-9712(21)00138.
    >> Share

  929. HUANG E, Isonaka S, Yang H, Salce E, et al
    Tocilizumab Treatment in Critically Ill Patients with COVID-19: A Retrospective Observational Study.
    Int J Infect Dis. 2021 Feb 17. pii: S1201-9712(21)00143.
    >> Share

  930. CHOI YJ, Park MJ, Park SJ, Hong D, et al
    Types of COVID-19 clusters and their relationship with social distancing in Seoul Metropolitan area in South Korea.
    Int J Infect Dis. 2021 Feb 17. pii: S1201-9712(21)00144.
    >> Share

  931. TWOREK A, Jaron K, Uszynska-Kaluza B, Rydzewski A, et al
    Convalescent plasma treatment is associated with lower mortality and better outcomes in high risk COVID-19 patients - propensity score matched case-control study.
    Int J Infect Dis. 2021 Feb 16. pii: S1201-9712(21)00140.
    >> Share

  932. MAYNARD S, Ros-Soto J, Chaidos A, Innes A, et al
    The role of ibrutinib in COVID-19 hyperinflammation: a case report.
    Int J Infect Dis. 2021 Feb 16. pii: S1201-9712(21)00142.
    >> Share

  933. MUMOLI N, Florian C, Cei M, Evangelista I, et al
    Palliative care in a COVID-19 Internal Medicine Ward: a preliminary report.
    Int J Infect Dis. 2021 Feb 16. pii: S1201-9712(21)00139.
    >> Share

  934. DAVIDO B, Gautier S, Riom I, Landowski S, et al
    First wave of COVID-19 in hospital staff members of a tertiary care hospital in the greater Paris area: surveillance and risk factors study.
    Int J Infect Dis. 2021 Feb 16. pii: S1201-9712(21)00141.
    >> Share

  935. MEDISETTY MK, Patel A, Pujari S
    Letter to the editor on "Efficacy and Safety of Favipiravir, an Oral RNA-Dependent RNA Polymerase Inhibitor, in Mild-to-Moderate COVID-19: A Randomized, Comparative, Open-Label, Multicenter, Phase 3 Clinical Trial" by Udwadia Z et al.
    Int J Infect Dis. 2021 Feb 15. pii: S1201-9712(21)00121.
    >> Share

  936. AL SULAIMAN KA, Al Juhani OA, Eljaaly K, Alharbi AA, et al
    Clinical Features and Outcomes of Critically Ill Patients with Coronavirus Disease 2019 (COVID-19): A Multicenter Cohort Study.
    Int J Infect Dis. 2021 Feb 15. pii: S1201-9712(21)00123.
    >> Share

  937. ORTIZ-PRADO E, Rivera-Olivero IA, Freire-Paspuel B, Lowe R, et al
    Testing for SARS-CoV-2 at the core of voluntary collective isolation: Lessons from the indigenous populations living in the Amazon region in Ecuador.
    Int J Infect Dis. 2021 Feb 13. pii: S1201-9712(21)00125.
    >> Share

  938. DE LA CALLE C, Lopez-Medrano F, Pablos JL, Lora-Tamayo J, et al
    Effectiveness of anakinra for tocilizumab-refractory severe COVID-19. A single centre retrospective comparative study.
    Int J Infect Dis. 2021 Feb 13. pii: S1201-9712(21)00127.
    >> Share

  939. STEUWER B, Jamrozik E, Eyal N
    Prioritizing between second-generation SARS-CoV-2 vaccines through low-dosage challenge studies.
    Int J Infect Dis. 2021 Feb 13. pii: S1201-9712(21)00124.
    >> Share

  940. YANG Q, Xiao X, Gu X, Liang D, et al
    Surveillance of common respiratory infections during COVID-19 pandemic demonstrates preventive effectiveness of non-pharmaceutical interventions.
    Int J Infect Dis. 2021 Feb 11. pii: S1201-9712(21)00113.
    >> Share

  941. ONYEGHALA C, Alasia D, Eyaru O, Nsirim P, et al
    Multisystem Inflammatory Syndrome (MIS-C) in an Adolescent Nigerian Girl with COVID-19: A call for vigilance in Africa.
    Int J Infect Dis. 2021 Feb 11. pii: S1201-9712(21)00103.
    >> Share

  942. MARTHA JW, Pranata R, Wibowo A, Lim MA, et al
    Tricuspid Annular Plane Systolic Excursion (TAPSE) Measured by Echocardiography and Mortality in COVID-19: A Systematic Review and Meta-analysis.
    Int J Infect Dis. 2021 Feb 11. pii: S1201-9712(21)00115.
    >> Share

  943. ECHEVERRIA G, Guevara A, Coloma J, Ruiz AM, et al
    Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay.
    Int J Infect Dis. 2021 Feb 11. pii: S1201-9712(21)00120.
    >> Share

  944. MAIA CMF, Marques NP, de Lucena EHG, de Rezende LF, et al
    Increase in the number of Herpes Zoster cases in Brazil related to the COVID-19 pandemic.
    Int J Infect Dis. 2021 Feb 11. pii: S1201-9712(21)00119.
    >> Share

  945. HERRERA LA, Hidalgo-Miranda A, Reynoso-Noveron N, Meneses-Garcia AA, et al
    Saliva is a reliable and accessible source for the detection of SARS-CoV-2.
    Int J Infect Dis. 2021 Feb 10. pii: S1201-9712(21)00095.
    >> Share

  946. YI B, Fen G, Cao D, Cai Y, et al
    Epidemiological and clinical characteristics of 214 families with COVID-19 in Wuhan, China.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00106.
    >> Share

  947. BORDONI V, Tartaglia E, Sacchi A, Fimia GM, et al
    The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00105.
    >> Share

  948. KITTEL M, Findeisen P, Muth MC, Thiaucourt M, et al
    Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys(R) Anti-SARS-CoV-2 immunoassay.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00110.
    >> Share

  949. ABDI A, Ahmed AY, Mohamed A, Karanja M, et al
    Preliminary findings of COVID-19 infection in health workers in Somalia: a reason for concern.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00078.
    >> Share

  950. LIMA-MORALES R, Mendez-Hernandez P, Flores YN, Osorno-Romero P, et al
    Effectiveness of a multidrug therapy consisting of ivermectin, azithromycin, montelukast and acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00100.
    >> Share

  951. LY TDA, Nguyen NN, Hoang VT, Goumballa N, et al
    Screening of SARS-CoV-2 among homeless people, asylum-seekers and other people living in precarious conditions in Marseille, France, March-April 2020.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00112.
    >> Share

  952. SAIDI O, Malouche D, Saksena P, Arfaoui L, et al
    Impact of contact tracing, respect of isolation and lockdown in reducing the number of cases infected with COVID-19: Case study: Tunisia's response from March 22 to 04 May 2020.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00096.
    >> Share

  953. DARBANDI A, Asadi A, Ghanavati R, Afifirad R, et al
    The Effect of Probiotics on Respiratory Tract Infection with Special Emphasis on COVID-19: A Periodic Review during 2010-2020.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00097.
    >> Share

  954. LIU J, Liu J, He Z, Yang Z, et al
    The duration of SARS-CoV-2 positive in the environments of quarantine rooms: a perspective analysis.
    Int J Infect Dis. 2021 Feb 9. pii: S1201-9712(21)00111.
    >> Share

  955. HIROTSU Y, Maejima M, Shibusawa M, Amemiya K, et al
    Prospective Study of 1,308 Nasopharyngeal Swabs from 1,033 Patients using the LUMIPULSE SARS-CoV-2 Antigen Test: Comparison with RT-qPCR.
    Int J Infect Dis. 2021 Feb 5. pii: S1201-9712(21)00090.
    >> Share

  956. PALKA-KOTLOWSKA M, Custodio-Cabello S, Oliveros-Acebes E, Khosravi-Shahi P, et al
    Review of risk of covid-19 in cancer patients and their cohabitants.
    Int J Infect Dis. 2021 Feb 5. pii: S1201-9712(21)00085.
    >> Share

  957. SEONG H, Hyun HJ, Yun JG, Noh JY, et al
    Comparison of the second and third waves of the COVID-19 pandemic in South Korea: Importance of early public health intervention.
    Int J Infect Dis. 2021 Feb 5. pii: S1201-9712(21)00089.
    >> Share

  958. BISWAS S, Sukla S, Roy S, Nath H, et al
    Response to: Serological cross-reaction and co-infection of dengue and COVID-19 in Asia: Experience from Indonesia.
    Int J Infect Dis. 2021 Feb 5. pii: S1201-9712(21)00074.
    >> Share

  959. ELIAS C, Sekri A, Leblanc P, Cucherat M, et al
    Incubation period of COVID-19: a meta-analysis.
    Int J Infect Dis. 2021 Feb 3. pii: S1201-9712(21)00081.
    >> Share

  960. LAU K, Dorigatti I, Miraldo M, Hauck K, et al
    SARIMA-modelled greater severity and mortality during the 2010/11 post-pandemic influenza season compared to the 2009 H1N1 pandemic in English hospitals.
    Int J Infect Dis. 2021 Feb 3. pii: S1201-9712(21)00082.
    >> Share

  961. SANGINETO M, Arena F, De Nittis R, Villani R, et al
    Temporal profile of SARS-CoV-2 viral load in posterior nasopharyngeal samples: analysis of 944 patients in Apulia, Italy.
    Int J Infect Dis. 2021 Feb 2. pii: S1201-9712(21)00080.
    >> Share

  962. CAZELLES B, Comiskey C, Nguyen Van Yen B, Champagne C, et al
    Identical trends of SARS-Cov-2 transmission and retail and transit mobility during non-lockdown periods.
    Int J Infect Dis. 2021 Feb 1. pii: S1201-9712(21)00079.
    >> Share

  963. ZHANG J, Xu J, Zhou S, Wang C, et al
    The characteristics of 527 discharged COVID-19 patients undergoing long-term follow-up in China.
    Int J Infect Dis. 2021 Feb 1. pii: S1201-9712(21)00075.
    >> Share

  964. LEE TC, McDonald EG, Butler-Laporte G, Harrison LB, et al
    Remdesivir and Systemic Corticosteroids for the Treatment of COVID-19: A Bayesian Reanalysis.
    Int J Infect Dis. 2021 Feb 1. pii: S1201-9712(21)00077.
    >> Share

    January 2021
  965. OGUZ F, Paseau T, Reper P
    A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer: if early cytokines scoring results available, to compare with existing severity scores and CT scan observations.
    Int J Infect Dis. 2021 Jan 30. pii: S1201-9712(21)00070.
    >> Share

  966. DIAZ H, Espana G, Castaneda N, Rodriguez L, et al
    Dynamical characteristics of Covid-19 epidemic: Estimation from Colombia's case.
    Int J Infect Dis. 2021 Jan 30. pii: S1201-9712(21)00064.
    >> Share

  967. GUPTA D
    Why are COVID-19 fatality rates among medical doctors higher than those among medical nurses?
    Int J Infect Dis. 2021 Jan 29. pii: S1201-9712(21)00061.
    >> Share

  968. PENARRUBIA L, Ruiz M, Porco R, Rao SN, et al
    In Response to: Multiple assays in a real-time RT-PCR Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak.
    Int J Infect Dis. 2021 Jan 27. pii: S1201-9712(21)00060.
    >> Share

  969. LI H, Xiong N, Li C, Gong Y, et al
    Efficacy of ribavirin and interferon-alpha therapy for hospitalized patients with COVID-19: a multicenter, retrospective cohort study.
    Int J Infect Dis. 2021 Jan 27. pii: S1201-9712(21)00066.
    >> Share

  970. MORETTO F, Sixt T, Devilliers H, Abdallahoui M, et al
    Is there a need to widely prescribe antibiotics in patients hospitalized for COVID-19?
    Int J Infect Dis. 2021 Jan 25. pii: S1201-9712(21)00062.
    >> Share

  971. ORONSKY B, Gruber HE, Reiners W, Reid TR, et al
    A Short Discussion About The SARS-CoV-2 mRNA-1273 Vaccine.
    Int J Infect Dis. 2021 Jan 22. pii: S1201-9712(21)00059.
    >> Share

  972. JIAN SW, Kao CT, Chang YC, Chen PF, et al
    Risk Assessment for COVID-19 Pandemic in Taiwan.
    Int J Infect Dis. 2021 Jan 21. pii: S1201-9712(21)00054.
    >> Share

  973. SIDDIQUI SN, Jayasekhar R, Tshering S, Jugjali R, et al
    A Unique Tale of COVID-19 Induced Concomitant Overt DIC and Acute Bi-lateral Pulmonary Embolism.
    Int J Infect Dis. 2021 Jan 21. pii: S1201-9712(21)00051.
    >> Share

  974. LIAO M, Wu J, Dai M, Li H, et al
    Rapid detection of SARS-CoV-2 under replicating or non-replicating status in samples using RT-PCR.
    Int J Infect Dis. 2021 Jan 21. pii: S1201-9712(21)00053.
    >> Share

  975. MOSTAFA A, Kandil S, El-Sayed MH, Girgis S, et al
    SARS-CoV-2 seroconversion among 4040 Egyptian healthcare workers in 12 resource-limited healthcare facilities: A prospective cohort study.
    Int J Infect Dis. 2021 Jan 20. pii: S1201-9712(21)00048.
    >> Share

  976. SERRE-MIRANDA C, Nobrega C, Roque S, Canto-Gomes J, et al
    Performance assessment of 11 commercial serological tests for SARS-CoV-2 on hospitalized COVID-19 patients.
    Int J Infect Dis. 2021 Jan 20. pii: S1201-9712(21)00049.
    >> Share

  977. NG CFS, Seposo XT, Moi ML, Tajudin MABA, et al
    Erratum to "Characteristics of COVID-19 epidemic and control measures to curb transmission in Malaysia" [Int J Infect Dis 101 (December) (2020) 409-411].
    Int J Infect Dis. 2021 Jan 19. pii: S1201-9712(21)00034.
    >> Share

  978. PETERSEN E, Lucey D, Blumberg L, Kramer LD, et al
    COVID-19 vaccines under the International Health Regulations - we must use the WHO International Certificate of Vaccination or Prophylaxis.
    Int J Infect Dis. 2021 Jan 19. pii: S1201-9712(21)00050.
    >> Share

  979. HOONG CWS, Amin MNME, Tan TC, Lee JE, et al
    Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms.
    Int J Infect Dis. 2021 Jan 18. pii: S1201-9712(21)00043.
    >> Share

  980. SCARABEL L, Guardascione M, Dal Bo M, Toffoli G, et al
    Pharmacological strategies to prevent SARS-CoV-2 infection and to treat the early phases of COVID-19 disease.
    Int J Infect Dis. 2021 Jan 18. pii: S1201-9712(21)00046.
    >> Share

  981. AL YAZIDI LS, Al Hinai Z, Al Waili B, Al Hashami H, et al
    Epidemiology, characteristics, and outcomes of hospitalized children with COVID-19 in Oman: A multicenter cohort study.
    Int J Infect Dis. 2021 Jan 18. pii: S1201-9712(21)00047.
    >> Share

  982. BANJAR A, Al-Tawfiq JA, Alruwaily A, Alserehi H, et al
    Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early month of the pandemic in Saudi Arabia.
    Int J Infect Dis. 2021 Jan 16. pii: S1201-9712(21)00040.
    >> Share

  983. WILBURN J, Blakey E, Trindall A, Burr H, et al
    COVID-19 within a large prison with high number of vulnerable adults in the UK, March to June 2020: an outbreak investigation and screening event.
    Int J Infect Dis. 2021 Jan 16. pii: S1201-9712(21)00038.
    >> Share

  984. ELEC AD, Oltean M, Goldis P, Cismaru C, et al
    COVID-19 after kidney transplantation: Early outcome and renal function following antiviral treatment.
    Int J Infect Dis. 2021 Jan 13. pii: S1201-9712(21)00033.
    >> Share

  985. DASH P, Turuk J, Behera SK, Palo SK, et al
    Sequence analysis of Indian SARS-CoV-2 isolates shows a stronger interaction of mutated receptor binding domain with ACE2 receptor.
    Int J Infect Dis. 2021 Jan 12. pii: S1201-9712(21)00029.
    >> Share

  986. CHEN M, Qin R, Mei J, Yang Z, et al
    Clinical applications of detecting IgG, IgM, or IgA antibody for the diagnosis of COVID-19: A meta-analysis and systematic review.
    Int J Infect Dis. 2021 Jan 12. pii: S1201-9712(21)00026.
    >> Share

  987. CHEN C, Zhu C, Yan D, Liu H, et al
    The epidemiological and radiographical characteristics of asymptomatic infections with the novel coronavirus (COVID-19): A systematic review and meta-analysis.
    Int J Infect Dis. 2021 Jan 11. pii: S1201-9712(21)00027.
    >> Share

  988. GHOLAMI M, Fawad I, Shadan S, Rowaiee R, et al
    COVID-19 and Healthcare Workers: A Systematic Review and Metaanalysis.
    Int J Infect Dis. 2021 Jan 11. pii: S1201-9712(21)00023.
    >> Share

  989. MARCOLINO MS, Ziegelmann PK, Souza-Silva MVR, do Nascimento IJB, et al
    Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: results from the Brazilian COVID-19 Registry.
    Int J Infect Dis. 2021 Jan 11. pii: S1201-9712(21)00030.
    >> Share

  990. SHAYAK B, Sharma MM, Gaur M, Mishra AK, et al
    Impact of reproduction number on multiwave spreading dynamics of COVID-19 with temporary immunity: a mathematical model.
    Int J Infect Dis. 2021 Jan 11. pii: S1201-9712(21)00028.
    >> Share

  991. HUANG C, Fei L, Li W, Xu W, et al
    Efficacy Evaluation of Intravenous Immunoglobulin in Non-severe Patients with COVID-19: A Retrospective Cohort Study Based on Propensity Score Matching.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00015.
    >> Share

  992. MELIS M, Littera R
    Undetected infectives in the Covid-19 pandemic.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00018.
    >> Share

  993. FREIRE-PASPUEL B, Garcia-Bereguiain MA
    Low Clinical Performance of "Isopollo COVID19 detection kit" (Monitor, South Korea) for RT-LAMP SARS-CoV-2 diagnosis: a call for action against low quality products for developing countries.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00017.
    >> Share

  994. FERNANDEZ-ROJAS MA, Esparza MAL, Romero AC, Calva-Espinosa DY, et al
    Epidemiology of COVID-19 in Mexico, symptomatic profiles and presymptomatic people.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00012.
    >> Share

  995. LUCIEN MAB, Canarie MF, Kilgore PE, Jean-Denis G, et al
    Antibiotics and Antimicrobial Resistance in the COVID-19 Era.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00016.
    >> Share

  996. SOKHNA C, Goumballa N, Hoang VT, Bassene H, et al
    The Grand Magal of Touba was spared by the COVID-19 pandemic.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00011.
    >> Share

  997. DA SILVA QUEIROZ JA, de Cassia Pontello Rampazzo R, da Silva Filho EB, Oliveira GS, et al
    Development of a quantitative one-step multiplex RT-qPCR assay for the detection of SARS-CoV-2 in a biological matrix.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00002.
    >> Share

  998. TANDON M, Kataria S, Patel J, Mehta TR, et al
    A Comprehensive Systematic Review of CSF analysis that defines Neurological Manifestations of COVID-19.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00003.
    >> Share

  999. MARZIALI ME, Hogg RS, Oduwole OA, Card KG, et al
    Predictors of COVID-19 testing rates: A cross-country comparison.
    Int J Infect Dis. 2021 Jan 9. pii: S1201-9712(21)00005.
    >> Share

  1000. LUBNOW M, Schmidt B, Fleck M, Salzberger B, et al
    Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson's disease: balancing immunosuppression.
    Int J Infect Dis. 2021 Jan 4. pii: S1201-9712(20)32571.
    >> Share

  1001. YAMAMOTO K, Suzuki M, Yamada G, Sudo T, et al
    Utility of the antigen test for coronavirus disease 2019: Factors influencing the prediction of the possibility of disease transmission.
    Int J Infect Dis. 2021 Jan 2. pii: S1201-9712(20)32603.
    >> Share

  1002. IHLOW J, Michaelis E, Greuel S, Heynol V, et al
    B Cell Depletion and Signs of Sepsis Acquired Immunodeficiency in Bone Marrow and Spleen of COVID-19 Deceased.
    Int J Infect Dis. 2021 Jan 2. pii: S1201-9712(20)32602.
    >> Share

  1003. KU CW, Durai S, Kwan JQT, Loy SL, et al
    Validation of self-collected buccal swab and saliva as a diagnostic tool for COVID-19.
    Int J Infect Dis. 2021 Jan 2. pii: S1201-9712(20)32604.
    >> Share

  1004. LIU N, Sun J, Wang X, Zhang T, et al
    Low vitamin D status is associated with coronavirus disease 2019 outcomes: A systematic review and meta-analysis.
    Int J Infect Dis. 2021 Jan 2. pii: S1201-9712(20)32600.
    >> Share

  1005. KOZLOVSKAYA L, Piniaeva A, Ignatyev G, Selivanov A, et al
    Corrigendum to isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak [Int. J. Infect. Dis. 99 (2020) 40-46].
    Int J Infect Dis. 2021 Jan 2. pii: S1201-9712(20)32543.
    >> Share

    December 2020
  1006. FOY BH, Wahl B, Mehta K, Shet A, et al
    Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study.
    Int J Infect Dis. 2020;103:431-438.
    >> Share

  1007. GENERALI D, Bosio G, Malberti F, Cuzzoli A, et al
    Canakinumab as treatment for COVID-19-related pneumonia: a prospective case-control study.
    Int J Infect Dis. 2020 Dec 29. pii: S1201-9712(20)32597.
    >> Share

  1008. LATIANO A, Tavano F, Panza A, Palmieri O, et al
    False Positive Results Of IgM/IgG antibodies against antigen of the SARS-CoV-2 in sera stored before the 2020 Endemia in Italy.
    Int J Infect Dis. 2020 Dec 28. pii: S1201-9712(20)32591.
    >> Share

  1009. ROHIT A, Rajasekaran S, Shenoy S, Rai S, et al
    Reprocessing of N95 masks: our experience from a resource limited setting in India.
    Int J Infect Dis. 2020 Dec 28. pii: S1201-9712(20)32594.
    >> Share

  1010. LO SH, Lin CY, Hung CT, He JJ, et al
    The impact of universal face masking and enhanced hand hygiene for COVID-19 disease prevention on the incidence of hospital acquired infections in a Taiwanese hospital.
    Int J Infect Dis. 2020 Dec 28. pii: S1201-9712(20)32596.
    >> Share

  1011. IENI A, Tuccari G
    The COVID-19 pandemic: pathologist's support to clinical infectious team.
    Int J Infect Dis. 2020 Dec 28. pii: S1201-9712(20)32593.
    >> Share

  1012. BABU GR, Khetrapal S, John DA, Deepa R, et al
    Pandemic Preparedness and Response to COVID-19 in South Asian Countries.
    Int J Infect Dis. 2020 Dec 25. pii: S1201-9712(20)32572.
    >> Share

  1013. BATCHI-BOUYOU AL, Lobaloba L, Ndounga M, Vouvoungui JC, et al
    High SARS-COV2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo.
    Int J Infect Dis. 2020 Dec 25. pii: S1201-9712(20)32589.
    >> Share

  1014. CORTES MF, Espinoza EPS, Noguera SLV, Silva AA, et al
    Decontamination and reuse of surgical masks and respirators during COVID-19 pandemic.
    Int J Infect Dis. 2020 Dec 23. pii: S1201-9712(20)32580.
    >> Share

  1015. SANDS K, Wenzel R, McLean L, Korwek K, et al
    No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19.
    Int J Infect Dis. 2020 Dec 23. pii: S1201-9712(20)32583.
    >> Share

  1016. WAHAIBI AA, Al-Maani A, Alyaquobi F, Harthy KA, et al
    Effects of COVID-19 on mortality: a 5-year population-based study in Oman.
    Int J Infect Dis. 2020 Dec 22. pii: S1201-9712(20)32578.
    >> Share

  1017. LIU Y, Tang JW, Lam TTY
    Transmission dynamics of the COVID-19 epidemics in England.
    Int J Infect Dis. 2020 Dec 22. pii: S1201-9712(20)32579.
    >> Share

  1018. CAMPRUBI-FERRER D, Gaya A, Marcos MA, Marti-Soler H, et al
    Persistent replication of SARS-CoV-2 in a severely immunocompromised treated with several courses of remdesivir.
    Int J Infect Dis. 2020 Dec 21. pii: S1201-9712(20)32574.
    >> Share

  1019. PAOLUCCI S, Cassaniti I, Novazzi F, Fiorina L, et al
    EBV DNA increase in COVID-19 patients with impaired Lymphocyte subpopulation count.
    Int J Infect Dis. 2020 Dec 21. pii: S1201-9712(20)32575.
    >> Share

  1020. RAIMONDI A, Poma G, Piralla A, Meroni V, et al
    Looking for fever in Covid-19 nursing home residents: a false friend?
    Int J Infect Dis. 2020 Dec 21. pii: S1201-9712(20)32576.
    >> Share

  1021. AL-MAHRUQI S, Al-Wahaibi A, Khan AL, Al-Jardani A, et al
    Molecular epidemiology of COVID-19 in Oman: a molecular and surveillance study for the early transmission of COVID-19 in the country.
    Int J Infect Dis. 2020 Dec 21. pii: S1201-9712(20)32573.
    >> Share

  1022. JARVA H, Lappalainen M, Luomala O, Jokela P, et al
    Laboratory-based surveillance of COVID-19 in the Greater Helsinki area, Finland, February-June 2020.
    Int J Infect Dis. 2020 Dec 19. pii: S1201-9712(20)32561.
    >> Share

  1023. CEVALLOS-VALDIVIEZO H, Vergara-Montesdeoca A, Zambrano-Zambrano G
    Measuring the impact of the COVID-19 outbreak in Ecuador using preliminary estimates of excess mortality, March 17-October 22, 2020.
    Int J Infect Dis. 2020 Dec 19. pii: S1201-9712(20)32567.
    >> Share

  1024. WANG Y, Cao Z, Zeng DD, Zhang Q, et al
    The collective wisdom in the COVID-19 research: comparison and synthesis of epidemiological parameter estimates in preprints and peer-reviewed articles.
    Int J Infect Dis. 2020 Dec 19. pii: S1201-9712(20)32563.
    >> Share

  1025. HUH K, Ji W, Kang M, Hong J, et al
    Association of prescribed medications with the risk of COVID-19 infection and severity among adults in South Korea.
    Int J Infect Dis. 2020 Dec 19. pii: S1201-9712(20)32565.
    >> Share

  1026. CHEN B, Jiang C, Han B, Guan C, et al
    High prevalence of occult thrombosis in mild/moderate COVID-19.
    Int J Infect Dis. 2020 Dec 19. pii: S1201-9712(20)32566.
    >> Share

  1027. KOSANOVIC D, Yaroshetskiy AI, Tsareva NA, Merzhoeva ZM, et al
    Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale.
    Int J Infect Dis. 2020 Dec 19. pii: S1201-9712(20)32568.
    >> Share

  1028. HWANG SE, Chang JH, Bumjo O, Heo J, et al
    Possible Aerosol Transmission of COVID-19 Associated with an Outbreak in an Apartment in Seoul, South Korea, 2020.
    Int J Infect Dis. 2020 Dec 17. pii: S1201-9712(20)32558.
    >> Share

  1029. LI Y, Shi K, Qi F, Yu Z, et al
    Thalidomide Combined with Short-term Low-Dose Glucocorticoid Therapy for the Treatment of Severe COVID-19: A Case-Series Study.
    Int J Infect Dis. 2020 Dec 14. pii: S1201-9712(20)32546.
    >> Share

  1030. FISHER MJ, Raymundo LAM, Monteforte M, Taub EM, et al
    Tocilizumab in the Treatment of Critical COVID-19 Pneumonia: A Retrospective Cohort Study of Mechanically Ventilated Patients.
    Int J Infect Dis. 2020 Dec 14. pii: S1201-9712(20)32544.
    >> Share

  1031. FURUSE Y
    Genomic Sequencing Effort for SARS-CoV-2 by Country during the Pandemic.
    Int J Infect Dis. 2020 Dec 14. pii: S1201-9712(20)32557.
    >> Share

  1032. LIU J, Li K, Cheng L, Jingjin S, et al
    A high-throughput drug screening strategy against Conroviruses.
    Int J Infect Dis. 2020 Dec 14. pii: S1201-9712(20)32556.
    >> Share

  1033. RANDREMANANA R, Lazoumar RH, Tejiokem MC, Manirakiza A, et al
    Institut Pasteur international network's efforts to guide the control measure against Coronavirus Disease 2019 (COVID-19) epidemic among health care workers in Africa.
    Int J Infect Dis. 2020 Dec 14. pii: S1201-9712(20)32553.
    >> Share

  1034. CHUN JY, Baek G, Kim Y
    Corrigendum to "Transmission onset distribution of COVID-19" [Int. J. Infect. Dis. 99(October) (2020) 403-407].
    Int J Infect Dis. 2020 Dec 14. pii: S1201-9712(20)32501.
    >> Share

  1035. DELEERS M, Breiman A, Daubie V, Maggetto C, et al
    Covid-19 and blood groups: ABO antibody levels may also matter.
    Int J Infect Dis. 2020 Dec 13. pii: S1201-9712(20)32549.
    >> Share

  1036. NI M, Xu H, Luo J, Liu W, et al
    Simultaneous detection and differentiation of SARS-CoV-2, influenza A virus and influenza B virus by one-step quadruplex real-time RT-PCR in patients with clinical manifestations.
    Int J Infect Dis. 2020 Dec 13. pii: S1201-9712(20)32550.
    >> Share

  1037. KOWALSKA JD, Kase K, Vassilenko A, Harxhi A, et al
    The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease - a report from Central and Eastern Europe.
    Int J Infect Dis. 2020 Dec 13. pii: S1201-9712(20)32548.
    >> Share

  1038. SAXENA S, Khurana A, B S, Sardana K, et al
    Severe Type 2 leprosy reaction with COVID-19 with a favourable outcome despite continued use of corticosteroids and methotrexate and a hypothesis on the possible immunological consequences.
    Int J Infect Dis. 2020 Dec 13. pii: S1201-9712(20)32547.
    >> Share

  1039. RALLI M, Morrone A, Arcangeli A, Ercoli L, et al
    Asymptomatic patients as a source of transmission of COVID-19 in homeless shelters.
    Int J Infect Dis. 2020 Dec 12. pii: S1201-9712(20)32555.
    >> Share

  1040. CELOTTO S, Veronese N, Barbagallo M, Ometto F, et al
    An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of hydroxychloroquine and chloroquine therapy.
    Int J Infect Dis. 2020 Dec 11. pii: S1201-9712(20)32541.
    >> Share

  1041. BAO Y, Ling Y, Chen YY, Tian D, et al
    Dynamic Anti-Spike Protein Antibody Profiles in COVID-19 Patients.
    Int J Infect Dis. 2020 Dec 10. pii: S1201-9712(20)32537.
    >> Share

  1042. HU P, Ma M, Jing Q, Ma Y, et al
    Retrospective study identifies infection related risk factors in close contacts during COVID-19 epidemic.
    Int J Infect Dis. 2020 Dec 10. pii: S1201-9712(20)32534.
    >> Share

  1043. OLIYNYK OV, Rorat M, Barg W
    Oxygen metabolism markers as predictors of mortality in severe COVID-19.
    Int J Infect Dis. 2020 Dec 10. pii: S1201-9712(20)32535.
    >> Share

  1044. NILSSON AC, Holm DK, Justesen US, Gorm-Jensen T, et al
    Comparison of six commercially available SARS-CoV-2 antibody assays - choice of assay depends on intended use.
    Int J Infect Dis. 2020 Dec 10. pii: S1201-9712(20)32540.
    >> Share

  1045. LINSCHOTEN M, Nab L, van der Horst ICC, Tieleman R, et al
    Response to "Early Hydroxychloroquine but not Chloroquine use reduces ICU admission in COVID-19 patients".
    Int J Infect Dis. 2020 Dec 9. pii: S1201-9712(20)32529.
    >> Share

  1046. KITTEL M, Muth M, Zahn I, Roth P, et al
    Clinical evaluation of commercial automated SARS-CoV-2 immunoassays.
    Int J Infect Dis. 2020 Dec 9. pii: S1201-9712(20)32526.
    >> Share

  1047. LAMMERS AJJ, Brohet RM, Theunissen REP, Koster C, et al
    Response to correspondence concerning: "Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients".
    Int J Infect Dis. 2020 Dec 9. pii: S1201-9712(20)32531.
    >> Share

  1048. VERHEIJEN S, van Luin M, Bruggemann RJ, de Mast Q, et al
    More gastro-intestinal adverse events in non-ICU hospitalized COVID-19 patients treated with chloroquine versus hydroxychloroquine.
    Int J Infect Dis. 2020 Dec 9. pii: S1201-9712(20)32533.
    >> Share

  1049. SIKKENS JJ, Collard D, Peters EJG
    Comparison of hospital treatment strategy or of actually received treatment with hydroxychloroquine in COVID-19?
    Int J Infect Dis. 2020 Dec 9. pii: S1201-9712(20)32530.
    >> Share

  1050. TARTERET P, Strazzulla A, Rouyer M, Gore C, et al
    Clinical features and medical care factors associated with mortality in French nursing homes during COVID-19 outbreak.
    Int J Infect Dis. 2020 Dec 7. pii: S1201-9712(20)32527.
    >> Share

  1051. JARYNOWSKI A, Wojta-Kempa M
    Exploring the link between risk perception in Internet media and COVID-19 prevalence in Europe.
    Int J Infect Dis. 2020 Dec 5. pii: S1201-9712(20)32525.
    >> Share

  1052. ALSHARIDAH S, Ayed M, Ameen RM, Alhuraish F, et al
    COVID-19 Convalescent Plasma Treatment of Moderate and Severe Cases of SARS-CoV-2 Infection: A Multicenter Interventional Study.
    Int J Infect Dis. 2020 Dec 4. pii: S1201-9712(20)32513.
    >> Share

  1053. GUPTA M, Mohanta SS, Rao A, Parameswaran GG, et al
    Transmission dynamics of the COVID-19 epidemic in India and modelling optimal lockdown exit strategies.
    Int J Infect Dis. 2020 Dec 3. pii: S1201-9712(20)32522.
    >> Share

  1054. LUDWIG M, Jacob J, Basedow F, Andersohn F, et al
    Clinical outcomes and characteristics of patients hospitalized for Influenza or COVID-19 in Germany.
    Int J Infect Dis. 2020 Dec 3. pii: S1201-9712(20)32520.
    >> Share

  1055. AHMED S, Karim MM, Ross AG, Hossain MS, et al
    A five day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness.
    Int J Infect Dis. 2020 Dec 2. pii: S1201-9712(20)32506.
    >> Share

  1056. TORRES B, Alcubilla P, Gonzalez-Cordon A, Inciarte A, et al
    Impact of low serum calcium at hospital admission on SARS-CoV-2 infection outcome.
    Int J Infect Dis. 2020 Dec 2. pii: S1201-9712(20)32523.
    >> Share

  1057. ZHANG M, Du L, Faleti OD, Huang J, et al
    Higher pharyngeal epithelial gene expression of Angiotensin-Converting Enzyme-2 in upper respiratory infection patients.
    Int J Infect Dis. 2020 Dec 2. pii: S1201-9712(20)32512.
    >> Share

  1058. MILLER FD, La Croix S, Brown T, Ramsey LT, et al
    Unique pattern of COVID-19 infection in the State of Hawai'i.
    Int J Infect Dis. 2020 Dec 1. pii: S1201-9712(20)32517.
    >> Share

  1059. MALAGON-ROJAS J, Parra E, Mercado M
    Letter to the editor on "Asymptomatic infection by SARS 2 coronavirus: Invisible but invincible" by Nikolai et al. 2020.
    Int J Infect Dis. 2020;101:391-392.
    >> Share

  1060. LANGER-GOULD A
    Editorial Response to Drs. Simone and Mancusi.
    Int J Infect Dis. 2020;101:367.
    >> Share

    November 2020
  1061. VELAVAN TP, Meyer CG
    COVID-19: A PCR-defined pandemic.
    Int J Infect Dis. 2020 Nov 30. pii: S1201-9712(20)32504.
    >> Share

  1062. VITA S, Di Bari V, Corpolongo A, Goletti D, et al
    Down Syndrome patients with COVID-19 pneumonia: a high-risk category for unfavourable outcome.
    Int J Infect Dis. 2020 Nov 30. pii: S1201-9712(20)32503.
    >> Share

  1063. MOTAYO BO, Oluwasemowo OO, Olusola BA, Akinduti PA, et al
    Evolution and genetic diversity of SARSCoV-2 in Africa using whole genome sequences.
    Int J Infect Dis. 2020 Nov 28. pii: S1201-9712(20)32505.
    >> Share

  1064. SAHA J, Chouhan P
    Lockdown and unlock for COVID-19 and its impact on residential mobility in India: an analysis of the COVID-19 Community Mobility Reports, 2020.
    Int J Infect Dis. 2020 Nov 27. pii: S1201-9712(20)32502.
    >> Share

  1065. NAGY B, Fejes Z, Szentkereszty Z, Suto R, et al
    A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient.
    Int J Infect Dis. 2020 Nov 26. pii: S1201-9712(20)32497.
    >> Share

  1066. RASAMBAINARIVO F, Rasoanomenjanahary A, Rabarison JH, Ramiadantsoa T, et al
    Monitoring for outbreak associated excess mortality in an African city: Detection limits in Antananarivo, Madagascar.
    Int J Infect Dis. 2020 Nov 26. pii: S1201-9712(20)32495.
    >> Share

  1067. SOVANN L, Sar B, Kab V, Yann S, et al
    An influenza A(H3N2) virus outbreak during the COVID-19 pandemic, Kingdom of Cambodia, 2020.
    Int J Infect Dis. 2020 Nov 26. pii: S1201-9712(20)32491.
    >> Share

  1068. HERTZOG RG, Bicheru NS, Popescu DM, Calborean O, et al
    Hypoxic preconditioning - a non-pharmacological approach in COVID-19 prevention.
    Int J Infect Dis. 2020 Nov 26. pii: S1201-9712(20)32494.
    >> Share

  1069. JANAPALA RN, Patel J, Belfaqeeh O, Alhashmi A, et al
    Novaferon, Treatment in COVID-19 Patients.
    Int J Infect Dis. 2020 Nov 25. pii: S1201-9712(20)32493.
    >> Share

  1070. ZHENG F, Zhou Y, Zhou Z, Ye F, et al
    Reply to "Novaferon, Treatment in COVID-19 Patients".
    Int J Infect Dis. 2020 Nov 25. pii: S1201-9712(20)32492.
    >> Share

  1071. CASSAR MR, Borg D, Camilleri L, Schembri A, et al
    A novel use of telemedicine during the COVID-19 pandemic.
    Int J Infect Dis. 2020 Nov 24. pii: S1201-9712(20)32481.
    >> Share

  1072. FERREIRA CE, Bonvehi PE, de la Torre JCG, Saenz-Flor KV, et al
    Algorithms for testing COVID-19 focused on use of RT-PCR and high-affinity serological testing: A consensus statement from a panel of Latin American experts.
    Int J Infect Dis. 2020 Nov 21. pii: S1201-9712(20)32484.
    >> Share

  1073. TSANKOV BK, Allaire JM, Irvine MA, Lopez AA, et al
    Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis.
    Int J Infect Dis. 2020 Nov 20. pii: S1201-9712(20)32475.
    >> Share

  1074. FINDEISEN P, Stiegler H, Lopez-Calle E, Schneider T, et al
    Clinical Performance Evaluation of a SARS-CoV-2 Rapid Antibody Test for Determining Past Exposure to SARS-CoV-2.
    Int J Infect Dis. 2020 Nov 20. pii: S1201-9712(20)32474.
    >> Share

  1075. HABICHT ME, Eppenberger PE, Ruhli F
    A critical assessment on proposed outbreaks of plague and other epidemic diseases in Ancient Egypt.
    Int J Infect Dis. 2020 Nov 20. pii: S1201-9712(20)32470.
    >> Share

  1076. MILETO D, Foschi A, Mancon A, Merli S, et al
    A case of extremely prolonged viral shedding: could cell cultures be a diagnostic tool to drive the COVID-19 patients discharge?
    Int J Infect Dis. 2020 Nov 20. pii: S1201-9712(20)32472.
    >> Share

  1077. HAUSDORFF WP, Flores J
    Low dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19.
    Int J Infect Dis. 2020 Nov 20. pii: S1201-9712(20)32482.
    >> Share

  1078. VAN NGUYEN Q, Cao DA, Nghiem SH
    The Spread of COVID-19 and Policy Responses in Vietnam: An Overview.
    Int J Infect Dis. 2020 Nov 18. pii: S1201-9712(20)32466.
    >> Share

  1079. ILIC I, Zdravkovic M, Timcic S, Stojanovic DU, et al
    Pneumonia in medical professionals during COVID-19 outbreak in cardiovascular hospital.
    Int J Infect Dis. 2020 Nov 18. pii: S1201-9712(20)32465.
    >> Share

  1080. NGIAM JN, Chew N, Tham SM, Beh DL, et al
    Demographic shift in COVID-19 patients in Singapore from an aged, at-risk population to young, migrant workers with reduced risk of severe disease.
    Int J Infect Dis. 2020 Nov 18. pii: S1201-9712(20)32467.
    >> Share

  1081. ALCOBA-FLOREZ J, Gil-Campesino H, Garcia-Martinez de Artola D, Diez-Gil O, et al
    Increasing SARS-CoV-2 RT-qPCR testing capacity by sample pooling.
    Int J Infect Dis. 2020 Nov 18. pii: S1201-9712(20)32468.
    >> Share

  1082. BALKHAIR A, Al-Zakwani I, Al Busaidi M, Al-Khirbash A, et al
    Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: results of a prospective, open-label, interventional study.
    Int J Infect Dis. 2020 Nov 17. pii: S1201-9712(20)32458.
    >> Share

  1083. FEDERGRUEN A, Naha S
    Crowding Effects Dominate Demographic Attributes in COVID-19 Cases.
    Int J Infect Dis. 2020 Nov 17. pii: S1201-9712(20)32267.
    >> Share

  1084. RABERAHONA M, Rakotomalala R, Rakotomijoro E, Rahaingoalidera T, et al
    Clinical and epidemiological features discriminating confirmed COVID-19 patients from SARS-CoV-2 negative patients at screening centres in Madagascar.
    Int J Infect Dis. 2020 Nov 17. pii: S1201-9712(20)32462.
    >> Share

  1085. DAIA C, Scheau C, Neagu G, Andone I, et al
    Nerve conduction study and electromyography findings in patients recovering from Covid-19 - case report.
    Int J Infect Dis. 2020 Nov 17. pii: S1201-9712(20)32455.
    >> Share

  1086. PATRIQUIN G, LeBlanc JJ
    SARS-CoV-2 sensitivity limbo - how low can we go?
    Int J Infect Dis. 2020 Nov 16. pii: S1201-9712(20)32446.
    >> Share

  1087. GORNY AW, Bagdasarian N, Koh Hong Kiat A, Lim YC, et al
    SARS-CoV-2 in Migrant Worker Dormitories: Geospatial Epidemiology Supporting Outbreak Management.
    Int J Infect Dis. 2020 Nov 16. pii: S1201-9712(20)32457.
    >> Share

  1088. UDWADIA ZF, Singh P, Barkate H, Patil S, et al
    Efficacy and Safety of Favipiravir, an Oral RNA-Dependent RNA Polymerase Inhibitor, in Mild-to-Moderate COVID-19: A Randomized, Comparative, Open-Label, Multicenter, Phase 3 Clinical Trial.
    Int J Infect Dis. 2020 Nov 16. pii: S1201-9712(20)32453.
    >> Share

  1089. TIWARI A, So MKP, Chong ACY, Chan JNL, et al
    Pandemic Risk of COVID-19 Outbreak in the United States: An Analysis of Network Connectedness with Air Travel Data.
    Int J Infect Dis. 2020 Nov 16. pii: S1201-9712(20)32454.
    >> Share

  1090. KUMAR G, Adams A, Hererra M, Rojas ER, et al
    Predictors and Outcomes of HAIs in COVID-19 Patients.
    Int J Infect Dis. 2020 Nov 15. pii: S1201-9712(20)32447.
    >> Share

  1091. ZOU H, Lu J, Liu J, Wong JH, et al
    Characteristics of pediatric multi-system inflammatory syndrome (PMIS) associated with COVID-19: a meta-analysis and insights into pathogenesis.
    Int J Infect Dis. 2020 Nov 14. pii: S1201-9712(20)32460.
    >> Share

  1092. GIANDHARI J, Pillay S, Wilkinson E, Tegally H, et al
    Early transmission of SARS-CoV-2 in South Africa: An epidemiological and phylogenetic report.
    Int J Infect Dis. 2020 Nov 12. pii: S1201-9712(20)32322.
    >> Share

  1093. LI P, Wang Y, Peppelenbosch MP, Ma Z, et al
    Systematically comparing COVID-19 with 2009 influenza pandemic for hospitalized patients.
    Int J Infect Dis. 2020 Nov 12. pii: S1201-9712(20)32321.
    >> Share

  1094. PATTERSON BK, Seethamraju H, Dhody K, Corley MJ, et al
    CCR5 Inhibition in Critical COVID-19 Patients Decreases Inflammatory Cytokines, Increases CD8 T-Cells, and Decreases SARS-CoV2 RNA in Plasma by Day 14.
    Int J Infect Dis. 2020 Nov 10. pii: S1201-9712(20)32305.
    >> Share

  1095. RODRIGUEZ-NAVA G, Yanez-Bello MA, Trelles-Garcia DP, Chung CW, et al
    Performance of the Quick COVID-19 Severity Index and the Brescia-COVID Respiratory Severity Scale in hospitalized patients with COVID-19 in a community hospital setting.
    Int J Infect Dis. 2020 Nov 9. pii: S1201-9712(20)32314.
    >> Share

  1096. XIAO J, Hu J, He G, Liu T, et al
    The time-varying transmission dynamics of COVID-19 and synchronous actions in China.
    Int J Infect Dis. 2020 Nov 9. pii: S1201-9712(20)32316.
    >> Share

  1097. JAIN A, Rophina M, Mahajan S, Krishnan BB, et al
    Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays.
    Int J Infect Dis. 2020 Nov 9. pii: S1201-9712(20)32290.
    >> Share

  1098. KHAMIS F, Al Naabi H, Al Lawati A, Ambusaidi Z, et al
    Randomized Controlled Open Label Trial on the Use of Favipiravir Combined with Inhaled Interferon beta-1b in Hospitalized Patients with Moderate to Severe COVID-19 Pneumonia.
    Int J Infect Dis. 2020 Nov 9. pii: S1201-9712(20)32319.
    >> Share

  1099. TSO FY, Lidenge SJ, Pena PB, Clegg AA, et al
    High prevalence of pre-existing serological cross-reactivity against SARS-CoV-2 in sub-Sahara Africa.
    Int J Infect Dis. 2020 Nov 8. pii: S1201-9712(20)32310.
    >> Share

  1100. JANG S, Rhee JY, Wi YM, Jung BK, et al
    Viral Kinetics of SARS-CoV-2 over the preclinical, clinical, and postclinical period.
    Int J Infect Dis. 2020 Nov 4. pii: S1201-9712(20)32302.
    >> Share

  1101. GRIMES JM, Khan S, Badeaux M, Rao RM, et al
    Arginine Depletion as a Therapeutic Approach for Patients with COVID-19.
    Int J Infect Dis. 2020 Nov 4. pii: S1201-9712(20)32304.
    >> Share

  1102. SHI F, Wei Y, Xia L, Shan F, et al
    Lung volume reduction and infection localization revealed in big data CT imaging of COVID-19.
    Int J Infect Dis. 2020 Nov 3. pii: S1201-9712(20)32300.
    >> Share

  1103. VIMERCATI L, De Maria L, Quarato M, Caputi A, et al
    COVID-19 hospital outbreaks: Protecting healthcare workers to protect frail patients. An Italian observational cohort study.
    Int J Infect Dis. 2020 Nov 3. pii: S1201-9712(20)32298.
    >> Share

  1104. LOPEZ JH, Romo AS, Molina DC, Hernandez GA, et al
    DETECTION OF SARS-CoV-2 IN AIR OF TWO HOSPITAL IN HERMOSILLO, SONORA, MEXICO, UTILIZING A LOW-COST ENVIRONMENTAL MONITORING SYSTEM.
    Int J Infect Dis. 2020 Nov 3. pii: S1201-9712(20)32293.
    >> Share

  1105. TAKAHASHI W, Yoneda T, Koba H, Ueda T, et al
    Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation.
    Int J Infect Dis. 2020 Nov 3. pii: S1201-9712(20)32297.
    >> Share

  1106. AL-QAHTANI M, AlAli S, Abdul Rahman AK, Salman Alsayyad A, et al
    The prevalence of asymptomatic and symptomatic COVID19 disease in a cohort of quarantined subjects.
    Int J Infect Dis. 2020 Nov 3. pii: S1201-9712(20)32294.
    >> Share

  1107. JAISWAL V, Nasa P, Raouf M, Gupta M, et al
    Therapeutic Plasma Exchange followed by Convalescent Plasma transfusion in critical COVID-19- an exploratory study.
    Int J Infect Dis. 2020 Nov 3. pii: S1201-9712(20)32289.
    >> Share

  1108. IPPOLITO G, Lauria FN, Locatelli F, Magrini N, et al
    Lessons from the COVID-19 Pandemic - Unique Opportunities for Unifying, Revamping and Reshaping Epidemic Preparedness of Europe's Public Health Systems.
    Int J Infect Dis. 2020 Nov 2. pii: S1201-9712(20)32303.
    >> Share

  1109. VEEPANATTU P, Singh S, Mendelson M, Nampoothiri V, et al
    Building resilient and responsive research collaborations to tackle antimicrobial resistance-Lessons learnt from India, South Africa, and UK.
    Int J Infect Dis. 2020;100:278-282.
    >> Share

    October 2020
  1110. TEHRANI S, Killander A, Astrand P, Jakobsson J, et al
    Risk factors for mortality in adult COVID-19 patients; frailty predicts fatal outcome in older patients.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32276.
    >> Share

  1111. FU H, Wang H, Xi X, Boonyasiri A, et al
    A database for the epidemic trends and control measures during the first wave of COVID-19 in mainland China.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32279.
    >> Share

  1112. ERDEM H, Lucey DR
    Health Care Worker Infections and Deaths due to COVID-9: A Survey from 37 Nations and a Call for WHO to Post National Data on their Website.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32268.
    >> Share

  1113. JOSHI S, Parkar J, Ansari A, Vora A, et al
    Role of favipiravir in the treatment of COVID-19.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32273.
    >> Share

  1114. PIRALLA A, Ricchi M, Cusi MG, Prati P, et al
    Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19: is prolonged quarantine always justified?
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32278.
    >> Share

  1115. JAEGER LH, Nascimento TC, Rocha FD, Vilela FMP, et al
    Adjusting RT-qPCR conditions to avoid unspecific amplification in SARS-CoV-2 diagnostic.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32283.
    >> Share

  1116. BROUQUI P, Amrane S, Million M, Cortaredona S, et al
    Asymptomatic hypoxia in COVID-19 is associated with poor outcome.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32271.
    >> Share

  1117. OLIVIERI A, Palu G, Sebastiani G
    Covid-19 cumulative incidence, intensive care and mortality in Italian regions compared to selected European countries.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32277.
    >> Share

  1118. NALUMANSI A, Lutalo T, Kayiwa J, Watera C, et al
    Field Evaluation of the Performance of a SARS-CoV-2 Antigen Rapid Diagnostic Test in Uganda using Nasopharyngeal Samples.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32275.
    >> Share

  1119. DANIELE F, Albert F
    The art of the possible in approaching efficacy trials for COVID19 convalescent plasma.
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32274.
    >> Share

  1120. EBRAHIM SH, Gozzer E, Ahmed Y, Imtiaz R, et al
    COVID19 in the Least Developed Fragile and Conflict-Affected Countries - How Can the Most Vulnerable be Protected?
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32259.
    >> Share

  1121. CELIK HG, Keske S, Sener U, Tekbas M, et al
    Why we should be more careful using hydroxychloroquine in influenza season?
    Int J Infect Dis. 2020 Oct 29. pii: S1201-9712(20)32284.
    >> Share

  1122. XIAO D, Li X, Su X, Mu D, et al
    Could SARS-CoV-2-induced lung injury be attenuated by vitamin D?
    Int J Infect Dis. 2020 Oct 28. pii: S1201-9712(20)32263.
    >> Share

  1123. BO Y, Guo C, Lin C, Zeng Y, et al
    Effectiveness of non-pharmaceutical interventions on COVID-19 transmission in 190 countries from 23 January to 13 April 2020.
    Int J Infect Dis. 2020 Oct 28. pii: S1201-9712(20)32270.
    >> Share

  1124. PASSARELLI VC, Faico-Filho K, Moreira LVL, Cunha AP, et al
    Asymptomatic COVID-19 in hospital visitors: underestimated potential of viral shedding.
    Int J Infect Dis. 2020 Oct 28. pii: S1201-9712(20)32261.
    >> Share

  1125. RAOULT D
    How useful is serology for COVID-19?
    Int J Infect Dis. 2020 Oct 28. pii: S1201-9712(20)32262.
    >> Share

  1126. CHOI MJ, Kang M, Shin SY, Noh JY, et al
    Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32266.
    >> Share

  1127. YASSINE HM, Al-Jighefee H, Al-Sadeq DW, Dargham SR, et al
    Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32246.
    >> Share

  1128. ESPINDOLA OM, Brandao CO, Gomes YCP, Siqueira M, et al
    Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32247.
    >> Share

  1129. HIRAYAMA A, Masui J, Murayama A, Fujita S, et al
    The characteristics and clinical course of patients with COVID-19 who received invasive mechanical ventilation in Osaka, Japan.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32255.
    >> Share

  1130. LOEVINSOHN G, Hardick J, Sinywimaanzi P, Fenstermacher KZJ, et al
    Respiratory pathogen diversity and co-infections in rural Zambia.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32258.
    >> Share

  1131. CABELLO A, Zamarro B, Nistal S, Victor V, et al
    COVID-19 DISEASE IN PEOPLE LIVING WITH HIV: A MULTICENTER CASE-SERIES STUDY.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32264.
    >> Share

  1132. GODIN A, Xia Y, Buckeridge DL, Mishra S, et al
    The role of case importation in explaining differences in early SARS-CoV-2 transmission dynamics in Canada - a mathematical modeling study of surveillance data.
    Int J Infect Dis. 2020 Oct 25. pii: S1201-9712(20)32251.
    >> Share

  1133. HERNANDEZ-MORA MG, Cabello Ubeda A, Perez LP, Alvarez FV, et al
    Compassionate Use of Tocilizumab in Severe SARS-CoV2 Pneumonia.
    Int J Infect Dis. 2020 Oct 25. pii: S1201-9712(20)32249.
    >> Share

  1134. FREIRE-PASPUEL B, Garcia-Bereguiain MA
    Analytical sensitivity and clinical performance of a triplex RT-qPCR assay using CDC N1, N2 and RP targets for SARS-CoV-2 diagnosis.
    Int J Infect Dis. 2020 Oct 25. pii: S1201-9712(20)32250.
    >> Share

  1135. MASYENI S, Santoso MS, Widyaningsih PD, Wedha Asmara DG, et al
    Serological cross-reaction and co-infection of dengue and COVID-19 in Asia: Experience from Indonesia.
    Int J Infect Dis. 2020 Oct 25. pii: S1201-9712(20)32248.
    >> Share

  1136. BURREL S, Hausfater P, Dres M, Pourcher V, et al
    Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19.
    Int J Infect Dis. 2020 Oct 25. pii: S1201-9712(20)32244.
    >> Share

  1137. CHEN CWS, Lee S, Dong MC, Taniguchi M, et al
    What Factors Drive the Satisfaction of Citizens on Governments' Responses to COVID-19?
    Int J Infect Dis. 2020 Oct 25. pii: S1201-9712(20)32254.
    >> Share

  1138. SHAROV KS
    HIV/SARS-CoV-2 co-infection: T cell profile, cytokine dynamics and role of exhausted lymphocytes.
    Int J Infect Dis. 2020 Oct 25. pii: S1201-9712(20)32253.
    >> Share

  1139. VELAVAN TP, Meyer CG
    Reply to: Asymptomatic infection by SARS 2 coronavirus: invisible but invincible.
    Int J Infect Dis. 2020 Oct 17. pii: S1201-9712(20)32238.
    >> Share

  1140. VENUGOPAL U, Jilani N, Rabah S, Shariff MA, et al
    SARS-CoV-2 Seroprevalence Among Health Care Workers in a New York City Hospital: A Cross-Sectional Analysis During the COVID-19 Pandemic.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32240.
    >> Share

  1141. HERZBERG J, Vollmer T, Fischer B, Becher H, et al
    A Prospective Sero-epidemiological Evaluation of SARS-CoV-2 among Health Care Workers in a German Secondary Care Hospital.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32230.
    >> Share

  1142. LAWAL Y
    Africa's low COVID-19 mortality rate: A paradox?
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32242.
    >> Share

  1143. ABAYOMI A, Odukoya O, Osibogun A, Wright O, et al
    Presenting Symptoms and Predictors of Poor Outcomes Among 2,184 Patients with COVID-19 in Lagos State, Nigeria.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32228.
    >> Share

  1144. NAKAMOTO T, Ishikane M, Sasaki R, Ohmagari N, et al
    Periungual desquamation in a Japanese Adult recovering from severe COVID-19.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32233.
    >> Share

  1145. MOHAMMAD A, Alshawaf E, Marafie SK, Abu-Farha M, et al
    Higher binding affinity of Furin to SARS-CoV-2 spike (S) protein D614G could be associated with higher SARS-CoV-2 infectivity.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32237.
    >> Share

  1146. BAECK M, Herman A
    COVID toes: where do we stand with the current evidence?
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32225.
    >> Share

  1147. DAUBY N, Bottieau E
    The unfinished story of hydroxychloroquine in COVID-19: the right anti-inflammatory dose at the right moment?
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32236.
    >> Share

  1148. STAADEGAARD L, Taylor RJ, Spreeuwenberg P, Caini S, et al
    Monitoring the mortality impact of COVID-19 in Europe: What can be learned from 2009 influenza H1N1p mortality studies?
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32241.
    >> Share

  1149. NG CFS, Seposo XT, Moi ML, Tajudin MABA, et al
    Characteristics of COVID-19 epidemic and control measures to curb transmission in Malaysia.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32231.
    >> Share

  1150. MOHANA A, Sulaiman T, Mahmoud N, Hassanein M, et al
    Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia.
    Int J Infect Dis. 2020 Oct 16. pii: S1201-9712(20)32235.
    >> Share

  1151. MADSEN LW, Lindvig SO, Rasmussen LD, Knudtzen FC, et al
    Low mortality of hospitalised patients with COVID-19 in a tertiary Danish hospital setting.
    Int J Infect Dis. 2020 Oct 12. pii: S1201-9712(20)32221.
    >> Share

  1152. LAI CC, Wang JH, Hsueh PR
    Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review.
    Int J Infect Dis. 2020 Oct 9. pii: S1201-9712(20)32214.
    >> Share

  1153. ZHOU F, You C, Zhang X, Qian K, et al
    Epidemiological Characteristics and Factors Associated with Critical Time Intervals of COVID-19 in Eighteen Provinces, China: A Retrospective Study.
    Int J Infect Dis. 2020 Oct 9. pii: S1201-9712(20)32220.
    >> Share

  1154. PIETSCH H, Escher F, Aleshcheva G, Baumeier C, et al
    Proof of SARS-CoV-2 Genomes in Endomyocardial Biopsy with Latency After Acute Infection.
    Int J Infect Dis. 2020 Oct 9. pii: S1201-9712(20)32215.
    >> Share

  1155. KIMURA T, Namkoong H
    Susceptibility of obese population to COVID-19.
    Int J Infect Dis. 2020 Oct 9. pii: S1201-9712(20)32218.
    >> Share

  1156. KLAUSNER Z, Fattal E, Hirsch E, Shapira SC, et al
    A single holiday was the turning point of the COVID-19 policy of Israel.
    Int J Infect Dis. 2020 Oct 9. pii: S1201-9712(20)32219.
    >> Share

  1157. ZHANG K, Vilches TN, Tariq M, Galvani AP, et al
    The impact of mask-wearing and shelter-in-place on COVID-19 outbreaks in the United States.
    Int J Infect Dis. 2020 Oct 8. pii: S1201-9712(20)32204.
    >> Share

  1158. COTA G, Freire ML, de Souza CS, Pedras MJ, et al
    Diagnostic performance of commercially available COVID-19 serology tests in Brazil.
    Int J Infect Dis. 2020 Oct 8. pii: S1201-9712(20)32211.
    >> Share

  1159. NAGANT C, Ponthieux F, Smet J, Dauby N, et al
    A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer.
    Int J Infect Dis. 2020 Oct 8. pii: S1201-9712(20)32206.
    >> Share

  1160. AL MASKARI Z, Al Blushi A, Khamis F, Al Tai A, et al
    Characteristic of Healthcare Workers Infected with COVID-19, a Cross-Sectional Observational Study.
    Int J Infect Dis. 2020 Oct 8. pii: S1201-9712(20)32212.
    >> Share

  1161. GAUTRET P, Colson P, Lagier JC, Camoin-Jau L, et al
    Different pattern of the second outbreak of COVID-19 in Marseille, France.
    Int J Infect Dis. 2020 Oct 7. pii: S1201-9712(20)32208.
    >> Share

  1162. SHIM E, Tariq A, Chowell G
    Spatial variability in reproduction number and doubling time across two waves of the COVID-19 pandemic in South Korea, February to July 2020.
    Int J Infect Dis. 2020 Oct 7. pii: S1201-9712(20)32210.
    >> Share

  1163. SIMULUNDU E, Mupeta F, Chanda-Kapata P, Saasa N, et al
    First COVID-19 Case in Zambia - Comparative phylogenomic analyses of SARS-CoV-2 detected in African countries.
    Int J Infect Dis. 2020 Oct 6. pii: S1201-9712(20)32196.
    >> Share

  1164. JIAN SW, Cheng HY, Huang XT, Liu DP, et al
    Contact tracing with digital assistance in Taiwan's COVID-19 outbreak response.
    Int J Infect Dis. 2020 Oct 6. pii: S1201-9712(20)32200.
    >> Share

  1165. RUBIO-RIVAS M, Ronda M, Padulles A, Mitjavila F, et al
    Beneficial Effect of Corticosteroids in Preventing Mortality in Patients Receiving Tocilizumab to Treat Severe COVID-19 Illness.
    Int J Infect Dis. 2020 Oct 6. pii: S1201-9712(20)32202.
    >> Share

  1166. SHIRIN T, Bhuiyan TR, Charles RC, Amin S, et al
    Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh.
    Int J Infect Dis. 2020 Oct 5. pii: S1201-9712(20)32199.
    >> Share

  1167. SUN M, Ruan X, Li Y, Wang P, et al
    Clinical characteristics of 30 COVID-19 patients with epilepsy: a retrospective study in Wuhan.
    Int J Infect Dis. 2020 Oct 2. pii: S1201-9712(20)32191.
    >> Share

  1168. CALDERARO A, De Conto F, Buttrini M, Piccolo G, et al
    Human respiratory viruses, including SARS-CoV-2, circulating in the winter season 2019-2020 in Parma, Northern Italy.
    Int J Infect Dis. 2020 Oct 2. pii: S1201-9712(20)32189.
    >> Share

  1169. DE SIMONE G, Mancusi C
    Finding the right time for anti-inflammatory therapy in COVID-19.
    Int J Infect Dis. 2020 Oct 1. pii: S1201-9712(20)32170.
    >> Share

  1170. NEWALL AT, Leong RNF, Nazareno A, Muscatello DJ, et al
    Delay-adjusted age- and sex-specific case fatality rates for COVID-19 in South Korea: evolution in the estimated risk of mortality throughout the epidemic.
    Int J Infect Dis. 2020 Oct 1. pii: S1201-9712(20)32194.
    >> Share

  1171. TAO J, Gao H, Zhu S, Yang L, et al
    Influenza versus COVID-19 cases among influenza-illness-like patients in travelers from Wuhan to Hong Kong in January 2020.
    Int J Infect Dis. 2020 Oct 1. pii: S1201-9712(20)32190.
    >> Share

  1172. MALVIYA A
    The continued dilemma about the usage of hydroxychloroquine: Respite is in randomized control trials.
    Int J Infect Dis. 2020;99:310-311.
    >> Share

    September 2020
  1173. LUCA P, Cassandro C, Ralli M, Gioacchini FM, et al
    Sudden sensorineural hearing loss and COVID-19: (commentary about "Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss" from Osman Kilic,
    Int J Infect Dis. 2020 Sep 30. pii: S1201-9712(20)32183.
    >> Share

  1174. MUSA HH, Musa TH, Musa IH, Musa IH, et al
    Addressing Africa's pandemic puzzle: perspectives on COVID-19 infection and mortality in sub-Saharan Africa.
    Int J Infect Dis. 2020 Sep 30. pii: S1201-9712(20)32172.
    >> Share

  1175. BAGHAKI S, Yalcin CE, Baghaki HS, Aydin SY, et al
    COX2 Inhibition in the Treatment of COVID-19: Review of Literature to Propose Celecoxib Repositioning for Randomized Controlled Studies.
    Int J Infect Dis. 2020 Sep 29. pii: S1201-9712(20)32182.
    >> Share

  1176. LAMMERS AJJ, Brohet RM, Theunissen REP, Koster C, et al
    Early Hydroxychloroquine but not Chloroquine use reduces ICU admission in COVID-19 patients.
    Int J Infect Dis. 2020 Sep 29. pii: S1201-9712(20)32175.
    >> Share

  1177. MAZHAR F, Hadi MA, Kow CS, Marran AMN, et al
    Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?
    Int J Infect Dis. 2020 Sep 29. pii: S1201-9712(20)32186.
    >> Share

  1178. MEYEROWITZ-KATZ G, Merone L
    A systematic review and meta-analysis of published research data on COVID-19 infection-fatality rates.
    Int J Infect Dis. 2020 Sep 29. pii: S1201-9712(20)32180.
    >> Share

  1179. KALCIOGLU MT, Cag Y, Kilic O, Tuysuz O, et al
    May COVID-19 cause sudden sensorineural hearing loss?
    Int J Infect Dis. 2020 Sep 29. pii: S1201-9712(20)32184.
    >> Share

  1180. VASSALLO M, Manni S, Pini P, Blanchouin E, et al
    Patients with Covid-19 exhibit different immunological profiles according to their clinical presentation.
    Int J Infect Dis. 2020 Sep 28. pii: S1201-9712(20)32154.
    >> Share

  1181. BLAGOJEVIC NR, Bosnjakovic D, Vukomanovic V, Arsenovic S, et al
    Acute pericarditis and SARS-CoV-2: case report.
    Int J Infect Dis. 2020 Sep 28. pii: S1201-9712(20)32156.
    >> Share

  1182. FACCINI-MARTINEZ AA, Rivero R, Garay E, Garcia A, et al
    Serological cross-reactivity using a SARS-CoV-2 ELISA test in acute Zika virus infection, Colombia.
    Int J Infect Dis. 2020 Sep 28. pii: S1201-9712(20)32167.
    >> Share

  1183. BAGNATO S, Boccagni C, Marino G, Prestandrea C, et al
    Reply to "SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?"
    Int J Infect Dis. 2020 Sep 28. pii: S1201-9712(20)32178.
    >> Share

  1184. KAMINSKI MA, Sunny S, Balabayova K, Kaur A, et al
    Tocilizumab Therapy of COVID-19: A Comparison of Subcutaneous and Intravenous Therapies.
    Int J Infect Dis. 2020 Sep 28. pii: S1201-9712(20)32164.
    >> Share

  1185. FINSTERER J, Scorza FA
    SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?
    Int J Infect Dis. 2020 Sep 28. pii: S1201-9712(20)32177.
    >> Share

  1186. SHAO S, Wang Y, Kang H, Tong Z, et al
    Effect of convalescent blood products for patients with severe acute respiratory infections of viral etiology: a systematic review and meta-analysis.
    Int J Infect Dis. 2020 Sep 28. pii: S1201-9712(20)32159.
    >> Share

  1187. AGERGAARD CN, Lis-Tonder J, Olsen DA, Kierkegaard H, et al
    Challenging diagnostics in familial transmission from asymptomatic COVID-19 carrier. Should we group SARS-CoV-2 samples from households?
    Int J Infect Dis. 2020 Sep 26. pii: S1201-9712(20)32158.
    >> Share

  1188. TAKOI H, Togashi Y, Fujimori D, Kaizuka H, et al
    Favipiravir-induced fever in coronavirus disease 2019: A report of two cases.
    Int J Infect Dis. 2020 Sep 26. pii: S1201-9712(20)32166.
    >> Share

  1189. KARAHASAN YAGCI A, Can Sarinoglu R, Bilgin H, Yanilmaz O, et al
    Relationship of the Cycle Threshold Values of SARS-CoV-2 Polymerase Chain Reaction and Total Severity Score of Computerized Tomography in Patients with COVID 19.
    Int J Infect Dis. 2020 Sep 26. pii: S1201-9712(20)32165.
    >> Share

  1190. CHAABNA K, Doraiswamy S, Mamtani R, Cheema S, et al
    Facemask use in community settings to prevent respiratory infection transmission: a rapid review and meta-analysis.
    Int J Infect Dis. 2020 Sep 25. pii: S1201-9712(20)32150.
    >> Share

  1191. ISERNIA V, Julia Z, Le Gac S, Bachelard A, et al
    SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University Hospital.
    Int J Infect Dis. 2020 Sep 25. pii: S1201-9712(20)32152.
    >> Share

  1192. KHABA MC, Ngale TC, Madala N
    COVID-19 in an HIV-infected patient. Lessons learned from an autopsy case.
    Int J Infect Dis. 2020 Sep 25. pii: S1201-9712(20)32151.
    >> Share

  1193. SKRIP L, Derra K, Kabore M, Noori N, et al
    Clinical management and mortality among COVID-19 cases in sub-Saharan Africa: A retrospective study from Burkina Faso and simulated case analysis.
    Int J Infect Dis. 2020 Sep 25. pii: S1201-9712(20)32148.
    >> Share

  1194. ABDULRAHMAN A, AlAli S, Yaghi O, Shabaan M, et al
    COVID-19 and Sickle Cell Disease in Bahrain.
    Int J Infect Dis. 2020 Sep 24. pii: S1201-9712(20)32149.
    >> Share

  1195. WANNIGAMA DL, Jacquet A
    NOD2-dependent BCG-induced trained immunity: a way to regulate innate responses to SARS- CoV2?
    Int J Infect Dis. 2020 Sep 24. pii: S1201-9712(20)32145.
    >> Share

  1196. MUKWENHA S, Dzinamarira T, Mugurungi O, Musuka G, et al
    Maintaining robust HIV and TB services in the COVID-19 era: A public health dilemma in Zimbabwe.
    Int J Infect Dis. 2020 Sep 23. pii: S1201-9712(20)32141.
    >> Share

  1197. COLSON P, Esteves-Vieira V, Giraud-Gatineau A, Zandotti C, et al
    Temporal and age distributions of SARS-CoV-2 and other coronaviruses, Southeastern France.
    Int J Infect Dis. 2020 Sep 22. pii: S1201-9712(20)32133.
    >> Share

  1198. PINNETTI C, Vergori A, Agrati C, Castilletti C, et al
    SARS-CoV-2 infection does not induce HIV viral escape in Central Nervous System: a case series.
    Int J Infect Dis. 2020 Sep 17. pii: S1201-9712(20)30756.
    >> Share

  1199. MORENO-PEREZ O, Leon-Ramirez JM, Fuertes-Kenneally L, Perdiguero M, et al
    Hypokalemia as a sensitive biomarker of disease severity and invasive mechanical ventilation requirement in COVID-19 pneumonia: a case series of 306 Mediterranean patients.
    Int J Infect Dis. 2020 Sep 17. pii: S1201-9712(20)30749.
    >> Share

  1200. D'ARMINIO MONFORTE A, Tavelli A, Bai F, Tomasoni D, et al
    The importance of patients' case-mix for the correct interpretation of the hospital fatality rate in COVID-19 disease.
    Int J Infect Dis. 2020;100:67-74.
    >> Share

  1201. SELTZER S
    Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection.
    Int J Infect Dis. 2020 Sep 17. pii: S1201-9712(20)30757.
    >> Share

  1202. LV H, Zhang W, Zhu Z, Xiong Q, et al
    Prevalence and recovery time of olfactory and gustatory dysfunctions of hospitalized patients with COVID19 in Wuhan, China.
    Int J Infect Dis. 2020 Sep 17. pii: S1201-9712(20)30755.
    >> Share

  1203. BABIN S
    Use of Weather Variables in SARS-CoV-2 Transmission Studies.
    Int J Infect Dis. 2020 Sep 17. pii: S1201-9712(20)30748.
    >> Share

  1204. PICON RV, Carreno I, da Silva AA, Mossmann M, et al
    Coronavirus Disease 2019 Population-based Prevalence, Risk Factors, Hospitalization, and Fatality Rates in Southern Brazil.
    Int J Infect Dis. 2020 Sep 16. pii: S1201-9712(20)30745.
    >> Share

  1205. ALAJMI J, Jeremijenko AM, Abraham JC, Alishaq M, et al
    COVID-19 Infection Among Healthcare Workers in a National Healthcare System: the Qatar Experience.
    Int J Infect Dis. 2020 Sep 16. pii: S1201-9712(20)30743.
    >> Share

  1206. OWOLABI OA, Jallow AO, Jallow M, Sowe G, et al
    Delay in diagnosis of pulmonary tuberculosis in The Gambia, West Africa: a cross-sectional study.
    Int J Infect Dis. 2020 Sep 16. pii: S1201-9712(20)30744.
    >> Share

  1207. LETELLIER A, Gibelin A, Voiriot G, Fartoukh M, et al
    Destructive pulmonary fibrosis after severe COVID-19 pneumonia.
    Int J Infect Dis. 2020 Sep 16. pii: S1201-9712(20)30741.
    >> Share

  1208. LEDNICKY JA, Lauzardo M, Hugh Fan Z, Jutla A, et al
    Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients.
    Int J Infect Dis. 2020 Sep 16. pii: S1201-9712(20)30739.
    >> Share

  1209. NG MY, Wan EYF, Wong HYF, Leung ST, et al
    Development and Validation of Risk Prediction Models for COVID-19 Positivity in a Hospital Setting.
    Int J Infect Dis. 2020 Sep 15. pii: S1201-9712(20)30738.
    >> Share

  1210. ZHANG A, Leng Y, Zhang Y, Wu K, et al
    Meta-Analysis of coagulation parameters associated with disease severity and poor prognosis of COVID-19.
    Int J Infect Dis. 2020 Sep 15. pii: S1201-9712(20)30737.
    >> Share

  1211. ZHAO SZ, Wong JYH, Luk TT, Wai AKC, et al
    Mental health crisis under COVID-19 pandemic in Hong Kong, China.
    Int J Infect Dis. 2020 Sep 15. pii: S1201-9712(20)30746.
    >> Share

  1212. VALENZUELA-RODRIGUEZ G, Zambrano LI, Munoz-Lara F, Pecho-Silva S, et al
    Intranational differences in the case fatality rates for COVID-19 among Peruvian physicians.
    Int J Infect Dis. 2020 Sep 13. pii: S1201-9712(20)30735.
    >> Share

  1213. AFRIN LB, Weinstock LB, Molderings GJ
    Covid-19 Hyperinflammation and Post-Covid-19 Illness May Be Rooted in Mast Cell Activation Syndrome.
    Int J Infect Dis. 2020 Sep 10. pii: S1201-9712(20)30732.
    >> Share

  1214. JOTHIMANI D, Kailasam E, Danielraj S, Nallathambi B, et al
    COVID-19: Poor outcomes in patients with Zinc deficiency.
    Int J Infect Dis. 2020 Sep 10. pii: S1201-9712(20)30730.
    >> Share

  1215. WEN J, Cheng Y, Ling R, Dai Y, et al
    Antibody-dependent enhancement of Coronavirus.
    Int J Infect Dis. 2020 Sep 10. pii: S1201-9712(20)30731.
    >> Share

  1216. SUARDI LR, Pallotto C, Esperti S, Tazzioli E, et al
    Risk factors for non-invasive/invasive-ventilatory support in patients with COVID-19 pneumonia: a retrospective study within a multidisciplinary approach.
    Int J Infect Dis. 2020 Sep 10. pii: S1201-9712(20)30728.
    >> Share

  1217. EGHTESSADI R, Mukandavire Z, Mutenherwa F, Cuadros D, et al
    Safeguarding gains in the Sexual and Reproductive Health and AIDS Response amidst COVID-19: The Role of African Civil Society.
    Int J Infect Dis. 2020 Sep 10. pii: S1201-9712(20)30725.
    >> Share

  1218. AZIZ AB, Raqib R, Khan WA, Rahman M, et al
    Integrated control of COVID-19 in resource poor countries.
    Int J Infect Dis. 2020 Sep 8. pii: S1201-9712(20)30724.
    >> Share

  1219. YASUI Y, Yasui H, Suzuki K, Saitou T, et al
    Analysis of the predictive factors for critical illness of COVID-19 during treatment - Relationship between serum zinc level and critical illness of COVID-19.
    Int J Infect Dis. 2020 Sep 7. pii: S1201-9712(20)30723.
    >> Share

  1220. DUGAS M, Schrempf IM, Ochs K, Frommel C, et al
    Association of contact to small children with mild course of COVID-19.
    Int J Infect Dis. 2020 Sep 5. pii: S1201-9712(20)30720.
    >> Share

  1221. SILVERIO A, Di Maio M, Ciccarelli M, Carrizzo A, et al
    Timing of national lockdown and mortality in COVID-19: the Italian experience.
    Int J Infect Dis. 2020 Sep 5. pii: S1201-9712(20)30722.
    >> Share

  1222. STEIN RA, Young LM
    From ACE2 to COVID-19: A Multiorgan Endothelial Disease.
    Int J Infect Dis. 2020 Sep 4. pii: S1201-9712(20)30716.
    >> Share

  1223. NIKOLAI LA, Meyer CG, Kremsner PG, Velavan TP, et al
    Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible.
    Int J Infect Dis. 2020 Sep 3. pii: S1201-9712(20)30706.
    >> Share

  1224. OZOG DM, Sexton JZ, Narla S, Pretto-Kernahan CD, et al
    The Effect of Ultraviolet C Radiation Against Different N95 Respirators Inoculated with SARS-CoV-2.
    Int J Infect Dis. 2020 Sep 3. pii: S1201-9712(20)30709.
    >> Share

  1225. ABUHABIB AA, Abu-Aita SN, Procter C, Al-Smeri I, et al
    Unique situation of Gaza Strip dealing with COVID-19 crisis.
    Int J Infect Dis. 2020 Sep 3. pii: S1201-9712(20)30699.
    >> Share

  1226. TRAN TA, Cezar R, Frandon J, Kabani S, et al
    CT scan does not make a diagnosis of Covid-19: a cautionary case report.
    Int J Infect Dis. 2020 Sep 2. pii: S1201-9712(20)30703.
    >> Share

  1227. BELDOMENICO PM
    Response to Gal Almogy: Superspreaders do matter.
    Int J Infect Dis. 2020;98:187.
    >> Share

    August 2020
  1228. CORCHUELO J, Ulloa FC
    Oral manifestations in a patient with a history of asymptomatic COVID-19. Case Report.
    Int J Infect Dis. 2020 Aug 31. pii: S1201-9712(20)30700.
    >> Share

  1229. ABOU GHAYDA R, Lee KH, Han YJ, Ryu S, et al
    Estimation of global case fatality rate of coronavirus disease 2019 (COVID-19) using meta-analyses: Comparison between calendar date and days since the outbreak of the first confirmed case.
    Int J Infect Dis. 2020 Aug 31. pii: S1201-9712(20)30694.
    >> Share

  1230. BAI Y, Jiang D, Lon JR, Chen X, et al
    Comprehensive evolution and molecular characteristics of a large number of SARS-CoV-2 genomes reveal its epidemic trends.
    Int J Infect Dis. 2020 Aug 28. pii: S1201-9712(20)30695.
    >> Share

  1231. SCIALPI M
    Pneumonia misinterpretation in COVID-19: revisitation and update.
    Int J Infect Dis. 2020 Aug 28. pii: S1201-9712(20)30696.
    >> Share

  1232. REGEN F, Eren N, Heuser I, Hellmann-Regen J, et al
    A Simple Approach to Optimum Pool Size for Pooled SARS-CoV-2 Testing.
    Int J Infect Dis. 2020 Aug 28. pii: S1201-9712(20)30692.
    >> Share

  1233. MAHER B, Chavez R, Tomaz GCQ, Nguyen T, et al
    A fluid mechanics explanation of the effectiveness of common materials for respiratory masks.
    Int J Infect Dis. 2020 Aug 27. pii: S1201-9712(20)30621.
    >> Share

  1234. KIM YJ, Seo MH, Yeom HE
    Discussion on selecting the number of breaks in the pattern of spread of COVID-19 (a reply to Zhao and Liang).
    Int J Infect Dis. 2020 Aug 27. pii: S1201-9712(20)30693.
    >> Share

  1235. ZHAO S, Liang X
    A re-analysis to identify the structural breaks in the COVID-19 transmissibility during the early phase of the outbreak in South Korea.
    Int J Infect Dis. 2020 Aug 27. pii: S1201-9712(20)30690.
    >> Share

  1236. COLEBUNDERS R, Siewe Fodjo JN, Vanham G, Van den Bergh R, et al
    A call for strengthened evidence on targeted, non-pharmaceutical interventions against COVID-19 for the protection of vulnerable individuals in sub-Saharan Africa.
    Int J Infect Dis. 2020 Aug 27. pii: S1201-9712(20)30687.
    >> Share

  1237. SADASIVAM B, Atal S, Ray A, Sharma S, et al
    The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19.
    Int J Infect Dis. 2020 Aug 27. pii: S1201-9712(20)30688.
    >> Share

  1238. TORRES JP, Izquierdo G, Acuna M, Pavez D, et al
    Multisystem inflammatory syndrome in children (MIS-C): Report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic.
    Int J Infect Dis. 2020 Aug 27. pii: S1201-9712(20)30691.
    >> Share

  1239. HINOJOSA-VELASCO A, de Oca PVB, Garcia-Sosa LE, Mendoza-Duran JG, et al
    A Case Report of Newborn Infant with Severe COVID-19 in Mexico: Detection of SARS-CoV-2 in Human Breast Milk and Stool.
    Int J Infect Dis. 2020 Aug 26. pii: S1201-9712(20)30684.
    >> Share

  1240. GUAN Q, Sadykov M, Mfarrej S, Hala S, et al
    A genetic barcode of SARS-CoV-2 for monitoring global distribution of different clades during the COVID-19 pandemic.
    Int J Infect Dis. 2020 Aug 22. pii: S1201-9712(20)30681.
    >> Share

  1241. MARVISI M, Ferrozzi F, Balzarini L, Mancini C, et al
    First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: factors predicting fibrotic evolution.
    Int J Infect Dis. 2020 Aug 22. pii: S1201-9712(20)30683.
    >> Share

  1242. ADAMSON PC, Goodman-Meza D, Vijayan T, Yang S, et al
    Diagnostic yield of repeat testing for SARS-CoV-2: Experience from a large health system in Los Angeles.
    Int J Infect Dis. 2020 Aug 21. pii: S1201-9712(20)30678.
    >> Share

  1243. XU Y, Cheng M, Chen X, Zhu J, et al
    Current approach in laboratory testing for SARS-CoV-2.
    Int J Infect Dis. 2020 Aug 20. pii: S1201-9712(20)30671.
    >> Share

  1244. AL WAHAIBI A, Al Manji A, Al Maani A, Al Rawahi B, et al
    COVID-19 epidemic monitoring after non-pharmaceutical interventions: the use of time-varying reproduction number in a country with a large migrant population.
    Int J Infect Dis. 2020 Aug 20. pii: S1201-9712(20)30668.
    >> Share

  1245. LIU J, Zeng W, Cao Y, Cui Y, et al
    Effect of a Previous History of Antiretroviral Treatment on Clinical Picture of Patients with Co-infection of SARS-CoV-2 and HIV: A Preliminary Study.
    Int J Infect Dis. 2020 Aug 20. pii: S1201-9712(20)30674.
    >> Share

  1246. BONILLA-ALDANA DK, Jimenez-Diaz SD, Arango-Duque JS, Aguirre-Florez M, et al
    Bats in Ecosystems and their Wide Spectrum of Viral Infectious Threats: SARS-CoV-2 and other emerging viruses.
    Int J Infect Dis. 2020 Aug 20. pii: S1201-9712(20)30680.
    >> Share

  1247. MACAULEY P, Martin A, Epelbaum O
    CORTICOSTEROIDS IN THE TREATMENT OF SEVERE COVID-19 LUNG DISEASE: THE PULMONOLOGY PERSPECTIVE FROM THE FIRST UNITED STATES EPICENTER.
    Int J Infect Dis. 2020 Aug 20. pii: S1201-9712(20)30670.
    >> Share

  1248. TAKAHASHI H, Iwasaki Y, Watanabe T, Ichinose N, et al
    Case studies of SARS-CoV-2 treated with favipiravir among patients in critical or severe condition.
    Int J Infect Dis. 2020 Aug 20. pii: S1201-9712(20)30677.
    >> Share

  1249. AHERFI S, Gautret P, Chaudet H, Raoult D, et al
    Clusters of COVID-19 associated with Purim celebration in the Jewish community in Marseille, France, March 2020.
    Int J Infect Dis. 2020 Aug 20. pii: S1201-9712(20)30679.
    >> Share

  1250. PETERSEN E, Zumla A
    Advancing COVID-19 vaccines - avoiding different regulatory standards for different vaccines and need for open and transparent data sharing.
    Int J Infect Dis. 2020 Aug 18. pii: S1201-9712(20)30675.
    >> Share

  1251. GENDROT M, Duflot I, Boxberger M, Delandre O, et al
    Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate.
    Int J Infect Dis. 2020 Aug 14. pii: S1201-9712(20)30661.
    >> Share

  1252. LU YF, Pan LY, Zhang WW, Cheng F, et al
    A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19.
    Int J Infect Dis. 2020 Aug 13. pii: S1201-9712(20)30652.
    >> Share

  1253. OBOH MA, Omoleke SA, Ajibola O, Manneh J, et al
    Translation of genomic epidemiology of infectious pathogens: Enhancing African genomics hubs for outbreaks.
    Int J Infect Dis. 2020 Aug 12. pii: S1201-9712(20)30656.
    >> Share

  1254. KOH WC, Naing L, Wong J
    Estimating the impact of physical distancing measures in containing COVID-19: an empirical analysis.
    Int J Infect Dis. 2020 Aug 12. pii: S1201-9712(20)30655.
    >> Share

  1255. ORTOLAN A, Lorenzin M, Felicetti M, Doria A, et al
    Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis.
    Int J Infect Dis. 2020 Aug 12. pii: S1201-9712(20)30607.
    >> Share

  1256. LIM JT, Dickens BL, Cook AR, Khoo AL, et al
    The Costs of an Expanded Screening Criteria for COVID-19: A Modelling Study.
    Int J Infect Dis. 2020 Aug 12. pii: S1201-9712(20)30654.
    >> Share

  1257. HIROTSU Y, Maejima M, Shibusawa M, Nagakubo Y, et al
    Comparison of Automated SARS-CoV-2 Antigen Test for COVID-19 Infection with Quantitative RT-PCR using 313 Nasopharyngeal Swabs Including from 7 Serially Followed Patients.
    Int J Infect Dis. 2020 Aug 12. pii: S1201-9712(20)30658.
    >> Share

  1258. KLOPFENSTEIN T, Zayet S, Lohse A, Selles P, et al
    Impact of Tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients.
    Int J Infect Dis. 2020 Aug 12. pii: S1201-9712(20)30653.
    >> Share

  1259. IM JH, Je YS, Baek J, Chung MH, et al
    Nutritional status of patients with coronavirus disease 2019 (COVID-19).
    Int J Infect Dis. 2020 Aug 11. pii: S1201-9712(20)30647.
    >> Share

  1260. ISRAELI O, Beth-Din A, Paran N, Stein D, et al
    Evaluating the efficacy of RT-qPCR SARS-CoV-2 direct approaches in comparison to RNA extraction.
    Int J Infect Dis. 2020 Aug 10. pii: S1201-9712(20)30644.
    >> Share

  1261. LA HOZ-RESTREPO F, Alvis-Zakzuk NJ, la Hoz-Gomez JF, la Hoz-Gomez A, et al
    Is Colombia an example of successful containment of the COVID-19 2020 pandemic? A critical analysis of the epidemiological data. March to July 2020.
    Int J Infect Dis. 2020 Aug 10. pii: S1201-9712(20)30646.
    >> Share

  1262. LIN CY, Wang WH, Urbina AN, Tseng SP, et al
    Corrigendum to "Importation of SARS-CoV-2 infection leads to major COVID-19 epidemic in Taiwan" [Int J Infect Dis 97 (2020) 240-244].
    Int J Infect Dis. 2020;98:440.
    >> Share

  1263. DEL BRUTTO OH, Costa AF, Mera RM, Recalde BY, et al
    SARS-CoV-2-related mortality in a rural Latin American population.
    Int J Infect Dis. 2020 Aug 8. pii: S1201-9712(20)30630.
    >> Share

  1264. ANDERSON M, Mossialos E
    Time to strengthen capacity in infectious disease control at the European level.
    Int J Infect Dis. 2020 Aug 8. pii: S1201-9712(20)30631.
    >> Share

  1265. ZUMLA A, Azhar EI, Shafi S, Memish ZA, et al
    COVID-19 and the scaled-down 2020 Hajj Pilgrimage - Decisive, logical and prudent decision making by Saudi authorities overcomes pre-Hajj public health concerns.
    Int J Infect Dis. 2020 Aug 7. pii: S1201-9712(20)30643.
    >> Share

  1266. GUPTA R, Gant VA, Williams B, Enver T, et al
    Increased Complement Receptor-3 levels in monocytes and granulocytes distinguish COVID-19 patients with pneumonia from those with mild symptoms.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30632.
    >> Share

  1267. MUMOLI N, Vitale J, Mazzone A
    Clinical Immunity in Discharged Medical Patients with COVID 19.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30623.
    >> Share

  1268. LIN YC, Chen MY, Liu MC, Lin YJ, et al
    Quarantine Measures for Coronavirus Disease 2019 on a Cruise Ship, Taiwan, February 2020.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30641.
    >> Share

  1269. GAO J, Hu X, Sun X, Luo X, et al
    Possible intrauterine infection: Positive nucleic acid testing results and consecutive positive SARS-CoV-2-specific antibody levels within 50 days after birth.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30608.
    >> Share

  1270. MARTINCIC Z, Skopec B, Rener K, Mavric M, et al
    Severe immune thrombocytopenia in a critically ill COVID-19 patient.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30633.
    >> Share

  1271. KLOPFENSTEIN T, Zahra H, Kadiane-Oussou NJ, Lepiller Q, et al
    New loss of smell and taste: Uncommon symptoms in COVID-19 patients on Nord Franche-Comte cluster, France.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30637.
    >> Share

  1272. METTLER SK, Kim J, Maathuis MH
    Diagnostic serial interval as a novel indicator for contact tracing effectiveness exemplified with the SARS-CoV-2/COVID-19 outbreak in South Korea.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30611.
    >> Share

  1273. CHUN JY, Baek G, Kim Y
    Transmission onset distribution of COVID-19.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30612.
    >> Share

  1274. JUNG CY, Park H, Kim DW, Choi YJ, et al
    Clinical Characteristics of Asymptomatic Patients with COVID-19: A Nationwide Cohort Study in South Korea.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30634.
    >> Share

  1275. ZUMLA A, Azhar EI, Alqahtani S, Shafi S, et al
    COVID-19 and the scaled-down 2020 Hajj Pilgrimage - Decisive, logical and prudent decision making by Saudi authorities overcomes pre-Hajj public health concerns.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30635.
    >> Share

  1276. VARISCO TJ, Johnson ML, Thornton D
    Comment on Arshad et al: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19.
    Int J Infect Dis. 2020 Aug 6. pii: S1201-9712(20)30617.
    >> Share

  1277. LIU T, Gong D, Xiao J, Hu J, et al
    Cluster infections play important roles in the rapid evolution of COVID-19 transmission: a systematic review.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30619.
    >> Share

  1278. POTERE N, Di Nisio M, Rizzo G, La Vella M, et al
    Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30616.
    >> Share

  1279. BHAT P, Noval M, Doub JB, Heil E, et al
    COVID-19 and PCP co-infection in a severely immunocompromised 25 year-old patient.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30615.
    >> Share

  1280. WU J, Yu J, Zhou S, Zhang J, et al
    What can we learn from a COVID-19 lung biopsy?
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30610.
    >> Share

  1281. BRITO-AZEVEDO A
    Hydroxychloroquine in COVID-19: taking care of statistic to take care of patients.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30614.
    >> Share

  1282. GODDEK S
    Vitamin D3 and K2 and their potential contribution to reducing the COVID-19 mortality rate.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30624.
    >> Share

  1283. CAPONE A
    Simultaneous circulation of COVID-19 and flu in Italy: potential combined effects on the risk of death?
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30618.
    >> Share

  1284. PRASETYO YT, Castillo AM, Salonga LJ, Sia JA, et al
    Factors Affecting Perceived Effectiveness of COVID-19 Prevention Measures among Filipino during Enhanced Community Quarantine in Luzon, Philippines: Integrating Protection Motivation Theory and Extended Theory of Planned Behavior.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30622.
    >> Share

  1285. WISEMAN DM
    Re: Arshad S, Kilgore P, Chaudhry ZS et al. Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19. Int J Infect Dis: 2020. Epub 2020 Jul 1 http://doi.org/10.1016/j.ijid.2020.06.099.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30613.
    >> Share

  1286. LANGER-GOULD A, Smith JB, Gonzales EG, Castillo RD, et al
    Early Identification of COVID-19 Cytokine Storm and Treatment with Anakinra or Tocilizumab.
    Int J Infect Dis. 2020 Aug 5. pii: S1201-9712(20)30609.
    >> Share

  1287. VERHAGEN LM, de Groot R, Lawrence CA, Taljaard J, et al
    COVID-19 response in low- and middle-income countries: don't overlook the role of mobile phone communication.
    Int J Infect Dis. 2020 Aug 4. pii: S1201-9712(20)30625.
    >> Share

  1288. UHM JS, Ahn JY, Hyun JH, Sohn Y, et al
    Patterns of Viral Clearance in the Natural Course of Asymptomatic Coronavirus Disease 2019 (COVID-19): Comparison with Symptomatic Nonsevere COVID-19.
    Int J Infect Dis. 2020 Aug 4. pii: S1201-9712(20)30620.
    >> Share

  1289. BAGNATO S, Boccagni C, Marino G, Prestandrea C, et al
    Critical illness myopathy after COVID-19.
    Int J Infect Dis. 2020 Aug 4. pii: S1201-9712(20)30606.
    >> Share

  1290. ZHAO D, Wang M, Wang M, Zhao Y, et al
    Asymptomatic infection by SARS-CoV-2 in healthcare workers: a study in a large teaching hospital in Wuhan, China.
    Int J Infect Dis. 2020 Aug 3. pii: S1201-9712(20)30627.
    >> Share

  1291. ZHENG F, Zhou Y, Zhou Z, Ye F, et al
    SARS-CoV-2 Clearance in COVID-19 Patients with Novaferon Treatment: A Randomized, Open-label, Parallel Group Trial.
    Int J Infect Dis. 2020 Aug 3. pii: S1201-9712(20)30597.
    >> Share

  1292. ZHANG W, Li L, Liu J, Chen L, et al
    The characteristics and predictive role of lymphocyte subsets in COVID-19 patients.
    Int J Infect Dis. 2020 Aug 3. pii: S1201-9712(20)30514.
    >> Share

  1293. LU J, Wu D, Cao L, Ma X, et al
    Corrigendum to "Positive effects of COVID-19 control measures on pneumonia prevention" [Int J Infect Dis 96 (July) (2020) 548-549].
    Int J Infect Dis. 2020;97:404.
    >> Share

    July 2020
  1294. ZERVOS M, Arshad S, Kilgore P, Chaudhry ZS, et al
    A Sound Approach: Hydroxychloroquine Reduces Mortality in Severe COVID-19.
    Int J Infect Dis. 2020 Jul 31. pii: S1201-9712(20)30604.
    >> Share

  1295. IWATA K, Doi A, Miyakoshi C
    Was school closure effective in mitigating coronavirus disease 2019 (COVID-19)? Time series analysis using Bayesian inference.
    Int J Infect Dis. 2020 Jul 31. pii: S1201-9712(20)30598.
    >> Share

  1296. ALCOBA-FLOREZ J, Gil-Campesino H, de Artola DG, Gonzalez-Montelongo R, et al
    Sensitivity of different RT-qPCR solutions for SARS-CoV-2 detection.
    Int J Infect Dis. 2020 Jul 31. pii: S1201-9712(20)30603.
    >> Share

  1297. ATKINSON JG
    Problems with the analysis in "Treatment with Hydroxychloroquine, Azithromycin and Combination in Patients Hospitalized with COVID-19".
    Int J Infect Dis. 2020 Jul 29. pii: S1201-9712(20)30602.
    >> Share

  1298. D'ARMINIO MONFORTE A, Tavelli A, Bai F, Marchetti G, et al
    Effectiveness of Hydroxychloroquine in COVID-19 disease: A done and dusted situation?
    Int J Infect Dis. 2020 Jul 29. pii: S1201-9712(20)30600.
    >> Share

  1299. ROSENBERG ES, Holtgrave DR, Udo T
    Clarifying the record on hydroxychloroquine for the treatment of patients hospitalized with COVID-19.
    Int J Infect Dis. 2020 Jul 29. pii: S1201-9712(20)30599.
    >> Share

  1300. TAN L, Ma B, Lai X, Han L, et al
    Air and surface contamination by SARS-CoV-2 virus in a tertiary hospital in Wuhan, China.
    Int J Infect Dis. 2020 Jul 27. pii: S1201-9712(20)30571.
    >> Share

  1301. KESKE S, Tekin S, Sait B, Irkoren P, et al
    Appropriate use of Tocilizumab in COVID-19 Infection.
    Int J Infect Dis. 2020 Jul 26. pii: S1201-9712(20)30580.
    >> Share

  1302. NAKAGAWARA K, Masaki K, Uwamino Y, Kabata H, et al
    Acute Onset Olfactory/Taste Disorders are Associated with a High Viral Burden in Mild or Asymptomatic SARS-CoV-2 Infections.
    Int J Infect Dis. 2020 Jul 26. pii: S1201-9712(20)30578.
    >> Share

  1303. KANEKURA T, Kawahara K
    Adsorptive granulocyte and monocyte apheresis: a potentially relevant therapeutic option for COVID-19.
    Int J Infect Dis. 2020 Jul 25. pii: S1201-9712(20)30569.
    >> Share

  1304. ZHOU Y, Yang Q, Chi J, Dong B, et al
    Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis.
    Int J Infect Dis. 2020 Jul 25. pii: S1201-9712(20)30572.
    >> Share

  1305. KOZLOVSKAYA L, Piniaeva A, Ignatyev G, Selivanov A, et al
    Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during COVID-19 outbreak.
    Int J Infect Dis. 2020 Jul 25. pii: S1201-9712(20)30566.
    >> Share

  1306. SINHA P, Mostaghim A, Bielick CG, McLaughlin A, et al
    Early administration of Interleukin-6 inhibitors for patients with severe Covid-19 disease is associated with decreased intubation, reduced mortality, and increased discharge.
    Int J Infect Dis. 2020 Jul 25. pii: S1201-9712(20)30568.
    >> Share

  1307. ABENZA-ABILDUA MJ, Novo-Aparicio S, Moreno-Zabaleta R, Algarra-Lucas MC, et al
    Encephalopathy in severe SARS-CoV2 infection: Inflammatory or infectious?
    Int J Infect Dis. 2020;98:398-400.
    >> Share

  1308. LUETHGEN M, Eggeling J, Heyckendorf J, Lange C, et al
    Changes in taste and smell as an early marker for COVID-19.
    Int J Infect Dis. 2020 Jul 21. pii: S1201-9712(20)30562.
    >> Share

  1309. LEE JY, Hong SW, Hyun M, Park JS, et al
    Epidemiological and Clinical Characteristics of Coronavirus Disease 2019 in Daegu, South Korea.
    Int J Infect Dis. 2020 Jul 20. pii: S1201-9712(20)30561.
    >> Share

  1310. DE SOUSA E, Ligeiro D, Lerias JR, Zhang C, et al
    Mortality in COVID-19 disease patients: Correlating Association of Major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants.
    Int J Infect Dis. 2020 Jul 18. pii: S1201-9712(20)30560.
    >> Share

  1311. FUGLEBJERG NJU, Jensen TO, Hoyer N, Ryrso CK, et al
    Silent Hypoxia in Patients with SARS CoV-2 Infection before Hospital Discharge.
    Int J Infect Dis. 2020 Jul 11. pii: S1201-9712(20)30557.
    >> Share

  1312. SUN M, Xu Y, He H, Zhang L, et al
    Potential effective treatment for COVID-19: systematic review and meta-analysis of the severe infectious disease with convalescent plasma therapy.
    Int J Infect Dis. 2020 Jul 4. pii: S1201-9712(20)30542.
    >> Share

  1313. SAIDAN MN, Shbool MA, Arabeyyat OS, T Al-Shihabi S, et al
    Estimation of the probable outbreak size of novel coronavirus (COVID-19) in social gathering events and industrial activities.
    Int J Infect Dis. 2020 Jul 4. pii: S1201-9712(20)30540.
    >> Share

  1314. DIOSCORIDI L, Carrisi C
    Covid-19 exposure risk for family members of healthcare workers: an observational study.
    Int J Infect Dis. 2020 Jul 4. pii: S1201-9712(20)30541.
    >> Share

  1315. DENG Z, Zhang M, Zhu T, Liu Z, et al
    Dynamic changes of peripheral blood lymphocytes subsets in adult patients with COVID-19.
    Int J Infect Dis. 2020 Jul 4. pii: S1201-9712(20)30545.
    >> Share

  1316. KIM S, Castro MC
    Spatiotemporal pattern of COVID-19 and government response in South Korea (as of May 31, 2020).
    Int J Infect Dis. 2020 Jul 4. pii: S1201-9712(20)30546.
    >> Share

  1317. ALMOGY G
    Superspreaders and the spread pattern of COVID-19: Response to: "Do superspreaders generate new superspreaders? A hypothesis to explain the propagation pattern of COVID-19", International Journal of Infectious Diseases 96 (2020) 461-463.
    Int J Infect Dis. 2020 Jul 2. pii: S1201-9712(20)30537.
    >> Share

  1318. AL-SADEQ DW, Nasrallah GK
    The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: a systematic review.
    Int J Infect Dis. 2020 Jul 2. pii: S1201-9712(20)30533.
    >> Share

  1319. ARSHAD S, Kilgore P, Chaudhry ZS, Jacobsen G, et al
    Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19.
    Int J Infect Dis. 2020 Jul 2. pii: S1201-9712(20)30534.
    >> Share

  1320. YU X, Duan J, Jiang Y, Zhang H, et al
    Distinctive trajectories of COVID-19 epidemic by age and gender: a retrospective modeling of the epidemic in South Korea.
    Int J Infect Dis. 2020 Jul 2. pii: S1201-9712(20)30536.
    >> Share

  1321. LEE TC, MacKenzie LJ, McDonald EG, Tong SYC, et al
    An Observational Cohort Study of Hydroxychloroquine and Azithromycin for COVID-19: (Can't Get No) Satisfaction.
    Int J Infect Dis. 2020 Jul 2. pii: S1201-9712(20)30530.
    >> Share

  1322. TANG B, Xia F, Tang S, Bragazzi NL, et al
    The effectiveness of quarantine and isolation determine the trend of the COVID-19 epidemic in the final phase of the current outbreak in China.
    Int J Infect Dis. 2020;96:636-647.
    >> Share

  1323. ZHANG H, Li HB, Lyu JR, Lei XM, et al
    Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection.
    Int J Infect Dis. 2020;96:19-24.
    >> Share

  1324. ZHU W, Li X, Wu Y, Xu C, et al
    Community quarantine strategy against coronavirus disease 2019 in Anhui: An evaluation based on trauma center patients.
    Int J Infect Dis. 2020;96:417-421.
    >> Share

    June 2020
  1325. DE NARDO P, Gentilotti E, Mazzaferri F, Cremonini E, et al
    Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage.
    Int J Infect Dis. 2020 Jun 30. pii: S1201-9712(20)30516.
    >> Share

  1326. DUBERT M, Visseaux B, Isernia V, Bouadma L, et al
    Case reports study of the first five patients COVID-19 treated with remdesivir in France.
    Int J Infect Dis. 2020 Jun 30. pii: S1201-9712(20)30528.
    >> Share

  1327. ALKHAMIS MA, Youha SA, Khajah MM, Haider NB, et al
    Spatiotemporal Dynamics of COVID-19 epidemic in the State of Kuwait.
    Int J Infect Dis. 2020 Jun 30. pii: S1201-9712(20)30512.
    >> Share

  1328. CHEN X, Zhu B, Hong W, Zeng J, et al
    Associations of Clinical Characteristics and Treatment Regimens with Viral RNA Shedding Duration in Patients with COVID-19.
    Int J Infect Dis. 2020 Jun 30. pii: S1201-9712(20)30526.
    >> Share

  1329. NOH JY, Song JY, Yoon JG, Seong H, et al
    Safe Hospital Preparedness in the Era of COVID-19: The Swiss Cheese Model.
    Int J Infect Dis. 2020 Jun 30. pii: S1201-9712(20)30529.
    >> Share

  1330. SEIDU AA, Hagan JE Jr, Ameyaw EK, Ahinkorah BO, et al
    The role of testing in infectious disease control: A case of COVID-19 in Africa.
    Int J Infect Dis. 2020 Jun 30. pii: S1201-9712(20)30525.
    >> Share

  1331. LIANG Y, Xu J, Chu M, Mai J, et al
    Neurosensory dysfunction: a diagnostic marker of early COVID-19.
    Int J Infect Dis. 2020 Jun 29. pii: S1201-9712(20)30519.
    >> Share

  1332. BAJUNIRWE F, Izudi J, Asiimwe S
    Long distance truck drivers and the increasing risk of COVID-19 spread in Uganda.
    Int J Infect Dis. 2020 Jun 29. pii: S1201-9712(20)30522.
    >> Share

  1333. SHEN C, Yue X, Wang J, Shi C, et al
    Nocturnal oxygen therapy as an option for early COVID-19.
    Int J Infect Dis. 2020 Jun 26. pii: S1201-9712(20)30515.
    >> Share

  1334. MANNUCCI E, Nreu B, Monami M
    Factors associated with increased all-cause mortality during the COVID-19 pandemic in Italy.
    Int J Infect Dis. 2020 Jun 26. pii: S1201-9712(20)30510.
    >> Share

  1335. FUKUMOTO T, Iwasaki S, Fujisawa S, Hayasaka K, et al
    Efficacy of a novel SARS-CoV-2 detection kit without RNA extraction and purification.
    Int J Infect Dis. 2020 Jun 26. pii: S1201-9712(20)30509.
    >> Share

  1336. HE D, Shi Z, Li Y, Cao P, et al
    Comparing COVID-19 and the 1918-19 influenza pandemics in United Kingdom.
    Int J Infect Dis. 2020 Jun 26. pii: S1201-9712(20)30511.
    >> Share

  1337. AHMED MAM, Colebunders R, Siewe Fodjo JN
    Evidence for important COVID-19 community transmission in Somalia using a clinical case definition.
    Int J Infect Dis. 2020 Jun 25. pii: S1201-9712(20)30503.
    >> Share

  1338. ADAMU AA, Jalo RI, Habonimana D, Wiysonge CS, et al
    COVID-19 and routine childhood immunization in Africa: leveraging systems thinking and implementation science to improve immunization system performance.
    Int J Infect Dis. 2020 Jun 24. pii: S1201-9712(20)30507.
    >> Share

  1339. BAVARO DF, Poliseno M, Scardapane A, Belati A, et al
    Occurrence of Acute Pulmonary Embolism in COVID-19 - A Case Series.
    Int J Infect Dis. 2020 Jun 22. pii: S1201-9712(20)30501.
    >> Share

  1340. VELAVAN TP, Pollard AJ, Kremsner PG
    Herd Immunity and Vaccination of children for COVID19.
    Int J Infect Dis. 2020 Jun 22. pii: S1201-9712(20)30500.
    >> Share

  1341. KHAMIS F, Al-Zakwani I, Al Hashmi S, Al Dowaiki S, et al
    Therapeutic Plasma Exchange in Adults with Severe COVID-19 Infection.
    Int J Infect Dis. 2020 Jun 22. pii: S1201-9712(20)30499.
    >> Share

  1342. GALVIN CJ, Li Jack YC, Malwade S, Syed-Abdul S, et al
    COVID-19 preventive measures showing an unintended decline in infectious diseases in Taiwan.
    Int J Infect Dis. 2020 Jun 22. pii: S1201-9712(20)30496.
    >> Share

  1343. AMZAT J, Aminu K, Kolo VI, Akinyele AA, et al
    Coronavirus Outbreak in Nigeria: Burden and Socio-Medical Response during the First 100 Days.
    Int J Infect Dis. 2020 Jun 22. pii: S1201-9712(20)30502.
    >> Share

  1344. TARIQ A, Mateen RM, Afzal MS, Saleem M, et al
    Paromomycin: a potential dual targeted drug effectively inhibits both Spike (S1) and Main Protease of COVID-19.
    Int J Infect Dis. 2020 Jun 21. pii: S1201-9712(20)30498.
    >> Share

  1345. LAM HY, Lam TS, Wong CH, Lam WH, et al
    The Epidemiology of COVID-19 cases and the Successful Containment Strategy in Hong Kong - January to May 2020.
    Int J Infect Dis. 2020 Jun 21. pii: S1201-9712(20)30492.
    >> Share

  1346. HE S, Zhou C, Lu D, Yang H, et al
    Relationship between Chest CT manifestations and immune response in COVID-19 patients.
    Int J Infect Dis. 2020 Jun 20. pii: S1201-9712(20)30494.
    >> Share

  1347. POURGHASEMI HR, Pouyan S, Heidari B, Farajzadeh Z, et al
    Spatial modelling, risk mapping, change detection, and outbreak trend analysis of coronavirus (COVID-19) in Iran (days between 19 February to 14 June 2020).
    Int J Infect Dis. 2020 Jun 20. pii: S1201-9712(20)30493.
    >> Share

  1348. SARTOR G, Riccio MD, Poz ID, Bonanni P, et al
    COVID-19 in Italy: considerations on official data.
    Int J Infect Dis. 2020 Jun 20. pii: S1201-9712(20)30495.
    >> Share

  1349. AMIR M, Djaharuddin I, Sudharsono A, Ramadany S, et al
    COVID-19 Concomitant Infective Endocarditis: A-Case Report and Review of Management.
    Int J Infect Dis. 2020 Jun 20. pii: S1201-9712(20)30497.
    >> Share

  1350. KIM YJ, Seo MH, Yeom HE
    Estimating a breakpoint in the spread pattern of COVID-19 in South Korea.
    Int J Infect Dis. 2020 Jun 19. pii: S1201-9712(20)30489.
    >> Share

  1351. ALESSANDRA D, Lepore L, Palazzolo C, Barreca F, et al
    Acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection in an Italian patient: mini-review of the literature.
    Int J Infect Dis. 2020 Jun 18. pii: S1201-9712(20)30491.
    >> Share

  1352. EBRAHIM SH, Zhuo J, Gozzer E, Ahmed QA, et al
    All Hands on Deck: A Synchronized Whole-of-World Approach for COVID-19 Mitigation.
    Int J Infect Dis. 2020 Jun 18. pii: S1201-9712(20)30484.
    >> Share

  1353. KRONBICHLER A, Kresse D, Yoon S, Lee KH, et al
    Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis.
    Int J Infect Dis. 2020 Jun 17. pii: S1201-9712(20)30487.
    >> Share

  1354. LOBO AP, Cardoso-Dos-Santos AC, Rocha MS, Pinheiro RS, et al
    COVID-19 epidemic in Brazil: where we at?
    Int J Infect Dis. 2020 Jun 16. pii: S1201-9712(20)30479.
    >> Share

  1355. TURCATO G, Panebianco L, Zaboli A, Scheurer C, et al
    Correlation between arterial blood gas test and CT volumetry in patients with SARS-CoV-2 in the emergency department.
    Int J Infect Dis. 2020 Jun 15. pii: S1201-9712(20)30468.
    >> Share

  1356. FILICE C, Poma GL, Above E, Dellafiore C, et al
    Is the fear of Covid-19 infection the same in all subjects?
    Int J Infect Dis. 2020 Jun 15. pii: S1201-9712(20)30475.
    >> Share

  1357. GUALLAR MP, Meirino R, Donat-Vargas C, Corral O, et al
    Inoculum at the time of SARS-CoV-2 exposure and risk of disease severity.
    Int J Infect Dis. 2020 Jun 14. pii: S1201-9712(20)30470.
    >> Share

  1358. EBINA-SHIBUYA R, Namkoong H, Shibuya Y, Horita N, et al
    Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Insights from simultaneous familial Kawasaki Disease cases.
    Int J Infect Dis. 2020 Jun 14. pii: S1201-9712(20)30450.
    >> Share

  1359. SATICI C, Demirkol MA, Altunok ES, Gursoy B, et al
    Performance of Pneumonia Severity Index and CURB-65 in Predicting 30-day mortality in patients with COVID-19.
    Int J Infect Dis. 2020 Jun 14. pii: S1201-9712(20)30473.
    >> Share

  1360. ALI S, Pappachan JM, Mathew S
    Acute cor pulmonale from saddle pulmonary embolism in a patient with previous Covid-19 - should we prolong prophylactic anticoagulation?
    Int J Infect Dis. 2020 Jun 13. pii: S1201-9712(20)30474.
    >> Share

  1361. LIU Z, Chu R, Gong L, Su B, et al
    The assessment of transmission efficiency and latent infection period on asymptomatic carriers of SARS-CoV-2 infection.
    Int J Infect Dis. 2020 Jun 13. pii: S1201-9712(20)30471.
    >> Share

  1362. LIN CY, Wang WH, Urbina AN, Tseng SP, et al
    Importation of SARS-CoV-2 infection leads to major COVID-19 epidemic in Taiwan.
    Int J Infect Dis. 2020 Jun 13. pii: S1201-9712(20)30466.
    >> Share

  1363. RUTAYISIRE E, Nkundimana G, Mitonga HK, Boye A, et al
    What works and what does not work in response to COVID-19 prevention and control in Africa.
    Int J Infect Dis. 2020 Jun 11. pii: S1201-9712(20)30460.
    >> Share

  1364. PENARRUBIA AL, Ruiz M, Porco R, Rao SN, et al
    Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak.
    Int J Infect Dis. 2020 Jun 11. pii: S1201-9712(20)30463.
    >> Share

  1365. LI Y, Wang H, Wang F, Du H, et al
    Comparison of Hospitalized Patients with pneumonia caused by COVID-19 and influenza A in children under 5 years.
    Int J Infect Dis. 2020 Jun 11. pii: S1201-9712(20)30462.
    >> Share

  1366. XIAO Y, Tang B, Wu J, Cheke RA, et al
    Linking key intervention timings to rapid decline of the COVID-19 effective reproductive number to quantify lessons from mainland China.
    Int J Infect Dis. 2020 Jun 11. pii: S1201-9712(20)30449.
    >> Share

  1367. SZMUDA T, Ali S, Hetzger TV, Rosvall P, et al
    Are Online Searches for the Novel Coronavirus (COVID-19) Related to Media or Epidemiology? A Cross-sectional Study.
    Int J Infect Dis. 2020 Jun 11. pii: S1201-9712(20)30464.
    >> Share

  1368. MIYAMAE Y, Hayashi T, Yonezawa H, Fujihara J, et al
    Duration of viral shedding in asymptomatic or mild cases of novel coronavirus disease 2019 (COVID-19) from a cruise ship: A single-hospital experience in Tokyo, Japan.
    Int J Infect Dis. 2020 Jun 11. pii: S1201-9712(20)30456.
    >> Share

  1369. KILIC O, Kalcioglu MT, Cag Y, Tuysuz O, et al
    Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss.
    Int J Infect Dis. 2020 Jun 11. pii: S1201-9712(20)30458.
    >> Share

  1370. BOHNING D, Rocchetti I, Maruotti A, Holling H, et al
    Estimating the undetected infections in the Covid-19 outbreak by harnessing capture-recapture methods.
    Int J Infect Dis. 2020 Jun 10. pii: S1201-9712(20)30444.
    >> Share

  1371. ZHOU Y, Zeng Y, Chen C
    Presence of SARS-CoV-2 RNA in Isolation Ward Environment 28 Days after Exposure.
    Int J Infect Dis. 2020 Jun 10. pii: S1201-9712(20)30451.
    >> Share

  1372. SANTOS JAD, Normando AGC, Silva RLCD, Paula RM, et al
    Oral mucosal lesions in a COVID-19 patient: new signs or secondary manifestations?
    Int J Infect Dis. 2020 Jun 8. pii: S1201-9712(20)30447.
    >> Share

  1373. FINZI E
    Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients.
    Int J Infect Dis. 2020 Jun 6. pii: S1201-9712(20)30441.
    >> Share

  1374. AZIZ H, Fatima S, Iqbal H, Faheem M, et al
    Recent Advances in Molecular diagnosis curbing the COVID-19.
    Int J Infect Dis. 2020 Jun 6. pii: S1201-9712(20)30439.
    >> Share

  1375. ESPINDOLA OM, Siqueira M, Soares CN, Lima MASD, et al
    Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid.
    Int J Infect Dis. 2020 Jun 4. pii: S1201-9712(20)30431.
    >> Share

  1376. LI H, Xu XL, Dai DW, Huang ZY, et al
    Air Pollution and temperature are associated with increased COVID-19 incidence: a time series study.
    Int J Infect Dis. 2020 Jun 2. pii: S1201-9712(20)30383.
    >> Share

  1377. ZHANG L, Tao Y, Wang J, Ong JJ, et al
    Early characteristics of the COVID-19 outbreak predict the subsequent epidemic size.
    Int J Infect Dis. 2020 Jun 2. pii: S1201-9712(20)30429.
    >> Share

  1378. LEE KCH, Sewa DW, Phua GC
    Potential role of statins in COVID-19.
    Int J Infect Dis. 2020 Jun 2. pii: S1201-9712(20)30422.
    >> Share

  1379. MIZUMOTO K, Kagaya K, Chowell G
    Effect of the Wet Market on the coronavirus disease (COVID-19) transmission dynamics in China, 2019-2020.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30398.
    >> Share

  1380. EDEAS M, Saleh J, Peyssonnaux C
    Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30417.
    >> Share

  1381. MACINTYRE CR, Chughtai AA, Seale H, Dwyer DE, et al
    HUMAN CORONAVIRUS DATA FROM FOUR CLINICAL TRIALS OF MASKS AND RESPIRATORS.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30399.
    >> Share

  1382. PORTE L, Legarraga P, Vollrath V, Aguilera X, et al
    Evaluation of novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30405.
    >> Share

  1383. SHAH AUM, Safri SNA, Thevadas R, Noordin NK, et al
    COVID-19 Outbreak in Malaysia: Actions Taken by the Malaysian Government.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30400.
    >> Share

  1384. MING DK, Sorawat S, Chanh HQ, Nhat PTH, et al
    Continuous physiological monitoring using wearable technology to inform individual management of infectious diseases, public health and outbreak responses.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30393.
    >> Share

  1385. KENYON C
    The prominence of asymptomatic superspreaders in transmission mean universal face masking should be part of COVID-19 de-escalation strategies.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30409.
    >> Share

  1386. LUO S, Guo Y, Zhang X, Xu H, et al
    A Follow-up Study of Recovered Patients with COVID-19 in Wuhan, China.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30426.
    >> Share

  1387. PAPAMICHALIS P, Papadogoulas A, Katsiafylloudis P, Skoura AL, et al
    Combination of thrombolytic and immunosuppressive therapy for coronavirus disease 2019: A case report.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30425.
    >> Share

  1388. BUONSENSO D, Cinicola B, Raffaelli F, Sollena P, et al
    Social consequences of COVID-19 in a low resource setting in Sierra Leone, West Africa.
    Int J Infect Dis. 2020 Jun 1. pii: S1201-9712(20)30411.
    >> Share

  1389. RUOCCO G, Feola M, Palazzuoli A
    Hypertension prevalence in human coronavirus disease: the role of ACE system in infection spread and severity.
    Int J Infect Dis. 2020;95:373-375.
    >> Share

  1390. WU D, Lu J, Liu Y, Zhang Z, et al
    Positive effects of COVID-19 control measures on influenza prevention.
    Int J Infect Dis. 2020;95:345-346.
    >> Share

    May 2020
  1391. LI P, Chen L, Liu Z, Pan J, et al
    Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19.
    Int J Infect Dis. 2020 May 31. pii: S1201-9712(20)30415.
    >> Share

  1392. ITAYA T, Furuse Y, Jindai K
    Does COVID-19 infection impact on the trend of seasonal influenza infection? 11 countries and regions, from 2014 to 2020.
    Int J Infect Dis. 2020 May 31. pii: S1201-9712(20)30395.
    >> Share

  1393. ALCOBA-FLOREZ J, Gonzalez-Montelongo R, Inigo-Campos A, de Artola DG, et al
    Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples.
    Int J Infect Dis. 2020 May 31. pii: S1201-9712(20)30406.
    >> Share

  1394. KANG CK, Han GC, Kim M, Kim G, et al
    Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity.
    Int J Infect Dis. 2020 May 31. pii: S1201-9712(20)30413.
    >> Share

  1395. DE MEYER S, Bojkova D, Cinatl J, Van Damme E, et al
    Lack of Antiviral Activity of Darunavir against SARS-CoV-2.
    Int J Infect Dis. 2020 May 29. pii: S1201-9712(20)30392.
    >> Share

  1396. MA S, Lai X, Chen Z, Tu S, et al
    Clinical Characteristics of Critically Ill Patients Co-infected with SARS-CoV-2 and the Influenza Virus in Wuhan, China.
    Int J Infect Dis. 2020 May 26. pii: S1201-9712(20)30375.
    >> Share

  1397. MIDDELBURG RA, Rosendaal FR
    COVID-19: how to make between-country comparisons.
    Int J Infect Dis. 2020 May 26. pii: S1201-9712(20)30373.
    >> Share

  1398. LIN YC, Cheng CY, Cheng-Pin C, Cheng SH, et al
    A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti-SARS-CoV-2 antibody response.
    Int J Infect Dis. 2020 May 26. pii: S1201-9712(20)30377.
    >> Share

  1399. RIVAS AL, Febles JL, Smith SD, Hoogesteijn AL, et al
    Early network properties of the COVID-19 pandemic - the Chinese scenario.
    Int J Infect Dis. 2020 May 26. pii: S1201-9712(20)30356.
    >> Share

  1400. JANG S, Rhee JY
    Three cases of treatment with Nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy.
    Int J Infect Dis. 2020 May 26. pii: S1201-9712(20)30379.
    >> Share

  1401. WANG Q, Hu Z
    Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification.
    Int J Infect Dis. 2020 May 26. pii: S1201-9712(20)30372.
    >> Share

  1402. WU D, Lu J, Cao L, Ma X, et al
    Positive effects of COVID-19 control measures on pneumonia prevention.
    Int J Infect Dis. 2020 May 26. pii: S1201-9712(20)30376.
    >> Share

  1403. OLUM R, Bongomin F
    Uganda's First 100 COVID-19 Cases: Trends and Lessons.
    Int J Infect Dis. 2020 May 25. pii: S1201-9712(20)30380.
    >> Share

  1404. EAASWARKHANTH M, Madhoun AA, Al-Mulla F
    Could the D614 G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality?
    Int J Infect Dis. 2020 May 25. pii: S1201-9712(20)30378.
    >> Share

  1405. ANDREA V, Gianluca F, Rodolfo P, Paolo T, et al
    Unheralded Lower Limb Threatening Ischemia in a COVID-19 Patient.
    Int J Infect Dis. 2020 May 21. pii: S1201-9712(20)30367.
    >> Share

  1406. BEARMAN G, Pryor R, Vokes R, Cooper K, et al
    Reflections on the COVID-19 Pandemic in the USA: Will We Better Prepared Next Time?
    Int J Infect Dis. 2020 May 20. pii: S1201-9712(20)30366.
    >> Share

  1407. ZENG F, Huang Y, Guo Y, Yin M, et al
    Association of inflammatory markers with the severity of COVID-19: a meta-analysis.
    Int J Infect Dis. 2020 May 18. pii: S1201-9712(20)30362.
    >> Share

  1408. MARAIS BJ, Sorrell TC
    Pathways to COVID-19 'community protection'.
    Int J Infect Dis. 2020 May 18. pii: S1201-9712(20)30365.
    >> Share

  1409. OVERHOFF D, Walter T, Gruettner J, Janssen S, et al
    Acute pulmonary embolism mimicking COVID - 19 pneumonia.
    Int J Infect Dis. 2020 May 18. pii: S1201-9712(20)30360.
    >> Share

  1410. ZUMLA A, Wang FS, Ippolito G, Petrosillo N, et al
    Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - achieving global consensus and visibility for cellular host-directed therapies.
    Int J Infect Dis. 2020 May 17. pii: S1201-9712(20)30347.
    >> Share

  1411. MACHIDA M, Nakamura I, Saito R, Nakaya T, et al
    Changes in implementation of personal protective measures by ordinary Japanese citizens: A longitudinal study from the early phase to the community transmission phase of the COVID-19 outbreak.
    Int J Infect Dis. 2020 May 17. pii: S1201-9712(20)30346.
    >> Share

  1412. QI L, Yang Y, Jiang D, Tu C, et al
    Factors associated with duration of viral shedding in adults with COVID-19 outside of Wuhan, China: A retrospective cohort study.
    Int J Infect Dis. 2020 May 17. pii: S1201-9712(20)30352.
    >> Share

  1413. HOEFER A, Pampaka D, Wagner ER, Herrera AA, et al
    Management of a COVID-19 outbreak in a Hotel in Tenerife, Spain.
    Int J Infect Dis. 2020 May 17. pii: S1201-9712(20)30354.
    >> Share

  1414. XIA Y, Hong H, Feng Y, Liu M, et al
    Dynamics of antibodies to SARS-CoV-2 in a case with SARS-CoV-2 infection.
    Int J Infect Dis. 2020 May 17. pii: S1201-9712(20)30349.
    >> Share

  1415. ZHAO N, Liu Y, Smaragiassi A, Bernatsky S, et al
    Tracking the origin of early COVID-19 cases in Canada.
    Int J Infect Dis. 2020 May 17. pii: S1201-9712(20)30353.
    >> Share

  1416. HU B, Qiu J, Chen H, Tao V, et al
    First, second and potential third generation spreads of the COVID-19 epidemic in mainland China: an early exploratory study incorporating location-based service data of mobile devices.
    Int J Infect Dis. 2020 May 17. pii: S1201-9712(20)30355.
    >> Share

  1417. RAINISCH G, Undurraga EA, Chowell G
    A dynamic modeling tool for estimating healthcare demand from the COVID19 epidemic and evaluating population-wide interventions.
    Int J Infect Dis. 2020 May 16. pii: S1201-9712(20)30350.
    >> Share

  1418. FRANZETTI M, Pozzetti U, Carugati M, Pandolfo A, et al
    Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe Coronavirus disease 2019: A case report.
    Int J Infect Dis. 2020 May 15. pii: S1201-9712(20)30357.
    >> Share

  1419. CHONG KC, Cheng W, Zhao S, Ling F, et al
    Monitoring disease transmissibility of 2019 novel coronavirus disease in Zhejiang, China.
    Int J Infect Dis. 2020;96:128-130.
    >> Share

  1420. CALDERARO A, Arcangeletti MC, De Conto F, Buttrini M, et al
    SARS-CoV-2 infection diagnosed only by cell culture isolation before the local outbreak in an Italian seven-week-old suckling baby.
    Int J Infect Dis. 2020 May 14. pii: S1201-9712(20)30342.
    >> Share

  1421. LEE H, Park SJ, Lee GR, Kim JE, et al
    The Relationship between the COVID-19 Prevalence Trend and Transportation Trend in South Korea.
    Int J Infect Dis. 2020 May 14. pii: S1201-9712(20)30339.
    >> Share

  1422. KIM S, Jeong YD, Byun JH, Cho G, et al
    Evaluation of COVID-19 epidemic outbreak caused by temporal contact-increase in South Korea.
    Int J Infect Dis. 2020 May 14. pii: S1201-9712(20)30343.
    >> Share

  1423. WORKMAN J
    Proportion of COVID-19 Cases that Are Asymptomatic in South Korea: Comment on Nishiura et al.
    Int J Infect Dis. 2020 May 14. pii: S1201-9712(20)30344.
    >> Share

  1424. KOWALSKA JD, Skrzat-Klapaczynska A, Bursa D, Balayan T, et al
    HIV care in times of the COVID-19 crisis - where are we now in Central and Eastern Europe?
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30319.
    >> Share

  1425. MBOERA LEG, Akipede GO, Banerjee A, Cuevas LE, et al
    Mitigating lockdown challenges in the response to COVID-19 in Sub-Saharan Africa.
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30325.
    >> Share

  1426. FAN H, Zhang L, Huang B, Zhu M, et al
    Cardiac injuries in patients with coronavirus disease 2019: Not to be ignored.
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30331.
    >> Share

  1427. FILOCAMO G, Mangioni D, Tagliabue P, Aliberti S, et al
    Use of anakinra in severe COVID-19: a case report.
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30333.
    >> Share

  1428. ZHOU R, Li F, Chen F, Liu H, et al
    Viral dynamics in asymptomatic patients with COVID-19.
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30337.
    >> Share

  1429. GUALANO G, Musso M, Mosti S, Mencarini P, et al
    Usefulness of bronchoalveolar lavage in the management of patients presenting with lung infiltrates and suspect COVID-19-associated pneumonia: A case report.
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30334.
    >> Share

  1430. SOARES F, Yamashita GH
    On the crucial role of multilingual biomedical databases on epidemic events (SARS-CoV-2 analysis).
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30330.
    >> Share

  1431. CHINTALAPUDI N, Battineni G, Sagaro GG, Amenta F, et al
    COVID-19 outbreak reproduction number estimations and forecasting in Marche, Italy.
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30336.
    >> Share

  1432. BELDOMENICO PM
    Do superspreaders generate new superspreaders? a hypothesis to explain the propagation pattern of COVID-19.
    Int J Infect Dis. 2020 May 10. pii: S1201-9712(20)30332.
    >> Share

  1433. RAN J, Zhao S, Zhuang Z, Chong MK, et al
    Quantifying the improvement in confirmation efficiency of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the early phase of outbreak in Hong Kong in 2020.
    Int J Infect Dis. 2020 May 8. pii: S1201-9712(20)30321.
    >> Share

  1434. BORGHESI A, Zigliani A, Golemi S, Carapella N, et al
    Chest X-ray severity index as a predictor of in-hospital mortality in coronavirus disease 2019: A study of 302 patients from Italy.
    Int J Infect Dis. 2020 May 8. pii: S1201-9712(20)30328.
    >> Share

  1435. PUTRA BE, Adiarto S, Dewayanti SR, Juzar DA, et al
    Viral Exanthem with "Pin and Needles Sensation" on Extremities of COVID-19 Patient.
    Int J Infect Dis. 2020 May 8. pii: S1201-9712(20)30327.
    >> Share

  1436. SO MKP, Tiwari A, Chu AMY, Tsang JTY, et al
    Visualising COVID-19 Pandemic Risk through Network Connectedness.
    Int J Infect Dis. 2020 May 8. pii: S1201-9712(20)30317.
    >> Share

  1437. SHANG Y, Xu C, Jiang F, Huang R, et al
    Clinical characteristics and changes of chest CT features in 307 patients with common COVID-19 pneumonia infected SARS-CoV-2: A multicenter study in Jiangsu, China.
    Int J Infect Dis. 2020;96:157-162.
    >> Share

  1438. SHEN M, Peng Z, Guo Y, Rong L, et al
    Assessing the Effects of Metropolitan-Wide Quarantine on the Spread of COVID-19 in Public Space and Households.
    Int J Infect Dis. 2020 May 8. pii: S1201-9712(20)30326.
    >> Share

  1439. ABBARA A, Rayes D, Fahham O, Alhiraki OA, et al
    Coronavirus 2019 and health systems affected by protracted conflict: The case of Syria.
    Int J Infect Dis. 2020;96:192-195.
    >> Share

  1440. GALLINA P, Ricci M
    Covid-19 health crisis management in Europe: decisive assessment is needed now.
    Int J Infect Dis. 2020 May 7. pii: S1201-9712(20)30316.
    >> Share

  1441. QUADRI SA
    COVID-19 and religious congregations: Implications for spread of novel pathogens.
    Int J Infect Dis. 2020;96:219-221.
    >> Share

  1442. LI Y, Wang J, Wang C, Yang Q, et al
    Characteristics of respiratory virus infection during the outbreak of 2019 novel coronavirus in Beijing.
    Int J Infect Dis. 2020 May 7. pii: S1201-9712(20)30314.
    >> Share

  1443. ZHOU MY, Xie XL, Peng YG, Wu MJ, et al
    From SARS to COVID-19: What we have learned about children infected with COVID-19.
    Int J Infect Dis. 2020 May 7. pii: S1201-9712(20)30309.
    >> Share

  1444. GIRAUD-GATINEAU A, Colson P, Jimeno MT, Zandotti C, et al
    Comparison of mortality associated with respiratory viral infections between December 2019 and March 2020 with that of the previous year in Southeastern France.
    Int J Infect Dis. 2020;96:154-156.
    >> Share

  1445. SHETE A
    Urgent need for evaluating agonists of Angiotensin-(1-7)/ Mas receptor axis for treatment of patients with COVID-19.
    Int J Infect Dis. 2020 May 7. pii: S1201-9712(20)30307.
    >> Share

  1446. OMORI R, Mizumoto K, Nishiura H
    Ascertainment rate of novel coronavirus disease (COVID-19) in Japan.
    Int J Infect Dis. 2020 May 7. pii: S1201-9712(20)30292.
    >> Share

  1447. KIM SE, Jeong HS, Yu Y, Shin SU, et al
    Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients.
    Int J Infect Dis. 2020 May 3. pii: S1201-9712(20)30299.
    >> Share

  1448. ZHAO Q, Meng M, Kumar R, Wu Y, et al
    Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis.
    Int J Infect Dis. 2020 May 3. pii: S1201-9712(20)30301.
    >> Share

  1449. SHEN CY
    A logistic growth model for COVID-19 proliferation: experiences from China and international implications in infectious diseases.
    Int J Infect Dis. 2020 May 3. pii: S1201-9712(20)30303.
    >> Share

  1450. LUO Y, Yuan X, Xue Y, Mao L, et al
    Using the diagnostic model based on routine laboratory tests to distinguish patients infected with SARS-CoV-2 from those infected with influenza virus.
    Int J Infect Dis. 2020 May 1. pii: S1201-9712(20)30295.
    >> Share

  1451. WANG X, Tan L, Wang X, Liu W, et al
    Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously.
    Int J Infect Dis. 2020;94:107-109.
    >> Share

  1452. HE D, Zhao S, Lin Q, Zhuang Z, et al
    The relative transmissibility of asymptomatic COVID-19 infections among close contacts.
    Int J Infect Dis. 2020;94:145-147.
    >> Share

  1453. WANG J, Feng H, Zhang S, Ni Z, et al
    SARS-CoV-2 RNA detection of hospital isolation wards hygiene monitoring during the Coronavirus Disease 2019 outbreak in a Chinese hospital.
    Int J Infect Dis. 2020;94:103-106.
    >> Share

  1454. MACHIDA M, Nakamura I, Saito R, Nakaya T, et al
    Adoption of personal protective measures by ordinary citizens during the COVID-19 outbreak in Japan.
    Int J Infect Dis. 2020;94:139-144.
    >> Share

  1455. YE F, Xu S, Rong Z, Xu R, et al
    Delivery of infection from asymptomatic carriers of COVID-19 in a familial cluster.
    Int J Infect Dis. 2020;94:133-138.
    >> Share

  1456. XIE M, Chen Q
    Insight into 2019 novel coronavirus - An updated interim review and lessons from SARS-CoV and MERS-CoV.
    Int J Infect Dis. 2020;94:119-124.
    >> Share

    April 2020
  1457. AHMADI A, Kheiril S, Mohammadian-Hafshejani A, Raeisi H, et al
    The accuracy of "Preliminary estimation of the novel coronavirus disease (COVID-19) cases in Iran: A modelling analysis based on overseas cases and air travel data".
    Int J Infect Dis. 2020 Apr 30. pii: S1201-9712(20)30287.
    >> Share

  1458. GU Y, Lu J, Yang Z
    Pilgrimage and COVID-19: the risk among returnees from Muslim countries.
    Int J Infect Dis. 2020 Apr 30. pii: S1201-9712(20)30282.
    >> Share

  1459. OCHOA YC, Sanchez DER, Penaloza M, Motta HFC, et al
    Effective Reproductive Number estimation for initial stage of COVID-19 pandemic in Latin American Countries.
    Int J Infect Dis. 2020 Apr 30. pii: S1201-9712(20)30285.
    >> Share

  1460. ZHUANG Z, Zhao S, Lin Q, Cao P, et al
    Preliminary estimation of the novel coronavirus disease (COVID-19) cases in Iran: A reply to Sharifi.
    Int J Infect Dis. 2020 Apr 30. pii: S1201-9712(20)30289.
    >> Share

  1461. UJIIE M, Tsuzuki S, Ohmagari N
    Effect of temperature on the infectivity of COVID-19.
    Int J Infect Dis. 2020 Apr 30. pii: S1201-9712(20)30284.
    >> Share

  1462. MUBARAK N
    Corona and Clergy: The missing link for an effective social distancing in Pakistan. Time for some unpopular decisions.
    Int J Infect Dis. 2020 Apr 30. pii: S1201-9712(20)30283.
    >> Share

  1463. PETERSEN E, Wasserman S, Lee SS, Go U, et al
    COVID-19-We urgently need to start developing an exit strategy.
    Int J Infect Dis. 2020 Apr 28. pii: S1201-9712(20)30251.
    >> Share

  1464. QIANCHENG X, Jian S, Lingling P, Lei H, et al
    Coronavirus disease 2019 in pregnancy.
    Int J Infect Dis. 2020 Apr 27. pii: S1201-9712(20)30280.
    >> Share

  1465. OHIA C, Bakarey AS, Ahmad T
    COVID-19 and Nigeria: Putting the realities in context.
    Int J Infect Dis. 2020 Apr 27. pii: S1201-9712(20)30281.
    >> Share

  1466. WANG X, Zhou Y, Jiang N, Zhou Q, et al
    Persistence of intestinal SARS-CoV-2 infection in patients with COVID-19 leads to re-admission after pneumonia resolved.
    Int J Infect Dis. 2020 Apr 27. pii: S1201-9712(20)30279.
    >> Share

  1467. CHANDA-KAPATA P, Kapata N, Zumla A
    COVID-19 and malaria: A symptom screening challenge for malaria endemic countries.
    Int J Infect Dis. 2020;94:151-153.
    >> Share

  1468. VELAVAN TP, Meyer CG
    Mild versus severe COVID-19: laboratory markers.
    Int J Infect Dis. 2020 Apr 25. pii: S1201-9712(20)30277.
    >> Share

  1469. MI YN, Huang TT, Zhang JX, Qin Q, et al
    Estimating instant case fatality rate of COVID-19 in China.
    Int J Infect Dis. 2020 Apr 24. pii: S1201-9712(20)30271.
    >> Share

  1470. SCIALPI M, Scialp S, Piscioli I, Scalera G, et al
    Pulmonary thromboembolism in criticall ill COVID-19 patients.
    Int J Infect Dis. 2020 Apr 24. pii: S1201-9712(20)30272.
    >> Share

  1471. WANG P, Lu JA, Jin Y, Zhu M, et al
    Statistical and network analysis of 1212 COVID-19 patients in Henan, China.
    Int J Infect Dis. 2020 Apr 24. pii: S1201-9712(20)30267.
    >> Share

  1472. AMIRIAN ES
    Potential Fecal Transmission of SARS-CoV-2: Current Evidence and Implications for Public Health.
    Int J Infect Dis. 2020 Apr 23. pii: S1201-9712(20)30273.
    >> Share

  1473. WANG M, Luo L, Bu H, Xia H, et al
    Case Report: One Case of Coronavirus Desease 2019(COVID-19) in Patient Co-nfected by HIV With a Low CD4+ T Cell Count.
    Int J Infect Dis. 2020 Apr 23. pii: S1201-9712(20)30276.
    >> Share

  1474. CAO D, Yin H, Chen J, Tang F, et al
    Clinical analysis of ten pregnant women with COVID-19 in Wuhan, China: A retrospective study.
    Int J Infect Dis. 2020 Apr 23. pii: S1201-9712(20)30263.
    >> Share

  1475. DOUGLAS D, Douglas R
    Addressing the corona virus outbreak: will a novel filtered eye mask help?
    Int J Infect Dis. 2020 Apr 22. pii: S1201-9712(20)30255.
    >> Share

  1476. ZHU Z, Cai T, Fan L, Lou K, et al
    Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019.
    Int J Infect Dis. 2020 Apr 22. pii: S1201-9712(20)30257.
    >> Share

  1477. HU Z, Cui Q, Han J, Wang X, et al
    Evaluation and prediction of the COVID-19 variations at different input population and quarantine strategies, a case study in Guangdong province, China.
    Int J Infect Dis. 2020 Apr 22. pii: S1201-9712(20)30226.
    >> Share

  1478. HINJOY S, RoyceTsukayama, Chuxnum T, Masunglong W, et al
    A self-assessment of the Thai Department of Disease Control's communication for international response at early phase to the COVID-19.
    Int J Infect Dis. 2020 Apr 22. pii: S1201-9712(20)30258.
    >> Share

  1479. ZHUANG Z, Zhao S, Lin Q, Cao P, et al
    Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020.
    Int J Infect Dis. 2020 Apr 22. pii: S1201-9712(20)30259.
    >> Share

  1480. DU W, Han S, Li Q, Zhang Z, et al
    Epidemic update of COVID-19 in Hubei Province compared with other regions in China.
    Int J Infect Dis. 2020 Apr 20. pii: S1201-9712(20)30246.
    >> Share

  1481. OMORI R, Mizumoto K, Chowell G
    Changes in testing rates could mask the novel coronavirus disease (COVID-19) growth rate.
    Int J Infect Dis. 2020;94:116-118.
    >> Share

  1482. EFFENBERGER M, Kronbichler A, Shin JI, Mayer G, et al
    Association of the COVID-19 pandemic with Internet Search Volumes: A Google Trends(TM) Analysis.
    Int J Infect Dis. 2020 Apr 16. pii: S1201-9712(20)30249.
    >> Share

  1483. PETERSEN E, McCloskey B, Hui DS, Kock R, et al
    COVID-19 travel restrictions and the International Health Regulations - call for an open debate on easing of travel restrictions.
    Int J Infect Dis. 2020 Apr 16. pii: S1201-9712(20)30245.
    >> Share

  1484. SEE KC, Liew SM, Ng DCE, Chew EL, et al
    COVID-19: Four Paediatric Cases in Malaysia.
    Int J Infect Dis. 2020 Apr 15. pii: S1201-9712(20)30181.
    >> Share

  1485. WANG R, Pan M, Zhang X, Fan X, et al
    Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China.
    Int J Infect Dis. 2020 Apr 11. pii: S1201-9712(20)30203.
    >> Share

  1486. KENYON C
    The serostatus approach to fighting COVID-19.
    Int J Infect Dis. 2020 Apr 7. pii: S1201-9712(20)30213.
    >> Share

  1487. DAI H, Zhang X, Xia J, Zhang T, et al
    High-resolution Chest CT Features and Clinical Characteristics of Patients Infected with COVID-19 in Jiangsu, China.
    Int J Infect Dis. 2020 Apr 6. pii: S1201-9712(20)30218.
    >> Share

  1488. LI X, Wang L, Yan S, Yang F, et al
    Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China.
    Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30186.
    >> Share

  1489. JIN Y, Wang M, Zuo Z, Fan C, et al
    Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019.
    Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30198.
    >> Share

  1490. MAO ZQ, Wan R, He LY, Hu YC, et al
    The enlightenment from two cases of asymptomatic infection with SARS-CoV-2: is it safe after 14 days of isolation?
    Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30173.
    >> Share

  1491. HONG X, Xiong J, Feng Z, Shi Y, et al
    Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19?
    Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30191.
    >> Share

  1492. MORIGUCHI T, Harii N, Goto J, Harada D, et al
    A first Case of Meningitis/Encephalitis associated with SARS-Coronavirus-2.
    Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30195.
    >> Share

  1493. LAW S, Leung AW, Xu C
    Severe Acute Respiratory Syndrome (SARS) and Coronavirus disease-2019 (COVID-19): From Causes to Preventions in Hong Kong.
    Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30192.
    >> Share

  1494. KANG D, Choi H, Kim JH, Choi J, et al
    Spatial epidemic dynamics of the COVID-19 outbreak in China.
    Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30209.
    >> Share

    March 2020
  1495. YUAN J, Li M, Lv G, Lu ZK, et al
    Monitoring Transmissibility and Mortality of COVID-19 in Europe.
    Int J Infect Dis. 2020 Mar 28. pii: S1201-9712(20)30182.
    >> Share

  1496. ZHENG C, Wang J, Guo H, Lu Z, et al
    Risk-adapted Treatment Strategy For COVID-19 Patients.
    Int J Infect Dis. 2020 Mar 27. pii: S1201-9712(20)30179.
    >> Share

  1497. ZHANG X, Cai H, Hu J, Lian J, et al
    Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings.
    Int J Infect Dis. 2020 Mar 20. pii: S1201-9712(20)30172.
    >> Share

  1498. ZHANG JF, Yan K, Ye HH, Lin J, et al
    SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern regarding the present standard for discharge.
    Int J Infect Dis. 2020 Mar 18. pii: S1201-9712(20)30126.
    >> Share

  1499. SHIM E, Tariq A, Choi W, Lee Y, et al
    Transmission potential and severity of COVID-19 in South Korea.
    Int J Infect Dis. 2020 Mar 17. pii: S1201-9712(20)30150.
    >> Share

  1500. LI P, Fu JB, Li KF, Chen Y, et al
    Transmission of COVID-19 in the terminal stage of incubation period: a familial cluster.
    Int J Infect Dis. 2020 Mar 16. pii: S1201-9712(20)30146.
    >> Share

  1501. MENDELSON M
    Could enhanced influenza and pneumococcal vaccination programs help limit the potential damage from SARS-CoV-2 to fragile health systems of southern hemisphere countries this winter?
    Int J Infect Dis. 2020 Mar 16. pii: S1201-9712(20)30149.
    >> Share

  1502. XU T, Chen C, Zhu Z, Cui M, et al
    Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19.
    Int J Infect Dis. 2020 Mar 13. pii: S1201-9712(20)30141.
    >> Share

  1503. NISHIURA H, Kobayashi T, Suzuki A, Jung SM, et al
    Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19).
    Int J Infect Dis. 2020 Mar 13. pii: S1201-9712(20)30139.
    >> Share

  1504. LIU F, Xu A, Zhang Y, Xuan W, et al
    Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression.
    Int J Infect Dis. 2020 Mar 12. pii: S1201-9712(20)30132.
    >> Share

  1505. YANG J, Zheng Y, Gou X, Pu K, et al
    Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis.
    Int J Infect Dis. 2020 Mar 12. pii: S1201-9712(20)30136.
    >> Share

  1506. HUSNAYAIN A, Fuad A, Su EC
    Applications of google search trends for risk communication in infectious disease management: A case study of COVID-19 outbreak in Taiwan.
    Int J Infect Dis. 2020 Mar 12. pii: S1201-9712(20)30140.
    >> Share

  1507. WU D, Wu T, Liu Q, Yang Z, et al
    The SARS-CoV-2 outbreak: what we know.
    Int J Infect Dis. 2020 Mar 11. pii: S1201-9712(20)30123.
    >> Share

  1508. ZHUANG Z, Zhao S, Lin Q, Cao P, et al
    Preliminary estimation of the novel coronavirus disease (COVID-19) cases in Iran: A modelling analysis based on overseas cases and air travel data.
    Int J Infect Dis. 2020 Mar 11. pii: S1201-9712(20)30138.
    >> Share

  1509. TANG B, Xia F, Tang S, Bragazzi NL, et al
    The effectiveness of quarantine and isolation determine the trend of the COVID-19 epidemics in the final phase of the current outbreak in China.
    Int J Infect Dis. 2020 Mar 11. pii: S1201-9712(20)30137.
    >> Share

  1510. CHEN D, Xu W, Lei Z, Huang Z, et al
    Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report.
    Int J Infect Dis. 2020 Mar 5. pii: S1201-9712(20)30122.
    >> Share

  1511. NISHIURA H, Linton NM, Akhmetzhanov AR
    Serial interval of novel coronavirus (COVID-19) infections.
    Int J Infect Dis. 2020 Mar 4. pii: S1201-9712(20)30119.
    >> Share

  1512. LIN Q, Zhao S, Gao D, Lou Y, et al
    A conceptual model for the outbreak of Coronavirus disease 2019 (COVID-19) in Wuhan, China with individual reaction and governmental action.
    Int J Infect Dis. 2020 Mar 4. pii: S1201-9712(20)30117.
    >> Share

  1513. PETERSEN E, Hui D, Hamer DH, Blumberg L, et al
    Li Wenliang, a face to the frontline healthcare worker? The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak.
    Int J Infect Dis. 2020 Mar 3. pii: S1201-9712(20)30111.
    >> Share

    February 2020
  1514. KAPATA N, Ihekweazu C, Ntoumi F, Tajudeen R, et al
    Is the Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic? - lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future.
    Int J Infect Dis. 2020 Feb 28. pii: S1201-9712(20)30107.
    >> Share

  1515. XIE C, Jiang L, Huang G, Pu H, et al
    Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests.
    Int J Infect Dis. 2020 Feb 27. pii: S1201-9712(20)30108.
    >> Share

  1516. ALBARELLO F, Pianura E, Di Stefano F, Cristofaro M, et al
    2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation.
    Int J Infect Dis. 2020 Feb 26. pii: S1201-9712(20)30101.
    >> Share

  1517. ZHANG S, Diao M, Yu W, Pei L, et al
    Estimation of the reproductive number of Novel Coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis.
    Int J Infect Dis. 2020 Feb 22. pii: S1201-9712(20)30091.
    >> Share

  1518. ZHAO S, Lin Q, Ran J, Musa SS, et al
    The basic reproduction number of novel coronavirus (2019-nCoV) estimation based on exponential growth in the early outbreak in China from 2019 to 2020: A reply to Dhungana.
    Int J Infect Dis. 2020 Feb 20. pii: S1201-9712(20)30083.
    >> Share

  1519. DHUNGANA HN
    Comments on "Preliminary estimation of the basic reproduction number of novel Coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven Analysis in the early phase of the outbreak".
    Int J Infect Dis. 2020 Feb 20. pii: S1201-9712(20)30082.
    >> Share

  1520. HUI DS, I Azhar E, Madani TA, Ntoumi F, et al
    The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China.
    Int J Infect Dis. 2020;91:264-266.
    >> Share

    January 2020
  1521. ZHAO S, Lin Q, Ran J, Musa SS, et al
    Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak.
    Int J Infect Dis. 2020 Jan 30. pii: S1201-9712(20)30053.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016